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Abstract 
THE CONTROL OF HUMAN CYTOMEGALOVIRUS LATENT AND LYTIC 
GENE EXPRESSION BY CHROMATIN REMODELLING 
It is now well established that the differentiation-dependent control of human 
cytomegalovirus (HCMV) latent infection is regulated by the association of chromatin 
around the major immediate early promoter (MIEP). However, whether chromatin-
mediated regulation of viral immediate early (IE) gene expression also occurs during a 
productive infection is not known. Consequently, the role of chromatin structure on viral 
gene expression during HCMV infection of a permissive cell type was investigated. 
Experiments demonstrated that the MIEP was, indeed, associated with chromatin 
throughout infection and was subject to modification consistent with the known temporal 
transcription of IE genes. However, immediately upon infection, the MIEP was associated 
with a repressed chromatin structure. This repression was relieved through use of the 
histone deacetylase (HDAC) inhibitor Trichostatin-A (TSA), confirming that the regulation 
of IE gene expression at this time was mediated by an inhibitory chromatin structure. 
Furthermore, down-regulation of the ND 10-associated transcriptional repressor, hDaxx, 
which is known to interact with HDACs, led to similar relief from repression. Further 
analysis of promoters of prototypic viral early and late genes, UL44 and pp28 respectively, 
also revealed that all classes of viral genes are subject to chromatin-mediated regulation 
throughout productive infection, consistent with their known transcription profile. 
Although differentiation-dependent regulation of MIEP activity underpins viral latency and 
reactivation, down-regulation of the intrinsic anti-viral repressor hDaxx in in vitro latent 
model systems did not permit reactivation of IE gene expression. Consequently, in contrast 
to lytic viral infection, repression of IE gene expression by hDaxx does not appear to be 
involved in regulation of viral latency and reactivation. 
In conclusion, immediately upon infection of permissive cells, intrinsic repress10n of 
HCMV IE gene transcription occurs through the establishment of an inhibitory chromatin 
structure around the MIEP, mediated by hDaxx and HDACs. This repression is overcome 
by viral factors before full productive infection can begin. Full lytic infection then involves 
regulation of viral gene expression through remodelling of chromatin structure at all 
classes of HCMV promoters. 
Ian Groves 
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1. Introduction 
1.1 The Herpesviridae 
The Herpesviridae are a numerous family of widely distributed large DNA viruses that 
naturally infect humans, other mammals and invertebrates (Minson et al., 2000). 
Characteristics of herpesviruses include the self-provision of enzymes involved in nucleic 
acid metabolism, DNA synthesis and protein production; the synthesis of viral DNA and 
capsid assembly in the nucleus, whilst the final virion is produced in the cytoplasm; and 
production of infectious progeny virus, usually concomitant with destruction of the 
infected cell (Pellett & Roizman, 2007). However, the hallmark of the Herpesviridae 
lifecycle is latency whereby, after primary infection, the viral genome is able to persist in 
the absence of virus production. 
Membership of the family Herpesviridae has historically been based on the architecture of 
the virion. However, formal taxonomy of the herpesviruses has been addressed since 1971 
by the International Committee on Taxonomy of Viruses (ICTV; Wildy, 1971). A 
provisional approach to formally name herpesviruses was begun thereafter (Roizman et al., 
1973) and was followed with classification of the family into three subfamilies: Alpha-, 
Beta- and Gammaherpesvirinae, initially on the basis of biological characteristics 
(Roizman et al., 1981 ). Further division into genera was then carried out using more 
precise genomic analysis (Roizman et al., 1992) as well as through extensive molecular 
phylogenetic analysis, which included studies of size, genome structure and sequence 
comparisons (McGeoch et al., 2000). Herpesvirus subfamilies have been further 
segregated into ~everal genera (Davison et al., 2005; see Fig. 1.1 ). 
Over two hundred herpesviruses have now been classified into these three subfamilies, 
with an additional genus (Jctalurivirus) not attached to any subfamily and a large number 
still not assigned to specific genera (Davison, 2007). As outlined above, the Herpesviridae 
infect a range of species with all but one of the viruses assigned to taxa infecting either 
mammals or birds. In addition, a large number of unassigned herpesviruses infect lower 
vertebrate (fish, reptiles and amphibians) and invertebrate (bivalve) hosts (Davison, 2007). 
However, due to the extensive nucleotide sequence data from an increasing number of 
. these divergent genera, a revision has been recently proposed by the Herpesvirus Study 
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Group of the ICTV: the entire taxon of herpesviruses is redefined under a new order, 
Herpesvirales (see Fig. 1.1). The Herpesvirales will then be split into three virus families: 
the Alloherpesviridae (fish and amphibians); the Malacoherpesviridae (bivalves); and the 
Herpesviridae, encompassing the herpesviruses of mammals, birds and reptiles as already 
recognised (reviewed in: McGeoch et al., 2006). 
1.2 The Herpesviridae subfamilies 
As explained above, the members of the Herpesviridae were initially classified on the basis 
of their biological characteristics and they were further subdivided into subfamilies: the 
Alpha-, Beta- and Gammaherpesvirinae. 
1. 2.1 The Alphaherpesvirinae 
The Alphaherpesvirinae share distinguishing qualities such as variable host range, short 
reproductive cycle, rapid spread in in vitro culture, efficient destruction of the infected 
cells and the ability to establish latency primarily within sensory ganglia. Main examples 
include Herpes Simplex virus-I and -2 (HSV-1 & -2) from the Simplexviruses, which are 
the major causes of oral and genital herpes respectively and Varicella-Zoster virus (VZV), 
the cause of chicken-pox and shingles, from the Varicelloviruses. Both have mammalian 
hosts, whilst avian and reptilian hosts exist for the other members of the subfamily (see 
Fig. 1.1 ). 
1.2.2 The Betaherpesvirinae 
The Betaherpesvirinae subfamily is distinguished from others in the family by a long 
reproductive cycle and a slow infection rate in cell culture. Furthermore, the 
betaherpesviruses have a restricted host range, although this is not specific to the 
subfamily. A common biological characteristic is an enlargement of the infected cell 
(cytomegalia) and this feature is exemplified by the prototypic genus Cytomegalovirus. 
Other genera within the subfamily are Muromegalovirus, which includes murine 
cytomegalovirus (MCMV), and Roseolovirus, represented in the . human host by human 
herpesvirus-6 (HHV -6) and which has been expanded to include the betaherpesviruses of 
mandrils and chimpanzees. The proposed Proboscivirus genus also includes those of large 
mammals such as endotheliotropic elephant herpesvirus-1 (ElHV-1 ). Across the range of 
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Order Family Subfamily Genus Host 
a unnamed Reptiles 
Jltovirus Birds 
Mardivirus Birds 
Varicellovirus Mammals 
Simplexvirus Mammals 
Herpesviridae 
Cytomegalovirus Mammals 
Muromegalovirus Mammals 
Roseolovirus Mammals 
Proboscivirus Mammals 
y Lymphocryptovirus Mammals 
(Herpesvirales) Macavirus Mammals 
Percavirus Mammals 
Rhadinovirus Mammals 
(Alloherpesviridae) 
Fish and amphibians (Malacoherpesviridae) 
Oysters 
Figure 1.1 The Herpesviridae - major herpesvirus phylogenetic relationships and taxonomic subunits. 
The schematic shows branching patterns of all the assigned subfamilies and genera within the 
herpesviridae, including an unnamed genus with reptilian host species. In addition to the above scheme 
there is a further genus (Jctalurivirus) that remains unattached to any subfamily and a number of species 
that are not assigned to any genera (Davison & Bhella, 2007). Furthermore, labels shown in brackets are 
those from the proposed incorporation of the entire taxon into the order Herpesvirales. (Adapted from 
Fields Virology Fifth Ed.). 
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viruses within this subfamily, the virus can be maintained in latent form m kidneys, 
secretary glands and lymphoreticular glands amongst other tissues. 
1.2.3 The Gammaherpesvirinae 
Viruses of the Gammaherpesvirinae are usually specific for either T or B lymphocytes, 
although in vitro all members are able to replicate in lymphoblastoid cells (immature 
leukocytes) with some causing lytic infections in some types of epitheloid and fibroblastic 
cells. Latent virus is also often found in lymphoid tissue. The gammaherpesviruses are 
composed of two genera: the Lymphocryptovirus, includes the prototypic 
gammaherpesvirus Epstein-Barr virus (EBV) and the Rhadinovirus genus, exemplified by 
human herpesvirus-8 (HHV-8). Further, it has been proposed that the Rhadinovirus genus 
be expanded to include two new genera: the Macavirus genus infecting ruminants and the 
Percavirus genus hosted by perissodactyl (hoofed) and carnivore species (McGeoch et al., 
2006). 
1.3 The Human Herpesviruses (HHVs) 
Since herpesviruses are so highly disseminated in nature, it is not surprising that amongst 
mammalian species infected is the human. To date, there are eight main examples of 
herpesviruses known to infect the human host (with HHV-6 having two variants, A and B), 
representing all the major lineages populated by mammalian viruses (McGeoch & 
Davison, 1999). Indeed, the major human herpesviruses constitute the prototypic examples 
of each of the subfamily groups (see Table 1.1) and show a range of pathogenicity from 
oral and genital lesions (HSV-1 & -2), chickenpox and shingles (VZV) to cancer, such as 
Burkitt' s lymphoma/nasopharyngeal carcmoma (EBV) and Kaposi ' s sarcoma 
(KSHV /HHV-8)" However, some HHV s only show subclinical symptoms upon infection 
in the immunocompetent host, including HHV-6, -7 and the largest known human 
herpesvirus human cytomegalovirus (HCMV /HHV-5). , 
1.4 Human Cytomegalovirus (HCMV) 
1. 4. 1 Introduction 
Human Cytomegalovirus (HCMV), as the prototypic member of the Betaherpesvirinae, 
shares a number of the characteristics of this subfamily. These include salivary gland 
tropism, strict species specificity (which has hindered the establishment of animal models 
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Designation 
HHV-1 
HHV-2 
HHV-3 
HHV-4 
HHV-5 
HHV-6A 
HHV-6B 
HHV-7 
HHV-8 
s Simplexvirus 
v Varicellovirus 
L Lymphocryptovirus 
c Cytomegalovirus 
Ro Roseolovirus 
Rh Rhadinovirus 
Common name 
Herpes simplex 
virus type 1 
Herpes simplex 
virus type 2 
Varicella-zoster 
virus 
Epstein-Barr virus 
Human 
cytomegalovirus 
Human 
herpesvirus 6A 
Human 
herpesvirus 6B 
Human 
herpesvirus 7 
Kaposi 's 
sarcoma-
assoc iated herpes 
virus 
* Genome size range reflects different strains. 
Abbreviation Subfamily Genome size Sites of latency (kbp)* 
HSV-1 as 152 Neurones (sensory ganglia) 
HSV-2 as 155 Neurones (sensory ganglia) 
vzv aV 125 Neurones (sensory ganglia) 
EBY yL 172 B lymphocytes 
HCMV ~c 230/236 Blood monocytes 
Monocytes, HHV-6A ~Ro 159/170 
T lymphocytes 
HHV-6B ~Ro 162/168 Monocytes, 
T lymphocytes 
HHV-7 ~Ro 145 Unknown 
KSHV yRh 170/210 B lymphocytes 
Table 1.1 The Human Herpesviruses - classification and associated medical conditions. 
Major associated diseases 
Oral and genital herpes 
Genital and oral herpes 
Varicella (chickenpox) 
and zoster (shingles) 
Burkitt's lymphoma, 
Hodgkin disease and 
nasopharyngeal carcinoma 
Subclinical symptoms and 
congenital illness 
Exanthem subitum 
(roseola) and febrile 
illnesses 
Similar clinical symptoms 
to HHV-6A 
Subclinical symptoms 
Kaposi's sarcoma, 
Castleman's Disease, oral 
and genital lesions 
...... 
~ 
~ 
0 
~ 
~ 
...... 5· 
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for research purposes) and slow growth in cultured cells in vitro (Ho, 1991 a; Ho, 2007; 
Mocarski et al., 2007). The etiological appearance of HCMV infected cells was first 
formally described in the 1950s with cells typically demonstrating an enlarged cytomegalic 
appearance and the presence of intracellular inclusion bodies (Plummer, 1973; Roizman et 
al., 1981; Rowe et al., 1956; Smith, 1956; Weller et al., 1957), although these had been 
described as early as 1881 without the knowledge of the associated agent (Ribbert, 1904). 
Indeed, HCMV was first known as salivary gland virus due to its tropism until the 
Cytomegalovirus nomenclature was proposed and the virus finally named human 
cytomegalovirus (Weller et al., 1957). 
1.4.2 Clinical features of HCMV 
HCMV is a ubiquitous virus infection with seroepidemiological studies demonstrating 
worldwide distribution of the virus amongst human populations. The prevalence of 
infection is largely due to the success of the virus as a persistent pathogen with efficient 
mechanisms of transmission but is also affected by socio-economical factors: developed 
countries have levels from 40-60% seroprevalence whereas areas of the developing world 
have seroprevalence levels as high as 100%. 
Primary infection with HCMV is often asymptomatic but results in lifelong persistence in 
the host. Infected individuals are therefore able to pursue a normal life but persistence 
provides the virus with a higher chance of transmission through bodily secretions at times 
of viral shedding (Ho, 1990). It has been shown that infants are able to shed large 
quantities of virus in both saliva and urine for long periods of time following infection, 
providing an opportunity for transmission of the virus, with hand washing following 
contact with infants reducing the risk of HCMV transmission considerably (Adler, 1986a; 
Adler, 1986b ). In addition, the transmission of HCMV can occur vertically as well as 
horizontally. Mothers are able to pass on HCMV to ·their foetus in utero and during 
passage through the birth canal, resulting in a number of congenital defects in newborns, 
and also to their children through breast feeding or via saliva or urine contact (Numazaki et 
al., 1970; Pass, 1985; Stagno et al., 1986). In addition to infection during the perinatal 
period (0-2 years), horizontal transmission after puberty through sexual contact represents 
the second most important natural mode of transmission and both comprise the key times 
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associated with the natural acquisition of HCMV (Drew et al. , 1981; Chandler et al., 1985; 
Handsfield et al., 1985; Doerr, 1987). 
A maJor feature of the HCMV lifecycle, particular to all herpesviruses, that aids 
transmission of the virus is persistence of the virus in the infected individual due to the 
period of latency, whereby the viral genome is maintained in the absence of virus 
production (Sinclair & Sissons, 2006). The virus can then be transmitted through 
transplantation of solid organ or bone marrow tissues and following whole blood 
transfusion from a seropositive individual and can result in severe life-threatening disease 
(Rubin, 1990; Miller et al., 1991). 
1. 4. 3 HCMV associated disease, treatment and prevention 
The number of syndromes associated with HCMV infection, whether reactivation or 
primary infection, in addition to the resultant cost of treating patients undergoing 
prophylactic or pre-emptive therapy has led to the National Institutes of Health (NIH) 
designating HCMV as one of the major targets for extended research. 
Acute pathogenicity of HCMV infection is usually only observed in the absence of an 
effective host immune response. Complications can arise in individuals whose immune 
system is immature: congenital infection of the immature foetus can cause a major risk to 
the development and long term health of the baby causing such conditions as hearing loss, 
jaundice and mental retardation through encephalitis in the womb (Boppana et al., 1992; 
Raynor, 1993). However, HCMV also represents a significant opportunistic pathogen of 
immunocompromised individuals. Indeed, HCMV was first recognised as an opportunistic 
pathogen in immunocompromised patients soon after the introduction of allograft 
transplantation (Rifkind, 1965; Singh et al., 1988; Ho, 1991b; Rubin, 2001). Problems 
were observed with individuals who were immunocompromised by suppression with drug 
treatment, including virus reactivation in transplant recipients but also transfer from 
latently infected allograft donors (Adler, 1983; Drew, 1988; Rubin, 1990; Reinke et al. , 
1999). HCMV infection in renal transplant recipients is a known inajor clinical problem, 
with both short and long term sequelae and the importance of recipient and donor 
serostatus well recognised: seronegative patients are at greatest risk after transplantation 
- 7 -
1. Introduction 
from a seropositive donor, although reactivation in a seropositive recipient can also cause a 
major health risk (Hughes et al., 2008). 
Primary infection and reactivation of latent virus has also begun to pose a serious health 
threat, more recently, in HIV carriers who eventually develop acquired immunodeficiency 
syndrome (AIDS); up to 90% of patients now develop an active or invasive HCMV 
infection (Jacobson & Mills, 1988) with HCMV infection symptoms becoming one of the 
hallmarks of late stage AIDS. However, severe infection is now becoming less common 
with active retroviral therapy (ART), including anti-virals directed at herpesviruses, being 
used prophylactically. Indeed, due to the increase in resistance to pharmaceuticals against 
herpesvirus infections, several treatments are now available targeting different constituents 
of the viruses and their lifecycle. The main treatments for HCMV are ganciclovir (GCV), 
cidofovir (CDV) and foscarnet (PFA) which target the viral DNA polymerase (UL54) and 
are used for severe life threatening disease (Landolfo et al., 2003). New treatments have 
focussed on disabling the activity of other components of the virus, such as proteases, 
including the drug maribavir which was fast-tracked by the US Food and Drug 
Administration (FDA) into clinical trials and production due to its activity against the 
UL97 gene product (Biron et al., 2002; Drew et al., 2006). However, it is becoming 
apparent that resistance is now occurring towards this new era of anti-HCMV drugs such 
that novel targets and pharmaceuticals will become necessary with time. 
Rather than treatment of HCMV disease, it has been hypothesised that prevention of 
disease in the first instance should be possible. High risk groups are also known, which 
could aid targeting of sub-populations for vaccination to reduce the risks of disease in later 
life. There are no apparent obstacles to immunisation against HCMV with data supporting 
the feasibility of this form of prevention (Adler, 2008). The guinea pig model of congenital 
CMV has provided good evidence that both active and passive immunisation are effective 
at reducing pup mortality and congenital infections using live attenuated virus, killed virus 
and recombinant vaccines or immune sera (Bia et al., 1984; Schleiss et al., 2002; Schleiss 
et al., 2007). Indeed, itis also known that immunity is induced during natural infection of 
the human host, which reduces the rate of re-infection in immunocompetent adults (Plotkin 
et al., 1989; Adler et al. , 1995), and that women can be passively immunised when 
infected during pregnancy (Nigro et al., 2005). Hence, the likelihood for positive results 
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from human immunisation is high. This has led to the production of two vaccines currently 
in phase II clinical trials. The gB/MF59 vaccine is based on the major glycoprotein of 
HCMV administered with the adjuvant MF59 which has been shown to create high levels 
of neutralising antibodies in animals and humans and stimulate the cytotoxic T lymphocyte 
response (Mitchell et al., 2002). Secondly, the second vaccine is based on the live 
attenuated HCMV Towne strain which is not able to reactivate in either healthy or 
immunosuppressed patients. It is able to stimulate neutralising antibodies and cellular 
immune responses, and has also shown protection for renal transplant patients from severe 
post-transplantation HCMV disease (Adler et al., 1998; Jacobson et al., 2006). However, 
due to difficulties in carrying out trials and the lack of public awareness of HCMV 
infection and disease, the production of a vaccination applicable to the human population is 
yet to be formally produced. 
1.5 HCMV structure and life cycle 
1.5.1 HCMV structure 
The mature HCMV virion ranges in size from between 150nm to 250nm in diameter and, 
as with other herpesviruses, contains a single linear, double stranded DNA (dsDNA) 
genome (Geelen et al., 1978a; Geelen et al., 1978b; Irmiere & Gibson, 1985; Butcher et 
al., 1998). The genome is encapsidated within an icosahedral nucleocapsid, 100nm in size 
(McGavran & Smith, 1965; Irmiere & Gibson, 1985; Butcher et al., 1998), which is coated 
in a tegument layer composed of a number of different proteins underlying the viral 
envelope, which has numerous viral glycoproteins embedded within it (Spaete et al., 1994; 
Britt & Mach, 1996) (Fig. 1.2). This layered structure is composed of around 35 different 
proteins with over 40% of the total protein mass and a number of key viral proteins being 
found in the tegupient including the phosphoproteins pp65 (UL83), pp71 (UL82) and pp28 
(UL99) (Irmiere & Gibson, 1983; Roby & Gibson, 1986). Although the functions of these 
phosphoproteins are still being fully elucidated, a number of them appear to be involved in 
transactivation of viral gene expression (Liu & Stinski, 1992; Winkler & Stamminger, 
1996; Homer et al. , 1999; Schierling et al., 2004; Cantrell & Bresnahan, 2005; Cantrell & 
Bresnahan, 2006; Saffert & Kalejta, 2006; Hwang & Kalejta, 2007) or in the disruption of 
host cell processes prior to de nova protein synthesis (Hoffman et al. , 2002; Kalejta et al., 
2003; Kalejta & Shenk, 2003a; Kalejta & Shenk, 2003b ). A number of the viral and, 
indeed, cellular proteins that compose an HCMV virion have been identified by 
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capsid envelope 
--gB 
tegument 
genome 
gH,gL,gO 
GPCR 
150 - 250nm 
Figure 1.2 The HCMV virion structure. The HCMV infectious virion ranges in size from 150-250nm in 
diameter. It is comprised of a 230-236kbp linear double stranded DNA (dsDNA) genome encapsulated in 
an icosohedral capsid structure. The capsid is surrounded by a layer of tegument which is comprised of a 
number ofphosphoproteins including pp71 and pp65. Enclosing the tegument is a lipid bilayer covered in a 
number of glycoproteins and glycoprotein complexes (gX) necessary for mediating virus entry into the 
target cell and the G-protein coupled receptor (GPCR). 
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biochemical and immunological approaches (Baldick & Shenk, 1996; Gibson, 1996). The 
cellular component of the virion includes CDI3 aminopeptidase N, P2-microglobulin, 
protein phosphatase I, annexin II and actin-related protein 2/3 (Arp2/3) (Baldick & Shenk, 
1996; Giugni et al., 1996; Grundy et al., · 1987; Michelson et al., 1996; Stannard, 1989; 
Wright et al., 1995). However, more recently developed sophisticated liquid phase 
separations and mass spectrometry (MS)-based approaches for analysing complex mixtures 
of polypeptides has allowed more detailed and total analysis of the proteome of the mature 
virion (Varnum et al., 2004). 
1.5.2 HCMV genome organisation 
The HCMV genome has a predicted size of 230kbp based on analysis of the laboratory 
strain AD 169 (Chee et al., 1990a) and is maintained in a linear formation and enclosed 
within the viral nucelocapsid of the infectious virion (McGavran & Smith, 1965). The 
sequence analysis initially performed on AD169 identified 208 possible open reading 
frames (ORFs), which encoded for over 100 amino acids, although only 189 were thought 
to be unique due to duplication within the RL region of the genome. The ORFs were 
numbered sequentially with the genome being organised into unique short and long regions 
(Us and UL) flanked by inverted short and long terminal repeats (TRs and TRL) and further 
internal repeats (IRs and IRL) at the L-S junction (Fig. 1.3). However, additional analysis 
of the Toledo strain has found differences to the high passage AD 169 strain that had been 
extensively passaged in the laboratory to create a live attenuated vaccine (Elek & Stem, 
1974). A 15kbp region named the ULb' region, not present in the AD169 strain, and a 
further 929bp (present in AD169) affecting UL42 and UL43 exist within the genome (Cha 
et al., 1996; Dargan et al., 1997). This finding has also been confirmed with analysis of the 
wild-type clinical isolate Merlin (Dolan et al., 2004). Further comparison and alignment 
analysis of AD169 to chimpanzee CMV (CCMV) has also led to a re-evaluation of the 
gene complement, which is more likely around 145 ORFs, with a wild type HCMV 
complement probably between 164-167 ORFs (Davison et al., 2003). However, additional 
alignment analyses and coding potential re-evaluation of low passage strains, such as 
Toledo, against other recent clinical isolates (FIX/VR1814, PH and TR) has demonstrated 
up to 252 possible ORFs and multiple sequence alignments revealing substantial variation 
in the amino acid sequences encoded by many of the conserved ORFs (Murphy et al. , 
2003a; Murphy et al., 2003b). In addition, as well as providing further sequence data for 
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Figure 1.3 HCMV genome organisation. HCMV has a 230-236kb double stranded DNA genome. It 
comprises both long (L) and short (s) tenninal repeats (TR), internal repeats (IR.) and unique regions (U) 
where the majority of the coding ORFs reside. The HCMV genome pictured above is that of the highly passaged laboratory strain AD169. However, the genome of other clinical isolates, such as HCMV Toledo 
and TB40/E, have much shorter TRL and IR.L regions. The latter region is replaced by a unique region (ULb') known to encode multiple immune evasion genes found unnecessary for AD169 replication in fibroblasts. (* = position of the HCMV l\1IEP). 
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the HCMV strain TB40/E, recent work has also shown that the plaque purified form of this 
virus may actually contain three separate clones (Sinzger, et al., 2008). 
1. 5. 3 HCMV entry 
Although certain human cell types do not fully support HCMV replication, entry of HCMV 
into cells appears to be promiscuous with the virus capable of binding and penetrating 
virtually all vertebrate cell lines used commonly (Nowlin et al., 1991). Entry of HCMV 
into cells such as fibroblasts takes place via two defined stages, both involving sequential 
interactions between viral and cellular components and being fully pH-independent. First, 
the virus binds to cell surface in a tethering step to heparin sulphate proteoglycans via 
glycoprotein B (gB) and/or the gM/gN heterodimer on the viral envelope (Kari & Gertz, 
1992; Compton et al., 1993; Compton, 2004). This interaction is then secured through 
docking of gB with a further receptor or receptors, which due to the current widely 
differing opinions in the field will be discussed further below. Through gB, and via 
interactions with other glycoproteins (gH/gL/gO) and probably cellular integrins, fusion of 
the viral envelope with the cellular membrane occurs and thus entry of the virion 
(Compton et al., 1992; Compton, 2004; Kinzler & Compton, 2005). 
Although surface fusion of the virion in cells such as fibroblasts remains the principal 
mechanism by which HCMV is thought to infect cells, it has now become apparent that 
HCMV is also able to enter biologically relevant epithelial and endothelial cell types in a 
pH-dependent fashion following an endocytic route. Work from a number of groups using 
the highly passaged AD 169 strain and low passage clinical isolates has shown that proteins 
encoded by viral genes UL128, UL130 and UL131 form a complex with the gH/gL 
heterodimer and ·are necessary for adsorption to, and penetration of, epithelial cells and 
also promote the early stages of virus replication (Wang & Shenk, 2005a; Wang & Shenk, 
2005b; Ryckman et al., 2006; Jarvis & Nelson, 2007; Ryckman et al., 2008; Sinzger et al., 
2008; Sinzger, 2008). It has also been proposed that the cell type that the HCMV particle is 
produced in also influences its subsequent spread, due most likely to a change in the 
balance of glycoprotein complexes found on the surface of the envelope (Wang et al., 
2007) and that antibodies from human serum directed specifically at UL 128/UL 130/UL 131 
can inhibit infection of epithelial and endothelial infection whilst infection of fibroblasts is 
unaffected (Gema et al. , 2008). Ultimately, however, the viral capsid is still released from 
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the virion through fusion of the envelope, although in this case through a pH-dependent 
mechanism with the internal lipid bilayer of the host endosome. 
Upon uncoating of the virion, the capsid is released into the cytosol along with numerous 
associated tegument proteins (Fig. 1.4). The viral genome is delivered to the nucleus by the 
capsid after trafficking to a nuclear pore, possibly involving viral proteins and likely 
facilitated via cytoplasmic microtubules (Dohner & Sodeik, 2005), where it is released at a 
nuclear pore, most likely aided by the large tegument protein (LTP, UL48) and a binding 
protein (LTPbp, UL47) (Dunn et al., 2003; Yu et al., 2003). The genome then rapidly 
circularises and may be deposited at or near nuclear domain-10 (ND 10) bodies, with 
increasing evidence from the herpesvirus family supporting this (Maul, 1996; Maul, 1998; 
Everett et al. , 2007). It is at this point that the permissiveness for infection is then 
determined: it is known that in non-permissive cell types the prevention of productive 
infection is exerted after viral entry and that in model cell systems the viral genome can be 
found in a nuclear location within these cells (Nelson & Groudine, 1986). 
As alluded to above, much work has focussed on finding the receptor(s) necessary for 
HCMV entry. During HCMV infection, considerable changes in the metabolic state of the 
cell occur. These changes also occur upon infection with UV-inactivated virus (Fortunato 
et al., 2000; Compton, 2004). Consequently, the process of binding of the virus to the cell 
surface is sufficient to result in significant homeostatic and transcriptional changes within 
the cell prior to de nova viral protein synthesis (Boldogh et al., 1991 b; Kowalik et al., 
1993; Yurochko et al., 1995; Boyle et al., 1999). Signalling pathways that appear to be 
affected have prompted the investigation of the epidermal growth factor (EGF) response, 
as internalisation_of the EGF-receptor (EGF-R) results from virus binding. Consistent with 
this, it was shown that an EGF-R null breast cancer cell line was resistant to HCMV 
infection but that the reintroduction of EGF-R through transfection led to susceptibility to 
infection (Wang et al., 2003). Furthermore, this investigation also found that gB co-
immunoprecipitated with EGF-R, suggesting an active role for EGF-R in HCMV entry. 
However, other studies have determined a different mechanism for the interaction between 
HCMV and EGF-R. It was observed that HCMV inhibited signalling via EGF-R and also 
that infection caused a down-regulation of transcription and resultant cell surface 
expression of EGF-R, although this was dependent on viral gene expression and therefore 
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Figure 1.4 The HCMV life cycle. (A) HCMV enters cells via attachment to and fusion of the cellular lipid 
membrane. (B) Initial attachment leads to intracellular signalling, (C) whilst the capsid transits to the 
nucleus. (D) The genome is released at a nuclear pore and circularises before association of NDlO 
components with the episome or deposition of the episome at ND 10 bodies occurs. (E) Tegurnent proteins 
traffic to ND 10 domains where they can act as transactivators of viral gene expression. (F) In productive 
infection, a temporally regulated cascade of gene expression occurs alongside genome replication, leading 
to packaging in the nucleus. (G) Capsids exit the nucleus via an envelopment-deenvelopment pathway, (H) 
before acquiring a final envelope at a late cytoplasmic compartment and egress from the cell. (Cy = 
cytoplasm; Nu= nudeus). 
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Figure 1.4 The HCMV life cycle. (A) HCMV enters cells via attachment to and fusion of the cellular lipid 
membrane. (B) Initial attachment leads to intracellular signalling, (C) whilst the capsid transits to the 
nucleus. (D) The genome is released at a nuclear pore and circularises before association of NDlO 
components with the episome or deposition of the episome at ND 10 bodies occurs. (E) Tegument proteins 
traffic to ND 10 domains where they can act as transactivators of viral gene expression. (F) In productive 
infection, a temporally regulated cascade of gene expression occurs alongside genome replication, leading 
to packaging in the nucleus. (G) Capsids exit the nucleus via an envelopment-deenvelopment pathway, (H) before acquiring a final envelope at a late cytoplasmic compartment and egress from the cell. (Cy = 
cytoplasm; Nu= nucleus). 
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argued for a different mechanism ofEGF-R regulation at later times of infection (Fairley et 
al., 2002; Beutler et al., 2003). It is important to note, though, that EGF-R is not expressed 
on haematopoietic monocytes, macrophage or dendritic cells (DC), all of which have been 
shown as sites of primary infection or latency with HCMV (Ewald et al., 2003). Indeed, 
more recent work has shown that EGF-R does not appear to have any role in the process of 
HCMV entry into fibroblast, epithelial or endothelial cell lines (Isaacson et al. , 2007) but 
that certain ~ 1 and ~3 integrin heterodimers are critical mediators of entry into permissive 
fibroblasts through interaction with gB (Feire et al., 2004). However, interactions between 
integrins and EGF-R are known to occur on the cell surface (Miyamoto et al., 1996; Li et 
al., 1999) and since integrins appear to be indispensable for infection of fibroblasts, it is 
possible that multiple mechanisms, including the need for EGF-R in some cell types, may 
be at play during cell entry of HCMV. 
The envelope proteins of HCMV, as explained above, are an important component of the 
virion's structure with involvement in cell entry, cell activation, changes in signalling 
pathways and interaction with the immune system. The glycoprotein gB had been thought 
to be predominant on the surface of the virion, most likely due to its multifunctional 
properties in cell entry, cell to cell transmission through fusion and signal pathway 
transduction (Britt & Mach, 1996; Compton et al., 1993; Navarro et al., 1993). In addition, 
gB is also known to bind cellular annexin II indicating a possible role in trafficking and 
egress of the virus (Pietropaolo & Compton, 1997; Pietropaolo & Compton, 1999; Singh & 
Compton, 2000). However, it is important to note that recent evidence suggests that the 
levels of gB on a virion surface are much lower than first thought, being just 1 % of the 
total virion protein content, whereas gM (UL 100) displays a much higher proportion 
(Varnum et al., 2004). However, gB remains a major target for neutralising antibodies in 
the serum of infected patients (Navarro et al., 1997) and this has led to the identification of 
several gB epitopes that have been important for collectio~ of epidemiological data on the 
spread of HCMV worldwide (Chou & Dennison, 1991; Chou, 1992; Fries et al., 1994 ). 
Indeed, gB has been one of the primary candidates for the development of an HCMV 
vaccine (Spaete, 1991; Marshall et al., 1992; Gonczol et al., 1995; Pass et al. , 1999). 
Neutralising antibodies directed at the major glycoprotein complex of gH/gL/gO also have 
profound effects on viral penetration and transmission indicating that these proteins are 
also essential for viral entry (Rasmussen et al., 1984; Keay & Baldwin, 1991 ). 
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1.5.4 HCMV DNA replication 
HCMV is able to productively infect a number of different cell types including fibroblast, 
epithelial, endothelial, smooth muscle, macrophage and dendritic cells, dependent upon 
viral strain (Lathey etal., 1990; Ibanez et al., 1991; Sinzger et al., 1993; Sinzger et al., 
1995; Riegler et al., 2000). After deposition of the genome in the nucleus and 
circularisation, which is thought to occur within the first four hours, viral gene expression 
is initiated ( discussed fully in section 1.6). Although many viruses rely on the host 
transcriptional machinery to replicate their own DNA, HCMV encodes a number of 
proteins to carry out this process (Huang, 1975; Anders et al., 1986; Anders & McCue, 
1996) and the replication of viral DNA is ultimately dependent on the expression of these 
proteins (White & Spector, 2006). Replication of viral DNA begins via directional rolling 
circle replication at around 18 hours post-infection and peaks at 60-80 hours post-infection 
(Stinski, 1978) resulting in the production of several thousand copies of viral DNA in 
replication compartments. Replicating viral DNA is generally greater in size than genome 
unit length and lacks terminal fragments, consistent with rolling circle replication 
(Lafemina & Hayward, 1983; McVoy & Adler, 1994) and not a limited theta replication 
form hypothesised by some. Replicated viral genomes are eventually packaged and 
releas_ed in mature virions over a further period of 48 hours (Stinski et al., 1979; Penfold & 
Mocarski, 1997). 
HCMV encodes a number of conserved proteins that bind the viral replication fork, 
including a DNA polymerase (UL54), an associated processivity factor (UL44), a single 
strand DNA binding protein (UL57) and a helicase constructed from three sub-units 
(UL70, UL102 and UL105) (Anders & McCue, 1996; Sarisky & Hayward, 1996). These 
proteins are able to bind to the viral lytic origin (oriLyt) and function to initiate replication 
with some additional viral gene products (see below) (Prichard et al. , 1996). The viral 
DNA polymerase is one of the most conserved proteins across the herpesviridae family 
and, as such, has become a significant target for anti-viral therapeutics, including 
ganciclovir (GCV) (Freitas et al., 1985). HCMV does not encode a thymidine kinase (Estes 
& Huang, 1977), as other herpesviruses such as HSV-1 and -2 do and is, therefore, less 
susceptible to nucleotide analogues as anti-virals. However, it does express a kinase 
(UL97) which is able to use GCV as a substrate (Littler et al., 1992) leading to the 
accumulation of the triphosphate form of GCV which when incorporated into replicated 
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DNA causes termination of DNA strand extension (Sullivan et al., 1992). However, it is 
now known that many point mutations in the DNA polymerase of HCMV and in the UL97 
gene product are able to render this drug ineffective (Chou et al., 1997; Smith et al., 1997). 
Therefore, other drugs have been generated to combat this problem, including cidofovir 
(CDV) (Xiong et al., 1996) and foscamet (PFA) (Wahren et al., 1985) as well as more bio-
available forms of GCV such as valGCV. In addition, other drugs such as maribavir, which 
specifically acts on the serine/threonine kinase UL97, shown recently to stabilise pRb 
during infection (Prichard et al. , 2008), are now in clinical trials (Drew et al., 2006), 
although it is again becoming apparent that resistance can still form even to these new 
drugs (Chou et al., 2007). 
Other viral proteins also appear indispensable for viral DNA replication. Some immediate 
early (IE) proteins, such as TRSl/IRSl, UL84 and the ULl 12 and UL113 gene products 
are also important (Pari et al., 1993; Pari & Anders, 1993; Iskenderian et al., 1996). It is 
possible that the major IE and TRS 1/IRS 1 proteins act as transactivators for the 
transcription of the DNA replication machinery and therefore are necessary indirectly for 
producing a host cell environment conducive to DNA replication (Pari et al. , 1993). 
However, it has been suggested that the UL84 gene product is much more directly 
involved in the process due to its ability to sequester the six herpesvirus-conserved 
replication fork proteins and drive replication from the oriLyt sequence (Sarisky & 
Hayward, 1996): UL84 mutant viruses are defective for viral synthesis and growth (Xu et 
al., 2004). The four ULl 12-ULl 13 encoded phosphoproteins (pp34, pp43 , pp50 and 
pp84), produced as a result of alternate mRNA splicing (Wright et al. , 1988; White & 
Spector, 2006), are also critical during initiation of viral DNA synthesis (Park et al., 2006). 
All four proteins form a complex, accumulate compartmentally prior to replication 
initiation (Ahn et al. , 1999) and are essential for the targeting of UL44 and the replication 
machinery to the viral genome at the pre-replication foci near NDlO (Penfold & Mocarski , 
1997). 
1. 5. 5 HCMV assembly, maturation and egress 
The HCMV capsid is first assembled in the nucleus from the five viral proteins: the major 
capsid protein (MCP; UL86), the minor capsid protein (mCP, UL85), the assembly protein 
(AP) precursor (pAP, UL80.5), the smallest capsid protein (SCP, UL48.5) and the mCP 
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binding protein (mC-BP, UL46) (Gibson, 1996). The capsid is composed of 162 capsid 
polypeptides arranged as hexons and pentons in an icosahedral lattice structure studded 
with the SCP (Streblow et al., 2006). A MCP:AP (1:1) precursor complex controls the 
formation of capsids that initially associates with an pAP conserved carboxyl terminal 
domain following synthesis at cytoplasmic sites and is responsible for translocating the 
MCP to the nucleus (Plafker & Gibson, 1998). This initiates the capsid assembly process. 
Within the nucleus, a conserved amino terminal pAP domain then facilitates 
oligomerisation which drives the formation of the MCP:AP complex described above 
before the SCP caps the structure and a number of protease cleavage steps separate AP 
from MCP. This inactivates the protease, completing the formation of the so called B 
capsid. Once assembled, it is thought that these immature particles are then transported to 
DNA replication compartments through direct interaction with viral proteins UL93 and 
UL52. These fibrillar networks can then be seen as dense inclusions by light microscopy 
(Fons et al., 1986). Although much work has elucidated the various proteins involved in 
the encapsidation of the HCMV genome after replication, this process is best understood 
through observations with the alphaherpesvirus HSV-1. Upon HCMV DNA synthesis, 
encapsidation proteins recognise the concatemeric genomes through conserved cis-acting 
elements located within the terminal sequence of the viral genome. One full length genome 
is inserted into the capsid, a junction sequence is then recognised and cleavage of the 
genome occurs, producing a nucleocapsid containing a single viral genome. This modified 
'head-full' packaging process is reminiscent of that with bacteriophage (Yamagishi & 
Okamoto, 1978). In total, ten herpesvirus core genes (UL51, UL52, UL56, UL77, UL89, 
UL93, UL95, UL97, ULI03 , and ULI04) influence encapsidation and include elements of 
the packaging machinery and all are essential for HCMV replication (Mocarski et al. , 
2007). The insertion of genome into so-called type B capsids displaces assembly protein 
(UL80.5) and causes the capsids to locate to a thickened concave area whereupon egress 
can begin to occur (Gibson, 1996). 
Viral egress occurs around two days after replication has been completed (Penfold & 
Mocarski, 1997). Initially, nucleocapsids collect in the nucleus before budding into the 
perinuclear space (Fons et al., 1986; Gibson, 1996). This is facilitated by recruited cellular 
kinases that dissolve the nuclear lamina (Muranyi et al. , 2002). Egress from the nucleus 
requires two core functions, the UL50 and UL53 gene products (Mettenleiter, 2004). It is 
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still unclear how the development of the HCMV coat and release of the mature virion takes 
place: indeed, the topic is contentious with exit from the nucleus and acquisition of the 
envelope both in question (reviewed in: Campadelli-Fiume et al. , 2006). However, it has 
been generally accepted that this does occur at least through a process of envelopment and 
de-envelopment similar to that seen with HSV-1, where the perinuclear envelope is lost 
during maturation with acquisition of the final envelope from a cytoplasmic compartment 
(Skepper et al. , 2001), and recent work with gO deletion viruses has shown the necessary 
presence of this glycoprotein during egress and secondary envelopment within multiple 
cell lines (Jiang et al., 2008). The release of viral progeny then occurs in vesicles via the 
Golgi apparatus and secretion from the surface of the cell (Eggers et al. , 1992). 
In addition to mature infectious virions, HCMV infected cells generate two further types of 
particle. Non-infectious enveloped particles (NIEPs) are composed of the same viral 
proteins as infectious virions but lack viral DNA, and are distinguishable from infectious 
particles by electron microscopy (EM) due to an electron dense core (Mocarski et al., 
2007). Secondly, a uniquely characteristic particle produced during HCMV and simian 
CMV (SCMV) infection is the dense body (DB), a non-replicating fusion competent 
particle composed predominantly of the tegument protein pp65 (UL83). The quantities and 
ratios of each of these different particles produced during an infection are dependent on the 
viral strain but also on the multiplicity of infection (Irmiere & Gibson, 1983; Gibson & 
Irmiere, 1984; Gibson, 1996). Importantly, clinical isolates .of the virus accumulate fewer 
dense bodies and less pp65 than laboratory strains do (Klages et al., 1989) and dense 
bodies are not observed in tissues or during infection of fibroblasts with a pp65 mutant 
virus (Schmolke et al., 1995). Due to the absence of a packaged genome in DBs, and thus 
the inability to ~ause an infection per se, DBs have been touted as a vehicle for 
vaccination. As pp65 is one of the major antigens during infection (Reddehase, 2002) a 
new direction has been to produce DBs constructed fr?m pp65 fused to further major 
antigens, such as IE72 (Mersseman, et al., 2008). 
1.6 HCMV productive infection 
1.6.J Immediate Early (IE) gene expression 
In permissive cell types, viral transcription initiates with the expression of the IE genes, 
sometimes referred to as the alpha genes (a) (see Fig. 1.5) and has been mapped to four 
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regions: UL36 and UL37, UL122 and UL123 (IE72 and IE86), TRSl and IRSl and US3. 
All of these regions give rise to multiple transcripts and gene products. The US3 region 
gives rise to gene products associated with inhibition of trafficking of MHC class I 
molecules to the plasma membrane (Ahn et al., 1996; Jones et al., 1996; Mocarski, 2004). 
The UL36 and UL37 ORFs have multifunctional gene products: in addition to UL37x3 
being associated with gene regulation activities (Hayajneh et al., 2001), UL37xl encodes a 
cell death suppressor denoted viral mitochondrial inhibitor of apoptosis (vMIA) 
(Goldmacher et al., 1999; Goldmacher, 2002; Goldmacher, 2005). Furthermore, UL36 
encodes a betaherpesvirus-conserved cell death suppressor, the viral inhibitor of caspase 8 
activation (vICA) (Skaletskaya et al., 2001; McCormick et al., 2003; Goldmacher, 2005). 
The two gene products of the Us regions IRS 1 and TRS 1, in addition to their ability to 
regulate gene expression (Blankenship & Shenk, 2002), are able to inhibit IFN-inducible 
protein kinase R (PKR) (Child et al., 2004). Although UL36, UL37, UL37xl, TRSl and 
IRS 1 are all individually dispensable for viral replication, a number of mutants have been 
shown to be highly affected by a loss of two or more of these gene products, demonstrating 
the multifunctional and necessary nature of these proteins for virus infection (Mocarski et 
al., 2007). 
The expression of the major IE (MIE) gene products IE72 and IE86, sometimes termed IE1 
and IE2 respectively, is driven by the major immediate early promoter/enhancer (MIEP), 
independent of de nova protein synthesis (Wathen et al., 1981; Wathen & Stinski, 1982). 
The MIEP is one of the strongest known promoters and is responsible for the high levels of 
IE72 and IE86 RNA, generated from differential splicing of a common primary transcript, 
within 3 hours of infection. IE protein expression from this locus is critical for the 
regulation of the temporal cascade of viral gene expression typically associated with 
herpesviruses and is essential for the initiation of the early (E) phase of viral gene 
expression (Spector, 1996). IE72 and IE86 have a central regulatory role in HCMV 
infection (Colberg-Poley, 1996; Stenberg, 1996; Fortunato et al., 2000; Castillo & 
Kowalik, 2002; Goldmacher, 2004) and, as such, the multifunctional importance of these 
two proteins will be discussed later (see section 1.9.2). 
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Figure 1.5 The temporal cascade of HCMV gene expression. Following infection of a permissive cell 
with HCMV, alpha (a) gene expression can be detected as early as 1 hour post-infection. The predominant products of this period are IE72 and IE86, whose expression is seen to peak between 4-8 hours post-infection. The initiation of beta (~) gene expression is ultimately dependent on the success of alpha gene 
expression: this begins 6-12 hours post-infection. These genes are split into two classes, ~1 and ~2 dependent upon the time of protein expression. Lastly, gamma (y) gene expression occurs last from 24 hours post-infection, with the genes again being separated into two groups: Yi, the leaky late, and y2, the true late genes. However, these genes are separated into two groups determined by a sensitivity to a block in viral DNA synthesis (arrow). Release of viral progeny usually occurs 96 hours post-infection. 
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1. 6. 2 Early (E) gene expression 
Following expression of the MIE proteins, IE72 and IE86, a large proportion of the viral 
genome becomes transcriptionally active. The initiation of early (E) genes, sometimes 
known as the beta (P) genes, occurs from '6 hours post-infection and continues through to 
24 hours post-infection when viral DNA replication initiates (see Fig. 1.5). At least 23 
early genes are known to play essential roles in replication with many more having an 
important impact when individually disrupted in laboratory strains of HCMV (Dworsky et 
al. , 1983; Yu et al. , 2003). They include gene products required for viral DNA synthesis, 
capsid maturation and proteins necessary for altering the cellular environment and 
modulating the host cell response. 
The early genes expressed during infection are further subdivided into two groups: the p1 
and the P2 depending on time of expression. One set of prototypic P1 genes is encoded by 
the ULI 12-113 region, which encodes four proteins necessary for the initiation of DNA 
replication. Analyses have shown that this locus is transcriptionally active during the early 
period of gene expression but also during the late period, with a shift in transcriptional start 
site occurring 62bp upstream via the A TF /CREB transcription sites and also the action of 
the IE86 protein (Rodems et al., 1998). An example of a prototypic p2 gene is ORF UL54, 
the catalytic subunit of the viral DNA polymerase. Expression of this gene is detectable by 
8 hours post infection, however it reaches much higher levels at later times. Indeed, as with 
the UL 112-113 locus, IE86 is able to cause, possibly in conjunction with the transcription 
factor Sp 1, up-regulation of UL54 expression at later times (Wu et al., 1998). 
In addition to the prototypic early genes described above, a number of tegument proteins, 
including pp65, pp71, pp150 and the LTP are transcriptionally active as early genes even 
though their function is more important at maturation or upon entry into host cells. Also, 
intriguingly, one of the major early genes transcribed, but not translated, is the P2.7 
transcript (Spector, 1996). The p2. 7 transcript accounts for over 20% of the total RNA 
transcribed at this timepoint and initially investigation into its activities with HCMV 
strains deleted of the region found these viruses still viable in cell culture (McSharry et al., 
2003). However, further investigation has shown that the P2.7 transcript acts to stabilise 
Complex I of the mitochondrion during infection, such that the production of A TP is 
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maintained during infection and that the mitochondrion is protected from pro-apoptotic 
stimuli (Reeves et al., 2007). 
I. 6. 3 Late (L) gene expression 
The functions carried out by the viral late (L) genes gt!nerally involve capsid maturation, 
DNA encapsidation, virion maturation and egress of the virion from the cell. Despite the 
level of investigation into gene products expressed during this phase of infection, little is 
known that allows clear distinction between ~2 early genes. Many HCMV late genes are 
expressed with kinetics similar to those for the ~2 genes, with expression initiating within 
the first 24 hours post-infection. However, those being expressed after 24 hours post-
infection, and also having resistance to the effects of viral DNA synthesis inhibitors, are 
known as the yl or 'leaky' late genes. Those that are sensitive to viral DNA synthesis and 
its inhibitors are known as 'true' late or y2 genes. The expression of these genes is 
promoted by both viral and cellular factors (Depto & Stenberg, 1989; Depto & Stenberg, 
1992), although a number of viral late promoters appear to contain little more than a TA TA 
box to activate gene expression (Kerry et al. , 1997; Wing et al., 1998). The pp28 tegument 
protein (UL99) expression occurs as two transcripts from separate transcription start sites 
with the major transcription occurring as a true late gene. The pp28 promoter does not 
appear very responsive to transactivation and does not rely on particular upstream 
elements, with sequences upstream of -40 (relative to the transcription start site) being 
completely dispensable for transcriptional activation (Depto & Stenberg, 1992; Kerry et 
al., 1997). In addition, as with other HSV-1 truly late transcripts, the promoter is not as 
tightly controlled when used outside the context of the virus in an episome or when 
integrated into the viral genome elsewhere (Wu et al., 2001 b ). A similar basal promoter 
fragment also appears to be sufficient for the UL94 true late gene (-45 to + 1 relative to the 
start site), thus transcriptional and translational control of these genes, although important, 
is still not completely understood. 
I. 6. 4 Viral proteins and the infected cell 
Viral gene products expressed throughout infection are able to modulate numerous 
functions in the infected cell affecting cellular gene expression, cell cycle progression and 
cellular behaviour. The cell responds to infection in culture by HCMV immediately with 
modification of cellular gene expression occurring immediately upon virus attachment 
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probably via viral gB, as explained above (Boldogh et al., 1990; Boldogh et al., 1991c; 
Simmen et al., 2001). Analysis of global changes in gene expression in the infected cell 
have demonstrated that pathways analagous to the toll-like receptor (TLR) signalling, 
interferon (IFN) response, hormone stimulation and growth factor activation occur 
immediately post-infection (Mocarski & Courcelle, 2001 ). In cell culture models, antiviral 
genes and inflammatory cytokine expression are activated with either HCMV virions or 
soluble gB alone, hence the in:iportance of determining a receptor for this ligand during 
infection, with induction of IFN-stimulated genes occurring post-entry (Boehme et al. , 
2004; Netterwald et al. , 2004). The overall effect of these changes is believed, in part, to 
activate the NF-KB response. Although contentious, activation of NF-KB by the virus is 
thought to occur in two stages: fibroblasts respond as soon as 5 minutes after exposure to 
virus particles which is followed by the activation of NF-KB gene expression by 24 hours 
post-infection, possibly important for the enhancement of MIE gene expression (Demeritt 
et al. , 2004; Compton & Fiere, 2006). 
The stimulation of cells is then modulated post-entry of the vmon via both vmon 
associated tegument proteins and with de novo viral gene expression. Although pp65 is 
dispensable for replication (Schmolke et al., 1995), it is able to down-modulate the virus-
mediated IFN-like response, possibly through a reduction in the level of NF-KB activation 
(Browne & Shenk, 2003). The tegument protein is also thought to be able to block 
interferon regulatory factor (IRF)-3 activation and translocation to the nucleus (Abate et 
al. , 2004). Expression of MIE proteins is then further able to cause a second level of 
modulation: IE72 forming a complex with ST A Tl and STAT2 preventing the association 
with IRF-9 and thus preventing activation IFN-responsive promoters, whilst IE86 
contributes to down-modulation in ways that are not yet fully understood (Paulus et al. , 
2006; Taylor & Bresnahan, 2006). The MIE gene products are also important for various 
functions during infection and will be discussed later. (see section 1.9.2). In addition, 
another important feature of HCMV infection is the ability of certain gene products to 
modulate and counteract cell death which is discussed above (see section 1.6.1). 
1.6.5 HCMV and cell cycle 
Upon infection, HCMV is able to subvert normal cell cycle (reviewed in: Swanton & 
Jones, 2001); although there appears to be no absolute consensus on the effect of HCMV 
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on cell cycle, a number of studies have aided the elucidation of viral effects. Many studies 
have investigated cell cycle modulation using human fibroblasts due to the ease of 
obtaining synchronised cell populations and their full permissiveness for HCMV lytic 
infection. These studies have led to much data showing the profound effects HCMV 
infection has on normal cell cycle at numerous points, with the effects of infection being 
partly dependent upon when in the cycle infection occurred (Salvant et al., 1998). Indeed, 
if the cell is infected during Go or 0 1 phase, this leads to obstruction of cellular DNA 
synthesis. However, if the cell is infected is S phase, viral gene expression may be delayed 
and cells transit through S phase and mitosis (Fortunato et al., 2002; Bain & Sinclair, 
2007). Hence, HCMV appears to preferentially control the entry of the cell into S phase 
such that viral replication is optimised. The inhibition of cellular DNA synthesis seen upon 
infection is likely such that the virus can produce an environment highly conducive to viral 
DNA synthesis with this taking place through mechanisms involving several viral proteins. 
Virion components themselves are able to carry out some of the initial functions necessary 
to establish the correct environment: in particular the tegument protein pp71 and the 
tegument associated gene product of UL69 (pUL69). The phosphoprotein pp71 first 
translocates to the nucleus upon infection of the cell (Hensel et al., 1996) and is able to 
transactivate the MIEP to promote the expression of IE genes (Bresnahan & Shenk, 2000), 
which is discussed further in section 1.9. However, it also been shown in transfection 
assays that pp71 is able to accelerate cell cycle progression and stimulate DNA synthesis in 
quiescent cells via proteosomal degradation of the retinoblastoma protein, pRb, and 
associated pocket family proteins p107 and p130 (Kalejta et al. , 2003; Kalejta & Shenk, 
2003a; Kalejta & Shenk, 2003b ). Cell cycle progression then occurs as a result of the loss 
of repression on _the E2F family members which are then able to activate S phase genes 
(reviwed in: Bain & Sinclair, 2007). pUL69, a homologue of the HSV ICP27 protein 
(Winkler et al., 1994; Winkler & Stamminger, 1996) is further able to cause accumulation 
of HCMV infected cells in the 0 1 phase of the cell cycle with UL69 deletion viruses 
impaired for viral DNA replication and late mRNA expression (Lu & Shenk, 1999; 
Hayashi et al., 2000). Furthermore, it is thought that pUL69 acts in conjunction with pp71 
and the major IE gene products to create an early S phase like state that can be exploited by 
the virus. It has been shown that IE72 and IE86 are both able to target the pocket family 
proteins, IE72 with p 107 and IE86 with pRb, thus mediating 0 1 to S phase progression 
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(Hagemeier et al., 1994; Poma et al., 1996). In addition, IE72 is also thought to interact 
directly with E2F 1 and have the ability to phosphorylate other pocket family and E2F 
family proteins (Margolis et al., 1995; Pajovic et al., 1997). IE86 has also been shown to 
abrogate the cdk inhibitor p2 l by direct interaction further aiding cell cycle progression 
from the G1 to S phase (Sinclair et al., 2000). 
Although the ability of HCMV to advance cell cycle into early S phase would result in a 
beneficial environment to replicate in, this cell cycle transition would also be conducive to 
cellular DNA synthesis. However, as noted above, this does not occur. Studies using 
transient expression of IE86 in cells have shown that it also has specific roles in inhibiting 
cellular DNA synthesis and that this inhibition is p53 dependent (Murphy et al., 2000; 
Wiebusch & Hagemeier, 2001; Wiebusch et al., 2003a; Song & Stinski, 2005). Further 
work has determined that IE86 may function by targeting the formation of pre-replication 
complexes (pre-RCs) and interfere with their correct assembly by blocking the loading of 
the mini chromosome maintenance (MCM) complex onto chromatin which is an essential 
process in the assembly of competent RCs (Biswas et al., 2003; Wiebusch et al., 2003b). 
Furthermore, the down-regulation of chromatin licensing and DNA replication factor 1 
(Cdtl) expression and an increase in the expression of Geminin, an inhibitor of replication, 
during HCMV infection is likely to play a part in prevention of cellular DNA synthesis 
(Biswas et al., 2003). Although unpublished data from our laboratory suggests that IE86 
alone is unable to prevent licensing of cellular origins of replication (Bain & Sinclair, 
unpublished), it would appear that HCMV has developed mechanisms to alter cell cycle to 
ensure optimum conditions for viral but not cellular DNA replication. 
1. 7 HCMV interactions with the immune system 
Primary infection of an immunocompetent individual with HCMV is usually 
asymptomatic. However, virus can be detected in the secretions of infected individuals and 
viral DNA in the blood for up to several months after the initial infection (Zanghellini et 
al., 1999). The ability of HCMV to avoid clearance by the immune system for such a 
prolonged period is likely to result from the number of mechanisms the virus employs to 
avoid the host immune response. HCMV encodes a number of genes that can modulate 
various functions involved in the host immune response. These include down-regulation of 
antibody and complement responses, sequestration of ~-chemokines, abrogation of 
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apoptotic signals as well as down-regulation of the adaptive and the innate immune 
responses (Loenen et al., 2001; Braud et al., 2002; Mocarski, 2002). These mechanisms 
allow the virus to evade clearance and enable viral persistence and latency. 
1. 7.1 HCMV and the innate immune system 
The innate immune system is devoted to sensing and controlling microbial replication 
during the time that precedes the induction of the adaptive immune response. The cells of 
the innate immune system use receptors that recognise structurally conserved molecular 
patterns on a range on microorganisms, including viruses, with major receptors including 
Toll-like receptors (TLRs) that recognise pathogen-associated molecular patterns 
(PAMPs). However, cells of the immune system are also able to recognise certain 
endogenous ligands with the importance of the NKG2D receptor and ligands during virus 
infection becoming apparent in recent times. 
The immune cells to come into contact with virus and virus infected cells first appear to be 
the Natural Killer (NK) cells. NK cells are clearly important for control of HCMV 
infection and consistent with this HCMV encodes a number of genes to inhibit NK-
mediated killing of infected cells (Mocarski, 2004). In addition, it has also been 
demonstrated that MHC class I down-modulation by HCMV makes cells more susceptible 
to NK cell lysis (Falk et al., 2002). A number of viral MHC mimics and other MHC-
interacting proteins have been demonstrated and shown to be inhibitors ofNK cell activity, 
such that the infected cells are not killed due to loss of MHC class I expression on the cell 
surface as has been understood for some time (Ljunggren & Karre, 1985). These include 
the viral UL16, ULl 8, UL40, UL141 and UL142 gene products that all play roles in NK 
cell down-modulation via varying mechanisms (see Fig 1.6) (reviewed in: Wilkinson et al., 
2008). The UL 16 protein, first found as a glycoprotein dispensable for growth in vitro 
(Kaye et al., 1992), was later found to down-regulate activating ligands for NKG2D 
(ULBPl, ULBP2, and MICB) (Wilkinson et al., 2008) thus inhibiting cell lysis, whereas 
the UL40 gene product binds to HLA antigen-E to maintain surface expression of 
inhibitory ligands and retain NK repression via CD94:NKG2A (Tomasec et al., 2000). 
Additionally, UL18 is a virally encoded MHC class I homologue and expression on the 
cell surface further inhibits NK cell mediated lysis of infected cells (Browne et al., 1992; 
Leong et al., 1998). 
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Recently it has become clear that the ULb' region of the viral genome is dispensable for in 
vitro growth of HCMV but is found in clinical isolates. Examination of the proteins 
encoded by this region has brought further NK cell evasion tactics to our attention. The 
UL141 protein post-translationally down-regulates the NK cell activatory ligand CD155 
which is recognised by the activating receptor CD226 (Tomasec et al., 2005). Additionally, 
the UL142 protein has been identified as having MHC class I homology that inhibits NK 
cell lysis in a clonally dependent manner (Wills et al., 2005) and that this may be mediated 
by down-regulation of MICA, an activating ligand for NKG2D (Chalupny et al., 2006). 
However, UL 142 cannot target all alleles of the MICA molecule known in the human 
population. Consequently, UL142 may target multiple NK cell ligands. Other mechanisms 
the virus has developed to target ligands for NKG2D include the recently highlighted 
micro RNA (miRNA) pathway. HCMV is able to abrogate the expression of a further 
ligand, MICB, through production of the miR-UL122-1 miRNA (Stern-Ginossar et al. , 
2007). Therefore, the importance of the NK cell immune response is obvious with the 
number of overlapping methods employed by HCMV to inhibit this defence. 
I. 7.2 HCMV and the adaptive immune system 
As with modulation of the innate immune response, HCMV encodes a number of genes 
that target the adaptive immune response (see Fig. 1.6). The US2-US11 region has been 
shown to be important for regulation of immunosurveillance by targeting the antigen 
presentation pathway in multiple ways. The CD8+ cytotoxic T lymphocyte (CTL) response 
is abrogated by the down-regulation of antigen presentation via retention of MHC class I in 
the ER by the US3 gene product (Ahn et al. , 1996), destruction of MHC class I molecules 
by the US2 and US 11 proteins (Hengel et al., 1996) and inhibition of peptide loading onto 
MHC class I by prevention of TAP-mediated translocation of peptides across the ER by 
US6 (Lehner et al., 1997). Additionally, HCMV also phosphorylates the major antigen 
IE72, mediated by pp65, such that it can no longer be processed for antigen presentation to 
T cells (Gilbert et al., 1996). Furthermore, HCMV also targets the CD4+ T cell response by 
down-regulating the expression of MHC class II molecules: this occurs via the US2 gene 
product (Tomazin et al., 1999; Johnson & Hegde, 2002). The virus also encodes a viral 
homologue of IL-10 that may down-regulate MHC class II expression on the cell surface, 
with evidence of transcription during latency and productive infection 
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Figure 1.6 cns+ T cell and NK cell evasion by HCMV infected cells. During HCMV infection, the _viral 
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(Jenkins et al., 2004; Jenkins et al., 2008), although there are no data to confirm the 
importance of this homologue during productive viral infection or latency (Kotenko et al. , 
2000; Pepperl-Klindworth et al., 2006). 
Despite the numerous virus-encoded functions to evade the immune response, HCMV 
infection is generally well controlled in immunocompetent hosts. An analysis of the T cell 
antigen specificities in the memory pool has indicated that more than 1 % of the CTLs 
recognise HCMV epitopes. Although work has demonstrated that this pool can be specific 
for a number of HCMV glycoproteins, tegument proteins and others (Boppana & Britt, 
1996), it is generally accepted that the major epitopes recognised are from the pp65 and 
IE72 proteins (McLaughlin-Taylor et al., 1994; Wills et al. , 1996; Gillespie et al., 2000). 
This prevalence of HCMV-specific CTLs is likely due to the duration of primary infection 
but also probably an indication of the exposure to viral antigen upon sporadic sub-clinical 
reactivation of the virus. 
I. 7.3 HCMV additional immune evasion tactics 
A further threat to HCMV infected cells is complement mediated lysis. One study has 
shown that the virus is able to incorporate cellular proteins that are important for 
complement binding to cells, CD55 and CD59, into virions (Spear et al. , 1995). It is 
thought that delivery of these proteins into the cell upon infection could aid down-
regulation of complement and thus prevent the process leading to cell lysis. Therefore, it 
isn 't surprising that HCMV has been shown to up-regulate the expression of complement 
regulators such as CD55 and CD46 on the cell surface following infection to further 
promote an environment that prevents the action of complement (Spiller et al., 1996). The 
virus is also able to affect multiple signalling pathways between infected cells and effector 
cells of the immune system. Cells are able to respond to extracellular cytokines via the 
action of G-protein coupled receptors (GPCRs) that inactivate a number of cellular 
signalling pathways. HCMV encodes four GPCR homologues (Chee et al., 1990b) of 
which US28 appears functionally active, encoding a C-C chemokine GPCR (Neote et al., 
1993) capable of binding CC (Gao & Murphy, 1994) and CX3C chemokines (Kledal et al., 
1998). The outcome of US28 expression is likely to be the alteration of the infected cells to 
extracellular chemokines via sequestration such as those promoting chemotaxis (Bodaghi 
et al., 1998), however more recent data confounds the importance of US28 altogether 
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(Hertel & Mocarski, 2004). Chemokines likely to be affected are 'regulated on activation, 
normal T cell expressed and secreted' (RANTES) and macrophage inflammatory protein-
1 p (MIP-1 P), as following infection of endothelial cells (ECs ), RANTES secretion is 
reduced. This could possibly assist evasion of local immune responses (Billstrom 
Schroeder & Worthen, 2001 ). US28 has also been proposed to promote smooth muscle cell 
(SMC) migration, which may be the result of intracellular signalling cascades activated 
upon binding to RANTES (Streblow et al., 2003). Viral chemokines encoded by HCMV 
also have a role during infection: the UL146 gene product encodes a potent alpha 
chemokine, vCXC-1, which is an IL-8 homologue (Penfold et al., 1999) that attracts 
neutrophils and possibly myeloid cells expressing CXCR2 to the site of infection. It is 
possible that the biological role of this process is to attract cells that may be able to 
disseminate the virus to other sites in the host, including cells known to be sites of latency. 
The importance of this type of process has gained further weight with a study suggesting 
that HCMV infection may promote monocyte differentiation and migration as a vehicle for 
dissemination (Smith et al. , 2004), although other studies have suggested that HCMV 
infection inhibited differentiation, perhaps aiding the formation of latency (Gredmark & 
Soderberg-Naucler, 2003). 
1.8 Latency and reactivation 
Latency, or the ability of a virus to establish a lifelong persistent infection of a host in the 
absence of any detectable production of infectious virus, is a property of HCMV that is 
common to all the herpesviruses (reviewed in: Sinclair & Sissons, 2006; Sinclair, 2008). 
Establishment of latency occurs following primary infection and, although a hallmark of 
the herpesviridae, is not exclusive to this family. For instance other viruses such as the 
retroviruses also appear to persist as a latent infection. Latency is likely to be broken by 
sporadic reactivation events, ultimately facilitating dissemination, and normally only 
leading to either sub-clinical or benign clinical symptoms. However, reactivation of 
herpesviruses can pose a serious health threat in patients who are severely 
immunocompromised or immunosuppressed, particularly in the case of HCMV, and thus a 
number of studies have been undertaken to determine the mechanisms that control this 
event. 
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1. 8.1 Sites of human herpesvirus latency 
In order to understand HCMV latency, it is first important to establish where or in which 
cell types the virus is latent. Sites of latency of human herpesviruses differ between the 
sub-families and species of each. The alphaherpesviruses HSV-1 and HSV-2 are 
neurotropic. After primary replication at the site of infection, HSV -1 is able to gain access 
to sensory nerve terminals and, following retrograde axonal transport to neuronal cell 
bodies, is able to establish latency within trigeminal ganglia. In the case of HSV-2, which 
is usually sexually transmitted, this occurs within neurons of the anatomically related 
sacral ganglia (Efstathiou & Preston, 2005). 
The gamrnaherpesvirus Epstein-Barr virus (EBV), a member of the Lymphocryptovirinae, 
is restricted to the B lymphocyte population of the lymphoid cell lineage. Infection of 
resting B cells results in their conversion to a lyphoblastoid cell which can be propagated 
as a lymphoblastoid cell line (LCL) (Aman et al., 1994; Aman et al., 1996) and defines the 
oncogenic potential of the virus. Similarly, another gammaherpesvirus Kaposi's Sarcoma-
associated herpesvirus (KSHV) is also able to establish a persistent infection of latently 
infected B cells (Decker et al., 1996). In addition, like EBV, infection of B cells with 
KSHV causes transformation to a LCL phenotype (Kliche et al., 1998). 
Similar to the other sub-families of the herpesvirus family, betaherpesviruses share a 
number of similarities in growth kinetics, genomic structure and coding and indeed also 
share sites of latency. The DNA of the Roseoloviruses HHV-6A and HHV-6B can be 
detected in the peripheral blood mononuclear cells (PBMC) of healthy seropositive 
individuals (Cuende et al., 1994) as is the case with HCMV (Taylor-Wiedeman et al. , 
1991 ). However, both HHV-6 sub-species and HHV-7 additionally show a preferential 
tropism for T lymphocytes (Ablashi et al., 1991 ), whereas in contrast the presence of 
HCMV DNA in T lymphocytes cannot be detected (Taylor-Wiedeman et al., 1993). 
1.8.2 HCMV latency and the myeloid lineage 
Healthy HCMV-seropositive blood donors are able to transmit HCMV infection and 
transmission of HCMV in donated blood can be reduced by using leukocyte depleted blood 
products. Consequently, one site of carriage of the virus has long been proposed to be in 
the peripheral blood compartment (Yeager et al, 1981; Adler, 1983; Tolpin et al., 1985; de 
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Graan-Hentzen et al., 1989). However, identification of the blood component carrying 
viral genome only occurred with the advent of sensitive analysis techniques such as 
polymerase chain reaction (PCR) allowing detection of low copy numbers of viral DNA 
sequences viral DNA. Using this approach, many groups have been able to show the 
presence of HCMV DNA · in the peripheral blood leukocytes of healthy seropositive 
individuals (Taylor-Wiedeman et al., 1991; Stanier et al., 1992; Larsson et al., 1998). 
Further analysis, using granulocyte-macrophage colony-stimulating factor (GM-CSF)-
mobilised peripheral blood cells has shown that the frequency of mononuclear cells 
carrying viral genome could be as low as 1: 10,000 (Slobedman & Mocarski, 1999). 
By sorting PBMC, it has now been shown a major site of carriage of the virus is the 
peripheral blood monocyte population (Taylor-Wiedeman et al., 1991; Larsson et al., 
1998). Monocytes arise from pluripotent CD34+ stem cells present in bone marrow, which 
are able to differentiate along the myeloid lineage to monoblasts, then promonocytes in the 
bone marrow before entering the blood stream where they lose the CD34 surface antigen 
and develop into monocytes (Katz et al. , 1985). Interestingly, the presence ofHCMV DNA 
can also be detected in these CD34+ bone marrow progenitors (Mendelson et al., 1996). 
Interestingly, these progenitor cells are also able to develop into B cells, T cells and 
polymorphoneuclear leukocytes (PMNL). However, HCMV genome has never been 
detected in these cells (see Fig. 1.7) (Taylor-Wiedeman et al., 1991; Taylor-Wiedeman et 
al., 1993). Analyses using reverse transcription (RT)-PCR with the aim of detecting viral 
lytic transcripts in CD34+ cells and myeloid derivatives of healthy, seropositive carriers 
has also failed to detect viral IE gene expression despite the presence of HCMV genome in 
these cells (Taylor-Wiedeman et al., 1994; Mendelson et al., 1996), consistent with a lack 
of any virus production. However, differentiation with hydrocortisone (HC) or phorbol 
myristate acetate (PMA) to a macrophage-like cell was sufficient to initiate lytic gene 
expression (Taylor-Wiedeman et al., 1994) consistent with the finding that macrophages 
are permissive for HCMV infection in vitro (Ibanez et al., 1991 ). 
Although there is now good evidence that myeloid cells are a true site of HCMV latency in 
vivo, it is also possible that other sites of latent virus may exist in a normal healthy carrier. 
CD34+ cells, as well as giving rise to the myeloid lineage, may also be able to develop into 
endothelial cells (EC) ( Quirici et al., 2001) and therefore the possibility of this cell pool 
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Figure 1. 7 Model of HCMV latency and reactivation. Viral DNA can be detected in all cells of the 
myeloid lineage during latent carriage of a normal seropositive HCMV carrier. However, viral IE gene 
expression only occurs upon differentiation of cells (macrophage/DC) due to a change in transcriptional 
milieu conducive to MIEP activation and reactivation. (Adapted from Sinclair & Sissons, 2006). 
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acting as a reservoir for latent virus has been proposed (Jarvis & Nelson, 2002). However, 
despite circumstantial evidence that has linked HCMV with atherosclerosis (Epstein et al., 
1996), work from our laboratory has been unable to show any presence of latent viral DNA 
in ECs or vascular smooth muscle cells from a seropositive individual even though latent 
DNA could be readily detected in monocytes concomitantly (Reeves et al., 2004). Further 
work, addressing the possibility of persistence via low-level productive infection in aortic 
ECs acting as a mechanism for what appears to be latent carriage has been shown (Fish et 
al., 1996; Strehlow & Nelson, 2003). However, due to the specific tissue in question, it 
remains difficult to obtain ex viva samples from healthy seropositives to confirm these 
cells as sites of HCMV latency in viva. 
Since the carriage of HCMV genome in myeloid cells in viva is not associated with any 
substantial level of lytic infection (Taylor-Wiedeman et al., 1994; Mendelson et al., 1996), 
it is unlikely that genome persists due to low-level productive infection in these cells. 
Some evidence does support the existence of the viral genome in an episomal formation 
during carriage in monocytic cells (Bolovan-Fritts et al., 1999) suggesting that the genome 
could be maintained in a similar fashion to the EBV genome during latency. In EBV, the 
latent gene product Epstein-Barr nuclear antigen 1 (EBNAl) tethers the episomal viral 
DNA to the cellular chromosomal DNA (Adams, 1987; Leight & Sugden, 2000). However, 
there is little evidence for a latent origin of replication in HCMV, although deletion 
analyses near to the MIE region has defined a region of the HCMV genome that may be 
involved in genome maintenance during experimental latency in granulocyte-macrophage 
precursors (GMPs) (Mocarski et al., 2006). Consequently, the mechanism by which the 
HCMV genome persists in the absence of lytic infection in cells of the myeloid lineage 
remains largely enigmatic. 
I. 8. 3 Maintenance of herpesvirus latency 
The mechanism by which herpesvirus latency is maintained has been much investigated 
and studies performed across the herpesvirus families have identified a number of 
transcripts produced from viral genomes during latent infection. Most notable was the 
identification of a latency-specific, large non-coding RNA known as the latency associated 
transcript (LAT) in HSV-1 (reviewed in: Preston, 2000). The LAT was first identified as a 
mRNA species that was anti-sense to the alpha genes and was expressed during HSV-1 
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latent infection of neurons (Stevens et al. , 1987). Further work determined that the LAT 
was an 8.5-9kb product that was inherently unstable and was also spliced to produce a 
further major 2.2kb product (Wagner et al. , 1988), although current understanding is that 
poly A negative transcripts of 2.0 and 1.5 kb termed major LATs are derived by splicing of 
the 8.3kb primary transcript termed minor LAT (mLA T) (Efstathiou & Preston, 2005). The 
LAT has been found to regulate the establishment of latency (Thompson & Sawtell, 1997) 
and a number of mechanisms for LAT function during latency have been proposed, 
including the anti-sense down-regulation of ICPO and ICP4, modification of the genome, 
control of reactivation and active retention of the virus in the latent state (reviewed in: 
Roizman et al., 2007). Some studies have shown that the LAT actively prevents IE gene 
expression (ICPO, ICP4 and ICP27) thus promoting latency (Mador et al., 1998). This 
supports earlier work where studies using LAT null mutants demonstrated an increase in 
the overall expression of lytic genes (Garber et al., 1997) which was concomitant with a 
reduction in the number of neurons in which latent infection was established. However, 
other work has suggested the necessity of the first 1.5kb of the LAT for reactivation (Perng 
et al., 1996) and, additionally, that the LAT is responsible for preventing apoptosis and 
promoting survival of neurons during infection with HSV (Inman et al., 2001; Thompson 
& Sawtell, 2001 ). Differing opinion still exists as to the action of the LAT during 
productive infection, although it is agreed that this region remains important during latent 
infection. 
In contrast to HSV, EBV encodes a number of proteins that are expressed during latent 
infection ofB lymphocytes (reviewed in: Young & Rickinson, 2004). These latent proteins 
comprise six EBY-encoded nuclear antigens, EBNAs 1, 2, 3A, 3B, 3C and - LP, and three 
latent membrane proteins, LMPs 1, 2A and 2B. In addition, LCLs also show expression of 
small, non-polyadenylated RNAs termed EBERl and EBER2, although the function of 
these transcripts is still yet to be fully determined (Middleton et al., 1991). The expression 
of these genes can differ depending on the stage of infection and differentiation state of the 
infected cell. These differing variations of latent gene expression have been found specific 
to certain malignancies: type I latency · with Burkitts lymphoma and type II latency with 
Hodgkins disease (Rickinson & Kieff, 2007). However, the full pattern of gene expression 
described above is referred to as latency III causing proliferation of B cells whilst latency 
0/I and II only occur in resting B cells . 
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EBNAl, as well as being found to interact with promoters of other EBNAs and influence 
transcriptional regulation, is able to bind to the plasmid origin of replication (OriP) and 
maintain the episomal viral genome in the transformed cells (Sugden & Warren, 1989). 
EBNAl elicits only a poor CTL immune response due to a Gly-Ala repeat in the protein 
that limits proteasomal breakdown and its presentation on the cell surface to CTLs (Lee et 
al., 2004; Tellam et al., 2004; Voo et al. , 2004). The EBNA2 gene product is crucial for 
the establishment of transformation of cells. It appears to function by interacting with a 
sequence-specific DNA binding protein, JK-recombination-binding protein (RBP-JK), to 
activate transcription of cellular genes such as CD23 and the viral LMPl and LMP2A 
genes (Grossman et al., 1994; Hsieh & Hayward, 1995). Additionally, EBNA2 is able to 
interact with EBNA-LP which is necessary for efficient outgrowth of virus-transformed 
cells in vitro (Mannick et al. , 1991; Sinclair et al., 1994). The transcriptional activation 
driven principally by EBNA2 but also EBNA-LP, LMPl and LMP2A is directed by the 
EBNA3 family: EBNA3A-C are able to repress transactivation (Robertson et al., 1996), 
most likely through interactions of the proteins with transcriptional modulators (Radkov et 
al., 1999). 
The LMPl protein is essential for transformation of infected B cells (Wang et al., 1985; 
Kaye et al., 1993). LMP 1 has many effects on the cells from inducing the production of 
cell surface adhesion molecules and an up-regulation of anti-apoptotic genes (Eliopoulos & 
Young, 2001 ). Resembling CD40, providing both growth and differentiation signals to the 
infected B cells and acting as a constitutively activated tumour necrosis factor receptor (TNFR), LMPl activates several downstream signalling pathways in a ligand-independent 
manner (Mosialos et al. , 1995; Eliopoulos & Young, 2001). In contrast, the LMP2 proteins (LMP2A and LMP2B) are not essential for B cell transformation in vitro (Longnecker, 
2000). However, LMP2A is able to drive proliferation and survival of the B cell in the 
absence of signalling from the B cell receptor (BCR) and can transform epithelial cells and 
increase their adhesion and motility (Scholle et al., 2000). The LMP2A protein acts to 
induce gene expression of cellular genes involved in cell-cycle induction, inhibition of 
apoptosis and suppression of cell-mediated immunity which likely provides an anti-
differentiation environment to enhance cell survival (Longnecker, 2000). The result of all 
these virus directed changes to cellular signalling and gene expression ultimately cause the 
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infected cell to take on characteristics of a memory B cell to aid long term maintenance of 
the viral genome. 
The betaherpesviruses have also been found to encode latency associated transcripts. 
HHV-6 appears to encode a single latency transcript in the PBMCs of seropositive hosts 
(Rotola et al., 1998; Kondo et al., 2002). Transcripts from across the U94 gene locus have 
been detected and although their exact function remains unclear, they appear to promote 
the establishment of latency through inhibition of viral lytic gene expression (Rotola et al. , 
1998). In contrast, no latent transcription has been found associated with HHV-7 infection 
ofPBMC. 
Latency associated transcripts have also been analysed during HCMV infection. Using 
experimental latency models of GMPs, several transcripts have been identified that are 
expressed in the absence of virus production in long term culture (Kondo et al. , 1994; 
Kondo & Mocarski, 1995). These transcripts have been termed cytomegalovirus latency-
specific transcripts (CLTs) and include novel spliced and unspliced transcripts from both 
strands of the HCMV MIE region of the genome. Some of these transcripts have also been 
identified in healthy, seropositive carriers of the virus (Kondo & Mocarski, 1995; Kondo et 
al., 1996; Hahn et al., 1998) as well as in infected cells in culture (Lunetta & Wiedeman, 
2000). Antibodies to some putative CL T ORFs have also been detected in healthy carriers 
(Landini et al. , 2000). However, no viral gene products from any of these regions have, so 
far; been confirmed to play a role during viral latency. Using the same experimental 
system, a novel transcript from the ULI 11.5A region of the genome has also been 
identified that is predicted to encode a viral homologue of IL-10 (vlL-10) with the 
suggestion that expression during latency may aid avoidance of the immune system. 
However, this transcript has also been detected in monocytes from HCMV seronegative 
individuals (Jenkins et al. , 2004) and therefore its importance remains somewhat unclear. 
Long term growth of CD34+ progenitor cells from healthy seropositive individuals has also 
been used to further examine the possibility of viral transcription and gene expression 
during latency (Goodrum et al., 2002). Initial work identified a number of viral RNAs 
associated with carriage of the virus in the absence of the production of viral progeny. 
However, some transcripts detected were known lytic cycle genes (Goodrum et al. , 2002). 
- 39 -
1. Introduction 
Further analysis of the sub-populations of these cells showed that different sub-populations 
were able to support HCMV infection to different levels, ranging from productive infection 
to latency (Goodrum et al., 2004). Consequently, whether these transcripts identified truly 
represent latency associated transcription awaits further analysis. However, based on this 
work, analysis of RNA isolated from monocytes of healthy seropositives has identified 
viral transcripts anti-sense to the UL81-82 region of the viral genome from which the 
MIEP transactivator phosphoprotein pp71 is encoded (Bego et al., 2005). This led to the 
suggestion that the gene product could be involved in the maintenance of latency by 
restricting the induction of IE gene expression (Bego et al., 2005), although there is no 
direct evidence for this. Furthermore, an additional transcript identified during 
experimental infection of hematopoietic progenitor cells in vitro and confirmed in viva is 
produced from UL138, an ORF of the ULb' region, and may help to establish or maintain 
latency during natural infection (Goodrum et al., 2007). 
1. 8. 4 Herpesvirus reactivation 
Reactivation from latency is dependent upon the initiation of lytic gene expression from 
endogenous virus genomes which necessarily must occur in the absence of transactivating 
virion structural proteins. Reactivation has been linked to a number of scenarios, including 
host stress and immunosupression. 
Many studies on HSV have provided evidence that the exit of the virus from a latent state 
is dependent on the activation and expression of ICPO (Wilcox et al., 1997). Infection 
studies with ICPO null mutants at a low multiplicity of infection (MOI) have shown a 
predisposition of the viruses to a latent state (Stow & Stow, 1986; Sacks & Schaffer, 1987) 
and these mutants also show greatly reduced ability to reactivate form latency in animal 
models (Leib et al., 1989; Halford & Schaffer, 2001). In addition, it has also been shown 
that ICPO expression is capable of aiding reactivation of the latent genome (Harris et al., 
1989; Zhu et al., 1990; Preston & Nicholl, 1997). Although, in these experiments the 
differences between the ICPO null mutants used and the methods of quantifying the 
efficiency of reactivation does make it difficult to determine how important ICPO is during 
this transition. Furthermore, additional analyses have focussed on the possibility of 
reactivation being a consequence of the number of virus genomes present per infected cell: 
work with infected mice demonstrated a correlation of reactivation with the number of 
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latently infected neurones in the ganglia (Sawtell, 1998) whilst infection of permissive 
cells with ICPO-null mutants illustrated a limit of the efficiency of reactivation at low 
MOis and that competition between genomes occurs at high MOis (Preston, 2007). 
However, it remains that most models of HSV reactivation focus on either the activation of 
the ICPO promoter and subsequent ICPO expression through induced cellular factors or the 
induction of cellular proteins that imitate the action of ICPO (Cai & Schaffer, 1991; Yao & 
Schaffer, 1995; Jordan et al., 1998; Loiacono et al. , 2003). The expression of ICPO, which 
is a promiscuous activator of viral gene expression and functions as a DNA sequence-
independent transcription factor (Efstathiou & Preston, 2005), leads to the activation of 
many promoters most likely through a RING finger domain that mediates E3 ubiquitin 
ligase action (Everett et al., 1998b ). Subsequently, targeted ubiquitination leads to the 
proteasomal degradation of a number of cellular proteins, including components of ND 10 
(for further discussion see section 1.11 ). Another feature ofICPO that may aid its role as a 
mediator of reactivation is the ability of the protein to interact with a number of other 
cellular and viral proteins (Hagglund & Roizman, 2004). One such viral protein is ICP4. 
Some studies have suggested that co-activation of ICPO and ICP4 could be sufficient for 
the initiation of reactivation (Yang et al. , 2002). Therefore, although the data are not 
completely equivocal either in vitro or in viva analysis, it appears that the reactivation of 
HSV is likely to be dependent on the activation of IE gene expression but this still remains 
in need of further examination. 
The reactivation process of the gammaherpesviruses is exemplified by EBV. As with HSV, 
although the process is still not fully understood, it is likely to involve the down-regulation 
of latency associated viral proteins and the reactivation of lytic gene expression. 
Reactivation of EBV from Burkitts lymphoma cell lines can be induced by cross-linking of 
surface immunoglobulins or by the addition of TGFP (Takada & Ono, 1989; di Renzo et 
al., 1994). The exact consequences of these effectors are unknown, although it is likely that 
they cause a change to the transcriptional milieu of the cell which is conducive for 
expression of the master regulator of EBV lytic activation, BZLFl. Furthermore, specific 
elements (Zp) have been found in the promoter of BZLF 1 which are necessary for 
reactivation of BZLFl expression in response to BCR cross-linking (Binne et al., 2002). In 
addition, recent work has identified other transcription factors that are involved in the 
reactivation of BZLF 1 expression in certain latent cell types: in plasma cell lines and other 
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lymphoid lines, the plasma cell differentiation factor XBPl has been shown to activate 
expression of IE genes (Sun & Thorley-Lawson, 2007). Also, a further cellular 
transcription factor ZEB 1 has also been found recently to mediate reactivation, although in 
infected 293 cells (Yu et al. , 2007b ). Indeed, it is now thought that changes in the 
chromatin structure of the BZLF 1 promoter is critical for regulation of latency and 
reactivation (Bryant & Farrell, 2002), which may be mediated by differentiation-dependent 
transcription factors. It is becoming increasingly clear that reactivation of EBV may 
mechanistically be similar to that of HCMV. 
The clear link between the process of differentiation of a myeloid cell infected with 
HCMV and reactivation of IE gene expression (Taylor-Wiedeman et al., 1994) and 
production of infectious virus (Soderberg-Naucler et al., 1997) has led to the prediction 
that HCMV reactivation is ultimately dependent upon myeloid cell differentiation. A 
number of model cell lines predict that HCMV latency may involve repression of IE gene 
expression upon infection through the action of transcription factors which repress the viral 
MIEP present specifically in undifferentiated cells. However, upon differentiation, the 
transcriptional milieu of the cell alters and an environment that is conducive for IE gene 
expression occurs (Sinclair & Sissons, 2006). Unfortunately, the lack of animal models for 
HCMV and the lack of tractable in vitro model systems for HCMV latency have made 
analysis to determine the factors which control HCMV reactivation difficult. 
Although there are few good model systems in which to systematically analyse factors 
controlling HCMV latency and reactivation in vitro , certain cell systems that recapitulate 
the differentiation-dependent regulation of viral IE gene expression have been useful for 
these types of analyses. Certain cell models have led to an understanding of the role of 
cellular transcripti6nai activators and repressors of viral gene expression in latency and 
reactivation (Meier & Stinski, 1996). The embryonal carcinoma cell system NT2Dl (T2 
cells) and the myelocytic myeloma cell line THP 1 are non-permissive for viral infection 
due to a block in major IE gene expression. However, their differentiation results in a fully 
permissive phenotype. Both these cell lines have been used extensively to determine 
cellular factors important for permissiveness of HCMV infection and will be further 
discussed in Chapter 5. In general, however, overall it has been shown that decreases in 
transcriptional repressors concomitant with increases in transcriptional activators of viral 
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IE gene expression dictate permissiveness for HCMV IE gene expression and that this is 
mediated by chromatin remodelling of the MIEP (Murphy et al. , 2002). 
1.9 HCMV major immediate early region 
As alluded to earlier, whether the outcome bf HCMV infection is lytic or latent appears to 
be determined by whether or not viral IE gene expression is supported in the infected cell. 
The commencement of a fully lytic cycle is absolutely determined by whether 
transcriptional activation of MIE gene expression occurs and this depends on whether the 
major immediate early promoter (MIEP) is activated or repressed. 
1.9.J HCMVmqjor immediate early promoter (MIEP) 
The HCMV MIEP, sometimes termed the MIE promoter/enhancer, is one of the strongest 
known transcriptional promoters. The MIEP is composed of a number of different regions: 
a core promoter; an enhancer region, split into proximal and distal areas; a unique region; 
and a modulator area (see Fig. 1.8). Although the regulation of the MIEP is not fully 
understood, much information has been gained by transfection analyses of MIEP reporter 
constructs. Such analyses have shown that the transcriptional activity of the MIEP varies 
according to a number of criteria, including cell type, differentiation status and the activity 
of certain signalling pathways (reviewed in: Meier & Stinski, 1996). Overall, it has been 
determined that the conditional activity of the MIEP results from a range of cellular and 
viral factors that are able to both positively and negatively regulate MIEP transcriptional 
activity. 
The enhancer region of the HCMV MIEP is around 540bp in length and the two halves of 
the enhancer, distal and proximal, appear structurally divergent but function together to 
cause efficient promoter activation (Meier & Pruessner, 2000; Isomura & Stinski, 2003). It 
has been suggested that the distal element of the enhancer is important for interaction with 
virion components during lytic infection, as removal of this region has been found to 
significantly decrease MIEP activity at lows MOis but this can be overcome with infection 
at higher MOis (Meier & Pruessner, 2000; Meier et al., 2002). Indeed, the presence of 
multiple cis-acting elements in the distal enhancer has been shown to determine promoter 
activity (Meier et al., 2002). Experiments using truncation analysis of the proximal end 
have also demonstrated further positive cis-acting elements due to the progressive loss of 
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promoter activity (Isornura et al., 2004). Activation and repression of the MIEP is 
regulated by the range of cellular transcription factors that bind to these described elements (see Fig. 1.8). Some factors have multiple binding sites along the enhancer, whereas other 
factors bind to specific repeat elements within the MIEP (17, 18, 19 and 21bp). For instance, there are at least four 18bp repeat elements in the enhancer that bind NF-KB. Similarly, 19bp elements in the enhancer are able to bind CREB/ A TF (Hunninghake et al., 1989; Sambucetti et al., 1989). Additionally, these 19bp elements also bind Spl (Lang et 
al., 1992). The activity of each of these transcription factors is modulated by the 
environmental conditions set by the infected cell as well as the virus. The binding of positive factors is thought to strengthen basal transcription complex formation and aid 
recruitment of co-activators, such as chromatin remodelling enzymes, to the promoter. Studies of recombinant viruses with targeted mutations in the unique region or enhancer have shown little change to MIEP activity (Meier & Stinski, 1997; Pruessner & Meier, 2000; Meier, 2001 ). Similarly, specific mutations of the enhancer's cyclic AMP response 
element (CRE) or NF-KB binding sites show minimal effects during lytic infection (Keller 
et al., 2003; Benedict et al., 2004; Gusterns et al., 2006). This is also true of the Spl binding sites, although in conjunction with the removal of Sp3 sites some effects on 
transcription and replication could be detected (Isornura et al., 2005). However, these 
findings may also be due to trans-acting viral components such as pp 71 , UL69, TRS 1 /IRS 1 
and UL35 compensating for loss of sites at the MIEP (Liu & Stinski, 1992; Winkler & Starnrninger, 1996; Romanowski et al., 1997; Horner et al., 1999; Bresnahan & Shenk, 2000; Schierling et al., 2004). The unique region is also able to bind additional 
transcription factors such as PDXl (Chao et al., 2004). Similarly, the modulator element has an imperfect dyad symmetry which other factors bind specifically (Boshart et al., 1985; Lubon et al., 1989). These factors also have an impact on the expression of the 
UL127 ORF that is located in this region in the opposite direction to that of the MIEP but 
is not seen to be expressed during permissive infection of fibroblasts (Lundquist et al., 1999; Angulo et al., 2000; Lashmit et al., 2004; Lee et al., 2007b; Stinski & Isornura, 2008). Furthermore, the modulator has been shown to be sensitive to DNase I and this 
sensitivity changes depending on the differentiation status of the infected cell (Nelson et 
al., 1987; Lubon et al., 1989). Indeed, changes in binding of transcription factors may be important for differentiation-dependent regulation of permissiveness for lytic infection (Lubon et al., 1989; Ghazal et al., 1990; Nelson et al., 1990). A number of sequence 
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analyses have identified putative binding sites for a range of other transcription factors that 
may be able to associate with the MIEP and are known to act as transcriptional repressors: 
modulator binding factors (Shelbourn et al., 1989; Kothari et al., 1991), Yin Yang 1 (YYl) 
(Liu et al., 1994), methylated DNA-binding protein (MDBP) (Zhang et al. , 1991), 
modulator recognition factor (MRF) (Huang et al., 1996), growth factor independence- I 
(Gfi-1) (Zweidler-McKay et al., 1996), CCAAT/enhancer binding proteins (C/EBP) 
(Prosch et al., 2001) and Ets-2 repressor factor (ERF) (Bain et al. , 2003). It has been 
suggested that it is a balance of these activators and repressors that may be key to 
determining lytic or latent infection in a differentiation-dependent manner (Sinclair & 
Sissons, 1996). Three copies of the 21 bp repeat elements in the enhancer, as well as in the 
upstream modulator, have been shown to mediate transcriptional repression of the MIEP in 
undifferentiated cells (Nelson et al., 1987; Kothari et al., 1991; Sinclair et al., 1992; Liu et 
al., 1994). Indeed, YYl, ERF and silencing binding protein (SBP) have been shown to 
bind to these repeats in vitro (Liu et al., 1994; Huang et al., 1996; Thrower et al., 1996; 
Bain et al., 2003). However, removal of the 21bp repeats, the modulator or both from the 
viral genome has not shown a loss of repression of MIEP activity in undifferentiated cells 
(Meier & Stinski, 1997; Meier, 2001), although a loss of these sites does lead to a 
perturbation of IE gene expression even in permissive cells (Pruessner & Meier, 2000). 
Hence, confirmation of the role of the 21 bp repeat elements in the regulation of latency and 
lytic gene expression during infection still requires confirmation. Whilst mutation of CRE 
sites in the enhancer appears to have little effect to productive infection of a permissive 
cell type, stimulation of the cAMP signalling pathway by treatment with forskolin (FSK) 
has been shown to alleviate silencing of the MIEP in an undifferentiated non-permissive 
cell type (Keller et al., 2007). 
Although there is· good knowledge of the cellular transcription factors that regulate the 
viral MIEP, the mechanism by which negative regulators repress MIEP activity is still 
unclear. However, recently, the molecular mechanisms by which the MIEP may be 
regulated have been investigated using the T2 and THP 1 differentiation-dependent cell 
models. Using these cells, it has been found that the level of YYl protein decreases during 
differentiation whereas, . contrastingly, the steady state level of ERF does not (Pizzorno, 
2001; Bain et al., 2003). Thus, repression of the MIEP cannot simply be linked to the 
levels of repressor factors within the cells. Indeed, it is now known that it is the ability of 
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these factors to interact physically with and recruit chromatin remodelling enzymes that 
provides the ability to modulate MIEP activity (Wright et al., 2005). This mechanism and 
process of regulation of the viral MIEP will be discussed further in section 1.10. 
1.9.2 HCMV major immediate early proteins 
The MIEP drives the production of the major IE primary transcript that is differentially 
spliced to produce five mRNA species (Shirakata et al., 2002) (see Fig. 1.9). The MIE 
proteins produced from these transcripts include the most abundant IE72 protein (sometimes known as IE1, IE1-p72 and UL123), the IE86 protein (IE2, IE2-p86 and 
UL122) as well as more minor products which include p55 (IE2-p55), p38 (IE1-p38) and 
p 18 (IE2-p 18) (Wathen & Stinski, 1982; Stinski, 1993; Stenberg, 1996). Both IE72 and 
IE86 are conserved across the betaherpesvirus subfamily. 
IE72 is composed of 491 amino acids and is encoded by exons 2, 3 and 4 of the MIE 
region. It can be post-translationally modified by phosphorylation and sumoylation (attachment of small ubiquitin-like modifiers (SUMO)) (Pajovic et al., 1997; Xu et al., 
2001; Spengler et al., 2002). Upon expression, IE72 localises to the nucleus of lytically 
infected cells and locates to NDlO, causing their dispersal (see section 1.11) (Korioth et 
al., 1996; Ahn & Hayward, 1997; Ahn et al., 1998a; Wilkinson et al., 1998; Muller & 
Dejean., 1999). IE72 is also able to interact with metaphase chromatin (Lafemina et al., 
1989; Ahn et al., 1998a; Wilkinson et al., 1998; Nevels et al., 2004a; Reinhardt et al., 
2005). At low MOis, IE72 deletion viruses have defects in viral early and late gene 
expression, viral DNA synthesis as well as genome replication and plaque formation. 
However, this can be compensated for by high MOis (Mocarski et al., 1996; Greaves & 
Mocarski, 1998; Gawn & Greaves, 2002). Much of the work carried out on IE72 has been 
performed using transient transfection assays and these in vitro analyses have suggested 
that IE72 is able to promote transcription from various viral and cellular promoters. The 
IE72 protein is thought to carry out this function in a number of ways: physical interaction 
between IE72 and a number of transcriptional regulators important during cell cycle (see 
section 1.6.5). Association of IE72 with factors involved with initiation of transcription 
and NDl O associated proteins also occurs (see section 1.11 below) (Hayhurst et al., 1995; 
Margolis et al. , 1995; Poma et al., 1996; Lukac et al., 1997; Yurochko et al., 1997; Ahn et 
al., 1998a; Tang & Maul, 2003 ; Nevels et al., 2004b). IE72 is also known to be able to 
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Figure 1.9 Differential splicing of the MIE region. Differential splicing of the primary transcript results in the production of a number of MIE transcripts and gene products. The products can be split into two groups: the major products (IE72 and IE86) and the minor products (p55, p38 and pl8), although all share the first 3 exons (open boxes) and production of each is regulated by the enhancer. (Adapted from Shirakata et al., 2002). 
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promote the phosphorylation of certain cellular transcription factors, including pRB, E2F 
family members and c-Jun via its own kinase activity. Additionally, IE72 can promote the 
phosphorylation of other factors through the activation of cellular kinases (JNK and 
cyclinE/cdk2 kinase) in addition to interaction with the RelB NF-KB subunit (Pajovic et 
al., 1997; Zhang et al., 2003; Wang & Sonenshein, 2005). Furthermore, IE72 has also been 
demonstrated to interact with components of and cause the disruption of NDlO, 
overcoming this transcriptionally repressive cellular environment that will be discussed 
further in section 1.11 (Muller & Dejean, 1999; Xu et al., 2001; Tang & Maul, 2003; 
White & Spector, 2004). IE72 has also been found to direct cell cycle to an early S-like 
phase and impede cell apoptosis during infection, whilst it may also be able to inhibit the 
interferon response (Zhu et al., 1995; Castillo et al., 2000; Yu & Alwine, 2002). 
Intriguingly, IE72 is also able to stimulate transcription from the MIEP and through 
covalent linkage to SUMO-I during infection via lysine 450 may also be able to increase 
expression of IE86 (Cherrington & Mocarski, 1989; Nevels et al., 2004a). However, whilst 
the two MIE proteins are often found to synergistically transactivate promoters, IE72 has 
not been shown to physically interact with DNA or IE86 directly. 
IE86 is a 579 amino acid protein corresponding to exons 2, 3 and 5 of the MIE region. 
IE86 is able to form homodimers and, upon lytic infection, locates to the periphery of 
ND 10. However, it plays no role in dispersal of these domains (Macias & Stinski, 1993; 
Ishov et al., 1997; Ahn et al., 1998a). The indispensable nature of IE86 to the HCMV lytic 
cycle has been revealed using recombinant viruses with mutations in the protein, as with 
the functional homologue of MCMV, and the importance of IE86 during infection is 
highlighted during highjacking of the cell cycle (discussed in more detail in section 1.6.5.) 
(Angulo et al., 2000; Marchini et al., 2001 ). IE86 expression is vital for activation of viral 
early and late genes and also auto-repression during infection: due to its absolute 
indispensable nature all efforts to produce IE86 null mutants have failed (Marchini et al., 
2001; Heider et al., 2002a; White et al. , 2004). Therefore, as with IE72, much of the 
information established concerning IE86 function has arisen from the use of transient 
expression assays. These studies have demonstrated that IE86 is able not just to act as a 
transactivator of a range of viral and cellular promoters but also as a trans-repressor of the 
MIEP itself. The gene product is able to interact with TA TA boxes and specific cis-
elements via cellular transcription factors to stimulate RNA polymerase II-dependent 
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transcription. These interactions occur through components of the basal transcription 
initiation complex, such as TBP, certain transcription factors and also histone 
acetyltransferases (HATs) (Hagemeier et al., 1992a; Caswell et al., 1993; Furnari et al., 
1993; Jupp et al., 1993b; Lukac et al. , 1994; Sommer et al., 1994; Spier et al., 1994; Scully 
et al., 1995; Schwartz et al., 1996; Bonin & McDougall, 1997; Fortunato et al., 1997; 
Lukac et al., 1997; Bryant et al., 2000). In addition, IE86 is also able to cause 
transcriptional activation of viral early genes, including the ULl 12-113 region, via binding 
to a 14bp sequence of DNA that is upstream to the start site of transcription (Scully et al., 
1995; Rodems et al., 1998). Conversely, and rather intriguingly, IE86 is able to negatively 
autoregulate expression from the MIEP by binding the minor groove of a palindromic cis-
repression sequence (crs) between -13 to -1 relative to the transcriptional start site and 
affect the assembly of the pre-initiation transcription complex as well as the chromatin 
structure of the MIEP at late times of infection (Pizzomo & Hayward, 1990; Cherrington et 
al., 1991; Liu et al., 1991; Jupp et al., 1993a; Lang & Stamminger, 1993; Macias & 
Stinski, 1993; Wu et al., 1993; Reeves et al., 2006; Isomura et al., 2008a). It has also been 
found that the ability of IE86 to act as a transcriptional activator can be modulated by post-
translational phosphorylation of the protein as well as by sumoylation (Harel & Alwine, 
1998; Hofmann et al., 2000; Ahn et al. , 2001; Heider et al., 2002b; Barrasa et al. , 2005). 
Interestingly, despite the importance of IE86, the protein's amino acid sequence does differ 
amongst HCMV strains such that transcriptional activation of target promoters can be 
affected in assay systems. However, it is not known whether these differences affect the 
life cycle of the virus (Barrasa . et al. , 2003). Furthermore, although functions, such as 
inhibition of the IFN~ response and post-infection chemokine expression induction, have 
also been attributed to the IE86 gene product (Taylor & Bresnahan, 2005; Taylor & 
Bresnahan, 2006) effects including inhibition of apoptosis and transformation of cells still 
require further work to fully determine these roles for IE86 (Lukac & Alwine, 1999). 
1.10 Chromatin remodelling and regulation of gene expression 
I. I 0.1 Introduction 
It is now well recognised that the control of cellular gene expression involves not only the 
formation or inhibition of the transcriptional pre-initiation complex and the recruitment of 
certain basal transcription factors at gene promoters but also the higher order chromatin 
structure. As the understanding of the role chromatin structure plays in the regulation of 
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cellular gene express10n has advanced, it has also become apparent that chromatin 
structure may also play an important role in the regulation of viral gene expression. 
1.10. 2 Chromatin, hist ones and the nucleosome 
The term chromatin was first used by Flemming in 1882 to describe what he believed to be 
a nuclear scaffold that absorbed dye specifically at sites within the nucleus (Flemming, 
1882). It is now well established that chromatin is a complex of double stranded DNA with 
histone proteins that form the sub-unit of chromatin, nucleosomes (Kornberg, 1974; Oudet 
et al., 1975). Nucleosomes are present along a length of DNA with a characteristic 'beads 
on a string' appearance when viewed using an electron microscope (Oudet et al., 1975) and 
have been found to be composed of a number of histone proteins. Specifically, the 
nucleosome core comprises two copies each of histones H2A, H2B, H3 and H4 arranged 
into an octamer that interacts directly with the DNA (see Fig. 1.10) (Chung et al., 1978). A 
further association of histone Hl then secures the complex and its position on the length of 
DNA such that digestion with micrococcal nuclease first produces -166bp particles whilst 
histone H 1 is in place before further digestion results in -146bp particles after the loss of 
protection associated with Hl (Thomas, 1999). After nucleosomal construction, the 
chromatin can then be further compacted into the higher order 30nm solenoid form 
providing the distinctive electron dense appearance of cellular chromosomes. This 
compaction of DNA by higher order chromatin folding permits over one metre of DNA to 
be accommodated within the eukaryotic nucleus. However, it also results in an 
accessibility dilemma for DNA replication and transcription machinery. Initially, it was 
proposed that chromatinised DNA was transcriptionally inactive and that removal of the 
nucleosome complex would be necessary for transcriptional activation (Oudet et al., 1975). 
Later, it was found that the remodelling of chromatin structure within specific regions of 
DNA was playing a part in the regulation of transcription (Weintraub & Groudine, 1976; 
Lilley & Pardon, 1979) but that transcriptionally active DNA was not necessarily free from 
histone association (Kuo et al., 1998). More recently, it -has become established that it is 
biochemical modification by histone modifying enzymes of amino-terminal tails of the 
core histone proteins that leads to a change in the conformation of the chromatin structure 
(see Fig. 1.10). The possible modifications to each histone are numerous with over sixty so 
far detected and some will be discussed below (reviewed in: Berger, 2007; Kouzarides, 
2007a) (summarised in Table 1.2). However, overall, the remodelling of the chromatin 
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Figure 1.10 Nucleosome and chromatin structure. (A) The nucleosomal structure is composed of two 
copies each of histones H2A, H2B, H3 and H4 that form a complex and interact directly with double 
stranded DNA (dsDNA). This structure is subsequently stabilised by the association of histone HI with the 
dsDNA. (B) Nucleosomes along the length of dsDNA lead to the 'beads on a string' chromatin 
arrangement that is visible via electron microscopy. The histone tails, shown protruding from the 
nucleosomal structure in the cartoon, can be modified by chromatin remodelling enzymes which lead to 
changes in the local chromatin structure. Nucleosome sliding along the length of the dsDNA can also occur. 
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structure either leads to a more open or a more closed conformation generally resulting in 
transcriptional activation or repression, respectively (see Fig. 1.11 ). This determination of 
the transcriptional ability of chromatin based on the quantity and quality of the histone 
modifications has been termed the histone code hypothesis (Strahl & Allis, 2000). 
1.10. 3 Histone acetylation 
Chromatin remodelling can take place through changes to the contacts between different 
histones in adjacent nucleosomes or alterations to the interactions of histones with the 
associated DNA. Acetylation is one of the most well characterised post-translational 
modifications of histones and has the greatest potential to unfold chromatin as it neutralises 
the basic charge of the lysine. This has led to a strong correlation of histone acetylation 
with transcriptionally active regions of the eukaryotic genome (Kuo & Allis, 1998; Lusser, 
2002). The acetylation of amino-terminal lysines of histone tails that are more accessible 
for modification takes place via the action of histone acetylatransferases (HA Ts ). These 
enzymes can be divided into three main families : GNAT, MYST and CBP/p300 (Sterner & 
Berger, 2000). In general, the enzymes are able to modify more than one lysine, although 
some specificity occurs. Positively charged lysine residues are likely to form stable 
interactions with the negatively charged DNA producing a closed conformation of 
chromatin structure and repressing transcriptional activity. However, once acetylated, the 
association is disrupted and a more open conformation chromatin structure produced that 
allows access of transcription factors and the pre-initiation complex to the DNA (Cary et 
al., 1982; Bode et al. , 1983; Morgan et al., 1987). It has also been posited that acetylated 
lysine residues may also act as binding or recognition sites for bromodomains of other 
proteins that could allow association of chromatin remodelling enzymes, such as HA Ts, 
and components of the TF11 D transcription complex including TAF11250 (Dhalluin et al., 
1999; Jacobson e(al., 2000; Zeng & Zhou, 2002). 
As lysine acetylation, predominantly on histones H3 and H4, is associated with 
transcriptional activation, histone deacetylation correlates with transcriptional repression. 
This is likely due to a reversion in charge of histone protein and a subsequent closer 
association of DNA (Lusser, 2002). The process of lysine deacetylation is again carried out 
by a group of enzymes known as the histone deacetylases (HDACs) that can be sub-
divided into class I, II and IV HDACs and the class III NAD-dependent enzymes of the Sir 
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Histone modification Residue modified Position of modification Transcriptional function on histone* 
H3 (9, 14, 18, 56) 
Acetylation (ac) Lysine (K) H4 (5 , 8, 13, 16) Activation H2A 
H2B 
H3 (4, 36, 39) Activation 
Lysine (K) 
H3 (9, 27) Methylation (me) H4 (20) Repression 
Arginine (R) H3 (17, 23) Activation / Repression H4 (3) 
Deimination Methylated Arginine Activation / Repression (Rrne) 
Serine (S) H3 (3, I 0, 28) Phosphorylation Threonine (T) H2A Activation 
H2B 
Ubiquitination Lysine (K) H2A (119) Repression 
H2B (120) Activation 
Sumoylation Lysine (K) H2A (126) Repression H2B (6, 7) 
ADP ribosylation Glutamic acid (E) 
Proline isomerisation Proline (P) H3 (30-38) Activation / Repression 
* bold modification positions highlight those used as markers.for this study 
Table 1.2 Classes of histone modifications and function. A summary of the possible post-translational 
modifications of the amino-termini of histone tails, their position and function (Adapted from: Berger, 2007; Kouzarides, 2007) 
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family (Khochbin et al., 2001; Gregoretti et al., 2004). Most examples of these enzymes, 
again, have little specificity for a particular acetyl group. However, some yeast enzymes 
have been found to target certain residues, specifically, whilst the human enzyme SirT2 
has been recently demonstrated to have a preference for acetylated lysine 16 of histone H4 
(H4Kl 6ac) (Vaquero et al. , 2006). Although, in general histone acetylation and 
deacetylation is associated with transcriptional activation and repression, respectively, this 
is not always the case. Some promoters have been shown to become active in the absence 
of histone acetylation (Dudley et al., 1999). Hence, certain modifications have the ability 
to activate or repress under different conditions and therefore it is the context of 
modification that can decide transcriptional fate. 
1.10.4 Histone methylation 
In comparison to acetylation of histones, methylation is a much more specific process that 
can actually occur on lysine and arginine residues in amino-terminal histone tails. 
Historically, methylation of histones has been associated with transcriptional silencing and 
has been shown to be linked with epigenetic inheritance (Razin, 1998; Lachner et al. , 
2003). However, more recently, it has become clear that methylation can lead to both 
activation and repression of transcription given the context of modification (reviewed in: 
Bannister & Kouzarides, 2005; Klose & Zhang, 2007). 
Methylation of lysine residues on histone amino-terminal tails takes place through the 
action of histone methylatrasferases (HMTs). HMTs can append up to three methyl groups 
to lysine residues. This is usually catalysed by a SET domain, present in most HMTs, and 
the cofactor S-adenosyl-L-methione (SAM). Lysine methylation can have both an 
activatory or inhibitory effect on transcription. Methylation of lysines 4, 36 or 79 on 
histone H3 (H3K4, H3K36, H3K79) is implicated in activation of transcription. Indeed, 
methylated H3K4 localises to the 5' end of active genes in yeast and is associated with 
transcriptional elongation with a correlation of the initiated form of RNA pol II found 
associated also (Schneider et al., 2004). In contrast, methylation of H3K9, H3K27 and 
H4K20 is associated with transcriptional repression. Methylation of H3K9 has been 
implicated in the silencing of euchromatic genes as well as aiding the formation of silent 
heterochromatin and this appears to be dependent on the number of added methyl groups 
(Rice et al., 2003). Mono- and di-methylation of H3K9 is carried out by the G9a family of 
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Figure 1.11 Regulation of gene expression via chromatin remodelling. Control of gene expression in eukaryotes can take place via post-translational modifications to 
histone proteins associated with DNA in the chromatin complex. Methylation of histone lysine chains, a marker of transcriptionally silent regions, is performed by 
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1. Introduction 
HMTs, whereas tri-methylation of H3K9 is performed by the Suvar family of HMTs (Rice 
et al., 2003). The silencing of transcription via methylation at H3K9 also involves the 
recruitment of further markers of transcriptionally repressed chromatin, such as 
heterochromatin protein 1 (HPl). As the name suggest, HPl is predominantly found at 
sites of condensed, inactive heterochromatin and recruitment is dependent upon 
methylation of the lysine residues (James et al., 1989). HPl is also found in three isoforms: 
HP la, ~ and y (Jones et al., 2000; Maison & Almouzni, 2004). Methylation of H3K9 or 
H3K27 provides a target for the chromatin binding domain of HPl. This methylation 
promotes binding and the avidity of binding intensifies upon increasing lysine methylation 
(Khorasanizadeh, 2004). Therefore, transcriptionally silent heterochromatic regions can be 
recognised by both the association of methylated lysine residues but also HPl presence 
(Bannister et al., 2001). This dogma has been recently tested with the finding that tri-
methylated H3K9 (H3K9me3) and HPly are enriched in the coding region of active genes 
(Vakoc et al., 2005). However, it is possible that this merely highlights the fact that the 
presence of methylated histones or chromatin associated proteins may have a different 
meaning when examining the coding regions to genes. 
Since evidence has long existed that the action of HA Ts is opposed by the action of 
HDACs, it has been hypothesised that at least one enzyme must exist that de-methylates 
histone residues. The first to be discovered, lysine-specific demethylase 1 (LSDl) (Shi et 
al., 2004), has led to a number of further such enzymes (reviewed in: Kouzarides, 2007a). 
As yet, the enzymes described have two types of distinct demethylase domain: the LSDl 
domain and the JmjC domain. LSDl has been shown to have both activatory and 
repressive effects: demethylation of H3K4 causes repression of transcription, whereas, in 
androgen receptor activation, demethylaion of H3K9 causes transcriptional activation (Shi 
et al., 2004; Metzger et al., 2005). Activation and repression of transcription by Jumonji 
domain C (JmjC) enzymes has also been shown (reviewed in: Kouzarides, 2007a). Thus, it 
appears that the specificity of these enzymes relies upon ·the methylation state of lysines 
which they act upon but also the cofactors that they are bound to (Shi & Whetstine, 2007). 
In parallel to lysine methylation, argmme methylation can also result in either 
transcriptional activation or repression. Arginine methylation is carried out by protein 
arginine methyltransferases (PRMTs), with transfer of methyl groups from the SAM 
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cofactor, and these enzymes are recruited to promoters by transcription factors (Lee et al., 
2005). Interestingly, it has been found that the presence of modification of histones by 
arginine methylation sometimes appears to cycle during the activation of certain genes, 
such as at the oestrogen-regulated pS2 promoter, although the reason for this is not fully 
understood (Metivier et al., 2003). However, this is not the usual representation where the 
methylation of arginine residues on histone H4, such as H4R3, support the acetylation of 
the histone further and lead to transcriptional activation (Wang et al., 2001). In contrast to 
methylated lysine resides, there is still no evidence for the presence of any proteins that are 
either able to specifically bind to arginine-methylated histones or reverse arginine 
methylation. In spite of this, other mechanisms have been shown that may antagonise 
arginine methylation before it is able to take place. Recently, it has been shown that 
arginines are able to be deiminated such that they are converted to citrulline and cannot be 
methylated (Cuthbert et al., 2004; Wang et al., 2004c). This occurs through the action of 
the peptidylarginine deiminase 4 (PADI4) enzyme, which has also been shown in viva to 
deiminate mono-methylated arginines but not di-methylated residues (Wang et al., 2004c). 
Reversing this change has not yet been described, although the cycling of residues on 
activating promoters, such as pS2, strengthens the argument for the existence of such 
enzymes (Bannister & Kouzarides, 2005). 
I. I 0. 5 Other chromatin modifications 
Other modifications of histone residues and chromatin structure have been found to have 
effects on transcriptional regulation, although the overall functional outcome is still less 
well understood than those of acetylation and methylation. Phosphorylation of serine and 
threonine residues, mainly on histone H3, has been shown to cause activation of 
transcription. This may occur by promoting the acetylation of adjacent lysine residues (Lo 
et al., 2000) or by neutralising the effects of methylation of adjacent residues (Fischle et 
al., 2003). In addition, enzymes such as mitogen- and stress-activated protein kinase 1 
(MSKl), MSK2 as well as ribosomal serine 6 kinase, 2 (RSK2) have been shown to 
specifically target histone-H3 serine 10 (H3S 10) as well as Aurora B kinase (AuBK). 
AuBK phosphorylation of H3S 10 causes the dissociation of HPl from tri-methylated 
H3K9 and as such has been implicated in transcriptional activation (Fischle et al., 2005; 
Hirota et al., 2005). However, such phosphorylation of histones also has implications for 
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both opening and closing of the chromatin conformation, illustrating the importance of the 
context of these modifications (Berger, 2007). 
Ubiquitination is a very sizable modification that has only been found on histones H2A and 
H2B. Ubiquitination of histones has been implicated in regulatory roles during both 
mitosis and also transcription. The effects can be both repressive as well as activatory and 
may result from proteosomal degradation of ubiquitinated transcription factors (Conaway 
et al., 2002; Zhu et al., 2005; Wang et al., 2004a). Ubiquitination has also been implicated 
in transcriptional elongation by the histone chaperone FACT (Pavri et al. , 2006). It is still 
unclear how ubiquitination specifically functions to affect transcription levels. However, it 
may have a direct effect on the structure of the chromatin simply due to the size of the 
modification, opening the conformation and leading to increased access for the basal 
transcription machinery. Alternatively, ubiquitination may act to recruit other proteins in a 
similar manner to tri-methylation of H3K9 with HPl (Bannister et al., 2001). Also, 
ubiquitination may also affect the outcome of further histone modifications - a hypothesis 
still yet to be tested fully (Zhang, 2003). In yeast models, however, enzymes have been 
shown necessary to antagonise specific ubiquitination of histone residues, showing that 
both the addition and removal of ubiquitin in essential for stimulation of transcription 
(Henry et al., 2003). Deubiquitination of histone-H2B has also been implicated as a 
requirement for heterochromatic histone-H3 methylation and subsequent DNA methylation 
(Sridhar et al., 2007), which is a known epigenetic marker associated with long term 
repression. Indeed, a recent finding that monoubiquitinatioti of histone-H2B at the 5' 
coding region of mammalian genes supports the understanding of this marker as one of 
transcriptional activation (Minsky et al., 2008). 
Recently, the modification of histones via sumoylation has been highlighted, 
predominantly through studies with yeast. Initially, data suggested that sumoylation of 
histone-H4 in vivo could regulate transcription despite . the presence of the putative 
consensus sequence for sumoylation (Nathan et al., 2003; Shiio & Eisenman, 2003). 
Association of sumoylated histone-H4 with was also found with HPl and HDACl in 
immunoprecipitation assays and further work has identified additional modification sites 
on all four core histones (Nathan et al., 2006). Although it is now understood that 
sumoylation is able to antagonise both acetylation and ubiquitination of lysine residues to 
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cause transcriptional repression, the role of sumoylation is still unclear. Similarly, ADP 
ribosylation is an ill defined histone modification with respect to transcriptional regulation. 
This modification can occur as mono- or poly-ADP ribosylation and is mediated by mono-
ADP ribosyltransferases (MARTs) and poly-ADP ribose polymerases (PARPs) (Hassa et 
al., 2006). Additionally, the Sir family of NAD-dependent HDACs have been shown to 
have a low level of ADP ribosylation activity and may represent another class of this 
family. The understanding of the effects of this modification on control of transcription is 
limited but P ARP-I has recently been shown to cause chromatin changes to the oestrogen-
regulated PS2 gene during DNA repair (Ju et al., 2006). More recently, it has been shown 
that PARP-I and histone-HI have similar binding specificities to nucleosomal binding and, 
as such, PARP-I is able to exclude HI from promoters to drive transcription 
(Krishnakumar et al., 2008). Furthermore, an enzyme that causes proline isomerisation in 
budding yeast, FRP4, has been shown to distort the backbone of the histone-H3 
polypeptide such that the levels of methylation at nearby lysine residues is affected 
(Nelson et al., 2006), although the full consequence of this modification is, as yet, unclear. 
It is clear, then, that a wide range of chromatin modifications can interact synergistically or 
antagonistically for the control of transcription, DNA repair, DNA replication and 
chromosome structure throughout the cell cycle. The majority of those described have only 
come to light over the last ten to fifteen years. Hence, it is likely that enzymes capable of 
modifying histone tails in addition to those described above will continue to be identified. 
It is also important to note that, at the time of writing this thesis, a new nomenclature has 
been proposed for chromatin-modifying enzymes. This nomenclature takes into account 
the targeting of other substrates, such as non-histone proteins, such that they are named 
more generically related to the type of enzymatic activity they perform and the type of 
residue they modify. In short, this has led to the following renaming: lysine demethylases -
KDMs; lysine acetyltransferases - KA Ts; lysine methyltransferases - KMTs (fully 
reviewed in: Allis et al., 2007; Kouzarides, 2007b). However, for the duration of this 
thesis, the traditional names and terms will be used. 
1.10.6 Regulation of viral gene expression by chromatin remodelling 
It is becoming increasing clear that the ability of chromatin structure to regulate 
transcription of eukaryotic organisms also extends to the control of viral gene expression. 
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In work carried out over thirty years ago, it was demonstrated in vitro that bona jide 
nucleosome structures could be reconstituted following the incubation of phage lambda or 
adenovirus DNA with histone proteins (Oudet et al., 1975). Subsequent work has shown 
that the chromatin structure of DNA viruses has a profound regulatory effect on viral 
transcription and this plays an important role for viruses, such as herpesviruses, in the 
control of gene expression during viral latency and reactivation. 
Initial work suggesting that DNA viruses may be associated with histones employed 
electron microscopy to view the two-dimensional chromatin structure. However, more 
direct evidence that chromatin is associated with the control of virus gene expression has 
come from studies of proteins and enzymes associated with viral genomes. Probably the 
most extensively studied DNA virus with respect to its association with chromatin is HSV-
1. Studies have revealed that chromatin structure plays an important role in the control of 
viral transcription both during latent and lytic infection (reviewed in: Knipe & Cliffe, 
2008). Analysis of HSV-1 genomes in the brainstem tissue of a murine model first 
demonstrated that the latent viral genome appeared to be associated with nucleosomal 
chromatin (Deshmane & Fraser, 1989). In addition, viral DNA extracted from mouse 
dorsal root ganglia illustrated that viral genomes were not subject to significant DNA 
methylation but that the LAT promoter was associated with acetylated histones (Dressler et 
al., 1987; Bloom, 2004). In contrast, histones at the HSV-1 DNA polymerase promoter 
were extensively methylated consistent with transcriptional repression and further analysis 
showing increased methylation of lytic promoters in LAT-negative compared to LAT-
positive viruses (Bloom, 2004; Kubat et al., 2004; Wang et al., 2005). Furthermore, using 
a reactivation model in neuronal culture, the ICPO promoter was shown to be sensitive to 
TSA treatment and, as such, likely repressed by HDACs (Arthur et al., 2001). This was 
consistent with dorsal root ganglia explant data that demonstrates increased histone 
acetylation at the ICPO promoter (Amelio et al., 2006). More recently, an in viva study has 
also shown a direct correlation between changes to LAT -promoter and representative lytic 
gene promoter chromatin status during induced reactivation using sodium butyrate 
(Neumann et al., 2007). Various studies have also provided evidence that chromatinisation 
is also important for regulation of viral gene expression during lytic infection. Analysis by 
both chromatin immunoprecipitation (ChIP) assay and micrococcal nuclease digestion 
have demonstrated that both promoters and coding regions of various viral genes appear to 
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be associated with chromatin and that, intriguingly, modification to histone tails can occur 
throughout lytic infection which is consistent with temporal gene expression of herpesvirus 
gene classes (Herrera & Triezenberg, 2004; Kent et al., 2004; Coleman et al., 2008). 
Chromatin studies of herpesviruses other than HSV -1 have also been carried out. The 
understanding of association of the EBV genome with chromatin has been long standing 
(Dyson & Farrell, 1985). A number of EBV proteins appear to associate with chromatin 
remodelling enzymes, including EBNA-3C that interacts with HDACl , HDAC2 and p300 
(which possess HAT activity) (Radkov et al., 1999; Cotter & Robertson, 2000; Knight et 
al., 2003). Factors controlling reactivation in an EBV model system have also been 
identified. Using a Burkitts lymphoma (BL) cell line that has a similar pattern of gene 
expression to that observed in vivo during latent infection (Rowe et al., 1987), reactivation 
can be induced by cross-linking surface immunoglobulins or by the addition of TGF~ 
(Takada & Ono, 1989; di Renzo et al., 1994). Reactivation of EBV was concomitant with 
acetylation of the latent/lytic switch protein BZLFl and the activation of viral lytic 
transcription, whereas during latency the promoter appears to be deacetylated (Jenkins et 
al., 2000). Additionally, the use of HDAC inhibitors has also shown a correlation of 
increased histone acetylation and expression of LMPl in a nasopharyngeal carcinoma cell 
line, consistent with a repressed or poised chromatin status (Nishikawa et al. , 2004). 
Similarly, other members of the gammaherpesviruses, such as KSHV and herpesvirus 
saimiri (HVS), also demonstrate chromatin modification patterns. The KSHV LANA 
protein has been shown to bind to the mSin3 repressor complex that has HDAC activity 
and the C-terminus of LANA interacts with HPl, possibly providing a mechanism 
whereby KSHV latency is maintained (Krithivas et al., 2000; Lim et al., 2003). Similar to 
EBV and BZLFl , the ORF50 protein Rta is responsible for the lytic cycle of KSHV (Sun 
et al., 1998; Lukac et al., 2001). Reactivation of KSHV can be induced by treatment of 
latently infected cells with a number of reagents such as phorbol esters or the HDAC 
inhibitors sodium butyrate or TSA (Miller et al., 1997; Yu et al., 1999; Lu et al. , 2003) and 
it was subsequently found that the ORF50 promoter is associated with a number of 
chromatin remodelling enzymes (Lu et al., 2003). Recently, it has also been demonstrated 
that the closely related T-lymphotropic herpesvirus saimiri (HVS) has a similar histone 
modification pattern in infection of T-cells where lytic gene promoters appear repressed 
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(Alberter & Ensser, 2007). Thus, most examples of human herpesviruses are associated 
with some form of chromatin structure either during latency, lytic infection or both and this 
has also been examined for HCMV. 
I. I 0. 7 Regulation of HCMV gene expression by chromatin remodelling 
The association of chromatin or nucleosomal-like structures with viral DNA during 
HCMV infection has been recognised now for more than thirty years (Kierszenbaum & 
Huang, 1978; St Jeor et al., 1982). However, the relationship between these structures and 
the control of HCMV gene expression has only relatively recently been analysed. As 
explained in section 1.9, it is through regulation of IE gene expression from the MIEP that 
HCMV differentiation-dependent control of latency and reactivation appears to be 
mediated and there is good evidence that this regulation is mediated by higher order 
chromatin structure (Sinclair & Sissons, 2006; Sinclair, 2008). The differentiation-
dependent control of HCMV gene expression involves the association of cellular factors 
known to bind to the MIEP, such as YYl and ERF, which are able to recruit HDACs in 
undifferentiated cells. Upon differentiation, however, although the absolute level of these 
repressors is not completely reduced, the reduction in level of cofactor repressors such as 
HDACs does occur (Murphy et al., 2002; Bain et al., 2003; Wright et al., 2005). 
It could be predicted that the repressed state of the HCMV MIEP in undifferentiated, non-
permissive cells would correlate with chromatin markers of transcriptional repression. 
Contrastingly, infection of differentiated, permissive cells in which IE gene expression 
occurs, should result in the association of the viral MIEP with transcriptionally active 
chromatin markers. Models of HCMV latency and reactivation have been used to test this 
hypothesis. As with other herpesviruses, the use of HDAC inhibitors has been employed to 
examine the presence of repression of HCMV in the model cell line NT2Dl (T2). Here, 
TSA treatment of undifferentiated cells led to the induction of IE gene expression and, 
interestingly, the production of progeny infectious virus after experimental infection in 
vitro (Meier, 2001 ). Work from our laboratory using ChlP assay analysis of the MIEP in 
undifferentiated T2 cells has demonstrated that the MIEP is associated with low levels of 
acetylated histone-H4. However, when these cells are differentiated to their permissive 
form, T2RA cells, the MIEP now becomes associated with high levels of acetylated 
histone-H4 consistent with high levels of IE gene expression within the infected cells 
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(Murphy et al., 2002). In parallel experiments, ChIP analysis of infected, non-permissive 
monocytes, a site of natural carriage of the virus (Taylor-Wiedeman et al., 1991 ; Larsson 
et al. , 1998), has provided evidence that the MIEP is associated with low levels of 
acetylated histone-H4 but high levels of HP l~ (Murphy et al. , 2002), a hallmark of 
transcriptional repression (Jones et al., 2000). This association is then reversed upon the 
infection of differentiated, permissive macrophages with high levels of acetylated histone-
H4 but low levels of HPl~ found associated with the MIEP (Murphy et al., 2002). 
Further work from our laboratory, specifically usmg myeloid dendritic cell (DC) 
progenitors or CD34+ cells has confirmed this correlation between MIEP transcriptional 
activity and chromatin structure. CD34+ cells are known sites of HCMV latency and 
experimental infection of CD34+ cells and subsequent ChIP analysis, as described above, 
has shown that the MIEP is predominantly associated with HP 1 ~ in these cells and is 
transcriptionally inactive. Long term culture of these cells results in the carriage of viral 
genome during which time the MIEP remains associated with the repressive chromatin 
marker HPl~. In contrast, differentiation of these cells to mature dendritic cells (DCs) 
results in the association of acetylated histone-H4 with the MIEP and the concomitant 
reactivation of IE gene expression (Reeves et al., 2005a). Using an ex viva model, further 
work from our laboratory has shown that cultured CD34+ cells from a naturally infected, 
healthy seropositive individual confirm these findings. The MIEP of endogenous virus in 
CD34+ cells is found associated with HPl~ but, upon differentiation to mature DCs, 
chromatin remodelling of the MIEP results in the association of the MIEP with acetylated 
H4 consistent with reactivation of IE gene expression (Reeves et al., 2005b ). 
Consequently, reactivation of HCMV from latency appears to be intrinsically linked with 
the differentiation status of the infected cell and the subsequent chromatin status of the 
MIEP. 
Although it is known that differentiation-dependent regulation of HCMV gene expression 
is controlled, at least in part, by chromatin remodelling, it is still unclear whether 
chromatinisation of the MIEP is involved in regulation of this promoter during productive 
infection of fully permissive cell types as seen with other herpesviruses, notably HSV-1 
(Herrera & Triezenberg, 2004; Kent et al. , 2004; Coleman et al. , 2008). Investigations 
using MCMV have provided some evidence that the chromatin state of the viral genome 
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may be involved in control of viral IE gene expression even in fully permissive cells. For 
instance, use of TSA on permissive human U3 73 astrocytoma cells increases both the 
levels of murine IE 1 gene expression and the titre of the virus recovered from the cells 
(Tang & Maul, 2003). Consistent with this is the deposition of viral genomes upon 
infection at NDlO in the nucleus (Maul, 1998). These NDlO are known to recruit histone 
deacetylases (HDACs) and histone methyltransferases (HMTs), enzymes that could 
promote repression of the viral genome. Therefore, it has been suggested that activation of 
MCMV IE gene expression by TSA may be due to alleviation of chromatin mediated 
repression of the MIEP mediated by NDlO. Further studies on the association of HCMV 
genomes with ND 10 and the possible repression of IE gene expression mediated by ND 10 
will be further discussed below in section 1.11 and in Chapter 4. 
1.11 Nuclear domain 10 (ND10) bodies 
1.11.1 Introduction 
Nuclear domain 10 (NDlO) bodies, sometimes known as PML nuclear bodies (PML-NBs) 
or PML oncogenic domains (PODs), are discrete interchromosomal structures with, so far, 
unclearly defined cellular functions, approximately 0.2-1.0µm in diameter (reviewed in: 
Bernardi & Pandolfi, 2007; Everett & Chelbi-Alix, 2007). They comprise an accumulation 
of several proteins, including promyelocytic leukaemia protein (PML ), Sp 100 and death 
domain associated protein (Daxx) and have been observed in most reported cell lines 
typically numbering between 1 to 30 per nucleus, depending on the cell type, cell cycle I 
phase and differentiation status (Melnick & Licht, 1999; Dellaire & Bazett-Jones, 2004). 
Importantly, however, they are not found in the neuronal lineage (Daniel et al. , 1993; 
Flenghi et al., 1995; Gambacorta et al. , 1996) and this is highlighted in the neuronal 
teratoma cell line NT2D 1 (T2 cells) where ND 10 are only visible after retinoic acid 
induced differentiation to T2RA cells (Everett, 2001; Hsu & Everett, 2001). The integrity 
of ND 10 is dependent on PML, which recruits the other components via direct interactions 
(Ishov et al., 1999; Salomoni & Pandolfi, 2002). Despite their interchromasomal position, 
the presence of nucleic acid is not necessary for their structure to be maintained as RNAse 
and DNAse treatment do not disturb their morphology or distribution (Ascoli & Maul, 
1991; Stuurman et al., 1992). More recently, electron microscopy studies have determined 
that ND 10 are actually composed of a ring-like structure that does not contain nucleic acid 
within the ring, although extensive contact is made with chromatin fibres through the 
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periphery of the ring, which may aid the maintenance of structural integrity (Boisvert et 
al., 2000; Dellaire & Bazett-Jones, 2004; Eskiw et al. , 2004). These contacts appear not to 
be random with the domains becoming established in genomic regions that are rich in 
genes that are transcriptionally active (Wang et al. , 2004b ). Although the domains appear 
to be reasonably uniform, NDI O are structurally and functionally heterogenous and are 
dynamic structures (Bernardi & Pandolfi, 2007). 
ND I O were first recognised and investigated due to their association with disease 
(Bernstein et al. , 1984). However, primarily, NDlO are linked with a form of myelogenous 
leukaemia known as acute promyelocytic leukaemia (APL) from where PML itself gained 
its name. APL is characterised by a block in myeloid cell development at the promyelocyte 
stage where, in 98% of cases, PML is fused to the alpha-retinoic acid receptor (RARu) as a 
result of chromosomal translocation (Melnick & Licht, 1999). The NDlO then become 
disrupted resulting in a microparticulate pattern in the nucleus and cytoplasm (Kastner et 
al., 1992; Dyck et al., 1994; Weis et al., 1994). However, despite the association of disease 
and the great amount of investigation focussed on these domains providing insight into the 
correlation with regulation of various cellular functions such as the induction of apoptosis, 
cellular senescence, inhibition of proliferation, maintenance of genome stability, nuclear 
waste depots, sites of transcriptional regulation and DNA replication and antiviral 
responses (Ching et al. , 2005; Bernardi & Pandolfi, 2007), the molecular biology of both 
the NDlO and its constituents remain poorly understood. 
1. 11.2 NDlO dynamics 
NDlO not only have dynamic structures but also undergo significant changes in number, 
size and position under both normal circumstances and in response to cellular stress. Most 
ND lO appear relatively static during interphase of the cell cycle, most likely due to 
interactions with surrounding chromatin. Although, one study has shown that a group of 
smaller bodies, constituting 12% of the total NDIO, show rapid ATP-dependent movement 
(Muratani et al., 2002). However, this study used GFP tagged SplOO (speckled protein of 
lOOkDa - discussed further in section Ll 1.3) as a marker rather tha.n the more definitive 
PML and others have shown that some small foci containing Sp 100, but specifically not 
PML, are highly dynamic (Wiesmeijer et al., 2002). Hence this high dynamism may be 
specific to nuclear bodies only rich in Sp 100. One hypothesis for the abundance of these 
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highly motile structures is that they function to detect foreign proteins and then promote 
their degradation via the proteasome, which some of the bodies have been found to interact 
with (Anton et al., 1999; Lallemand-Breitenbach et al., 2001; Dino Rockel & von Mikecz, 
2002). However, this hypothesis requires additional analysis. Further experimentation has 
also shown that although ND 10 are predominantly static, PML itself is a dynamic 
component as it can exchange between bodies or the nucleoplasm (Wiesmeijer et al., 
2002). 
NDlO can not only undergo significant changes during both cell cycle progression but also 
in response to DNA damage and cellular stress. The number of visible bodies during 0 0 
phase of the cell cycle is low, but then this number increases as the cell enters 0 1 phase 
and proceeds to S and 0 2 phase (Chang et al., 1995; Koken et al., 1995; Terris et al., 1995; 
Kurki et al., 2003). The change in quantity of NDlO appears to be due to modifications of 
the surrounding chromatin environment that pull the ND 10 structure apart during 
chromosome retraction during early S phase. Consequently, there are almost twice as many 
ND 10 during 0 2 phase as 0 1 phase (Dellaire et al., 2006b ). It is thought that this change in 
appearance may have a surveillance function during replication of DNA, which is likely to 
be linked with their function to DNA damage (see below). A further change in NDlO 
morphology, specifically during mitosis, is that their ability to form large aggregates, 
although the PML becomes de-sumoylated and other components, such as SplOO and 
hDaxx, subsequently do not associate with them (Dellaire et al., 2006c ). This major change 
to the NDJ O body, and possibly its function, has led to the reclassification of this PML-
based body as a mitotic accumulation of PML protein (MAPP) during mitosis. As 
mentioned above, ND 10 are also able to respond to a number of different stimuli including 
DNA damage and cellular stress. Briefly, NDlO are able to redistribute into numerous 
smaller punctuate dots in response to heat shock, heavy metals and DNA damaging agents 
such as ultraviolet (UV) light, cysplatin and alkylating agents (Maul et al., 1995; Eskiw et 
al., 2003; Nefkens et al., 2003; Seker et al., 2003; Conlan et al., 2004; Salomoni et al., 
2005). However, other DNA damaging agents such as y-irradiation lead to an increase in 
the number of normal size domains whilst doxorubicin (an anthracycline antibiotic that can 
intercalate DNA) causes an accumulation of PML around the nucleolus (Carbone et al., 
2002; Bernardi et al., 2004; Dellaire et al. , 2006a). Again, although it is not yet clear why 
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such changes occur, ND 10 appear to sense cellular stress and it is likely that they function 
to act against specific stresses to prolong the life of the cell. 
1.11.3 ND] 0 constituent proteins 
NDlO appear to have multiple functions and this most likely depends upon the constituent 
proteins at any one time. Over fifty proteins have been reported to interact with the PML 
protein apparently identifying them as a component of ND 10. However, a number of these 
studies have used transient transfection and over-expression of the protein of interest and it 
is known that ND 10 act as a sink for over-expressed proteins (Melnick & Licht, 1999; 
Maul et al., 2000; Tsukamoto et al., 2000; Borden, 2002). Hence, the importance of the 
association of such proteins with ND 10 may be erroneous. Perhaps more meaningful data 
has been provided by the use of antibodies to detect endogenous levels of constituents and 
using cell lines stably transfected with potential NDl O constituent proteins. These types of 
studies have led to a much smaller number of constituents known to be present at ND I O at 
endogenous levels of expression: PML, SplOO, Daxx, BLM, SUMO and NDP55 (Negorev 
& Maul, 2001). 
As already stated, the major and defining constituent ofNDlO is PML. PML is part of the 
tripartite motif (TRIM) family of proteins defined by a zinc-finger called the RING motif, 
two additional B-boxes or zinc-finger motifs and a coiled coil domain, such that they are 
also known as RBCC family proteins (Borden et al., 1995; Jensen et al., 2001). The PML 
( or TRIM 19) gene contains nine ex ons and alternative splicing leads to the generation of 
several isoforms which have been classified into seven groups (PML I-VII). All isoforms 
share the N-terminal region of the protein, including the TRIM, but have differing C-
terminal regions and, as such, some lack the nuclear localisation signal (NLS) and are 
found predominantly in the cytoplasm (Jensen et al., 2001; Reymond et al., 2001). Rather 
like the numerous NDlO or NDlO-like bodies found within the nucleus, the number of 
PML isoforms may reflect the number of possible functions and localisation of isoforms 
(Beech et al., 2005; Condemine et al., 2006). PML-IV is highly multifunctional and has 
been found to induce premature cell senescence through binding of p53, promote Myc 
destabilisation and cellular differentiation as well as binding to PU.I and inducing PU.1-
mediated transcription (Fogal et al., 2000; Bischof et al., 2002; Buschbeck et al., 2007; 
Yoshida et al., 2007). Other isoforms appear to have a more moderate number of roles: 
- 68 -
I. Introduction 
PML-I is known to interact with the transcription factor AMLl to enhance AMLl-induced 
transcription (Nguyen et al. , 2005); PML-III interacts with the centrosome (Xu et al., 
2005); and a cytoplasmic isoform of PML has also been implicated in the regulation of 
TGFB signalling (Lin et al., 2004b ). 
The formation of NDlO is dependent not only on the presence of PML but also post-
translational modification of PML such as sumoylation. PML is able to directly bind to the 
small ubiquitin-like modifier (SUMO) and the SUMO-conjugating enzyme UBC9 that 
causes sumoylation of PML on three lysine residues (K65, K160 & K490) and has been 
shown to be necessary for formation of NDlO; UBC9 knockout cells have defective or 
absent ND 10 (Borden, 2002; Nacerddine et al., 2005). Whereas ubiquitin or ubiquitin-like 
tags usually target proteins for degradation, sumoylation appears to target proteins to 
NDlO (Melchior, 2000). UBC9 interacts with the RING domain of PML and covalently 
attaches to at least the SUMO-I protein and likely the SUM0-2 and -3 proteins that are 
also able to modify PML and form polymeric structures that have been found to be able to 
regulate the nuclear accumulation and structure ofNDIO (Kamitani et al., 1998; Duprez et 
al., 1999; Ishov et al., 1999; Ayaydin & Dasso, 2004; Fu et al., 2005; Shen et al., 2006; 
Mukhopadhyay et al., 2006). Upon sumoylation, PML can interact with other NDlO 
constituents, such as Sp 100 and Daxx, through the SUMO-binding domain and their 
recruitment to ND 10 takes place (Ishov et al., 1999; Shen et al., 2006). 
There appears to be a profound regulation of ND 10 structure during cell cycle such that 
ND 10 are disassembled during mitosis through de-sumoylation of PML (Sternsdorf et al., 
1997; Dellaire et al., 2006c). Then, during interphase of the cell cycle, PML becomes 
sumoylated and is able to interact with other PML molecules via the SUMO-binding motif, 
initiating the formation of new NDlO (Shen et al., 2006; Heun, 2007). PML is also able at 
this stage to interact with other ND 10 constituent proteins and recruit them to the structure, 
an example being Daxx that is targeted to ND 10 via interaction with PML through its 
SUMO-binding domain whilst also being modified by SUMO (Lin et al., 2006). 
A permanent constituent protein of ND 10, discovered through investigation using sera 
from patients suffering from primary biliary cirrhosis, is Sp 100 (Szostecki et al., 1990). 
Although SplOO is able to be sumoylated, SUMO modification does not appear to be 
- 69 -
1. Introduction 
essential for localisation of the protein to ND 10 (Stemsdorf et al., 1999). Like PML, Sp 100 
is expressed in the absence of IFN but its expression is increased by IFN treatment 
(Guldner et al., 1992; Chelbi-Alix et al., 1995). Sp 100 is also similar to PML in that 
alternative splicing of the primary transcript gives rise to several isoforms of Sp 100, some 
of which are able to bind DNA (SplOO-B & SplOO-HMG) (Guldner et al., 1999; 
Bottomley et al., 2001). Indeed, SplOO-B has been shown to act as a transcriptional 
repressor and, in addition, the SplOO-A isoform is able to interact with HPl isoforms a, ~ 
and y highlighting the possibility that Sp 100 may play a role in the control of gene 
expression of locally associated DNA or foreign DNA targeted to NDlO, such as virus 
genomes (Seeler et al., 1998; Isaac et al., 2006; Wilcox et al., 2005; Negorev et al., 2006). 
Intriguingly, a number of other NDIO components are also associated with the regulation 
of chromatin structure and control of gene expression. The chromatin modifier and histone 
chaperone HIRA has been found associated with NDlO as well as a SWI/SNF chromatin 
remodelling family member ATRX and Bloom's Syndrome DNA helicase (BLM) 
mentioned above (Negorev & Maul, 2001; Ishov et al., 2004; Zhang et al., 2005; Luciani 
et al., 2006). Furthermore, and interestingly, is the association of the Death domain-
associated protein or Daxx as it is more commonly known. Daxx acts as a multifunctional 
protein and was first identified due to its association with the control of apoptosis (Yang et 
al., 1997). However, with more than ten years of research into this association, the 
published literature remains contentious. Daxx has more recently become prominent due to 
its function as a transcriptional repressor, possibly through interactions with chromatin 
remodelling enzymes such as HDACs (Hollenbach et al., 2002). Due to the focus of this 
thesis, Daxx will be discussed in detail below and in Chapters 4 and 5. 
1.11.4 RNA virus-ND10 interactions 
Since the regulation of components of NDIO are controlled, at least in part, by IFN levels, 
it is not surprising that ND 10 have been suggested to play a role in the control of virus 
infections (reviewed in: Everett & Chelbi-Alix, 2007). RNA viruses have been found not 
just to be affected by the components of ND 10 but also to combat their effect. The 
methods by which PML is able to confer resistance to certain RNA virus infections falls 
into two groups: p53-independent and p53-dependent. IFN treatment of cells or exogenous 
expression of PML III isofom1 in p53 inactive cells lines (CHO & U373MG) leads to a 
decrease in the level of the retrovirus human foamy virus (HFV) gene expression through 
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an interaction of the N-terminal region of the viral transactivator, Tas, and subsequent 
suppression of viral DNA binding ability (Re gad et al., 2001 ). Similar studies using over-
expression of PML III isoform have also shown the sensitivity of vesicular stomatitis virus 
(VSV) and influenza virus to this ND 10 defining constituent. PML III appears to inhibit 
the replication of both viruses with effects on both mRNA and protein expression most 
likely through interaction with other viral or cellular proteins that regulate viral replication 
(Chelbi-Alix et al., 1998). Interestingly, though, a varied response of influenza virus to 
PML isoforms has been found: over-expression of PML IV and VI in Caco-2 cells also 
causes resistance to virus infection, whereas siRNA treatment to down-regulate all the 
PML isoforms causes an enhancement of viral replication (Iki et al., 2005). However, 
results of this type appear to be particularly cell specific since replication of influenza virus 
in wild type and PML-/- MEFs is equally effective (Engelhardt et al. , 2004). Conversely, 
PML-/- MEFs are more sensitive than wild type MEFs to rabies virus infection, although 
exogenous expression of PML III has little effect on viral replication (Blonde! et al., 2002). 
This was also found to be true upon analysis of lymphocytic choriomeningitis virus 
(LCMV) infection, whereas the ability of IFN to confer resistance to LCMV infection of 
PML-/- MEFs compared to wild type cells was higher (Djavani et al., 2001; Asper et al., 
2004). Indeed, although the precise PML isoforms at work are unknown, PML deficient 
mice also show greater susceptibility to LCMV and VSV infection (Bonilla et al., 2002). 
PML is also able to convey resistance to RNA virus infections through p53-dependent 
mechanisms. Infection of p53-/- mice with VSV results in higher virus loads and morbidity 
than in wild type mice most likely through the untimely induction of apoptosis (Takaoka et 
al., 2003). In addition, infection of cells with poliovirus has also been shown to involve 
p53: poliovirus infection induces activation of Mdm2 and Noxa in a PML-dependent 
manner, ultimately causing apoptosis and thus inhibiting virus replication. Inhibition of 
virus infection is also enhanced by over-expression of PML III. This is abolished when 
siRNA technology is used to down-regulate the expression of p53 or PML (Pampin et al., 
2006). Poliovirus is, however, able to act against this anti-viral ND 10-mediated response. 
Specifically, poliovirus infection induces the phosphorylation of PML and also increases 
sumoylation of PML. This results in an increased PML-dependent recruitment of p53 to 
NDIO, in addition to Mdm2 and proteosome components, such that degradation of p53 
occurs (Pampin et al., 2006). Other viruses also have mechanisms of action against the 
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an interaction of the N-terminal region of the viral transactivator, Tas, and subsequent 
suppression of viral DNA binding ability (Re gad et al., 2001 ). Similar studies using over-
expression of PML III isoform have also shown the sensitivity of vesicular stomatitis virus 
(VSV) and influenza virus to this ND 10 defining constituent. PML III appears to inhibit 
the replication of both viruses with effects on both mRNA and protein expression most 
likely through interaction with other viral or cellular proteins that regulate viral replication 
(Chelbi-Alix et al., 1998). Interestingly, though, a varied response of influenza virus to 
PML isoforms has been found: over-expression of PML IV and VI in Caco-2 cells also 
causes resistance to virus infection, whereas siRNA treatment to down-regulate all the 
PML isoforms causes an enhancement of viral replication (Iki et al., 2005). However, 
results of this type appear to be particularly cell specific since replication of influenza virus 
in wild type and PML-/- MEFs is equally effective (Engelhardt et al., 2004). Conversely, 
PML-/- MEFs are more sensitive than wild type MEFs to rabies virus infection, although 
exogenous expression of PML III has little effect on viral replication (Blonde! et al., 2002). 
This was also found to be true upon analysis of lymphocytic choriomeningitis virus 
(LCMV) infection, whereas the ability of IFN to confer resistance to LCMV infection of 
PML-/- MEFs compared to wild type cells was higher (Djavani et al., 2001; Asper et al. , 
2004). Indeed, although the precise PML isoforms at work are unknown, PML deficient 
mice also show greater susceptibility to LCMV and VSV infection (Bonilla et al., 2002). 
PML is also able to convey resistance to RNA virus infections through p53-dependent 
mechanisms. Infection of p53-/- mice with VSV results in higher virus loads and morbidity 
than in wild type mice most likely through the untimely induction of apoptosis (Takaoka et 
al., 2003). In addition, infection of cells with poliovirus has also been shown to involve 
p53: poliovirus infection induces activation of Mdm2 and Noxa in a PML-dependent 
manner, ultimately causing apoptosis and thus inhibiting virus replication. Inhibition of 
virus infection is also enhanced by over-expression of PML III. This is abolished when 
siRNA technology is used to down-regulate the expression of p53 or PML (Pampin et al., 
2006). Poliovirus is, however, able to act against this anti-viral NDI 0-mediated response. 
Specifically, poliovirus infection induces the phosphorylation of PML and also increases 
sumoylation of PML. This results in an increased PML-dependent recruitment of p53 to 
NDIO, in addition to Mdm2 and proteosome components, such that degradation of p53 
occurs (Pampin et al., 2006). Other viruses also have mechanisms of action against the 
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anti-viral defence of NDIO constituents. Although rabies virus replicates in the cytoplasm 
of the cell, it is able to cause reorganisation of ND 10 into larger and denser aggregates 
(Blondel et al., 2002). This occurs through a direct interaction of the viral phosphoprotein 
P, and its amino-terminal truncated product P3, with PML. This sequestration of PML by P 
results in co-localised foci in the cytoplasm with P3 causing the increase in ND 10 size 
(Blondel et al., 2002). Furthermore, the 1 llilla RING finger protein, Z, of LCMV is able to 
interact with PML and cause delocalisation from ND 10 to the cytoplasm thereby counter-
acting the anti-viral environment (Everett & Chelbi-Alix, 2007). Additionally, work with 
core protein from hepatitis C virus (HCV) has shown that it co-localises with PML and p53 
in NDIO and thus may counteract the pro-apoptotic function of p53 here (Herzer et al., 
2005). However, studies utilising HCV infected cells have subsequently found no 
association of viral core protein with ND 10, although an induction . of certain ND 10 
constituents does appear to occur through the presence of core protein. Thus, further 
investigation is required to establish a function, if any, of this interaction (Nguyen et al., 
2006; Rouille et al., 2006). Evidence that HIV is able to redistribute components of NDIO 
upon infection has also been reported (Turelli et al., 2001). However, one investigation of 
the accumulation and intra-nuclear distribution of unintegrated HIV-I DNA showed that 
the virus doesn't modify ND 10 at either early or late times of infection (Bell et al., 2001 ). 
Although more recent data does support an interaction of the retroviral integrase protein 
with Daxx that will be discussed further in Chapter 4 (Greger et al., 2006). 
1.11.5 DNA virus-NDlO interactions 
The interaction of viruses with ND 10 was first highlighted by the observation that HSV-1 
was able to disrupt the integrity of ND 10 through the viral immediate early protein I CPO 
(Maul et al., 1993) and later through the finding that the HSV-1, HCMV and adenovirus 
genomes become associated with ND 10 after infection (Ishov & Maul, 1996; Maul et al., 
1996). Since then, a number of other members of DNA virus families have been shown to 
have gene products that interact with and modulate the components and structure of ND 10 
(reviewed in: Everett, 2006; Everett & Chelbi-Alix, 2007). The interaction of herpesviruses 
and ND 10 will be discussed separately below (see section 1.11.6), whilst other DNA 
viruses interactions will be focussed upon in this section. 
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Upon infection of cells with adenoviruses, the viral proteins ElA and E4orf3 are able to 
traffic to NDlO. The NDlO in these cells are subsequently disrupted and early work 
showed that E4orf3 was sufficient for this disruption with later work providing evidence 
that the PML II isoform mediates this effect (Carvalho et al., 1995; Doucas et al., 1996; 
Ishov & Maul, 1996; Hoppe et al., 2006). This PML/E4orf3 interaction reorganises ND 10 
into thread-like structures, further including the ElB-55 protein. This has been suggested 
to prevent the restrictive effects of the cellular DNA repair machinery rather than 
particularly augment viral gene expression (Doucas et al., 1996; Stracker et al., 2005). 
Another study has suggested that ElB-55 could be a target for sumoylation by SUMO-I 
and subsequently be targeted to NDlO and that E4orf6 was then able to recruit ElB-55 
away from ND 10 (Lethbridge et al., 2003). This corresponds well with the known function 
of ElB-55, whereby it is able to interact with both the NDIO component protein Daxx and 
p53 and remove them from NDIO (Zhao & Liao, 2003; Zhao et al., 2003). This has led to 
the hypothesis that viral proteins help transformation of the infected cells, although the 
inhibition of apoptosis by sequestering the two cellular factors Daxx and p53 seems more 
likely. Nevertheless, the E4orf6 and ElB-55 proteins have also shown multifunctional 
properties, whereby their presence during infection is able to play some role in the control 
of mRNA trafficking and certainly inhibition of cellular mRNA nuclear export (Flint & 
Gonzalez, 2003). 
Another group of large DNA viruses known to interact with NDlO after infection are the 
papillomaviruses, although the importance of these interactions for virus infection is still 
not fully understood. It was first observed that the minor capsid protein, L2, of bovine 
papillomavirus (BPV) associated with NDIO and that L2 was able to recruit the major 
capsid protein, L 1, and the regulatory protein, E2, in transfected cells (Day et al. , 1998). 
Work with human papillomavirus (HPV) subsequently provided evidence that NDlO 
modified to act as a site of replication for the virus with regulatory proteins El and E2 
found along with replicating viral DNA at NDlO (Swindle et al., 1999). The L2 and E4 
virus proteins have also both been implicated in reorganisation of ND 10 into a replication 
compartment: E4 via interaction with PML; and L2 through recruitment of Daxx but 
removal of Sp 100, possibly with degradation of the protein (Florin et al., 2002; Roberts et 
al., 2003). Although recent work has shown in biologically relevant raft cultures that HPV 
proteins and viral DNA are associated with a higher number of NDIO visible in upper 
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differentiated cells than normal uninfected cells (Nakahara & Lambert, 2007), further 
investigation is necessary to fully establish the importance of NDlO as a site of HPV 
replication. 
The replication of papovaviruses, such as simian virus 40 (SV 40), has also been shown to 
involve NDIO. The large T antigen of SV40 activates viral DNA replication through 
binding to the viral origin of replication, whilst localising in foci juxtaposed to ND10 
(Carvalho et al., 1995; Doucas et al., 1996; Jiang et al., 1996). Indeed, viral transcription 
has been shown to occur near ND 10, although this may be a consequence of the genome 
being targeted to NDlO for viral DNA replication (Tang et al., 2000). Interestingly, using 
aphidicolin treatment to inhibit viral DNA replication or molecular disruption of the SV 40 
origin of replication is concomitant with the absence of ND 10 association of the viral 
genome, underpinning the necessity for the interaction of large T antigen with the viral 
genome for this association (Tang et al., 2000). 
Other viruses that require the presence of a helper virus for full replication have also been 
found to have some association with ND 10 during replication. Adeno-associated virus 
(AA V), a parvovirus, which requires another virus, such as HSV-1 or adenovirus, for 
replication also shows an interaction with NDlO. However, discriminating between the 
mechanisms of replication for two viruses within one infected cell can prove problematic. 
Assays that allowed visualisation of AA V replication in live cells have allowed 
determination that AA V replication compartments can associate with modified ND 10 in 
adenovirus infected cells. Conversely, in HSV-1 co-infected cells, association of 
replication compartments could not be found with ND 10, most likely due to the complete 
disruption of ND 10 caused by ICPO ( discussed further in section 1.11.6). Importantly, the 
use of an ICPO-null mutant of HSV-1 still resulted in the formation of AA V replication 
compartments. Consequently, the disruption of ND 10 appears not to be a prerequisite for 
AA V replication (Fraefel et al., 2004 ). Further, it has · been shown that only certain 
elements of the herpesvirus replication machinery are sufficient for replication of a plasmid 
carrying the AAV-2 genome: the helicase primase complex (UL5, UL8 & UL52) and the 
single-stranded DNA binding protein (UL29) (Weindler et al., 1991). However, in the 
absence of a lytically replicating helper virus, AA V integrates into the host genome and 
becomes latent. Another study also found that the localisation of ICPO to NDlO and their 
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disruption was not required for the activation of the AAV replication promoter, whereas 
binding of ICPO to the herpesvirus-associated ubiquitin-specific protease (HA USP) made a 
significant contribution to reactivation from the latent state of AA V (Geoffroy et al., 
2004). Once again, though, it could be theorised that this interaction is important in 
modification of p53 levels and subsequent effects on the infected cell since it is known that 
HA USP is able to cause accumulation and modification of p53 (Li et al., 2002). 
1.11. 6 Herpesvirus-ND 10 interactions 
Since the first discovery that HSV-1 genomes locate near to or at ND 10 during infection 
and that ICPO is necessary and sufficient to disrupt the NDlO structure (Maul et al., 1993; 
Ishov & Maul, 1996; Maul et al., 1996), members of all the herpesviridae have been 
examined for their ability to alter NDlO during infection (reviewed in: Everett, 2006; 
Everett & Chelbi-Alix, 2007). It has been found that all herpesvirus subfamilies do, indeed, 
interact with NDlO, although in different manners and through different mechanisms. 
HSV-1 has been studied most extensively regarding its association with NDlO. As alluded 
to above, HSV-1 genomes not only locate at NDlO but also encode gene products 
sufficient to disrupt the ND 10 structure itself. ND 10 components become associated with 
HSV-1 genomes as they enter the cell resulting in the formation of ND 10-like bodies on 
the viral genome (Everett et al., 2004; Everett & Murray, 2005). Neither viral transcription 
nor de nova protein synthesis is required for establishment of these NDlO-like structures 
(Everett et al., 2007). This accumulation of cellular protein at the viral DNA is thought to 
be an intrinsic antiviral cellular response but is a transitory one due to the synthesis of 
ICPO and disruption of ND 10. It has been determined that two domains of ICPO are 
important for this function of ND 10 disruption: near the C-terminal end of the protein is a 
region responsible · for targeting ICPO to NDlO after synthesis, whilst a RING-finger 
domain that holds ubiquitin E3 ligase activity is sufficient for inducing the degradation of 
PML and SUMO-modified isoforms of SplOO (Everett & Maul, 1994; Maul & Everett, 
1994; Boutell et al., 2002). The importance of ND 10 disruption by HSV-1 for efficient 
infection is reinforced by the observation that infection of cells with an ICPO-null mutant, 
which cannot disrupt ND 10, is severely impeded but that knockdown of PML and/or 
Sp 100 allows efficient infection with the mutant virus (Everett et al., 2006; Everett et al. , 
2008). However, cell-specific differences in ICPO-mediated PML degradation exist which 
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appear to depend on the particular isoform of PML examined. In Hep2 cells, the SUM0-1 
modified isoforms of PML are preferentially destabilised compared to the unmodified 
isoforms, whilst in human foetal lung (HFL) cells all isoforms of PML are readily 
degraded (Everett et al., 1998a; Parkinson & Everett, 2000). Additionally, although 
degradation of PML via ICPO interaction involves the proteasome, one study has reported 
that in in vitro assays ICPO alone does not ubiquitinate PML or interact with it directly, 
such that in vi1:__o degradation of PML via ICPO is likely to occur indirectly, possibly 
requiring other factors (Boutell et al., 2003). Nevertheless, despite these discrepancies, the 
disruption of ND 10 by HSV-1 ultimately leads to an environment conducive to full lytic 
infection (Everett, 2000). Indeed, other members of the alphaherpesviruses, such as VZV, 
pseudorabies virus (PRV) and type 1 bovine and equine herpesviruses, have also been 
found to encode orthologues ofICPO that disrupt NDlO, with their function dependent on a 
RING finger domain (Parkinson & Everett, 2000). 
In contrast to the prototypic alphaherpesvirus HSV-1, the genome of the prototypic 
gammaherpesvirus EBV does not become associated with ND 10 until lytic infection 
occurs (Sugden & Warren, 1989). Upon lytic activation NDlO become disrupted in a 
sequential manner with Daxx, SplOO and NDP55 with a slower dispersal of PML before 
viral replication compartments develop in association with the NDlO remnants (Bell et al., 
2000; Amon et al., 2006). Other work has pinpointed that the expression of the immediate 
early protein BZLFl and subsequent SUM0-1 modification is sufficient for PML dispersal 
and the dispersal of SplOO staining from NDlO (Adamson & Kenney, 2001; Deng et al., 
2001). More recent work has established that EBNA-LP is also able to disperse SplOO and 
HPla from NDlO and it was hypothesised that this may function to make SplOO-A 
isoform available to aid EBNA2 mediated stimulation of viral gene expression (Ling et al., 
2005). Other gammaherpesviruses have also been shown to interact with ND 10 and form 
replication complexes, with this best typified by KSHV (HHV-8). Whilst the genome is 
found associated with cellular DNA through latency, during lytic infection the K8 early 
protein of KSHV has been shown to target and interact with PML at ND 10 although ND 10 
structure is not necessarily affected. (Ballestas et al., 1999; Cotter et al., 1999; Katano et 
al., 2001; Wu et al., 2001 a). 
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Parallel studies have also been performed on betaherpesviruses. Analysis of the HHV-6 
subtypes have found that their IE 1 protein traffics to and forms a stable association with 
NDIO (Stanton et al., 2002; Gravel et al., 2004). However, this does not result in NDIO 
disruption. In contrast, infection with HHV-6B results in a decrease in the number of 
ND 10, although PML levels increase and the viral transcriptional activator U 19 localises to 
the centre of the enlarged ND 10 structures (Kofod-Olsen et al., 2008). Whilst the full 
importance of ND 10 for lytic infection of the HHV-6 subtypes has not been determined, 
the significance of ND 10 association and disruption is much more fully understood in the 
prototypic herpesvirus infection with HCMV. 
Analagous to HSV-1, the genome of HCMV has been found to reside near to or at ND 10 
during lytic infection (lshov & Maul, 1996; Maul et al., 1996; Maul & Negorev, 2008). 
Although a precise position of the viral genome during latency has not yet been confirmed, 
it is also likely to reside near to ND 10. Investigation of HCMV has also shown that the 
immediate early protein IE72 is necessary and sufficient for disruption of NDlO during 
lytic infection and that this is mediated by the C-terminal acidic region of IE72 which 
interacts with the N-terminal RING finger domain of PML to inhibit oligomerisation of 
NDIO components and cause PML dispersal (Kelly et al., 1995; Korioth et al., 1996; Ahn 
& Hayward, 1997; Ahn et al., 1998; Wilkinson et al., 1998; Lee et al., 2007a). However, 
unlike ICPO, IE72 mediated disruption of ND 10 does not result from targeting of PML for 
ptoteosomal degradation. Instead, PML appears simply to be relocalised with little 
evidence of change to the biochemical structure of the protein, although subsequent 
desumoylation of PML may be promoted after dispersal to inhibit regeneration of ND 10 
(Ahn et al., 1998a; Muller & Dejean, 1999; Kang et al., 2006). Furthermore, work using 
permissive U3 73 cells stably transfected with PML demonstrated that higher levels of 
PML lead to a delay of up to 6 hours for NDIO disruption and DNA replication 
compartment formation (Ahn & Hayward, 2000). These observations, together with 
observations of HSV-1, have implicated ND 10 as sites of intrinsic intracellular antiviral 
environments. Consistent with this, targeting of NDlO by HCMV factors appears to be 
necessary for efficient productive HCMV infection to occur. Studies have shown that the 
UL82 encoded HCMV tegument phosphoprotein pp71 traffics and accumulates at NDIO 
via interaction with human Daxx (hDaxx) (Hofmann et al., 2002; Ishov et al., 2002; 
Schierling et al., 2004). pp71 then acts as a transactivator and is able to regulate and 
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Figure 1.12 Model of HCMV interactions with ND10. (A) On e1.1try of the virus to the cell, tegument proteins are released and the capsid traffics to the nucleus before releasing the viral genome which 
circularises and becomes located near to or at NDlO, sites of known chromatin remodelling enzymes and transcriptional repressors. pp7 l is able to interact with Daxx, which itself is able to interact with Pl\1L and transit to NDlO. At NDlO, pp71 is able to transactivate the MIEP of the viral genome and IE72 is 
expressed. (B) Expression of IE72 and targeting to ND 10 leads to the Pl\1L-dependent disruption of ND 10, 
release of other transcriptional repressors and subsequent continuation of viral gene expression. 
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activate viral IE transcription, before high level expression of IE72 disrupts NDlO (see Fig. 
1.12) (Marshall et al., 2002). Previous work from our laboratory has also shown that 
permissive U373 cells stably transfected with hDaxx were completely refractory to viral 
gene expression during infection (Woodhall et al., 2006). Hence, hDaxx appears to have a 
profound role during infection with HCMV. · 
1.12 Project remit 
Investigations of HCMV latency and reactivation suggest that transcriptional regulation of 
IE gene expression is mediated by chromatin remodelling. Additionally, investigation into 
lytic infection with MCMV has also suggested the importance of chromatin remodelling of 
the viral genome. This regulation may be mediated through ND 10, a site where the viral 
genome is deposited after virus entry, and might involve an initial repressive cellular 
environment that needs to be overcome for full initiation of viral gene expression. 
Therefore, this thesis will detail analyses which investigate the chromatinisation of the 
viral MIEP during productive infection and whether chromatin remodelling is involved in 
regulation of viral IE gene expression during lytic infection. Whether regulation of 
chromatinisation of the viral genome is mediated by components of NDlO will also be 
examined. The possibility that such repressive factors may be involved in the 
establishment and maintenance of latency will also be examined. Finally, an analysis of 
whether promoters from other classes of HCMV genes are also regulated by chromatin 
structure will be described. 
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2. Materials and Methods 
2.1 Materials 
All reagents were purchased from Sigma-Aldrich and the United Kingdom (UK) unless 
otherwise stated. A list of abbreviations for materials used during the work described in 
this thesis is present in Appendix I. 
2.2 Cell culture 
2. 2.1 Cell propagation and maintenance 
Cells were grown in Eagle's Minimal Essential Medium (EMEM; Gibco, Invitrogen Corp.) 
supplemented with 10% (v/v) Fetal Calf Serum (FCS), lOOU/ml Penicillin, lOOµg/ml 
Streptomycin and 2mM L-glutamine (EMEM-10) at 37°C in a humidified 5% C02 
atmosphere unless otherwise stated. Cells were maintained as such: confluent monolayers 
in Tl 75 flasks were passed every 3-4 days via pre-washing of cells with phosphate 
buffered saline (PBS) before incubation with 3ml of Trypsin-EDTA (0.5g Trypsin, 0.2g 
EDTA, 0.85g NaCl/L, Gibco) in 7ml of PBS at 37°C for 5 min. Cells were then split 1:3 
into Tl 75 flasks (Coming) with 40ml of fresh medium. To maintain low passage stocks of 
cells, upon receipt of the cell line, cells were grown to bulk. Cells were then trypsinised as 
above before centrifugation (465g, 5 min) and re-suspension of the pellet to approximately 
2 x 106 cells per ml in filtered freezing medium (90% FCS, 10% DMSO). 1ml aliquots 
were then made in cryovials (Nunc) and stored at -80°C in cotton wool overnight before 
long term storage in liquid nitrogen. 
Human foreskin fibroblasts (HFFs), fully permissive for HCMV infection, were obtained 
from the American Type Culture Collection (ATCC, USA), passed as above and were used 
for virus propagation (see 2.4.2). The passage number of the cells used ranged between 15-
25 for all experiments. 
Murine embryonic fibroblasts (MEFs), a kind gift of Dr Mike Gill (Division of Virology, 
University of Cambridge) were grown in Dulbecco's modified Eagle's medium (DMEM; 
Gibco) supplemented with 2mM glutamine, 1 OOU/ml penicillin, 1 OOµg/ml streptomycin 
and 10% fetal calf serum (DMEM-10). Medium for MEFs was further supplemented with 
50µM 2-mercaptoethanol and cells were passed 1 :3 every 3-4 days as above. 
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The human glioblastoma/astrocytoma cell line, U373-MG, obtained from the European 
Collection of Cell Cultures (ECACC) and fully permissive for infection, was also passed 
1:4 every 4 days as above. U373-MG cells stably transfected with either pDsRed-Nl or 
pDsRed-Nl-hDaxx plasmids (U373-dsRed and U373-dsDaxx respectively (Woodhall et 
al., 2006)) were selected with G418 (lmg/ml; Invitrogen) supplemented medium and 
passaged as the parent cells. 
The human embryonal carcinoma cell line, NT2Dl (referred to herein as T2 cells), was 
obtained from ATCC. T2 cells were passed as above 1 :3 every 2-3 days and were 
differentiated to a fully permissive cell type (T2RA) by addition of 1 µM retinoic acid (RA) 
in EMEM-10 for 5 days. 
The human acute monocytic leukaemia cell line, THPl, was obtained from ATCC. As 
THPls grow in suspension, cells were first centrifuged at 465g for 5 min before being split 
1 :3 into a new Tl 75 with fresh RPMI-1640 medium (Gibco) supplemented as above 
(RPMI-10). Cells were differentiated to a macrophage-like (M0) permissive cell type 
through treatment with 20nM phorbol 12-myristate 13-acetate (PMA) and 50µM 
hydrocortisone (HC) supplemented RPMI-10 overnight. 
2. 2. 2 Trichostatin A (FSA) treatment of cells 
All TSA (Upstate) and control media was created fresh on the day of experimentation. 
I 
TSA medium was produced at a concentration of 330nM by dilution of TSA 1 :3 with the . J 
solvent DMSO and then 1: 1000 in EMEM-10. Control DMSO medium was produced by 
diluting the same volume of DMSO as used above 1:1000 into EMEM-10. Cells were then 
washed with 1ml of TSA or DMSO media before replacement with 2ml of fresh TSA or 
DMSO media for · 16 hours. All virus infections were then carried out in the appropriate 
media. 
2.2.3 Phosphonoformic acid (PFA) treatment of cells 
All PF A medium was created fresh on the day of experimentation. A working stock of 
lOmg/ml PFA in dH20 was diluted 1:100 into fresh EMEM-10. PFA media was then 
added to cells 24 hours prior to experimentation. 
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2.3 Monocyte isolation from peripheral blood and differentiation 
2. 3.1 Isolation of peripheral blood mononuclear cells (P BMC) 
Peripheral blood was collected via percutaneous venepuncture by a trained phlebotomist 
and anti-coagulated with heparin sulphate (10 units per 1ml blood; Addenbrooke's 
Hospital Pharmacy). The blood was then diluted 1: 1 in sterile PBS before 35ml was 
layered onto 15ml of Lymphoprep (9.6% (w/v) sodium metrizoate, 5.6% (w/v) 
polysaccharide; Axis-Shield) and centrifuged for 20 min at 800g, with no brake, to 
separate the cell populations. After this time, the cloudy white band of mononuclear cells, 
formed between the plasma and Lymphoprep layers, was carefully retrieved using a plastic 
Pasteur pipette. The cells were then washed in sterile PBS via centrifugation ( 450g, 10 
min) and the final pellet re-suspended in 5ml of PBS. 
2. 3. 2 Isolation of monocytes from P BMC by adherence 
Mononuclear cells isolated by density-dependent centrifugation were added to plastic 6-
well plates (Nunc) in sterile PBS for 2 hours at 37°C in 5% C02. The monocytes, which 
are adherent, were then isolated by washing of the wells with sterile PBS to remove 
lymphocytes and cultured by the addition of X-Vivo 15 medium (Biowhittaker) 
supplemented with 10% human serum and 2mM L-glutamine. 
2.3.3 Differentiation of monocytes to dendritic cells (DC) 
Monocytes were first differentiated to immature DCs by the addition of interleukin-4 (IL-
4, 1 OOOU/ml; Peprotech) and granulocyte macrophage colony-stimulating factor (GM-
CSF, lOOOU/ml; Peprotech) to the culture X-Vivo 15 medium and the cells grown for 6 
days at 37°C in 5% C02. Following incubation, the culture medium was further 
supplemented with lipopolysaccharide (LPS, 50ng/ml) for 3 days to induce full maturation. 
2.4 Viruses 
2. 4.1 HCMV strains 
Toledo is a commonly used low passage laboratory strain of HCMV. TB40/E (a kind gift 
of Christian Sinzger) is a low passage endothelial adapted clinical isolate that, although 
plaque purified, may contain up to three separate virus clones (Sinzger et al., 2008). The 
AD169 strain (VR-538; ATCC) is a commercially available laboratory adapted strain of 
HCMV. 
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2.3 Monocyte isolation from peripheral blood and differentiation 
2. 3.1 Isolation of peripheral blood mononuclear cells (P BMC) 
Peripheral blood was collected via percutaneous venepuncture by a trained phlebotomist 
and anti-coagulated with heparin sulphate ( 10 units per 1 ml blood; Addenbrooke' s 
Hospital Pharmacy). The blood was theri diluted 1: 1 in sterile PBS before 35ml was 
layered onto 15ml of Lymphoprep (9.6% (w/v) sodium metrizoate, 5.6% (w/v) 
polysaccharide; Axis-Shield) and centrifuged for 20 min at 800g, with no brake, to 
separate the cell populations. After this time, the cloudy white band of mononuclear cells, 
formed between the plasma and Lymphoprep layers, was carefully retrieved using a plastic 
Pasteur pipette. The cells were then washed in sterile PBS via centrifugation ( 450g, 10 
min) and the final pellet re-suspended in 5ml of PBS. 
2. 3. 2 Isolation of monocytes from P BMC by adherence 
Mononuclear cells isolated by density-dependent centrifugation were added to plastic 6-
well plates (Nurre) in sterile PBS for 2 hours at 37°C in 5% C02. The monocytes, which 
are adherent, were then isolated by washing of the wells with sterile PBS to remove 
lymphocytes and cultured by the addition of X-Vivo 15 medium (Biowhittaker) 
supplemented with 10% human serum and 2mM L-glutamine. 
2.3.3 Differentiation of monocytes to dendritic cells (DC) 
Monocytes were first differentiated to immature DCs by the addition of interleukin-4 (IL-
4, lOOOU/ml; Peprotech) and granulocyte macrophage colony-stimulating factor (GM-
CSF, lOOOU/ml; Peprotech) to the culture X-Vivo 15 medium and the cells grown for 6 
days at 37°C in 5% C02. Following incubation, the culture medium was further 
supplemented with lipopolysaccharide (LPS, 50ng/ml) for 3 days to induce full maturation. 
2.4 Viruses 
2. 4.1 HCMV strains 
Toledo is a commonly used low passage laboratory strain of HCMV. TB40/E (a kind gift 
of Christian Sinzger) is a low passage endothelial adapted clinical isolate that, although 
plaque purified, may contain up to three separate virus clones (Sinzger et al., 2008). The 
AD169 strain (VR-538; ATCC) is a commercially available laboratory adapted strain of 
HCMV. 
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2. 4. 2 Virus propagation 
Typically, between 10 and 20 Tl 75 flasks of HFFs were infected at a multiplicity of 
infection (MOI) of 0.1 in 7ml of EMEM-10 for 3 hours at room temperature with gentle 
rocking. After this time, 18ml of EMEM-10 was added and the flask incubated at 3 7°C in a 
humidified 5% C02 atmosphere. Upon 100% infection, seen via cytopathic effect (CPE), 
the media was removed and stored at -80°C with 25 ml of fresh media then being added to 
the flask. This was then repeated every 2 to 3 days, with pooling of the media, until all 
cells had become detached from the flask. 
Working stocks of HCMV were concentrated via centrifugation. Pooled frozen virus media 
was thawed and spun at 465g for 10 min at room temperature in an ALC PK 120 bench 
centrifuge to remove cellular debris. The supernatant was then taken and spun at 13,500g 
for 2 hours at 4 °C in a Beckman Coulter Optima L-90K ultracentrifuge (rotor 19) to pellet 
the virus. The pellets were then re-suspended in an appropriate volume of EMEM-10 and 
aliquoted into 200µ1 samples and stored at -80°C unless stock was needed for gradient 
purification, in which case the pellet was re-suspended in 2ml of PBS and used as below 
(see 2.4.3). 
2. 4. 3 Gradient purification of virus 
2. 4. 3.1 Fi coll protocol 
In two Ultra Clear 25mm tubes (Beckman Coulter), gradients were set up from 5ml of each 
of 15%, 12.5%, 10%, 7.5% and 5% Ficoll (w/v) made up in PBS. 1ml of the re-suspended 
clarified virus was then added to the surface of both gradients and the tubes spun at 
19,000g for 2 hours at 4°C in a Optima L-90K ultracentrifuge (rotor SW28; Beckman 
Coulter) with no braking to separate the non-infectious enveloped particles (NIEPs), 
virions and dense bodies (DBs). Bands were then harvested using sterile plastic pastettes 
and pooled into three separate tubes. The pooled material was then made up to 30ml with 
PBS and spun again at 49,500g for 1 hour at 4°C (rotor SW41). The supernatant was then 
poured off before the pellets were re-suspended in 500µ1 of PBS, aliquoted into 50µ1 
samples and stored at -80°C. 
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2. 4. 3. 2 Sorbitol protocol 
In two Ultra Clear 14mm tubes (Beckman Coulter), gradients were set up from 1.6ml of 
each of 70%, 60%, 50%, 40%, 30% and 20% sorbitol (w/v) made up in PBS. 1ml of the re-
suspended clarified virus was then added to the surface of both gradients and the tubes 
spun at 49,500g for 1 hour at 4°C (rotor SW41) with no braking to separate the non-
infectious enveloped particles (NIEPs), virions and dense bodies (DBs). Bands were then 
harvested using sterile plastic pastettes and pooled into three separate tubes. The pooled 
material was then made up to 10ml with PBS and spun again at 44,500g for 1 hour at 4°C 
(rotor SW 41 ). The supernatant was then poured off before the pellets were re-suspended in 
500µ1 of PBS, aliquoted into 50µ1 samples and stored at -80°C. 
2. 4. 4 Titration of virus 
2. 4. 4.1 Plaque assay 
To titre the virus, 24-well plates were seeded to between 80-90% with HFFs. The virus 
was then serially diluted in EMEM-10 and 250µ1 added in duplicate to two wells for each 
dilution, before rocking the plate for 3 hours at room temperature. After this time, the virus 
dilution media was aspirated from the well and each well washed with 0.5ml of fresh 
media before replacement with 1ml of EMEM-10 containing y-globulin (16µg/ml). Cells 
were then incubated at 3 7°C in a humidified 5% C02 atmosphere. After 14 days, cells were 
washed in PBS before fixation with 70% ethanol/dH20 for 10 min at -20°C, washed again 
and then stained with Giemsa stain before counting of plaques. 
2.4.4.2 TCJD50 
Due to the duration of time necessary to carry out plaque assay analysis on HCMV 
preparations, a quicker endpoint dilution analysis was employed: the tissue culture 
infective dose 50% (TCID50) analysis technique. HFFs are first re-suspended to 1 x 105 /ml 
in EMEM-10 and 180µ1 of the suspension aliquoted into each well of a 96-well plate. The 
virus being titred is then serially diluted 1: 10 (20µ1 into each well) along the length of the 
96-well plate in sextuplicate and the plate incubated at 3 7°C in a humidified 5% C02 
atmosphere. After 10 days, the plates were washed in PBS before fixation with 70% . I' 
ethan0I/dH20 for 10 min at ~20°C, washed again and then stained with Giemsa stain. It was 
then determined for each dilution where the endpoint dilution had occurred and the 
following calculation used to determine the TCID50 of the virus: 
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log10TC1Dso = A - [Bx (C -0.5)) 
where: 
A = the last index value of 100% infection 
B = the log of the dilution factor (i.e. log(IO) = 1) 
C = the sum of the percentage of infected wells 
The TCID50 per ml of virus is then determined before plaque forming units (PFU) per ml 
of virus is calculated by the following equation: 
PFU/ml = TCID5o/ml x 0.69 
For a full example of the TCID50 method, see Fig. 2.1. 
2.5 Western blot analysis of protein expression 
2.5.1 Denaturing SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Denaturing SDS-PAGE was carried out as follows. Cellular protein samples were prepared 
such that 105 cells were re-suspended in 20µ1 of Laemmli's loading buffer (0.125M Tris-
HCl, pH 6.8; 25% (v/v) glycerol; 1.25% (v/v) 2-Mercaptoethanol; 1.25% SDS; 72.5% 
(v/v) dH20). Electrophoresis of samples was typically performed on a 10% Bis-acrylamide 
resolving gel (10ml Bis-acrylamide [0.8:30]; 3.75ml 3M Tris, pH 8.8; 0.3ml 10% SDS; 
16.95ml dH20; 15µ1 TEMED; 1.5ml 1.5% ammonium persulphate) overlaid with 0.5ml 
H20-saturated butan-2-ol. After polymerisation had occurred, H20 was used to wash the 
surface of the resolving gel before the stacking gel was added (2.5ml Bis-acrylamide 
[0.8:30]; 5ml 0.5M Tris, pH 6.8 ; 0.2ml 10% SDS; 11.3ml dH20; 15µ1 TEMED; 1ml 1.5% 
ammonium persulphate ). After loading of 20µ1 samples, electrophoresis was carried out a 
IOOV for 1-2 hours in SDS running buffer (3g/l Tris-base; 14.4g/l glycine; lg/I SDS; dH20 
to 1 litre). Transfer to a nitrocellulose membrane was then performed overnight at +4°C in 
20% transfer buffer (lg/1 Tris-base; 4.8g/l glycine; 20% methanol; dH20 to 1 litre) at 20V. 
Protein transfer and size was checked by the use of rainbow . markers (Amersham 
Biosciences). If necessary, as a loading control, a duplicate SDS-PAGE gel was rocked in 
coomassie stain (10% acetic acid; 20% ethanol; 70% dH20) for 30 mins before being 
washed in destain (10% acetic acid; 20% ethanol; 69.9% dH20; 0.1% w/v brilliant blue) 
- 85 -
Ii 
11 . 
I 
Ii 
2. Materials and Methods 
Dilution factor (10') 
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Dilution 10-6 has all (6/6) wells infected= 1 
Dilution 10-7 has 4/6 wells infected= 0.66 
Dilution 10-8 has 1/6 wells infected= 0.16 
Dilution 10-9 has 0/6 wells infected = 0 
log10TCIDso = A- [Bx (C - 0.5)) 
Where: 
A= the last index value of 100% infection, i.e. -6 
B = the log of the dilution factor, i.e. log(lO) = 1 
C = the sum of the percentage of infected wells, i.e. 1 + 0.66 + 0.16 = 1.82 
log10TCIDso 
TCIDso 
= -6 - [l X (1.82 - 0.5)] 
= -7.32 
= 10-7.82 
= 1/10782 
= 1 / 2.1 X 107 in 20µ1 
= 1 / 1.0 X 109 in 1ml 
Therefore, the 50% end point titre is 1.0 x 109 
PFU/ml = 1.0 X 109 X 0.69 
= 7.2 X 108 
Figure 2.1 The TCID50 calculation. Quantitation of the concentration of virus in a sample by TDIDso and the resultant PFU determination was carried out as shown in the example above. 
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until clearly separated protein bands could be seen. Images were created using a Pulnix 
TM-300 imager. 
2. 5. 2 Western blot analysis 
Following transfer of SDS-:PAGE separated protein samples, nitrocellulose membranes 
were pre-treated in blocking solution, 5% dried milk (w/v) (Marvel; Chivers, Ireland) in 
PBS, for 30 min before antibody incubations. Primary antibody incubation was carried out 
in blocking solution for 60 min at room temperature at a concentration determined 
individually for each antibody (see Table 2.1 ). Primary antibodies were detected using 
horseradish peroxidase (HRP) -conjugated goat anti-rabbit IgG antiserum (Santa Cruz, 
USA) or HRP-conjugated rabbit anti-mouse IgG antiserum (DAKO) diluted 1 :2,000 in 
blocking solution, depending upon the primary isotype, for 30 min at room temperature. 
All antibody incubations were followed by four 15 min washes of the nitrocellulose 
membrane in PBS/0.1 % Tween-20. Detection of protein presence was performed using 
Enhanced Chemiluminescence (ECL, Amersham) by mixing equal quantities, typically 
500µ1, of solutions A and B before addition to each membrane for 1 min at room 
temperature with slight agitation. Excess ECL reagents were drained from the membrane, 
which was then placed in Saran wrap before exposure to autoradiographic film to quantify 
protein levels. 
2.6 Immunofluorescence analysis of protein expression 
2. 6.1 Immunofluorescence (IF) 
Typically, cells were seeded at 1 x 105 per well in 8 well glass chamber slides. Cells were 
then infected and/or transfected appropriately depending on the specific experiment before 
incubation at 37°C in a humidified 5% C02 atmosphere for a specified time. Media was 
then removed and, if using T2 cells, cells were then fixed in 4% paraformaldehyde for 10 
min at room temperature. All cells were then washed with PBS before the addition of 70% 
ethan0I/dH20 for 30 min at -20°C, as all other cell types were treated, for fixation and 
permeabilisation, unless permeabilisation was not needed for T2/T2RA surface staining. 
After the slides were subjected to four 10 min washes in PBS/1 % FCS, primary antibodies 
were added appropriately diluted in wash solution (see Table 2.1). Then, after a further 
round of washes, secondary FITC, TRITC or Alexa 594 conjugated antibodies were added 
as necessary at a dilution in wash solution determined for each, along with Hoechst 33342 
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Primary antibodies 
Antibody Manu. # Manu. WB IF ChIP Host GAPDH (HRP-eonj) ab9385 Abeam 1:2000 
- - Rabbit hDaxx D7810 Sigma I :4000 -
- Rabbit hDaxx 07-471 Upstate 
- 1:200 
- Rabbit Histone H3, CT, pan 07-690 Upstate 
-
- 1:200 Rabbit Histone H3, CT, pan 14-411 Upstate 1:5000 
-
- Rabbit Histone H3 dimethyl lys4 07-030 Upstate 
-
- 1:200 Rabbit Histone H3 dimethyl lys9 07-441 Upstate 1:2000 
- I :200 Rabbit Histone H4 aeetylated 06-866 Upstate 1:2000 
- 1:200 Rabbit HPl~(M31) MCA1946 Serotee 1:2000 1:100 1:200 Rat IE72/86 (El3) I 1-003 Argene 1:1200 1:100 
- Mouse mDaxx (M-112) se-7152 Santa Cruz 1:1000 -
- Rabbit Mouse serum M-5905 Sigma 
-
- 1:200 Mouse Oet4 abl9857 Abeam 1:2000 1:100 
- Rabbit PML P6746 Sigma I :2000 
-
- Mouse PML (N-19) se-9862 Santa Cruz 
- 1: 100 
- Goat pp28 ab6502 Abeam 1:5000 
-
- Mouse Rabbit serum R-9133 Sigma 
-
- 1:200 Rabbit Rat serum R-9759 Sigma 
-
- 1:200 Rat SSEA-3 abl6286 Abeam 
- 1:100 
- Rat UL44 (p52) M0757 Dako 1:1000 
-
- Mouse 
Secondary antibodies 
Antibody Manu. # Manu. WB IF Host Anti-goat FITC F2016 Sigma 
- 1 :30 Rabbit Anti-goat TRITC T-7028 Sigma 
- I :30 Rabbit Anti-mouse FITC F3008 Sigma 
- 1:30 Sheep Anti-mouse HRP-eonj P0260 DAKO 1:2000 
- Rabbit Anti-mouse IgG Alexa 594 A21203 lnvitrogen 
- I: 100 Donkey Anti-mouse TRITC T-5393 Sigma 
- 1 :30 Goat Anti-rabbit FITC Fl262 Sigma 
- 1 :30 Goat Anti-rabbit HRP-conj sc-2004 Santa Cruz 1:2000 
- Goat Anti 0 rabbit TRITC T-5268 Sigma 
- 1 :30 Goat Anti-rat HRP-eonj P0450 DAKO 1 :2000 
- Rabbit Anti -rat IgM Alexa 594 A21213 Invitrogen 
- I: 100 Goat 
Table 2.1 Primary and secondary antibodies and conditions of use. Listed are the primary and secondary antibodies used withi11 this study. All appropriate dilutions are given for Western blot (WB), immunofluorescence (IF) and Chromatin immunoprecipitation (ChIP). 
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(1 µg/ml) to counter stain nuclei, for 45 min before a final round of washes. Slides were 
then viewed using a Nikon Eclipse TE300 UV microscope and Hamamatsu colour chilled 
3CCD camera. 
2.6.2 Fluorescence activated cell sorting (FACS) 
2.6.2.1 FACS of infected fixed cells 
HFFs were seeded in 6 well plates at 1 x 106 per well. After 24 hours, media was aspirated 
from the monolayers and replaced with 0.5ml of pre-diluted virus mix (MOI 0.1) in 
EMEM-10 with incubation for 3hr at 37°C in a humidified 5% C02 atmosphere. The viral 
media was then removed and monolayers washed before replacement with fresh EMEM-
10 and overnight incubation. After a further 24 hours, cells were removed from wells via 
trypsinisation and pelleted (465g, 3 min) in FACS tubes before washing with 1ml of PBS. 
Cells were then fixed with 70% ethanol/dH20 for 30 min at -20°C. After pelleting, cells 
were then washed as above and stained as follows: 50µ1 of primary antibody, diluted as 
appropriate in PBS/1 % FCS, was added to the pellet and the cells re-suspended and 
incubated for 1 hour. Cells were stained for the presence of IE protein expression with the 
anti-IE72/86 antibody (El3, Argene) diluted 1:100. After this time, the cells were pelleted 
and washed twice in PBS before addition of secondary anti-mouse FITC antibody diluted 
1 :30 in PBS/1 % FCS for 45 min. Finally, the cells were washed twice again as above 
before resuspension of the final pellet in 0.5ml of 1 % formaldehyde/PBS. Analysis of the 
cells was then carried out on a Becton Dickinson F ACSort machine and then the data 
processed using WinMDI 2.8 flow cytometry application. 
2.6.2.2 FACS of live cells 
All sorting of live cells took place on a MoFlo High-Performance cell sorter (Dako) 
operated by Richard Grenfell at the Laboratory of Molecular Biology (LMB, University of 
Cambridge). A 528nm argon ion laser was used to detect dsRed-construct stably 
transfected U373s. Cells were re-suspended in fresh EMEM-10 before sorting through the 
disinfected machine and collected into 2ml of EMEM-10. This volume was then used to 
seed 1 well of a 6-well plate, the cells were allowed to grow and :finally bulked up as 
necessary. 
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2. 7 Chromatin Immunoprecipitation (ChlP) assay 
Cells were typically seeded at 1 x 106 per well on 6 well plates and after 24 hours were 
synchronised in serum-free media for 48 hours before infection with HCMV at a low MOI 
(0.1 ). Additionally, in order to exclusively analyse input genomes, cells were pre-treated 
with PF A (1 OOµg/ml) for 24 hours prior to infection with HCMV to inhibit replication of 
viral DNA. At the necessary time point, cells and chromatin were fixed via the addition of 
neat 40% formaldehyde (1 :40 dilution) for 10 min at room temperature (Fig. 2.2). 
Monolayers were then washed with PBS before replacement with 1ml of PBS, which the 
cells were then scraped into for harvesting. After pelleting (465g, 5 min), cells were lysed 
in 200µ1 of lysis buffer (1% SDS; lOmM EDTA; 50mM Tris, pH 8.1; lmM PMSF; lmM 
pepstatin A; lmM aproprotin) before sonication for 50 seconds (setting 5; Heat Systems 
sonicator XL). Cell debris was then removed by centrifugation of the samples at 4,000g for 
5 min. The supernatant was then made up to 2ml with dilution buffer (0.1 % SDS; 1 % 
Trition X-100; 2mM EDTA; 20mM Tris, pH 8.1; 150mM NaCl), with 200µ1 being 
removed and added to 300µ1 of elution buffer (1 % SDS; O.lM NaHC03) as an input (10%) 
sample, before addition of 160µ1 of protein A sepharose bead slurry (beads were pre-
swollen in PBS and supplemented with 200µg/ml of sheared herring sperm DNA) and 
rotation of tubes at 4°C for 30 min to pre-clear the sample. Samples were then spun 
( 4000g, 5 min) to pellet the beads and the supernatant aliquoted equally into separate tubes 
before addition of the appropriate antibodies. Chromatin was precipitated using anti-pan 
histone-H3 (panH3), anti-acetylated histone H4 (H4ac), anti-dimethyl lysine 4 histone H3 
(H3K4me2), anti-dimethyl lysine 9 histone H3 (H3K9me2) and anti-HPl~ antibodies or 
IgG normal serum controls, as detailed for each experiment. Immunoprecipitation was 
carried out with rotation at 4 °C overnight. 
Following incubation, 60µ1 of protein A sepharose bead slurry was added to the samples 
and each rotated at 4°C for a further 1 hour. Samples were then spun (16,000g, 5 min) and 
the supernatant removed to waste before the beads were washed with 0.5ml of dilution 
buffer. This process was then repeated using wash buffer 2 (0.1 % SDS; 1 % Tri ton Xl 00; 
2mM EDTA; 20mM Tris, pH 8.1; 500mM NaCl), wash buffer 3 (0.25M LiCl; 1% NP40; 
1% sodium deoxycholate; lmM EDTA; lOmM Tris, pH 8.1) and then two Tris-EDTA 
buffer washes. The protein complexes were then eluted from the beads with two 15 min 
rotating washes in 250µ1 of elution buffer at room temperature, retaining the supernatant 
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Figure 2.2 Chromatin immunoprecipitation (ChlP) assay. Cells are subjected to 1 % formaldehyde for 15 
min to fix protein:DNA interactions. The cells are then lysed and the sample sonicated to separate 
nucleosomes before incubation with specific antibodies. The primary antibody is then recovered using protein A sepharose beads and elution before the nascent DNA from the nucleosomes is isolated first by 
reversing the cross-links with NaCl and the DNA acquired by standard phenol/chloroform extraction. Purified DNA is precipitated in isopropanol and then can be analysed using specific PCR to determine the presence or absence of specific sequences. 
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from the pelleted beads each time. To each 500µ1 sample, 20µ1 of 5M NaCl was added 
before being incubated at 65°C for 4 hours. Then, a further 1 Oµl of 0.5M EDT A, 40µ1 of 
0.5M Tris (pH 6.8) and 2µ1 of proteinase K (1 Omg/ml in dH20) was added before 
incubation at 42°C for 1 hour. After this time, 1ml of phenol:chloroform:isoamyl alcohol (25 :24:1) was added to each sample and shaken for 2 min before being centrifuged (16,000g, 15 min) to extract the DNA. The upper aqueous solution was then added to an 
equal volume of isopropanol, shaken and then placed at -20°C overnight. Precipitated DNA 
was pelleted by centrifugation (16,000g, 30 min) and then re-suspended in TE buffer, 
typically in 0.5ml for inputs and 50µ1 for samples. Promoter specific PCR was then set up 
as detailed below using the same volume of input DNA as sample DNA in each reaction. 
In general, the volume used was 5 µl so that 0.1 % of total chromatin was used as an input 
and for ChlP samples the immunoprecipitated proportion from around 2-3% of starting 
total chromatin. Thus, although the amount of input DNA used for PCR was around 20-30 fold less than possible immunoprecipitated DNA, due to the efficiency of the ChIP assay 
this meant that PCR would provide sample data equivalent with input being set as 1 in the quantitative analysis when association of a modified histone was present. 
2.8 Polymerase chain reaction (PCR) 
2. 8.1 Semi-quantitative PCR 
PCR DNA amplification was performed using the BioMix Red reaction mix (Bioline) 
containing BioTaq Red DNA polymerase, dNTPs and MgCh (1.5mM). The user simply 
adds dH20, template and primers, and can increase the MgCh concentration as required (for primers and MgCh concentration see Table 2.2). Therefore, PCR was performed using 
the following mix per reaction (final concentrations of constituents given): 
5µ1 DNA template 
25 µl 2x Bio Mix Red 
1 µl sense primer (1 µM) 
1 µl antisense primer (1 µM) 
0.5-1.5µ1 MgCh (2-3mM) as necessary 
dH20 up to 50µ1 
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Promoter or Sense primer Antisense primer Annealing MgCl2 Target 
mRNA (5'-3') (5'-3') temp. {°C) cone. (mM) c-Fos Promoter GAGACCTCTGAGACAGGAACT CAGATGCGGTTGGAGTAC 55 3.0 Y-2lobin Promoter GCCTTGACCAATAGCCTTGACA GAAATGACCCATGGCGTCTG 55 1.5 MIEP Promoter TGGGACTTTCCTACTTGG CCAGGCGATCTGACGGTT 50 1.5 MrnPt Promoter ATTACCATGGTGATGCGGTT GGCGGAGTTGTTACGACAT 50 1.5 132.7 RT-PCR CGTTATCCGTTCCTCGTAGG GTTTCGTTGTTGTCGGTAGT 55 2.5 GAPDH mRNA GAGTCAACGGATTTGGTCGT TTGATTTTGGAGGGATCTCG 60 2.5 hDaxx mRNA GACGGACATTTCCTCTTCCA TCTCATGCACTGACCTTTGC 55 2.5 HP113 mRNA GTGGTAAAGGGCAAAGTGGA CCTCGTGGCTTTTCTGACTC 55 2.5 IE mRN A CGTCCTTGACACGATGGAGT ATTCTTCGGCCAACTCTGGA 55 2.5 Oct4 mRN A GCATACTGTGGACCTCAGG CCAAGGTGATCCTCTTCTG 55 2.5 PML mRN A TCCCCTTCAGCTTCTCTTCA CGCAGAAACTGGAACTCCTC 55 2.5 \0 *Unless reference given, primers designed using Primer 7 software. 
W tpc R primers internal to MIEP primers and product used as a probe fo r Southern blot analys is 
RTQ-PCR TM 
or Sense primer Antisense primer TaqMan probe Target SYBR (5'-3') (5'-3') (5'-FAM to 3'-TMR) (promoter) Green 
Y-!!:lobin TM GCCTTGACCAATAGCCTTGACA GAAATGACCCATGGCGTCTG ACCTCAGACGTTCCAGAAGCGAGTGT GAPDH TM CGGCTACTAGCGGTTTTACG AAGAAGATGCGGCTGACTGT CACGTAGCTCAGGCCTCAAGACCT 
MIEP TM CCAAGTCTCCACCCCATTGAC GACATTTTGGAAAGTCCCGTTG TGGGAGTTTGTTTTGGCACCAAA 0028 SG TGTTGCAGTCACACCCGGTGC TTAGCGTGGCCCTGAAGAGC N/A 
UL44 SG AACCTGAGCGTGTTTGTG CGTGCAAGTCTCGACTAAG N/A 
*Unless reference given, primers designed using Primer 7 software. 
Table 2.2 & 2.3 PCR and RTQ-PCR primer sequences and conditions of use. 
Product 
size (bp) 
230 
186 
285 
156 
302 
236 
224 
245 
194 
262 
232 
MgC12 Product 
cone. 
size (bp) (mM) 
4.5 186 
5.5 189 
4.5 71 
2.5 112 
2.5 275 
Reference* 
Nevels et al., (2004b) 
Bottardi et al. , (2003) 
Murphy et al., (2002) 
Reeves et al., (2005b) 
Reeves et al., (2007) 
Yu et al. , (2005) 
Hofmann et al., (2002) 
Reeves et al. , (2005b) 
Park et al. , (2007a) 
Reference* 
Bottardi et al. , (2003) 
Coleman et al. , (2008) 
Groves & Sinclair (2007) 
Nevels et al., (2004b) 
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DNA amplification then took place using the following parameters: 5 min at 95°C (initial 
denaturation of template), then between 20-60 cycles of 40 sec at 94°C (separation of 
template), 40 sec at 50-60°C (primer annealing - temperature set for individual primer 
reactions), and 90 sec at 72°C (primer extension). After the final extension step, the PCR 
samples were then cooled to 4°C. Due to the presence of a red dye and density of the 
reaction mix, it was unnecessary to add any further loading buffer. Therefore, 20µ1 of each 
sample was separated in a 2% agarose gel, with ethidium bromide (1 Ong per gel), at 1 OOV 
in TBE running buffer (40mM Tris-base; 90mM boric acid; lmM EDTA, pH 8.0). To 
initially quantify DNA levels, bands were then visualised by UV light and Image J analysis 
of band intensity used to semi-quantify the relative levels of PCR products. For more 
specific analysis, Southern blot analysis was employed (see 2.9). 
2.8.2 Real-time quantitative-PCR (RTQ-PCR) 
2.8.2.1 TaqMan RTQ-PCR 
During the course of the work presented in this thesis a RTQ-PCR assay was developed to 
enable more quantitative analysis of samples prepared from HCMV DNA. This 
development was carried out with the very kind help of Dr Heather Coleman (Division of 
Virology, University of Cambridge). 
TIB MolBiol (Berlin, Germany) was approached to design a TaqMan assay that would 
specifically detect the MIEP when used on a Rotor-Gene 3000 real-time PCR machine 
(Corbett Research). TaqMan analysis uses primers usually placed no more than 1 OObp 
apart and a probe sequence that anneals between the sites of the primers (see Fig. 2.3). The 
probe is manufactured so that a fluorescent reporter and a fluorescence quencher are 
attached to either end of the RNA probe: in this conformation only background 
fluorescence is visible by the detection filters. Upon initiation of PCR, the polymerase 
begins copying the complementary strand 5' to 3' but whilst doing so must displace and 
cleave the RNA probe. This is done via cleavage and leads to the dissociation of the 
fluorescent reporter from the close proximity to the quencher, and thus allows the reporter 
to fluoress. This output is detected in real-time by excitation and . detection from each 
reaction at least every cycle of the PCR run. Furthermore, the final analysis is termed fully 
quantitative due to serial 10 fold dilutions of standards of known copy number being used 
- 94 -
2. Materials and Methods 
Polymerisation 
Forward ~ primer 5' 5 , 
3' 
5' 
5' 
3' 
5' 
Reverse 
primer 
! Strand 
displacement 
5' 
~ , 
3' 
5' 
5' 
3' 
5' 
~ ! Cleavage 
- - 9;, -5' 
-
3 ' 
5' 
5' 
3' 
5' 
~ ! Polymerisation 
~ completed 
- - -
- -5' 
- 3' 3' 
5' 
5' 
3' 3' 
5' 
Figure 2.3 TaqMan real-time quantitative polymerase chain reaction (RTQ-PCR) analysis. The primers and probe first anneal to the denatured template DNA: one set per template strand. The RNA probe is composed of a fluorescent reporter (R) and a fluorescence quencher (Q) at either end of the RNA probe so that, until separation, the fluorescence in undetectable. Upon initiation, the polymerase progresses 5' to 3' down the template DNA and meets the probe where it is first displaced before being cleaved by the polymerase's nuclease activity. Due to release of the reporter from the close proximity to the quencher, fluorescence is now detectable and after completion of polymerisation and complete dissociation of reporter and quencher the fluorescent output can then be analysed quantitatively. 
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throughout the run to produce a standard curve. Hence, the technique is termed real-time 
quantitative PCR (RTQ-PCR). 
The TaqMan primers and probe were designed such that they would anneal between the 
sites of primers already used for MIEP PCR: + 13 to -272 relative to the MIEP transcription 
start site (see Table 2.3). In addition, the primers and probe were designed to work on all 
strains of HCMV with published genome sequences used routinely within the laboratory. 
The outcome were a sense and antisense primer that annealed complementary to positions -
157 and -86 relative to the MIEP start site and a TaqMan probe with a 5 '-6-
carboxyfluorescein (5'-FAM) fluorescent reporter and a 3 '-6-carboxy-tetramethyl-
rhodamine (3'-TMR) quenching element (see Fig. 2.4 for positions on sequence). The 
standard used for the MIEP RTQ-PCR was the pEScat plasmid (see 2.13.5). 
To preclude any contamination of the PCR reactions before analysis, all mixes other than 
including the template DNA were set up in a fully clean, uncontaminated PCR safe 
laboratory (room #5537, Dept. of Medicine). The master mix was composed of fully PCR 
safe reagents: 1 Ox PCR buffer, MgCb (to the necessary concentration) and HotStarTaq 
polymerase (Qiagen), lx dNTPs (Bioline), dH20 and the primers and probe (see Table 2.4 
for full details). This mix was then removed from the PCR safe laboratory and 12µ1 
aliquoted into each 0.1ml tube (Corbett Research) before addition of 8µ1 of DNA template, 
usually in triplicate. The tubes were then assembled into the rotor and the machine run for 
45 cycles as so: 95°C for 15 min (polymerase activation and template dissociation), 60°C 
for 60 sec (primer annealing and extension) and 95°C for 15 sec (separation of template). 
The fluorescence output was taken every cycle and the copy number in each sample 
calculated by the Rotor-Gene 3000 software (Rotor-Gene 6; Corbett Research) against the 
control standard curve (for an example see Fig. 6.3b). 
In addition to using TaqMan RTQ-PCR for analysis of the viral MIEP, this method was 
also used to quantitatively analyse the copy number of cellular human glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) and y-globin sequences within. a DNA sample. The 
TaqMan primers and probes were designed by TIB MolBiol and supplied by Heather 
Coleman. For further details of primer/probe design and reaction setup, see Tables 2.3 and 
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CCAGGCGATCTGACGGTTCACTAAACGAGCTCTGCTTATATAGACCTCCCACCGTACACGCCTACCGCCCATTTGCGTCA 
---------------------------------------------------TA-----
MIEP S 
ATGGGGCGGAGTTGTTACGACATTTTGGAAAGTCCCGTTGATTTTGGTGCCAAAACAAACTCCCATTGACGTCAATGGGG 
-c-------G---A------------------------------------------------------------------
-------------A---------------------------A--------------------------------------
MIEP TM 
TGGAGACTTGGAAATCCCCGTGAGTCAAACCGCTATCCACGCCCATTGATGTACTGCCAAAACCGCATCACCATGGTAAT 
------------------------------------------------G-------------------------------
MIEP A 
-272 
AGCGATGACTAATACGTAGATGTACTGCCAAGTAGGAAAGTCCCA 
--------------------------------------------G 
--------------------------------------------G 
Figure 2.4 MIEP RTQ-PCR primer sites. The figure shows the sites of the two primers, sense (S) and antisense (A), and the TaqMan probe (TM) for the MIEP specific RTQ-PCR analysis positioned along the aligned MIEP sequences of four strains (AD169, Toledo, Towne and Merlin) of HCMV from + 13 to -272 relative to the MIEP transcription start site. 
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2.4 respectively. Plasmid standards were also supplied (pGEM-T-Easy-yglobin and pGEM-T-Easy-GAPDH respectively; see 2.13 .8 and 2.13.9). 
2.8.2.2 SYER Green RTQ-PCR 
In addition to the use of a TaqMan primers and probe set, the use of SYBR Green to quantitatively analyse DNA samples during RTQ-PCR is also available. Here, instead of a fluorescent RNA probe, SYBR Green specifically intercalates into dsDNA and is only able 
to fluoress once this has occurred. Therefore, the fluorescence emitted by SYBR Green 
upon every cycle can be used to quantify the copy number of a starting DNA template 
when compared to a known standard curve. Furthermore, SYBR Green is readily available 
as a concentrated mix with polymerase, the necessary buffers, MgCh (2.5mM, unless 
concentration change was necessary) and dNTPs (Qiagen). Thus, the user simply adds 
specific primers and DNA template for each reaction. The master mix was again setup in 
the PCR safe laboratory (1 Oµl of 2x SYBR Green, 1 µl of sense primer and 1 µl of antisense primer per reaction; see Table 2.4) before removal and 12µ1 aliquoted into each 0.1ml tube before addition of 8µ1 of DNA template, usually in triplicate. The tubes were then loaded into the rotor (Rotor-Gene 3000) and the samples amplified for 45 cycles as follows: 95°C for 15 min (polymerase activation and template denaturation), 55°C for 20 sec (primer 
annealing), 72°C for 20 sec (primer extension) and 95°C for 5 sec ( denaturation). Readings 
were taken every cycle, as above, and the copy number determined via calculation 
dependent on a known standard curve. SYBR Green RTQ-PCR was used to analyse the 
copy number of viral early and late promoters, UL44 and pp28 respectively, and a 10 fold 
serial dilution of promoter standard plasmids used (see 2.13.2 and 2.13 .3). 
2.9 Southern blot analysis 
2. 9.1 Southern blo( 
Specific analysis of DNA levels produced by PCR using the BioMix Red reaction mix was 
achieved by using the Southern blot technique and hybridisation of DNA with a specific 
radio-labelled probe. After electrophoresis, the gel was washed in 0.25M HCI for 20 mins before a further wash in 0.4M NaOH for 20 min. DNA was then transferred overnight to 
nitrocellulose (Hybond N+, Amersham) via capillary action from the membrane-overlaid gel with residual 0.4M NaOH. Following transfer, the nitrocellulose membrane was 
washed in 5x SSC (20x SSC: 3M NaCl; IM sodium citrate, pH 7.0) and incubated with 
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Reagent y globin GAPDH MIEP pp28 UL44 
2x SYBR Green 10 10 
lOx buffer 2 2 2 
MgCl2 2.4 3.2 2.4 
dNTPs 1.6 1.6 1.6 
Sense primer 1.8 0.6 0.6 1 l 
Antisense primer 0.6 1.8 0.1 1 1 
TaqMan probe 0.1 0.1 0.05 
HotStarTaq 0.16 0.16 0.16 
H20 2.74 2.54 5.09 
DNA template 8 8 8 8 8 
Total 20 20 20 20 20 
Table 2.4 TaqMan & SYBR Green RTQ-PCR reaction setup. 
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15ml of pre-hybridisation buffer (10ml 50x Denhardts solution [5g polyvinylpyrollidone; 
5g BSA; 5g Ficoll; up to 500ml dH20]; 30ml 20x SSC; 0.5ml 20% SDS; 54.5ml dH20) 
supplemented with 0.5ml of 1 Omg/ml sheared herring sperm DNA in a Teche hybridisation 
tube for I hour at 62°C. After this time, a pre-boiled aliquot of specific radio-labelled 
probe was added to the tube and the membrane incubated overnight at 62°C. After 24 
hours, the membrane was washed twice in 50ml of 2x SSC/0.1 % SDS for 30 min at 62°C 
and then twice in 50ml of a high stringency 0.2x SSC/0.1 % SDS wash for 30 min at 62°C. 
The nitrocellulose membrane was then covered in Saran wrap and exposed to 
autoradiographic film. 
2. 9. 2 Probe manufacture 
DNA probes were produced via PCR from Toledo DNA usmg pnmers internally 
positioned compared to normal PCR amplification primers (see Table 2.2). The reaction 
products were column purified (Nucleobond) before being used to produce radio-labelled 
probes. Here, 25ng of probe DNA was made up to a volume of 45µ1 with dH20 and then 
denatured at 95°C for 5 min. This was then added to pre-aliquoted Rediprime II mix 
(Amersham) before being mixed with the addition of l .85MBq of 32P-labelled adCTP and 
incubated at room temperature for 1 hour. Purification of the probe was performed using a 
G50 Quickspin column (Boerhinger Mannheim), which was pre-spun at 830g for 3 min. 
The Rediprime mix was then added to the centre of the column before re-spinning at 830g 
for 3 min. Incorporation of the radionucleotide was estimated by comparing the level of 
radioactivity present within the eluant (labelled probe) to the column (unincorporated 
radionucleotide ). The probe was then aliquoted into 0.2MBq lots and stored at -20°C. 
2.10 Transfection protocols 
2.10.1 Lipofectamine transfection of siRNA oligonucleotides 
Cells were seeded 24 hours prior to requirement. Approximately 4 hours before 
transfection, medium was removed from cells and replaced with Opti-MEM (Gibco) serum 
free transfection medium before incubation at 37°C in a humidified 5% C02 atmosphere. 
For every 105 cells, I µl of siRNA oligonucleotide (20µM) was added to 49µ1 of Opti-
MEM and mixed gently. Separately, 0.5µ1 of Lipofectamine-2000 (Invitrogen) was added 
to 49.5µ1 of Opti-MEM and gently mixed. After 5 min, the Lipofectamine mixture was 
added to that of the siRNA and then incubated at room temperature for 20 min. Media was 
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then removed from the cells and 100µ1 of siRNA/Lipofectamine mix added to the 
monolayer before incubation at 37°C in a humidified 5% C02 atmosphere. After a further 4 hours, the cells were re-fed with EMEM-10. The cells were then used for investigation 
after 72 hours. 
2.10. 2 Lipofectamine transfection of plasmids 
Transfection of plasmid DNA was carried out essentially as described above (2.10.1 ). Approximately 4 hours before transfection, medium was removed from cells and replaced 
with Opti-MEM serum free transfection medium before incubation at 37°C in a humidified 5% C02 atmosphere. For every 105 cells, 0.4µ1 of plasmid (lµg/µl) was added to 49.6µ1 of 
Opti-MEM and mixed gently. Separately, 1 µI of Lipofectamine-2000 was added to 49µ1 of Opti-MEM and gently mixed. After 5 min, the Lipofectamine mixture was added to that of 
the plasmid and then incubated at room temperature for 20 min. Media was then removed from the cells and 100µ1 of plasmid/Lipofectamine mix added to the monolayer before incubation at 3 7°C in a humidified 5% C02 atmosphere. After a further 4 hours, the cells 
were re-fed with EMEM-10. The cells were then typically used for investigation after 24 hours. 
2.10. 3 Amaxa nucleofection of siRNA oligonucleotides 
Nucleofection of THPl cells was performed using the Cell Line Nucleofector Kit Vanda Nucleofector II machine (Amaxa Biosystems, Koeln, Germany). Cells were maintained at 
a density of 3-4 x I 05 cells/ml prior to nucleofection. The precise density of the cells was determined and I x I 06 cells per nucleofection centrifuged (90g, 5 min). The supernatant 
was discarded and the pellet re-suspended in 100µ1 of pre-warmed (to room temperature) Cell Line Nucleofector Soultion V. 3µ1 of siRNA oligonucleotide was then added to the 
cell suspension and this mix transferred into a nucleofector cuvette. The cells were then 
nucleofected using program V-00 I and the cell suspension immediately pipetted, using a fine Pasteur pipette, into pre-warmed RPMI-10 in a 6-well plate and the cells incubated at 37°C in a humidified 5% C02 atmosphere. The cells were then typically used for investigation 72 hours later. 
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2.11 siRNA oligonucleotides 
All DNA oligonucleotides for siRNA experiments were obtained from Dharmacon 
Research (Lafayette, Colorado, USA) as 2' hydroxyl, annealed and desalted duplexes. If 
necessary, the siRNA was made to 20µM stocks using a dilution of the supplied 5 x buffer 
in RNase-free water. Scramble (scr) oligonucleotides with no known homology to 
mammalian sequences were used as controls. All siRNA oligonucleotides used are 
described below and both sense and antisense sequences given (5' -3 '). 
2.11.1 scramble (scr) 
GCGCGCUUUGUAGGAUUCG CGAAUCCUACAAAGCGCGC 
Scramble is commercially available and is also known as 'Scramble II duplex'. 
2.11.2 hDaxxl 
GGAGUUGGAUCUCUCAGAA UUCUGAGAGAUCCAACUCC 
sihDaxxl has been previously described (Michaelson & Leder, 2003) and is also known as 
'hDx2'. The duplex targets bp 678-698 of the human Daxx coding region (GenBank 
AF015956). 
2.11.3 hDaxx2 
CUACAGAUCUCCAAUGAAA UUUCAUUGGAGAUCUGUAG 
sihDaxx2 is commercially available (siGENOME D-004420-01) and targets bp 1613-1631 
of the human Daxx coding region (GenBank NM_001350) . 
2.12.4 HPI/J 
GCGCAAAGCUGAUUCUGAUA UAUCAGAAUCAGCUUUGCGC 
siHPlP is available commercially (siGENOME D-009716-01) and targets bp 534-553 of 
the human CBXI (HPlP) coding region (GenBank NM_006807). 
2.12.5 mDaxx 
GGAGUUGGACCUGUCAGAG CUCUGACAGGUCCAACUCC 
simDaxx has been previously described (Michaelson & Leder, 2003) and is also known as 
'mDx2'. The duplex targets bp 666-684 of the murine Daxx coding region (GenBank 
NM_007829). 
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2.12.6 Oct4 
CAUCAAAGCUCUGCAGAAA 
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UUUCUGCAGAGCUUUGAUG 
si0ct4 is commercially available (siGENOME D-019591-05) and targets bp 468-486 of 
the human POU5Fl (Oct4) coding region (GenBank NM_002701). 
2.12. 7 PML 
CCGAGGAGGCAGAGAGAGU ACUCUCUCUGCCUCCUCGG 
siPML is available commercially (siGENOME D-006547-01) and targets the human PML 
coding region (GenBank NM_002675). 
2.12 Cloning and plasmid DNA preparation 
2.12.1 Purification of PCR products 
Where it was necessary for PCR products to be cloned into plasmid vectors for the creation 
of standard plasmids for use in RTQ-PCR, the QIAquick Gel Extraction kit (Qiagen) was 
used as per the manufacturers guidelines. 
PCR products, having been resolved on a 1-2% agarose gel, were excised from the gel 
using a scalpel and placed in a clean 1.5ml eppendorf. Having determined the mass of the 
gel fragment, three gel volumes of buffer QG (containing guanidine thiocyanate; 1mg -
1 µl) were added to the gel and the sample heated at 50°C for 10 min with occasional 
vortexing. After dissolution of the gel, 1 gel volume of isopropanol was added to 
precipitate the DNA fragments and after mixing was added to a QIAquick spin column 
before centrifugation for 1 min at 16,000g. With the DNA bound to the column, the flow 
through was discarded and a further 0.5ml of buffer QG was added to the column and the 
sample spun once again. The column was then washed with the addition of 0.75ml of 
buffer PE and centrifugation again for 1 min at 16,000g. Any final residue liquid was then 
centrifuged out of the column before 50µ1 of buffer EB was added to the centre of the 
column and it left to stand for 1 min before centrifugation again at 16,000g for 1 min to 
elute the DNA. 
2.12. 2 Restriction enzyme digest 
Restriction enzyme digests were used to prepare template plasmids for the cloning of PCR 
products and also for analysis of plasmid DNA preparations after cloning. Usually, digests 
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were carried out using 10 units of each enzyme in a final reaction mix of 20µ1: 1 µg DNA, 1 µ1 enzyme, 2µ1 of specified enzyme buffer or 1 Ox TAS buffer (330mM Tris-acetate, pH 7.9; 650mM potassium acetate; lOOmM magnesium acetate; 5mM dithiothreitol; 40mM 
spermidine; 2.5mg/ml BSA) and 16µ1 dH20. The reaction mix was incubated at 37°C in a 
water bath for 1 hour; For analysis of d1gested plasmid DNA, the reaction was then 
resolved on a 1 % agarose gel and the resultant digest pattern determined. 
2.12. 3 End filling of 5 'protruding termini 
In order to clone PCR products into a vector, restriction enzymes were used that created 5' protruding ends and the 3' recessed termini were then 'end filled' using DNA polymerase I large (Kienow) fragment (Promega) as follows: reaction mix was set up with 1 µg DNA, 1µ1 Klenow enzyme, 5µ1 lOx buffer as supplied by the manufacturer, 5µ125µM dNTP mix 
and dH20 up to 50µ1. This was then incubated at room temperature for 10 min before heat inactivation of the enzyme for 10 min at 75°C. The blunt end vector was then used for ligations. 
2.12. 4 Blunt end ligation 
Ligations of blunt end vector plasmid and PCR products were carried out using T4 DNA ligase (Promega) and DNA concentrations such that a 1: 1 molar ratio of vector to insert 
was maintained. Usually, reactions were set up as so: 5µ1 vector DNA, 5µ1 insert DNA, 2µ1 ligase lOx buffer, 2µ1 T4 DNA ligase and 6µ1 dH20. The mix was then incubated at l 6°C overnight after which between 1-1 Oµl of ligation reaction were used for transformation of bacteria. 
2.12. 5 Transformation 
For transformations~ 200µ1 of competent bacteria (E. coli DH5a) were thawed on ice. Between 1-20µ1 of plasmid DNA was then added to the bacteria and the cells incubated on ice for a further 30 min. The bacteria were then heat shocked for 90 sec at 42°C before being placed back on ice for 1 min. 0.8ml of Luria-Bertani (LB) broth (10g tryptone, 5g yeast extract, 1 Og NaCl made up to 1 litre with dH20) was then added to the bacteria before incubation for a further 1 hour at 3 7°C. After this time, bacterial cells were pelleted 
at 16,000g for 30 sec and the supernatant decanted. The bacteria were then re-suspended in the residual volume and plated out on ampicillin (50~tg/ml) agar plates (25ml of mix from: 
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5g tryptone, 2.5g yeast extract, 5g NaCl and 7.5g agar made up to 500ml with dH20) and 
incubated at 3 7°C overnight. 
2.12. 6 Small scale (Miniprep) plasmid preparation 
A single colony of transformed bacteria was picked and grown up overnight in 2ml of LB 
broth supplemented with 50µg/ml ampicillin. After this time, 1.5ml of culture was pelleted 
at 16,000g for 1 min and then re-suspended in 100µ1 of resuspension buffer (25mM Tris-
HCl; 50mM EDT A; 50mM sucrose; in dH20). The cells were then lysed using the alkaline 
SDS method whereby 200µ1 of lysis buffer (0.2M NaOH; 1 % SDS (w/v); in dH20) was 
added to the sample and mixed. A further 150µ1 of 3M sodium acetate was then added to 
the reaction before it was again mixed and incubated on ice for 10 min. The cell debris was 
then pelleted (16,000g for 1 min) and the supernatant added to a fresh eppendorf tube 
before the addition of 1ml of ethanol (-20°C), the sample mixed and then incubated at -
20°C for 20 min. Precipitated DNA was then pelleted by centrifugation (16,000g for 10 
min), the supernatant removed and the pellet re-suspended in 100µ1 of O.lM sodium 
acetate. The DNA was then re-precipitated by the addition of 200µ1 of ethanol (-20°C) and 
mixing. The samples were then centrifuged again (16,000g for 10 min), the supernatant 
removed and the final DNA pellet re-suspended in 50µ1 of dH20. To determine whether 
the plasmid DNA contained the required insert, restriction enzyme digestion was then 
carried out of 1 µl of DNA as above (see section 2.12.2). 
2.12: 7 Large scale (Maxiprep) plasmid preparation 
For the stock production of plasmids, purification was carried out using the Qiagen Maxi 
Kit (Qiagen) as per the manufacturer's guidelines. Usually, 500ml of LB broth 
supplemented with 50µg/ml ampicillin was used to culture transformed DH5a bacteria at 
37°C in a shaking i"ncubator (225rpm) overnight. The bacterial cells were then pelleted via 
centrifugation (3,800g for 15 min at 4°C; Sorvall SLA-1500 rotor) before re-suspension of 
the pellet in 10ml of buffer Pl (re-suspension buffer: 50mM Tris-HCl, pH 8.0; lOmM 
EDTA; lOOµg/ml RNase A). The bacteria were then lysed by the addition of 10ml of 
buffer P2 (lysis buffer: 200mM NaOH; 1 % SDS (w/v)) and th~ suspension mixed 
thoroughly before incubation at room temperature for 5 min. An additional 10ml of buffer 
P3 (neutralisation buffer: 3M potassium acetate, pH 5.5) was then added and the sample 
mixed again thoroughly before incubation on ice for 20 min. To clear the cell debris, 
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samples were centrifuged (17,200g for 30 min at 4°C; Sorvall SS-34 rotor) before the 
supernatant was placed into a fresh tube and centrifuged again (17,200g for 15 min at 4°C; 
Sorvall SS-34 rotor) to ensure removal of debris. Plasmid DNA was then harvested using Qiagen filter columns: 10ml of buffer QBT (equilibration buffer: 750mM NaCl; 50mM 
MOPS, pH 7.0; 15% isopropanol (v/v); 0.15% Trition X-100 (v/v)) was added to a column 
to equilibrate the filter. The clean supernatant from the lysed bacteria containing the 
plasmid DNA was then added to the column and allowed to enter the resin by gravitational 
flow, leaving the DNA on the resin. The column was then washed twice with 30ml of 
buffer QC (wash buffer: IM NaCl; 50mM MOPS, pH 7.0; 15% isopropanol (v/v)) by 
gravity flow. The DNA was then eluted from the resin into a clean tube by the addition of 
15ml of buffer QF (elution buffer: 1.25M NaCl; 50mM Tris-HCl, pH 8.5; 15% isopropanol (v/v)). The DNA was then precipitated by the addition of 10.5 ml of isopropanol to the 
solution, mixing and then centrifugation (17,200g for 30 min at 4°C; Sorvall SS-34 rotor). 
The supernatant was then decanted from the DNA pellet before washing of this with 5ml 
of 70% ethanol and centrifugation again (17,200g for 10 min at 4°C; Sorvall SS-34 rotor). 
Finally, the supernatant was decanted again and the DNA pellet allowed to air dry for 5-10 
min before re-suspension in 0.5ml of dH20. The concentration of the plasmid DNA was 
then determined using a NanoDrop ND-1000 UV spectrophotometer and restriction digest 
carried out to confirm the structure of the plasmid DNA. 
2.13 Plasmids 
All plasmids were kindly prepared and provided by Joan Baillie and diluted to a 
concentration of 1 µg/µl , unless otherwise stated. 
2.13.1 pcDNA3 
pcDNA3 is a commercially available plasmid (lnvitrogen) and is designed for eukaryotic 
expression. It contains a multiple cloning site (MCS) into which coding regions can be 
inserted, placing them under the control of the minimal HCMV MIEP. 
2. 13. 2 pcDNA3-UL44prom 
pcDNA3-UL44prom constitutes the PCR product of the UL44 promoter, using the PCR 
primers in Table 2.3, cloned into the parent pcDNA3 plasmid and was prepared by the 
author. 
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2.13. 3 pcDNA3-pp28prom 
pcDNA-pp28prom constitutes the PCR product of the pp28 promoter, using the PCR 
primers in Table 2.3, cloned into the parent pcDNA3 plasmid and was prepared by the 
author. 
2.13. 4 pCMV-Oct4 
pCMV-Oct4 constitutes the Oct4 coding region under the control of the minimal HCMV 
MIEP and has been previously described (Brehm et al., 1997). 
2.13.5 pEScat 
pEScat is composed of the chloramphenicol acetyltransferase ( cat) gene under the control 
of the full length MIEP (-2100 to +72) from HCMV strain AD169 and has been previously 
described (Shelboum et al., 1989b ). 
2.13. 6 pESluc 
pESluc constitutes the full length HCMV MIEP fused to the firefly luciferase gene in the 
pGL3-vector backbone. 
2.13. 7 pFC-MEKK 
pFC-MEKK is composed of the Mitogen-Activated Protein (MAP) Kinase Kinase Kinase 
(MEKK) coding region 360-672 under the control of the HCMV MIEP. pFC-MEKK is 
commercially available as a PathDetect cis-Reporting system (Stratagene Europe, 
Amsterdam, The Netherlands). 
2.13. 8 pGEM-T-Easy-yglobin 
pGEM-T-Easy-yglobin constitutes the PCR product of the y-globin promoter, using the 
PCR primers in Table 2.3 , cloned into the Promega pGEM-T-Easy plasmid and was 
supplied by Heather Coleman. 
2.13.9 pGEM-T-Easy-GAPDH 
pGEM-T-Easy-GAPDH constitutes the PCR product of the GAPDH promoter, using the 
PCR primers in Table 2.3, cloned into the Promega pGEM-T-Easy plasmid and was 
supplied by Heather Coleman. 
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2.13.10 p!SRE-luc 
pISRE-luc comprises an IFN-a/B-responsive element containing four tandem repeat 
sequences of the interferon-stimulated response element (ISRE) from the IFN-inducible 
gene fused to the firefly luciferase gene and is previously described (Poole et al., 2006). 
2.13.11 pJATlac 
pJATlac is composed of the Escherichia coli B-galactosidase gene under the control of the 
constitutively active rat B-actin promoter and is previously described (Poole et al., 2006). 
2.13.12 pNF-KB-Luc 
pNF-KB-Luc comprises a 5x repeat of the NF-KB responsive element 
(TGGGGACTTTCCGC) fused to the firefly luciferase gene. pNF-KB-Luc is 
commercially available as a PathDetect cis-Reporting system (Stratagene Europe, 
Amsterdam, The Netherlands). 
2.14 RT-PCR analysis of RNA synthesis 
2.14.1 Production of mRNA samples 
RNA was isolated from cells using the RNAzol B reagent (Biogenesis Ltd.) At the 
appropriate time point, 106 cells were lysed by direct addition of 0.5ml of reagent and 
repeated pipetting before aliquoting the sample. To this, 100µ1 of chloroform was added 
before vigorous shaking for 1 min and then incubation on ice for 5 min. The homogenate 
was then centrifuged at 16,000g for 15 min at 4°C. The upper aqueous layer was then 
removed and mixed with 0.5ml of isopropanol. After 10 min at room temperature, the 
sample was centrifuged at 16,000g for 5 min. The supernatant was removed and the RNA 
pellet was washed with 0.5ml of 75% ethanol/dH20 and spun at 4000g for 5 min. The 
supernatant was again removed and the pellet air-dried for 5-10 min before re-suspension 
in 30µ1 of nuclease-free H20. RNA samples were then treated with DNase to preclude 
contamination. lµl of DNase (Promega) and 1µ1 of DNase lOx buffer was added to 8µ1 of 
RNA in a 0.5ml eppendorf tube. This reaction mix was incubated at 37°C for 30 min 
before the addition of 1 µl of DNase Stop Solution to terminate the r.eaction. The mix was 
then incubated again at 65°C for 10 min to inactivate the DNase and, if necessary, the 
RNA re-isolated by standard phenol/chloroform extraction and isopropanol precipitation as 
above. 
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2.14.2 Reverse transcription of mRNA 
Reverse transcription was performed using the Promega Reverse Transcription kit. This 
uses the avian myeloblastosis virus reverse transcriptase (AMV RT) to synthesize single-
stranded cDNA from total mRNA. The procedure was carried out as per the 
manufacturer's instructions using 5µ1 of harvested mRNA with incubation of the mix at 
42°C for 20 min before an AMV RT denaturation incubation at 95°C for 5 min. Analysis of 
the produced cDNA was then carried out by PCR (see 2.8). 
2.15 DNA extraction from cells 
2.15.1 DNA extraction 
DNA was isolated from cells using the sodium perchlorate (NaCl04) method and dialysis 
of the resultant samples. Typically, 106 cells from 1 well of a 6-well plate were scraped 
into the medium before centrifugation ( 4000g, 5 min). The supernatant was then discarded 
and the pellet was re-suspended in 0.6ml of lOOmM NaCl/ 5rnM EDTA (pH 8.0). To this 
125µ1 of 10% SDS was added and the cells lysed by pipetting. Further, 150µ1 of SM 
NaC104 was then added to the sample and the solution agitated again by pipetting until the 
protein content had aggregated. DNA was then isolated by addition of 1ml of 
phenol:chloroform:isoamyl alcohol (25 :24: 1) and gentle mixing of the sample by inversion 
for 2 min before centrifugation (16000g, 15 min). The upper aqueous solution was then 
added to an equal volume of cold isopropanol (-20°C), shaken and then incubated at -20°C 
for at least 30 min. After this time, the sample was centrifuged (16000g, 30 min) and the 
supernatant discarded before washing of the DNA pellet with 0.5ml of 70% ethanol and 
further centrifugation (16000g, 10 min). The supernatant was again discarded and the 
pellet re-suspended in 100-200µ1 of TE buffer. 
2.15.2 Dialysis of DNA samples 
In order to eliminate excess salts that may interfere with PCR of the DNA samples, dialysis 
was used to further purify the isolated DNA. 5cm lengths -of UltraPure 1/4 inch diameter 
dialysis tubing (Gibco GRL) were cut and washed in excess dH20. An end of each length 
was then clamped and a sample carefully added within before clamping of the opposite end 
and placing of all samples into an excess volume of TE buffer. The samples were then 
mixed slowly overnight at 4 °C to allow dialysis to occur. After this time, one end of each 
tube was carefully unclamped and the dialysed samples added to fresh eppendorf tubes. If 
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necessary, the isopropanol precipitation method (see 2.14.1) was then again employed to 
isolate the DNA sample and aid re-suspension of all the samples in the appropriate volume. 
Analysis of the DNA samples was then carried out by PCR (see 2.8). 
2.16 Luciferase assay analysis 
2.16.1 Luciferase assay 
Cells were typically seeded on 6-well plates and transfected (see 2.10.2) with the 
appropriate luciferase constructs and controls 24 hours before analysis. After this time, the 
cells were washed in 2ml of PBS before addition of 200µ1 of luciferase buffer A (25mM 
Tris phosphate, pH 7.8; 8mM MgCb; lmM DTT; lmM EDTA; 1 % Triton X-100 (v/v); in 
dH20) for 2 min to lyse the cells. Then 200µ1 of luciferase buffer B (25mM Tris 
phosphate, pH 7.8; 8mM MgCb; lmM DTT; lmM EDTA; I% Triton X-100 (v/v); 0.8mM 
ATP; 2% BSA (w/v); 30% glycerol (v/v); in dH20) was added and the solutions mixed by 
gentle swirling before incubation of the plates at -20°C overnight to aid lysis of the cells. 
Plates were then thawed and lysed cells suspended by gentle pipetting before transfer to an 
eppendorf tube and centrifugation ( 4000g, I min) to remove cellular debris. The 
supernatant was then transferred to a luminometer tube (75 x 12mm, Sarstedt) and the 
samples analysed using an AutoLumat LB953 reader (Berthold) with automatic injection 
of I 00µ1 of 0.6mM luciferin to each sample. Background levels were detected using 
untransfected cell samples for analysis. 
2.16. 2 /J-galactosidase assay 
To normalise luciferase assay results to transfection efficiencies, cells were co-transfected 
with a ~-galactosidase construct (pJATlac, see 2.12.9) and the following analysis carried 
out. After luciferase analysis, 1ml of Lacz buffer/ONPG (60mM Na2HP04.7H20; 40mM 
NaH2P04.H20; lOmM KCl; 0.3% ~-mercaptoethanol (v/v); lmM MgS04.7H20) was 
added to each sample and the tubes incubated at 30°C. When the samples had turned 
yellow, the reaction was terminated by addition of 0.5ml of IM Na2C03 and the optical 
density at 420nm (OD420) determined by transfer to a 1ml cuvette (Sarstedt) and analysis 
using a BioSpec-I601E spectrometer (Shimadzu) for each sample against a control of 
mock transfected cells. The luciferase assay results were then normalised using the ~-
galactosidase results. 
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3. Results 
The MIEP of HCMV is chromatinised throughout productive infection 
3.1 Introduction 
It is now well established that the transcriptional regulation of gene expression m 
eukaryotic organisms is mediated by the modulation or remodelling of chromatin structure 
associated with promoters and coding sequences of their genes. Investigation over the last 
thirty years has led to a substantial increase in our knowledge of the modifications made to 
chromatin structure and the enzymes which carry this out. Indeed, this has led to a 
consensus that particular modifications at certain positions along gene promoters and 
coding regions are in fact hallmarks for repression or activation of gene expression and that 
they can be used to determine the transcriptional activity of the gene (see Fig. 1.11) 
(reviewed in: Kouzarides, 2007a). 
In addition, it is becoming increasing clear that the differentiation-dependent control of 
HCMV gene expression is regulated by the chromatin status of the viral MIEP. Studies 
using conditionally permissive cell models, such as T2 cells, cultured monocytes and 
CD34+ cells, have provided a wealth of information regarding the chromatin status of the 
MIEP. In the undifferentiated, non-permissive exogenously infected cells, the MIEP is 
associated with HP 1 p, a marker of transcriptional repression, whereas in the differentiated, 
permissive, exogenously infected cells the MIEP becomes associated instead with high 
levels of acetylated histone-H4 (Murphy et al., 2002; Reeves et al., 2005a). It has also been 
shown that in the THPI cell line, which is differentiation-dependently permissive for 
HCMV IE gene expression (Sinclair et al., 1992), the viral MIEP is associated with 
acetylated histone:-H3 at lysine 9 after differentiation to macrophage, with the absence of 
this residue in undifferentiated, non-permissive cells (Ioudinkova et al., 2006). These 
observations in experimentally infected cell models of lat~ncy have also been recapitulated 
in natural latency in CD34+ cells where the same repression of IE gene expression through 
repression of the viral MIEP occurs (Reeves et al., 2005b ). In addition, the maturation of 
these cells to fully mature DCs results in reactivation of endogenous latent virus 
concomitant with the association of acetylated histone H4 with the viral MIEP (Reeves et 
al., 2005b ). 
- 111 -
3. Results 
The gene expression of a number of other viruses has been shown to be regulated through 
chromatinisation of viral promoters and remodelling of chromatin. Examples include other 
herpesviruses, such as EBV, KSHV and HSV-1, where the control of latency and 
reactivation also appears to be tightly regulated by the chromatin status of certain 
promoters. Furthermore, the control of gene expression of different classes of viral genes 
throughout a productive, lytic infection of fully permissive cells with HSV-1 has also been 
shown to be mediated by chromatinisation and remodelling of promoters (Herrera & 
Triezenberg, 2004; Kent et al., 2004; Coleman et al., 2008). Similarly, in the case of 
MCMV, productive infection appears to be regulated by the chromatinisation of the viral 
MIEP: the promoter appears to be repressed to some degree during a lytic infection as the 
use of HDAC inhibitors causes increased IE gene expression and infectious virus progeny 
output (Tang & Maul, 2003). Furthermore, the impairment in growth of an IE72-deficient 
mutant HCMV can be rescued with the use of HDAC inhibitors (Nevels et al., 2004b). 
This repression has been hypothesised to be mediated by chromatin remodelling enzymes 
present at ND 10 where the viral genome is deposited upon infection. Therefore, it was first 
decided to investigate whether the MIEP of HCMV is chromatinised throughout a 
productive infection of fully permissive human fibroblasts and whether modulation of the 
chromatin structure occurs throughout infection. 
3.2 Results 
3: 2.1 The MIEP is associated with both acetylated and methylated histones throughout 
productive infection 
Human fibroblasts, fully permissive for HCMV lytic infection, were first incubated for 48 
hours with serum-free medium to synchronise the cells in the G0/G1 phase of the cell cycle 
prior to infection, such that the initiation of gene expression from infecting genomes would 
also be synchronised. After this, cells were infected in serum-containing medium at a low 
multiplicity of infection (MOI 0.1). At the appropriate timepoint (3, 24 or 96 hours post-
infection) the protein/DNA chromatin complexes within, the cell populations were fixed 
with formaldehyde (1 %) and ChIP assays carried out using either control serum (Con), an 
anti-acetylated histone-H4 antibody (H4ac), an anti-di-methyl lysine 9 histone-H3 
(H3K9me2) antibody or an anti-HPl~ (HPl~) antibody. Immunoprecipitated DNA 
fragments were then amplified using viral MIEP specific primers, complementary to 
positions -272 to + 13 of the transcriptional start site (Murphy et al., 2002), with 10% of the 
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total chromatin fraction being used as a relative input for each timepoint, and the products 
separated on a 2% agarose gel. To aid specificity of the analysis, Southern blotting was 
then carried out using a probe internal to the initial PCR primers and the resultant 
autoradiograph bands from each sample are displayed in Fig. 3 .1. 
Throughout the timecourse of infection, all amplification of input DNA provided visible 
levels after Southern blotting (Fig. 3 .1 , lane 1) and immunoprecipitation with control 
serum showed little to no precipitated DNA levels (Fig. 3 .1, lane 2). Upon analysis of the 
antibody immunoprecipitated samples, the viral MIEP appeared to be associated with 
histones and histone associated proteins across all timepoints. However, at this stage, to 
better compare the PCR data from the ChIP samples, Image J analysis was used to quantify 
the intensity of the bands from the autoradiograph and presented in a graphical form seen 
in Fig. 3 .2. This representation also contains data from triplicate PCRs and the level of 
immunoprecipitated DNA is quantified relative to the input DNA for that timepoint, taken 
as 1.0. This more quantitative data was then used to analyse the results. 
At 3 hours post-infection with HCMV, the viral MIEP was associated with acetylated 
histone-H4 (Fig 3.2a, lane 3), only minimally and, intriguingly, the incoming genomes also 
appeared to be associated with both H3K9me2 and HPlP (Fig. 3.2a, lane 4 & 5 
respectively). Since both H3K9me2 and HPlP modifications are markers for silenced 
chromatin (Kouzarides, 2007a), this would suggest that a significant proportion of MIEPs 
are associated with transcriptionally inactive chromatin immediately upon infection. 
At 24 hours post-infection, the proportion of viral MIEPs associated with acetylated 
histones substantially increased (Fig. 3.2b, lane 3) by as much as six-fold, which is 
consistent with the known increase in IE gene expression prior to the onset of early and 
late gene expression. In addition, the levels of both H3K9me2 and HPl p associated with 
the viral MIEP decreased substantially (Fig. 3.2b, lanes 4· & 5 respectively). Again, this is 
consistent with an active transcriptional chromatin conformation of the promoter at this 
time. 
At late times (96 hours post-infection), the largest change in the chromatin structure of the 
MIEP was a predominant re-association of HP 1 p (Fig. 3 .2c, lane 5) as well as a decrease in 
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Input Con H4ac H3K9me2 HP1jl (bp) 
3 hrp.i. 
- 285 
24 hr p.i. 
-285 
96 hr p.i. 
1 2 3 4 5 
Figure 3.1 The MIEP of HCMV is chromatinised throughout a productive lytic infection. ChIP assays were performed on serum-starved human fibroblasts infected with HCMV Toledo at 3, 24 and 96 hours post-infection (MOI 0.1). Analysis was carried out with either control serum (Con, lane 2), an anti-acetylated histone-H4 antibody (H4ac, lane 3), an anti-dimethyl lysine 9 histone-H3 antibody (H3K9me2, lane 4) or an anti-HPl~ antibody (HPl~, lane 5). Inputs (10% of total chromatin) are shown (Input, lane 1). Isolated DNA was amplified using an MIEP-specific PCR and products run on a 2% agarose gel before Southern blot analysis. 
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Figure 3.2 The MIEP of HCMV is chromatinised throughout a productive lytic infection - graphical 
representation. ChIP assays were performed on serum-starved human fibroblasts at 3, 24 and 96 (A-C) 
hours post-infection (MOI 0.1). Analysis was carried out with either control serum (Con), an anti-
acetylated histone-H4 antibody (H4ac), an anti-dimethyl lysine 9 histone-H3 antibody (H3K9me2) or an 
anti-HPl~ antibody (HPl~). Inputs are shown (Input). Isolated DNA was amplified using an MIEP-specific 
PCR and products run on a 2% agarose gel before Southern blot analysis. Image J analysis was then used to 
quantify autoradiograph bands. For comparison, the immunoprecipitated DNA was quantified relative to 
the input DNA. The data is representative of three independent experiments. Error bars, 1 S.D. of triplicate 
PCR reactions. 
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Figure 3.2 The MIEP of HCMV is chromatinised throughout a productive lytic infection - graphical 
representation. ChIP assays were performed on serum-starved human fibroblasts at 3, 24 and 96 (A-C) 
hours post-infection (MOI 0.1). Analysis was carried out with either control serum (Con), an anti-
acetylated histone-H4 antibody (H4ac), an anti-dimethyl lysine 9 histone-H3 antibody (H3K9me2) or an 
anti-HPlf3 antibody (HPif3). Inputs are shown (Input). Isolated DNA was amplified using an l\1IEP-specific 
PCR and products run on a 2% agarose gel before Southern blot analysis. Image J analysis was then used to 
quantify autoradiograph bands. For comparison, the immunoprecipitated DNA was quantified relative to 
the input DNA. The data is representative of three independent experiments. Error bars, I S.D. of triplicate 
PCR reactions. 
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the level of acetylated histone-H4 association (Fig. 3.2c, lane 3). This is consistent with the known negative auto-regulation of IE gene expression at late times of infection through the repression of the viral MIEP by IE86 (Meier & Stinski, 1996; Reeves et al., 2006). It is unclear why H3K9me2 association with the MIEP appears to decrease at this time (Fig. 3.2c, lane 4). However, this may be due to the increase in HPlP association which could mask the immunoprecipitation of di- and tri-methyl residues on the histone tail (Bannister et al., 2005). 
To ensure consistent immunoprecipitation of specific histone or histone associated proteins across each timepoint and throughout the full timecourse of infection, it was necessary to carry out a control PCR assay on each sample. Previous studies (Nevels et al., 2004b) have used c-Fos, a transcription factor constitutively expressed in fibroblasts, as a control for the immunoprecipitation of acetylated histone-H4 during infection with HCMV which showed little change in the chromatin associated with the c-Fos promoter. Therefore, this control was also employed here. For all samples, a PCR was carried out specifically for the c-Fos promoter. The resultant amplified products were resolved on a 2% agarose gel and viewed using ethidium bromide staining and ultraviolet light (Fig. 3.3). The bands present were then analysed using Image J analysis, as described above, and the quantitative representation is provided in Fig 3.4. 
UV analysis of the PCR products showed that the c-Fos promoter was predominantly associated with acetylated histone-H4 throughout infection as expected (Fig. 3.3, lane 3). However, levels of both H3K9me2 and HPlP, although less than acetylated histone-H4, were apparent (Fig. 3.3, lanes 4 & 5, respectively). The level of precipitation of acetylated histone-H4 varied slightly throughout the timecourse (Fig. 3.4a, lanes 1-3) although not significantly when compared quantitatively. Indeed, this was also the case for the two markers of repression (Fig. 3.3b & 3.3c). Hence, the immunoprecipitation of chromatin had occurred consistently throughout the analysis. 
Therefore, although the MIEP of HCMV is associated with both acetylated and methylated histones throughout infection, the overall state of chromatinisation of the promoter with respect to the known markers of transcriptional activation or repression is consistent with the levels of major IE transcription at these times. However, the MIEP does appear to be 
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Figure 3.3 PCR of the c-Fos promoter shows consistent immunoprecipitation of chromatin. ChIP 
assays were performed (MOI 0.1) on serum-starved human fibroblasts at 3, 24 and 96 hours post-infection. Analysis was carried out with either control serum (Con, lane 2), an anti-acetylated histone-H4 antibody (H4ac, lane 3), an anti-dimethyl lysine 9 histone-H3 antibody (H3K9me2, lane 4) or an anti-HPl~ antibody (HPl~, lane 5). Inputs (10% of total chromatin) are shown (Input, lane 1). Isolated DNA was amplified 
using an c-Fos-specific PCR and products run on a 2% agarose gel and visualised using UV light. 
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Figure 3.4 The chromatinisation of the c-Fos promoter does' not change throughout viral lytic 
infection. ChIP assays were performed on HCMV Toledo infected (MOI 0.1), serum-starved human 
fibroblasts at 3, 24 and 96 hours post-infection. Analysis was carried out with either (A) an anti-acetylated 
histone-H4 antibody, (B) an anti-dimethyl lysine 9 histone-H3 antibody or (C) an anti-HPI~ antibody. 
Isolated DNA was amplified using a c-Fos-specific PCR and products run out on a 2% agarose gel stained 
with ethidium bromide. Image J analysis was then used to quantify bands and represented as above. For 
comparison, the immunoprecipitated DNA was quantified relative to the input DNA. The data is 
representative of three independent experiments. Error bars, I S.D. of triplicate PCR reactions. 
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associated with a level of repressive chromatin immediately upon infection and from this 
analysis it cannot be established whether this association of repressive chromatin occurs 
upon infection and entry of naked viral DNA to the nucleus or whether the viral genome is 
packaged into the virion core with histone proteins after replication and thus enters in this 
form. 
3.2.2 The HCMV genome is not associated with histones in the virion 
Although the ChIP analysis had determined that upon infection with HCMV the incoming 
viral genomes were chromatinised and remodelled throughout infection, it could not be precluded that the viral genome was already associated with histones within the infectious 
virion. Therefore, to determine if this was so, infectious viral particles were first isolated 
from crude clarified virus preparations via density centrifugation. Initially, a gradient of 5-
15% Ficoll was used as a medium to separate the particles present in the concentrated, 
crude HCMV stock (Fig. 3.5a) as has been performed previously to separate HSV-1 
particles from non-infectious by-products (Szilagyi & Cunningham, 1991 ). This separation 
of crude HCMV infected fibroblasts supematants produced three bands as expected: non-
infectious enveloped particles (NIEPs), infectious virions and dense bodies (DBs). After harvest of each band, their infectivity was tested on fibroblasts (Fig. 3.5b ). After fixation 
and staining of infected cells for IE72/86 expression at 24 hours post-infection, it was found that although band 2 was associated with the highest level of infectious virus ( 4 7. 9% 
of total; Fig. 3.5c), all bands showed infectivity over 25%. Purified bands of NIEPs and 
DBs, due to the absence of packaged genome, should not show any infectivity (Irmiere & 
Gibson, 1983), suggesting that all bands were contaminated with infectious virions. 
Therefore, a further method was developed with the aim of isolating a purer preparation of 
infectious virions. This protocol was based on that used by the Compton group to purify 
HCMV infectious particles using a 20-70% sorbitol gradient (Reeves & Woodhall, personal communication) (Fig. 3.6a). With this method, the separation now produced five bands. These bands were, again, harvested and tested for 1.nfectious virus on fibroblasts 
with subsequent staining for IE72/86 expression after 24 hours as before (Fig. 3.6b). This 
showed that only bands 3 and 4 contained high levels of infectious virions, with bands 1, 2 
and 5 showing low levels of infection. Furthermore, infection with band 3 demonstrated 
the highest level of infected cells (58.8%) which corresponded to 50.3% of the total infectious virions isolated from the gradient (Fig. 3.6c). Indeed, the level of infectious 
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Figure 3.5 Ficoll gradient purification of HCMV Toledo particles. (A) A clarified virus preparation of HCMV Toledo was separated by high speed centrifugation (19,000g) through a Ficoll gradient (5-15%). (B) The visible bands were then harvested, pelleted and used to infect human fibroblasts. At 24 hours post-infection cells were fixed and stained for IE72/86 (green). Hoechst 33342 staining (blue) was used throughout to identify cell nuclei. The percentage of infected cells is stated in the bottom right comer of 
each view. (C) The percentage of infectious virus in each band was subsequently calculated from the total harvested from all the bands. 
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Figure 3.6 Sorbitol gradient purification of HCMV Toledo particles. (A) A clarified virus preparation 
of HCMV Toledo was separated by high speed centrifugation (49,500g) through a Sorbitol gradient (20-
70%). (B) The visible bands were then harvested, pelleted and used to infect human fibroblasts. At 24 hours 
post-infection cells were fixed and stained for IE72/86 (red). Hoechst 33342 staining (blue) was used 
throughout to identify cell nuclei. (C) The percentage of infectious virus in each band was subsequently 
calculated from the total harvested from all the bands. 
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virus isolated from the sorbitol gradient was approximately six-fold greater than that achieved with a Ficoll gradient. As such, band 3 of the sorbitol purified virions was used for all subsequent experimentation requiring purified virus. 
In order to determine whether the viral genome was packaged within the virion already associated with histones, the protein constituents of purified infectious virions were analysed by Western blotting (Fig. 3. 7). Three separate preparations of purified infectious HCMV Toledo virions were analysed (Fig. 3.7, lanes 1-3) in addition to crude clarified virus preparations of Toledo, TB40/E and Towne-GFP (Fig. 3.7, lanes 4, 6 & 7) and an uninfected clarified cellular pellet (Fig. 3.7, lane 5). lx105 plaque forming units (PFU) of virus preparations were loaded and an equivalent volume of uninfected clarified material. Coomassie blue staining of total protein loading was used as a loading control due to the differing nature of the samples and showed approximate equal loading between the purified virus and clarified virus samples (Fig. 3. 7, lanes 1-7). Staining for pp28, a tegument protein present in the infectious virion (Spaete et al. , 1994), confirmed that all virus preparations, both clarified and purified, had virions present (Fig. 3. 7, lane 1-4, 6 & 7) and that the control uninfected clarified pellet did not (Fig. 3.7, lane 5). However, upon staining for histone-H3 it was found that although all clarified pellets, both infected and uninfected, were associated with histone-H3 (Fig. 3.7, lanes 4-7), no histone-H3 could be detected in protein isolated from purified HCMV Toledo preparations (Fig. 3.7, lanes 1-3). Indeed, this was also observed when staining for the modified histone form, H3K9me2, whereby no histone was found associated with the purified virus preparations (Fig. 3.7). This finding is not entirely unexpected since it is consistent with findings from other groups using amino acid sequence analysis and mass spectrometry where no histone proteins have been found with purified virions (Baldick & Shenk, 1996; Varnum et al., 2004). Consequently, histones are not associated with the viral genome within the virion. 
3. 2. 3 TSA treatment of permissive fibroblasts increases the level of IE gene expression ChIP assays of productively infected, permissive human fibroblasts had shown that the viral MIEP appears to be associated with markers of repressive chromatin, such as methylated hi stones and HP 1 ~. at very IE times (Fig. 3 .1 ). The establishment of any chromatin structure around the MIEP would be dependent upon various chromatin remodelling enzymes, including histone deacetylases (HDACs). Therefore, to test whether 
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Figure 3. 7 Purified infectious HCMV virions are not associated with histones. Purified virions from 
three HCMV strain Toledo infections (lanes 1-3), clarified virus preparations of strains Toledo (lane 4), 
1B40/E (lane 6) and Towne-GFP (lane 7) and uninfected clarified cell debris (lane 5) were re-suspended in 
Laemlli ' s buffer and run on a 10% polyacrylamide gel to separate the protein content. Western blotting was 
then used to analyse viral late (pp28), histone-H3 (H3) and dimethyl-lysine 9 histone-H3 (H3K9me2) 
levels. Coomassie blue staining was used as a loading control. 
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this repressive chromatin structure of the MIEP at this time of infection was actually 
correlated with repression of viral gene expression, the use of a HDAC inhibitor 
Trichostatin-A (TSA) was employed. The addition of TSA to normally non-permissive, 
undifferentiated T2 cells has previously been shown to render them permissive for HCMV 
infection (Meier, 2001; Murphy et al., 2002) and treatment of normally permissive mouse 
embryonal fibroblasts (MEFs) before infection with MCMV has also been shown to lead to 
increases in viral gene expression and production of infectious virus (Tang & Maul, 2003). 
However, prolonged exposure to TSA can also be cytotoxic, thus it was necessary to 
establish the lowest concentration of TSA that could be used to treat cells. Fibroblasts were 
either mock treated (fresh medium), treated with a DMSO solvent control or a range of 
concentrations of TSA (50-450nM) for 16 hours. Cells were then harvested and analysed 
by Western blot for the levels of endogenous acetylated histone-H4 under each treatment 
(Fig. 3.8). DMSO and 50-250nM TSA treatment (Fig. 3.8, lanes 2-7) caused little or no 
increase in global endogenous acetylation of histone-H4 above normal levels seen with 
mock treatment (Fig. 3.8, lane 1). However, at a concentration of 300nM, TSA causes an 
increase in the level of acetylated histone-H4 (Fig. 3.8, lane 8) and this increase is 
maximised before plateauing at 330nM TSA (Fig. 3.8, lane 9; as used in: Murphy et al. , 
2002) with higher concentrations of TSA showing no further increase in endogenous 
acetylated histone-H4 levels (Fig. 3.8, lanes 10-12). As global histone-H4 acetylation had 
been observed, and no ill effects to the cells had been found with GAPDH loading levels 
remaining consistent across the range of TSA concentrations, all further TSA treatment of 
cells was conducted with TSA at a concentration of 330nM. 
To determine the effects ofTSA on viral IE gene expression, the steady state levels of viral 
RNA were first assessed. Fibroblasts were treated with fresh medium (mock), DMSO or 
TSA for 16 hours -before the cells were infected with HCMV Toledo (MOI 0.5). After 24 
hours, total RNA was harvested and reverse transcription followed by PCR (RT-PCR) was 
performed to determine relative levels of GAPDH, viral IE genes and the abundant viral 
~2.7 early RNA (McSharry et al., 2003). DMSO treated cells (Fig. 3.9, lane 2) showed 
normal levels of IE RNA after 24 hours in comparison to mock treated cells (Fig. 3.9, lane 
1) and both showed similar levels of the ~2. 7 transcript present within infected cells. 
However, TSA treatment prior to infection showed a clear increase in the abundance of IE 
RNA levels (Fig. 3.9, lane 3) when compared to the control samples. Concomitant with 
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Figure 3.8 Trichostatin A (TSA) causes global acetylation of histone-H4. Human fibroblasts were either 
mock treated (fresh media; lane 1), treated with DMSO media (lane 2) or with TSA media at a range of 
concentrations (50-450nM; lanes 3-12) for 16 hours. Cells were then hatvested and protein samples run on 
a 10% polyacrylamide gel before Western blot analysis for acetylated histone-H4 (H4ac) and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a loading control. 
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Figure 3.9 TSA treatment causes an increase in viral IE and early RNA production. Hwnan fibroblasts were treated with either fresh (mock), DMSO or TSA media. After 16 hours, cells were infected with HCMV Toledo (MOI 0.5) for 24 hours before harvest and extraction of total RNA. After reverse transcription, specific PCR was carried out for viral IE genes, viral early transcript ~2. 7 and GAPDH as a loading control. 
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this, an increase in ~2. 7 transcript levels was also apparent in the TSA treated infected 
fibroblasts (Fig. 3.9, lane 3). 
Having found that TSA treatment prior to HCMV infection did indeed lead to an increase 
in IE transcription levels, it was next decided to assess the effects of TSA on viral protein 
production. A parallel analysis was undertaken whereby fibroblasts were again treated with 
either fresh medium (mock), DMSO or TSA for 16 hours before the cells were infected 
with HCMV Toledo (MOI 0.5). After 24 hours, protein samples were taken and Western 
blot analysis for IE gene expression levels carried out (Fig. 3 .1 Oa). Consistent with the 
RNA analysis, DMSO treated cells (Fig. 3 .1 Oa, lane 2) showed a similar level of viral IE 
protein production as mock treated cells (Fig. 3 .1 Oa, lane 1 ). However, as with RNA levels, 
treatment of fibroblasts with TSA led to an overt increase in IE72 and IE86 protein levels 
(Fig. 3 .1 Oa, lane 3) compared with levels seen in control samples. 
In order to further examine the effect of TSA on viral IE gene expression, the permissive 
U373 cell line was employed and similar analysis carried out to ensure that the effects seen 
in human fibroblasts were not cell-specific. U373 cells were treated as above and after 16 
hours infected with HCMV Toledo (MOI 0.5). After a further 24 hours, protein samples 
were taken and Western blot analysis for IE gene expression levels again carried out (Fig. 
3 .1 Ob ). The control mock and DMSO treated cells again showed similar levels of IE72 and 
IE86 expression (Fig. 3.10b, lane 1 & 2). However, again TSA treatment of U373 cells 
prior to infection with HCMV led to an obvious increase in IE72 and IE86 protein 
production (Fig. 3.10b, lane 3) when compared to the control samples. Therefore, TSA 
treatment had a similar effect on U3 73 cells as it had on human fibroblasts. 
Since analysis of both viral RNA and protein levels had shown that DMSO treatment had 
no profound differential effect than the mock control, a sole DMSO control was used when 
treating cells with TSA from here on in. 
3. 2. 4 TSA treatment increases the level of permissiveness of lytic infection at low 
multiplicities of infection and levels of IE gene expression within an infected cell 
Inhibition of HDACs by TSA had led to an increase in both IE transcription levels and 
abundance of IE protein by 24 hours post-infection. However, RT-PCR and Western blot 
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Figure 3.10 TSA treatment causes increases in viral IE protein production. (A) Human fibroblasts 
were treated with either fresh (mock; lane 1), DMSO (lane 2) or TSA (lane 3) media. After 16 hours, cells 
were infected with HCMV Toledo (MOI 0.5) for 24 hours before harvest and analysis of protein content by 
Western blot for IE protein expression. Coomassie stained gels are presented as loading controls. (B) U373 
cells were treated and analysed as above. 
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analysis does not distinguish between an increase in viral IE gene expression in individual 
cells or an increase in the number of cells productively infected. Therefore, it was 
necessary to determine whether TSA simply increased levels of IE gene expression in cells 
already producing IE RNA or whether it increased the frequency of cells initiating IE gene 
expression. To this end, fibroblasts were treated with either DMSO or TSA media for 16 
hours before infection with HCMV Toledo at a low MOI (0.05). After 24 hours, cells were 
then fixed and stained for IE72/86 expression with counter-staining of nuclei through 
Hoechst 33342 and viewed under a fluorescent microscope (Fig. 3.11). Because of the low 
initial MOI (0.05), fibroblasts treated with DMSO medium showed a low level of 
infection, as expected (green staining; Fig. 3.1 la, upper panel). However, cells treated with 
TSA medium showed an obvious increased number of cells expressing IE72/86 after 
infection (Fig. 3.11 b, upper panel). Indeed, on average a five to six-fold increase in the 
number of cells showing IE72/86 expression occurred compared to the DMSO control. In 
order to preclude that this increase by TSA in permissiveness for IE gene expression was 
due to an increase in the level of virus entry, further analysis to determine the level of viral 
tegument protein, pp28, taken up during infection was carried out by Western blot analysis. 
No apparent difference could be seen in the amount of virus uptake between the DMSO 
(Fig. 3 .11 c, lane 1) or TSA (Fig. 3 .11 c, lane 2) treated cells. This result is also consistent 
with the findings of work on MCMV (Tang & Maul, 2003). 
Indirect irnrnunofluorescence analysis had already determined that TSA did lead to an 
increase in IE gene expression by increasing the number of cells initiating viral IE gene 
expression at a low MOI (0.05) independent of an increase in viral entry (Fig. 3.11). 
Consequently, further analyses at a range of MOis (0.01-1) were carried out. Fibroblasts 
were again treated with either DMSO or TSA medium for 16 hours before infection with 
HCMV Toledo ar a specified MOL The cells were then fixed and stained for the presence 
of IE72/86 expression and the percentage of infected cells calculated from at least ten 
fields of view (Fig. 3.12). Consistently, the DMSO treatment of cells resulted in levels of 
IE72/86 expected for the MOI used. However, TSA treated cells consistently showed an 
increase in the percentage of cells staining positive for IE72/86 across the range of MOis 
used. This result was most prominent at lower MOis, where the significant difference has a 
P value of less than 0.01 and where the fold increase in IE72/86 positive cells is greatest. 
The fold change in IE72/86 positive cells resulting from TSA treatment gradually 
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Figure 3.11 TSA treatment increases the permissiveness of lytic infection with HCMV at low 
multiplicities of infection independently of an increase in viral entry. Human fibroblasts were treated 
with either (A) DMSO or (B) TSA media. After 16 hours, cells were infected with HCMV Toledo (MOI 
0.05) for 24 hours before cells were fixed and stained for IE72/86 (green) and Hoechst 33342 (blue) as a 
marker for cell nuclei. Analysis was carried out by fluorescent microscopy. (C) Human fibroblasts were 
treated with either DMSO (lane 1) or TSA (lane 2) media. After 16 hours, cells were infected with HCMV 
Toledo (MOI 0.5) for 6 hours before harvest and analysis of protein content by Western blot for the level of 
tegument protein (pp28) present, acting as a marker of viral entry. GAPDH staining was also carried out as 
a loading control. 
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Figure 3.12 TSA treatment increases the perm1ss1veness of lytic infection with HCMV at low 
multiplicities of infection. Human fibroblasts were treated with either DMSO (grey bars) or TSA (black 
bars) media. After 16 hours, cells were infected with HCMV Toledo at a range of MOis (0.01 - l) for 24 
hours before cells were fixed and stained for IE72/86, using Hoechst 33342 as a marker for cell nuclei. 
Cells were then analysed by fluorescent microscopy with at least 10 fields of view counted per MOI, before 
the percentage of infected cells was calculated. Error bars, 1 S.D. of three independent experiments; * P 
value< 0.01. 
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decreases as higher MOis are used, where little to no increase in IE72/86 expression by 
TSA is observed at an MOI of 1. 
Although treatment of already permissive fibroblasts with TSA resulted in an increase in 
permissiveness of infection with HCMV at low MOis (Fig. 3.12), it was still necessary to 
confirm whether TSA also increased the level of IE gene expression within an infected 
cell. Therefore, a further quantitative technique was utilised to analyse the levels of 
expression within individual cells: fluorescence activated cell sorting (F ACS). Here, 
fibroblasts were treated with either DMSO or TSA medium for 16 hours before mock 
infection or infection with HCMV Toledo at a MOI of 3, such that all cells should have 
been infected. After 24 hours, cells were fixed and stained for IE72/86 protein expression 
before FACS analysis (Fig. 3.13). Fibroblasts treated with DMSO (Fig. 3.13a, red) or TSA 
(Fig. 3.13b, red) and then infected with HCMV Toledo showed predominant IE72/86 
expression, compared to the uninfected treated cell controls (Fig. 3.13, black lines). 
However, infected cells that had been treated with TSA showed an increase in the mean 
fluorescence of the population (Fig. 3.13b, red) compared to those treated with DMSO 
(Fig. 3.13a, red). Consequently, TSA appears not only to increase the number of cells 
initiating IE gene expression when infected at low MO Is but also the level of viral IE gene 
expression in the infected cells as well. 
3.2.5 TSA treatment causes increases in viral DNA replication, protein expression and 
infectious virus output 
TSA pre-treatment of HCMV infected cells had clearly shown increases in the levels of IE 
gene expression, consistent with observations using MCMV infection of MEFs (Tang & 
Maul, 2003). Consequently, the next aim was to determine whether the use of TSA had 
further consequences on viral lytic infection. Since herpesvirus gene expression is 
controlled in a temporally regulated cascade (Fig. 1.5), ultimately dependent upon the 
expression of IE genes, an increase in IE gene expression may promote the levels of 
expression of subsequent viral genes. Therefore, the effects of TSA on the levels of early 
and late viral gene products, in addition to IE gene products, were ass.essed throughout the 
course of lytic infection using Western blotting (Fig 3 .14 ). Fibroblasts were either DMSO 
or TSA treated for 16 hours and then infected with HCMV Toledo at a low MOI (0.1). 
Protein samples were then harvested at 6, 24, 48, 72 and 96 hours post-infection and levels 
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Figure 3.13 TSA treatment increases the level of viral gene expression within HCMV infected cells. 
Human fibroblasts were treated with either (A) DMSO or (B) TSA media. After 16 hours, cells were either 
mock infected (black line) or infected with HCMV Toledo (MOI 3; red) for 24 hours before cells were 
fixed, stained for IE72, washed and analysed by fluorescence associated cell sorting (F ACs) analysis. 
- 133 -
3. Results 
of viral protein expression were analysed. This included the major IE gene product IE72; 
the early UL44 gene product encoding the major DNA binding protein, p52, necessary for 
processivity of viral DNA replication (Anders & McCue, 1996); and the late gene product 
pp28 (UL99) - a tegument phosphoprotein essential for encapsidation of the genome and 
production of infectious virions (Spaete et al., 1994; Silva et al. , 2003). Low levels of IE72 
were observed in DMSO treated infected cells at 24 hours post-infection (Fig. 3.14, lane 
2), as expected. However, as seen in Fig. 3.10, at this timepoint TSA treatment caused an 
increase in the level of IE gene expression (Fig. 3 .14, lane 7). This increase in IE gene 
expression by TSA was observed throughout lytic infection right up to 96 hours post-
infection (Fig. 3.14, lanes 8-10). Analysis of the early gene product, UL44, showed a 
similar increase in expression with TSA treatment of cells. Expression of UL44 in DMSO 
treated cells was detectable as early as 72 hours post-infection (Fig. 3.14, lane 4). 
However, a comparable level of expression was seen in TSA treated cells by 24 hours post-
infection (Fig. 3 .14, lane 7). Indeed, this effect of increased viral gene expression was also 
observed with the late gene product, pp28; TSA treated cells showed pp28 expression as 
early as 48 hours post-infection (Fig. 3.14, lane 8). Clearly, TSA treatment of fibroblasts 
prior to infection with HCMV caused an increase in the levels of gene expression of IE, 
early and late genes throughout the lytic cycle in already permissive cells. 
The replication of viral DNA, for packaging into new virions, is entirely dependent on the 
expression of the prerequisite early viral gene products such as the UL44 coding protein, 
p52 (Anders & McCue, 1996). Since TSA clearly caused an increase in the levels of early 
gene expression upon infection with HCMV, an analysis of the effect of TSA on viral 
DNA replication was also undertaken (Fig. 3 .15). Cells were again treated with either 
DMSO or TSA medium for 16 hours prior to infection with HCMV Toledo (MOI 0.5). 
DNA was extracted from cells at 6, 24, 48, 72 and 96 hours post-infection and specific 
PCR for the viral MIEP was then carried out. PCR products were then run out on 2% 
agarose gels and the relative levels of amplified products were quantified using Image J 
software, using GAPDH as a loading control. Levels of viral DNA are shown relative to 
input viral DNA quantified at 6 hours post-infection. The control DMSO treated cells (Fig. 
3.15, grey bars) showed an increase in viral DNA levels at 48 hours post-infection, 
consistent with initiation of viral DNA replication. This increase then continued at both 72 
and 96 hours post-infection, finally reaching a 4-fold increase in the level of viral DNA 
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Figure 3.14 TSA treatment increases viral IE, early and late protein expression. Human fibroblasts 
were treated with either DMSO or TSA media. After 16 hours, cells were infected with HCMV Toledo 
(MOI 0.1) in fresh plain media and protein samples were taken at timepoints from 6-96 hours (lanes 1-5 & 
6-10). Samples for each timepoint were run on 10% polyacrylamide gels before Western blotting for viral 
IE (IE72), early (UL44) and late (pp28) proteins. Coomassie blue staining was used as a loading control. 
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compared to the input level at 6 hours post-infection. In TSA treated cells, though, at 72 
hours post-infection, the level of viral DNA detectable was increased by almost 3-fold and 
this trend continued through to the 96 hour post-infection timepoint. This result is also 
entirely consistent with the increase of early viral gene expression and production of early 
gene products, which viral DNA replication is ultimately dependent upon (Anders & 
McCue, 1996). Although this method does not account for the levels of viral genome 
escaping detection due to egress of infectious virus progeny from the cellular environment, 
it does show that TSA treatment prior to infection with HCMV also has the effect of 
increasing viral DNA replication. 
TSA treatment of fibroblasts clearly increased viral gene expression and viral DNA 
replication. It was next asked whether this led to an increase in output of infectious virus, 
as has been seen with TSA treatment of MEFs prior to MCMV infection (Tang & Maul, 
2003). Thus, the level of virus production from control or TSA treated cells was analysed. 
Fibroblasts were, again, treated with either DMSO or TSA and then infected with HCMV 
Toledo at a low MOI (0.01). Unadsorbed virus was then removed by washing twice with 
fresh EMEM-10 and the medium finally being replaced. Samples of the cell supernatant 
were then analysed every day for seven days and the output of virus from both populations 
of cells assessed by TCID50 as well as the virus input used to infect both sets of cells (Fig. 
3.16). From day O to day 3 post-infection, both DMSO (Fig. 3.16, grey diamonds) and 
TSA-treated cells (Fig. 3.16, black squares) showed little virus production, as expected, 
due to the eclipse period of the virus life cycle (Mocarski et al., 2007). At 4 days post-
infection, infectious virus was detectable in both control and TSA treated cells. However, 
by this timepoint TSA treated cells resulted in a 2-fold increase in the level of infectious 
virus progeny. Increased virus production from both populations of cells continued through 
the 5 and 6 day ·timepoints but TSA treated cells, again, showed further increases in 
infectious virus output, 3- and 4-fold respectively. However, the most prominent difference 
in virus output came at the 7 day post-infection timepoint when TSA treatment had caused 
a 14-fold increase in the total level of infectious virus output. Hence, TSA treatment of 
cells causes not only an increase in the levels of viral gene expression and subsequent 
DNA replication but also an increase in the total amount of infectious virus produced. 
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Figure 3.15 TSA treatment promotes viral DNA replication. Human fibroblasts were treated with either 
DMSO (grey) or TSA (black) media. After 16 hours, cells were infected with HCMV Toledo (MOI 0.5) in 
fresh plain media and DNA was extracted at timepoints from 6-96 hours. Both MIEP and GAPDH PCR 
was then performed on each sample, PCR products run on 2% agarose gels and the amount of viral DNA 
quantified by Image J analysis, expressed as a proportion of the input DNA (MIEP/GAPDH). Error bars, I 
S.D. of three independent experiments;* P value< 0.01. 
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Figure 3.16 TSA treatment promotes the production of infectious virus. Human fibroblasts were 
treated with either DMSO (grey) or TSA (black) media. After 16 hours, cells were infected with HCMV 
Toledo (MOI 0.01) and supernatant samples were taken at timepoints for 7 days. Each sample was then 
used in serial dilutions to infect human fibroblasts and TCID50 analysis carried out. The data is 
representative of three independent experiments. Error bars, 1 S.D. 
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3.2. 6 TSA treatment causes changes to the chromatinisation of the MIEP at IE and early 
times of infection 
Since TSA had led to substantial effects on HCMV gene expression and viral DNA 
replication, it was hypothesised that histone deacetylation must be involved in regulating 
viral gene expression. Consequently, ChIP analyses were carried out on fibroblasts either 
treated with DMSO or TSA for 16 hours to assess the viral MIEP with respect to the 
chromatin structure. Representative autoradiographs from the 3 hour and 24 hour post-
infection samples are displayed (Fig. 3.17a & 3.19a). The intensity of amplified products 
from triplicate PCRs of each sample were then quantified using Image J and the data 
represented in chart format for both timepoints (Fig. 3. l 7b & 3. l 9b ). As before, to ensure 
consistent imrnunoprecipitation of specific histone or histone associated proteins across 
each timepoint and throughout the full timecourse, a c-Fos PCR was carried out for both 
timepoints (Fig. 3 .18 & 3 .20). 
At 3 hours post-infection with HCMV, the viral MIEP in DMSO treated cells was 
predominantly associated with H3K9me2 and HPlP (Fig 3.17b, lane 2 & 3), with only low 
levels of acetylated histone-H4 (Fig. 3.17b, lane 1). This is consistent with repression of 
the MIEP immediately upon infection. In contrast, the MIEPs from TSA treated cells 
exhibited a very low level of association of H3K9me2 and HPlP (Fig 3.17b, lane 5 & 6) 
but a much higher level of association with acetylated histone-H4 (Fig. 3.17b, lane 4) . By 
24 hours post-infection, the association of the MIEP with H3K9me2 and HPlP in DMSO 
treated cells had diminished (Fig. 3. l 9b, lanes 2 & 3) with an increased recruitment of 
acetylated histone-H4 (Fig. 3.19b, lane 1). However, in stark contrast to this, TSA treated 
cells demonstrated much lower levels of association with H3K9me2 (Fig. 3.19b, lane 5) 
and acetylated histone-H4 with the MIEP (Fig. 3.19b, lane 4) and showed an increased 
association of HP"l p (Fig. 3.19b, lane 6). The control PCR for c-Fos used throughout the 
timecourse provided evidence that immunoprecipitation had occurred consistently 
throughout the analysis of 3 and 24 hour post-infection samples (Fig. 3. l 8b & 3 .20b, 
respectively). 
3.3 Discussion 
It is now increasingly clear that latency and reactivation of HCMV is maintained and 
regulated, at least in part, by chromatin structure of the viral MIEP. For instance, 
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Figure 3.17 TSA treatment causes changes to the chromatinisation of the MIEP at 3 hours post-infection. (A) ChIP assays were performed on serum-starved human fibroblasts, treated with either DMSO or TSA medium at 3 hours post-infection (MOI 0.1). Analysis was carried out with either an anti-acetylated histone-H4 antibody (H4ac, lane 1 & 4), an anti-dimethyl lysine 9 histone-H3 antibody (H3K9me2, lane 2 & 5) or an anti-HPl~ antibody (HPl~, lane 3 & 6). Inputs (10% of total chromatin) are not shown. Isolated DNA was amplified using a MIEP-specific PCR and products run on a 2% agarose gel before Southern blot analysis. (B) Image J analysis was then used to quantify autoradiograph bands in (A). For comparison, the immunoprecipitated DNA was quantified relative to the input DNA. The data is representative of three independent experiments. Error bars, 1 S.D. of triplicate PCR reactions. 
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Figure 3.18 TSA treatment does not affect c-Fos chromatinisation at 3 hours post-infection. (A) ChIP 
assays were performed on serum-starved human fibroblasts, treated with either DMSO or TSA medium at 3 
hours post-infection (MOI 0.1). Analysis was carried out with either an anti-acetylated histone-H4 antibody (H4ac, lane 1 & 4), an anti-dimethyl lysine 9 histone-H3 antibody (H3K9me2, lane 2 & 5) or an anti-HPl~ 
antibody (HPl~, lane 3 & 6). Inputs (10% of total chromatin) are not shown. Isolated DNA was amplified 
using a c-Fos-specific PCR and products run on a 2% agarose gel before visualisation using UV light. (B) 
Image J analysis was then used to quantify bands in (A). For comparison, the immunoprecipitated DNA 
was quantified relative to the input DNA. The data is representative of three independent experiments. 
Error bars, 1 S.D. of triplicate PCR reactions. 
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chromatin remodelling of the MIEP of HCMV clearly regulates viral gene expression 
following experimental infection of primary myeloid cells and model cell lines 
conditionally permissive for IE gene expression. Upon infection of T2 cells, THPl cells, 
undifferentiated monocytes and CD34+ myeloid progenitors there is a repressive chromatin 
structure around the MIEP consistent with a lack of viral IE gene expression in these cells. 
In contrast, infection of T2RA cells, macrophages and mature DCs results in the viral 
MIEP becoming associated with markers of transcriptionally active chromatin, consistent 
with their permissiveness for IE gene expression (Murphy et al., 2002; Reeves et al., 
2005a; Ioudinkova et al., 2006). Indeed, endogenous genomes present within CD34+ cells 
from a healthy seropositive individual when differentiated to mature DCs have also been 
shown to remodel the MIEP in the same way (Reeves et al., 2005b ). Thus, there is an 
intrinsic link between the differentiation state of cells, their permissiveness for IE gene 
expression and the specific pattern of chromatinisation of the MIEP upon infection. 
However, how changes in the chromatin structure of the viral MIEP might impinge upon 
infection in fully permissive cells is not known. 
In order to investigate this, human fibroblasts, which are fully permissive for HCMV 
infection (McDonough & Spector, 1983) were used to examine the chromatin state of the 
viral MIEP during productive infection. It was clear that the MIEP was chromatinised 
throughout infection but the specific association of markers of transcriptionally active or 
repressed chromatin appeared consistent with the known temporal regulation of major IE 
gene expression at early (24 hours) and late (96 hours) timepoints. At 24 hours post-
infection the MIEP was associated predominantly with acetylated histone-H4, consistent 
with transcription at this time. By 96 hours post-infection, recruitment of HP 1 ~ was 
observed, consistent with the auto-regulation of the MIEP at late times of infection by the 
major IE gene product IE86 (Reeves et al., 2006). However, a significant level of 
acetylated histone-H4 was still demonstrated: this may have been due to the 
chromatinisation of newly synthesised viral genomes at this time, although without the use 
of a viral DNA synthesis inhibitor such as PF A, this remained untested at this time (see 
Chapter 6). A low level of H3K9me2 present at viral MIEPs at this time was also apparent. 
However, this may have. been due to high levels of HP 1 ~ that would mask the presence of 
di- and tri-methylated lysine 9 of histone-H3 due to specific deposition at this site 
(Bannister et al., 2005). Pleasingly, though, these data fit with that of Reeves et al. (2006) 
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Figure 3.19 TSA treatment causes changes to the chromatinisation of the MIEP at 24 hours post-
infection. (A) ChIP assays were performed on serum-starved hmnan fibroblasts, treated with either DMSO 
or TSA medimn at 24 hours post-infection (MOI 0.1). Analysis was carried out with either an anti-
acetylated histone-H4 antibody (H4ac, lane 1 & 4), an anti-dimethyl lysine 9 histone-H3 antibody 
(H3K9me2, lane 2 & 5) or an anti-HPI~ antibody (HPI~, lane 3 & 6). Inputs (10% of total chromatin) are 
not shown. Isolated DNA was amplified using a MIEP-specific PCR and products run on a 2% agarose gel 
before Southern blot analysis. (B) Image J analysis was then used to quantify autoradiograph bands in (A). 
For comparison, the immunoprecipitated DNA was quantified relative to the input DNA. The data is 
representative of three independent experiments. Error bars, I S.D. of triplicate PCR reactions. 
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Figure 3.20 TSA treatment does not affect c-Fos chromatinisation at 24 hours post-infection. (A) ChIP 
assays were performed on serum-starved human fibroblasts, treated with either DMSO or TSA medium at 
24 hours post-infection (MOI 0.1). Analysis was carried out with either an anti-acetylated histone-H4 
antibody (H4ac, lane 1 & 4), an anti-dimethyl lysine 9 histone-H3 antibody (H3K9me2, lane 2 & 5) or an 
anti-HPl~ antibody (HPl~, lane 3 & 6). Inputs (10% of total chromatin) are not shown. Isolated DNA was 
amplified using a c-Fos-specific PCR and products run on a 2% agarose gel before visualisation using UV 
light. (B) Image J analysis was then used to quantify bands in (A). For comparison, the irnrnunoprecipitated 
DNA was quantifi€:d relative to the input DNA The data is representative of three independent 
experiments. Error bars, 1 S.D. of triplicate PCR reactions. 
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where fibroblasts had been infected with HCMV Towne and ChIP assays conducted across 
a 24 to 96 hour timecourse. More recently, a further report using acetylated histone-H4 as a 
marker of promoter activation has also provided evidence of the temporal association of 
this marker with the MIEP, consistent with data presented here (Park et al., 2007b). 
Intriguingly, however, the chromatin status of the MIEP at 3 hours post-infection did not 
appear as expected for an IE timepoint. The viral MIEP was associated with high levels of 
H3K9me2 and HPl~ consistent with repression of the promoter at this time. Therefore, 
despite the use of fully permissive fibroblasts for this study, the viral genome appeared to 
be chromatinised in a repressed form at this timepoint. To rule out that this immediate 
association of repressive chromatin with the MIEP could be due to packaging of 
synthesised genomes in this form, gradient purified virions were prepared for protein 
analysis via Western blot. Analysis of the levels of histone-H3 specifically in virion 
preparations, compared to crude virus preparations or cellular material, found no histone-
H3 associated with purified virions. In addition, these virions remained infectious after the 
purification process. The absence of histones associated with purified HCMV virions has 
also been suggested by other studies, including the use of high specificity mass 
spectrometry (MS)-based approaches (Baldick & Shenk, 1996; Varnum et al. , 2004). 
Additionally, more recent data suggests that the HSV-1 virion also contains no histone 
proteins (Ho & Fraser, 2008). Therefore, it is likely that the packaged HCMV genome is 
not associated with histone and that the repressive chromatin found at the MIEP 
immediately upon infection forms after release of the genome into the nucleus. Indeed, the 
assembly process of histones and nucleosomal structure onto naked infecting viral DNA 
has been observed before in studies using SV 40 virus (Stillman, 1986; Sugasawa et al., 
1990) and recruitment of histones to viral DNA may represent an automatic cellular 
response to nascent DNA and provide explanation for the immediate chromatinisation of 
the viral MIEP upon infection of cells. 
Throughout the study, specific PCR of the c-Fos promoter had been used as a control for 
examination of consistent immunoprecipitation of chromatin. This promoter was employed 
as it had previously been used as a similar control during HCMV infection of permissive 
MRC5 (embryonal lung) cells (Nevels et al., 2004b). In this study, during the first 12 hours 
of infection, there was no change in the levels of acetylated histone-H4 at the c-Fos 
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promoter. However, it had also previously been published that HCMV can substantially 
increase the level of c-Fos expression during infection of human fibroblasts by 12 hours 
and that the promoter in transfected cells could be trans-activated by IE gene expression 
(Hagemeier et al., 1992b ). In contrast, infection of human embryonal lung cells at an MOI 
of 10 had been found to increase c-Fos transcription almost 5-fold after 40 min but that 
expression returned to basal levels by 2 hours (Boldogh et al. , 1990a). Although the 
previous findings with fibroblasts argued against the use of the c-Fos promoter as a control 
for ChIP analysis of the viral MIEP, the further data fully supported its use from a 3 hour 
post-infection timepoint. Indeed, the results presented here also show very little change in 
the chromatin profile of the c-Fos promoter throughout the full timecourse of productive 
infection and thus it was validated as a robust control for the ChIP analyses presented. 
The chromatinisation of the viral MIEP appeared to occur very rapidly upon infection, with 
histone proteins detectable by ChIP analysis as early as 3 hours post-infection. However, 
intriguingly, at this time the MIEP appeared to be predominantly associated with hallmarks 
of repressed chromatin structure: H3K9me2 and HPlp. For repressive chromatin structure 
to be established, it is likely that chromatin remodelling enzymes such as HDACs would 
be involved. Therefore, to address whether this was the case, the HDAC inhibitor, TSA, 
was employed. Treatment of cells with TSA prior to infection with HCMV led to an 
increase in the production of IE RNA and protein in infected fibroblasts as well as in U373 
cells due to an increase in the number of cells initiating IE gene expression but also 
increases in levels of IE gene expression within each infected cell. This was not due to 
TSA-mediated increases in virus uptake as determined by incoming levels of pp28 
tegument protein with similar observations having been made during MCMV infection 
(Tang & Maul, 2003). 
Treatment of fibroblasts with TSA prior to infection with HCMV also resulted in increases 
in gene expression of all classes of viral genes: IE, early and late. The consequence of 
increases in early and late gene expression could be due, in part, to the initial increase in 
major IE gene expression whereby transactivation of the early and late classes of genes 
would occur earlier due to earlier accumulation of IE protein. However, the increases in 
early and late gene expression could also be explained more directly if the promoters of 
these genes were also chromatinised. This hypothesis will be tested and discussed in 
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Chapter 6. Nevertheless, the ability of TSA to increase expression of all classes of viral 
genes could result from a shortening of the infection cycle due to earlier and more efficient 
IE gene expression. Subsequent semi-quantitative PCR analysis of genome number 
throughout infection provided evidence to suggest that this was indeed occurring. Viral 
DNA synthesis was increased upon TSA treatment of infected fibroblasts and was 
concomitant with a 10-fold rise in the number of infectious virus particles produced after 
seven days post-infection. This finding is, again, consistent with similar studies carried out 
with MCMV (Tang & Maul, 2003). 
The effects of TSA treatment on HCMV IE gene express10n and productive cycle 
suggested that chromatin structure and, in particular, repression of the viral MIEP may 
occur immediately upon infection. To correlate this to the state of chromatin of the MIEP, 
ChIP analysis of the MIEP in fibroblasts was carried out. At 3 hours post-infection in 
control cells, the MIEP was associated with acetylated histones but predominantly 
methylated histones and HPI~. However, at the same timepoint in TSA treated fibroblasts, 
the MIEP was predominantly associated with acetylated histone-H4. This finding is 
consistent with the inhibition of HDAC activity by TSA resulting in increases in the levels 
of viral IE gene expression and subsequent early and late gene expression and virus 
production. The association of acetylated histones with the MIEP at 24 hours post-
infection in infected control cells is entirely consistent with levels of viral IE gene 
expression at this time. However, intriguingly, in TSA treated cells at the same timepoint, 
the viral MIEP was heavily associated with HP 1 ~- Data from this timepoint may at first 
appear contradictory to the RNA and protein level data, as obvious increases in IE gene 
expression were demonstrated at this time. One explanation for this could be the relative 
stability of the IE72 protein. Thus, protein levels would reflect the accumulation of IE gene 
product over the full 24 hour period. Therefore, the increase in gene expression throughout 
infection with TSA treatment is directly related to an earlier association of the viral MIEP 
with acetylated histone-H4 and most likely due to earlier initiation of viral IE gene 
expression. Additionally, the high association of the MIEP with HPl~ at 24 hours post-
infection with TSA treatment may be, in part, due to the earlier recruitment of HMTs by 
IE86 and auto-repression of the MIEP due to the shortening of the viral productive cycle 
resulting from earlier initiation of IE gene expression in TSA treated cells. 
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The use of c-Fos promoter specific PCR throughout this study controlled for any 
variability in immunoprecipitation of histones and histone associated proteins with the 
viral DNA. It is known that TSA does increase c-Fos transcription levels through 
increasing pre-initiation complex recruitment to the promoter (Fass et al., 2003). However, 
this published effect is only minor and, as the promoter is already constitutively active, 
does not appear to affect the chromatin structure of the c-Fos promoter significantly. 
Overall, the data presented in this chapter illustrate that the MIEP of HCMV is 
chromatinised throughout productive infection of permissive fibroblasts. Immediately upon 
infection, the MIEP is repressed due to chromatinisation which is at least in part mediated 
by HDACs. TSA treatment is able to abrogate this repression at the level of the chromatin 
status of the MIEP causing increases in viral gene expression and ultimately production of 
infectious virions. 
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hDaxx mediates HCMV IE gene expression repression through regulation of the 
chromatin structure of the MIEP 
4.1 Introduction 
The results presented m Chapter 3 had established that the MIEP of HCMV was 
temporally associated with chromatin structure which was remodelled throughout 
productive infection of human fibroblasts. Intriguingly, however, despite these cells being 
fully permissive for lytic infection, repressive forms of chromatin were found to be 
associated with the promoter at very IE times of infection. The use of the HDAC inhibitor 
TSA relieved this initial repression leading to changes in viral gene expression, replication 
and progeny virus output as well as chromatin structure at the MIEP. Therefore, HDACs 
are likely to play a major role in the recruitment of repressive chromatin to the MIEP upon 
infection. Interestingly, it is known that herpesvirus genomes, upon entry to the nucleus of 
an infected cell, are deposited at NDIO (Maul, 1998). NDlO are known to recruit HDACs 
and HMTs, and thus could promote an environment of repression at which the viral 
genome locates to (see section 1.11 ). However, chromatin remodelling enzymes do not act 
indiscriminately and are not targeted to ND 10 alone: they rely upon interaction with other 
proteins for specificity of location. As explained earlier ( see section 1.11 ), ND 10 are 
composed of several cellular proteins (Negorev & Maul, 2001). In addition to the PML 
protein, the defining component of NDlO, many other NDlO-associated proteins are 
known to have transcriptional control properties. One such protein is Daxx. 
Daxx was initially identified as a novel Fas-binding protein by two-hybrid screening (Yang 
et al., 1997) and is now known to interact with a range of cellular and viral proteins in a 
number of different key cell signalling pathways. Initially, the protein was suggested to be 
involved in the control of apoptosis, as transient over-~xpression studies using murine 
Daxx (mDaxx) demonstrated increases in the level of Fas-mediated apoptosis within 
certain cell types (Yang et al., 1997; Torii et al., 1999). However, conversely, transient 
over-expression of a truncated dominant-negative form ofmDaxx was found to inhibit Fas-
mediated apoptosis (Torii et al., 1999). mDaxx has also been reported to act as a 
cytoplasmic Fas-receptor adaptor molecule able to recruit the apoptosis signal-related 
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kinase ASKl (Chang et al., 1998) that can phosphorylate and activate transcription factors 
such as c-Jun (Kyraiakis & A vrush, 1996; Yang et al. , 1997). Further, mDaxx has also 
been postulated to act as a dominant-negative inhibitor of TGF~-induced apoptosis in 
hepatocytes (Perlman et al. , 2001 ). In contrast, studies using a dominant interfering human 
Daxx (hDaxx) have shown that hDaxx plays no physiological role in FasL-mediated JNK 
signalling and apoptosis (Villunger et al., 2000). Furthermore, it has been shown that cells 
subjected to siRNA technology to Daxx increase levels of apoptosis, therefore making it 
improbable that Daxx promotes Fas-induced apoptosis in this system (Michaelson & 
Leder, 2003). 
hDaxx resides primarily within the nucleus likely due to two putative nuclear localisation 
sequences (Pluta et al., 1998) and is a known component of NDlO (see section 1.11.3). 
Recruitment of hDaxx to ND 10 is mediated through interaction with PML, requiring 
sumoylation of PML by SUMO-I (Ishov et al., 1999). However, when not localised at 
ND 10, hDaxx is associated with condensed, transcriptionally inactive chromatin (Li et al. , 
2000a; Hollenbach et al. , 2002). The transcriptional repressive properties of hDaxx are 
consistent with four structural domains commonly found in other repressors: two predicted 
paired amphiphatic helices, an acid rich domain and a Ser/Pro/Thr rich domain 
(Hollenbach et al., 1999). hDaxx has been shown to have inhibitory effects on Pax3-
mediated transcription and the ability to interact with ETS 1 and repress transcription 
mediated by this proto-oncogene (Hollenbach et al., 1999; Li et al. , 2000b; Lehembre et 
al. , 2001}. Additionally, hDaxx has also been found to mediate suppression of the 
glucocorticoid, mineralcorticoid and androgen receptors, p53 family proteins, Smad4 and 
NF-KB predominantly through differential use of its SUMO-interacting motif and also 
IFN-induced STAT3 signalling (Lin et al. , 2002; Kim et al. , 2003; Lin et al., 2003 ; Lin et 
al., 2004a; Obradovic et al., 2004; Zhao et al., 2004; Chang et al., 2005; Croxton et al., 
2006; Muromoto et al. , 2006; Park et al., 2007a; Shih et al., 2007). However, in B cells, 
hDaxx was found to be able to either activate or repress Pax5-mediated transcription 
depending upon the cell line used and that activation via hDaxx was dependent upon the 
recruitment of the HAT CBP (Emelyanov et al., 2002). 
Although much is known of the multifunctional roles of hDaxx, the mechanism by which 
hDaxx is able to mediate repression has remained elusive. However, observations that 
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hDaxx can interact with HDACs and chromatin has shed some light on this. Dependent 
upon the post-translational phosphorylation state of the protein, Daxx has been 
demonstrated to interact with various chromatin remodelling enzymes including HDACl, 
HDAC2, DNA methyltransferase 1 (DNMTl) and a-thalassaemia/mental retardation 
syndrome X-linked (ATRX); ATRX can also interact with HPl as well as core histone 
proteins and the chromatin binding protein Dek (Hollenbach et al., 2002; Li et al., 2000a; 
Ishov et al., 2004; Muromoto et al., 2004; Waldmann et al., 2004; Puto & Reed, 2008). It 
was further hypothesised that the association of the HDAC2/hDaxx complex and its ability 
to bind to chromatin, through such proteins as Dek, then leads to the deacetylation of 
histones upon interaction with chromatin and the subsequent repression of transcription 
(Hollenbach et al., 2002). Furthermore, it has also more recently been reported that hDaxx 
is able to bind to SUMO-modified CBP and modulate CBP transcriptional control and that 
the expression of the c-met proto-oncogene is controlled by chromatin structure mediated 
by hDaxx and HDAC2 recruitment (Kuo et al., 2005). Therefore, hDaxx appears to be a 
distinct transcriptional repressor of various cellular genes that is also able to locate to 
NDIO. As such, hDaxx has acquired some attention from those investigating the control of 
herpesvirus gene expression. 
The possibility that hDaxx may play some role in the immediate repression of HCMV IE 
gene expression upon infection by recruiting repressors to modulate the chromatin 
structure of the MIEP has recently gained support through studies on the transactivation 
properties . of HCMV tegument phosphoprotein pp 71. Encoded by UL82, pp71 is loaded 
into the virion before egress of the progeny virus and as such is delivered to the cell upon 
entry (see Fig. 1.4). As well as forming a structural component of the virus, it has long 
been known that pp71 acts as a transactivator of the MIEP during HCMV lytic infection 
(Liu & Stinski, 1992; Schierling et al. , 2004). Further, pp71 has been shown to transduce 
gene expression from the MIEP in recombinant HSV-1 mutants; although, pp71 does not 
cause this through disruption of ND 10, as seen with IE72, which is unnecessary for this 
activity (Homer et al. , 1999; Marshall et al. , 2002; Preston & Nicholl, 2005). Interestingly, 
the mechanism by which pp71 is able to locate to NDlO is actually via interaction with a 
coiled-coil domain of the hDaxx protein which is then targeted to NDlO via recruitment by 
sumoylated PML (Hofmann et al., 2002; Ishov et al. , 2002). This mechanism, although 
surprising due to the repressive qualities of hDaxx, has been confirmed through work 
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showing that pp71 mutants unable to bind to hDaxx were not able to induce IE gene 
expression (see Fig. 1.12) (Cantrell & Bresnahan, 2005). In addition, intriguingly, it has 
further been established that the presence of pp7I during HCMV infection is both 
necessary and sufficient for proteasomal degradation of hDaxx during HCMV infection 
(Saffert & Kalejta, 2006). 
Since pp71 appears to target hDaxx for proteasomal degradation during HCMV infection, 
it has been hypothesised that hDaxx, when present at ND10, may play a role in the control 
of transcription of HCMV upon infection. Work performed in our laboratory has provided 
good evidence that hDaxx plays a fundamental role in the regulation of HCMV IE gene 
expression: stable over-expression of hDaxx in permissive U373 leads to a complete 
abrogation of herpesvirus lytic infection (Woodhall et al., 2006). Since there is now good 
evidence that hDaxx is able to repress gene expression through association with chromatin 
remodelling enzymes, it was investigated whether the association of repressive chromatin 
with the MIEP immediately upon infection was mediated by hDaxx. 
4.2 Results 
4. 2.1 TSA treatment causes de-repression of HCMV IE gene expression in infected hDaxx-
stably expressing U373 cells 
Since it had been established within the laboratory that normally permissive U373 cells 
stably expressing hDaxx as an RFP-hDaxx fusion protein (U373-RFP-hDaxx) were 
refractory .to infection with HCMV, but that virus super-infection at high MOI could 
abrogate this repression (Woodhall et al., 2006), it was first decided to investigate whether 
use of HDAC inhibitors could rescue virus gene expression in RFP-hDaxx expressing · I 
U373s. Initially, control cells stably transfected with the pDsRed-Nl construct (U373-
RFP) and expressing RFP were treated with either DMSO or TSA media for 16 hours. 
Cells were then infected with HCMV Toledo (MOI 0.2) for 24 hours before cells were 
fixed, permeabilised and stained for IE72/86 expression · with counter-staining of nuclei 
through Hoechst 33342. Staining was then viewed under a fluorescent microscope (Fig. 
4.la). U373-RFP cells treated with DMSO showed a low level of infection, as determined 
by expression of IE72/86 (green staining), which often co-localised with cells expressing 
RFP (Fig. 4.la, left panel). U373-RFP cells treated with TSA showed an obvious increase 
in the number of cells expressing IE72/86 after infection whether expressing RFP or not 
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showing that pp71 mutants unable to bind to hDaxx were not able to induce IE gene 
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further been established that the presence of pp71 during HCMV infection is both 
necessary and sufficient for proteasomal degradation of hDaxx during HCMV infection 
(Saffert & Kalejta, 2006). 
Since pp71 appears to target hDaxx for proteasomal degradation during HCMV infection, 
it has been hypothesised that hDaxx, when present at NDlO, may play a role in the control 
of transcription of HCMV upon infection. Work performed in our laboratory has provided 
good evidence that hDaxx plays a fundamental role in the regulation of HCMV IE gene 
expression: stable over-expression of hDaxx in permissive U3 73 leads to a complete 
abrogation of herpesvirus lytic infection (Woodhall et al., 2006). Since there is now good 
evidence that hDaxx is able to repress gene expression through association with chromatin 
remodelling enzymes, it was investigated whether the association of repressive chromatin 
with the MIEP immediately upon infection was mediated by hDaxx. 
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4. 2.1 TSA treatment causes de-repression of HCMV IE gene expression in infected hDaxx-
stably expressing U3 7 3 cells 
Since it had been established within the laboratory that normally permissive U373 cells 
stably expressing hDaxx as an RFP-hDaxx fusion protein (U373-RFP-hDaxx) were 
refractory to infection with HCMV, but that virus super-infection at high MOI could 
abrogate this repression (Woodhall et al., 2006), it was first decided to investigate whether 
use of HDAC inhibitors could rescue virus gene expression in RFP-hDaxx expressing 
U373s. Initially, control cells stably transfected with the pDsRed-Nl construct (U373-
RFP) and expressing RFP were treated with either DMSO or TSA media for 16 hours. 
Cells were then infected with HCMV Toledo (MOI 0.2) for 24 hours before cells were 
fixed, permeabilised and stained for IE72/86 expression with counter-staining of nuclei 
through Hoechst 33342. Staining was then viewed under a fluorescent microscope (Fig. 
4.la). U373-RFP cells treated with DMSO showed a low level of infection, as determined 
by expression of IE72/86 (green staining), which often co-localised with cells expressing 
RFP (Fig. 4.la, left panel). U373-RFP cells treated with TSA showed an obvious increase 
in the number of cells expressing IE72/86 after infection whether expressing RFP or not 
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(Fig. 4.1 a, right panel). To assess these mixed populations of cells quantitatively, the 
number of non-RFP or RFP-expressing cells co-expressing IE72/86 from at least 10 fields 
of view per experiment were counted (Fig. 4.1 b ). Both sub-populations of cells 
demonstrated approximately the same level of co-expression when treated with DMSO 
(Fig. 4.lb, grey bars). However, TSA treatment caused a 3- to 4-fold increase in the levels 
of IE gene expression in both RFP-expressing and non-expressing cells (Fig. 4.1 b, black 
bars). Hence, U373-RFP cells routinely expressed IE genes upon infection but TSA was 
able to induce an increase in this level, consistent with TSA treatment of infected 
fibroblasts in Chapter 3. 
The same analysis was then carried out on U373 cells stably expressing hDaxx (U373-
RFP-hDaxx) (Fig. 4.2). Although DMSO treated cells not expressing RFP-hDaxx showed 
a similar level of infection to that seen with non-RFP cells within the U373-RFP 
population, RFP-hDaxx expressing cells, known to be refractory to IE gene expression, 
showed little to no expression of IE72/86 (Fig. 4.2a, left panel). With TSA treatment, non-
RFP cells showed a clear increase in the number of IE72/86 expressing cells (Fig. 4.2a, 
right panel). However, TSA treatment of RFP-hDaxx expressing cells caused a clear 
increase in the level of IE72/86 and RFP-hDaxx co-staining (Fig. 4.2a, right panel). This 
data was again quantified as above (Fig. 4.2b ). This demonstrates that DMSO and TSA 
treated non-RFP cells in this population behave similarly to those from the U373-RFP 
population, with an approximate 4-fold increase in IE72/86 staining (Fig. 4.2, grey bars). 
However, RFP-hDaxx expressing cells treated with DMSO show a much lower level of IE 
gene expression (0.3%) which can be increased over 100-fold by the use of TSA treatment 
(32%) (Fig. 4.2b, black bars). Hence, TSA treatment can result in the de-repression of IE 
gene expression caused by hDaxx over-expression. 
4.2.2 The MIEP in infected hDaxx-stably expressing U373 cells is associated with 
repressive chromatin 
Since TSA treatment of RFP-hDaxx expressing cells had resulted in de-repression of IE 
gene expression upon infection, it was hypothesised that, in the presence of stable hDaxx 
expression, the MIEP might be subject to more potent repression. To analyse this, ChIP 
analysis was carried out on control U373-RFP cells and U373-RFP-hDaxx cells. However, 
as the U373-RFP and U373-RFP-hDaxx cells were mixed populations with variable levels 
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Figure 4.1 TSA causes an increase in permissiveness for infection of U373-RFP cells. U373-RFP cells, 
stably expressing RFP, were treated with either DMSO or TSA media for 16 hours. (A) Cells were then 
infected with HCMV Toledo (MOI 0.2) for 24 hours before cells were fixed and stained for IE72/86 
expression. Hoechst 33342 staining (blue) was used throughout to identify cell nuclei. (B) The number of 
RFP-expressing and non-red cells expressing IE72/86 was then quantified by fluorescent microscopy using 
at least 10 representative fields of view per experiment. Error bars, l S.D. of three independent 
experiments. 
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Figure 4.2 TSA causes de-repression of the HCMV IE gene expression in U373-RFP-hDaxx cells. 
U373-RFP-hDaxx cells, stably expressing hDaxx as an RFP fusion protein, were treated with either DMSO 
or TSA media for 16 hours. (A) Cells were then infected with HCMV Toledo (MOI 0.2) for 24 hours 
before cells were fixed and stained for IE72/86 expression. Hoechst 33342 staining (blue) was used 
throughout to identify cell nuclei. (B) The number of RFP-hDaxx expressing and non-red cells expressing 
IE72/86 was then quantified by fluorescent microscopy using at least 10 representative fields of view per 
experiment. Error bars, 1 S.D. of three independent experiments. 
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of transgene expression (Fig. 4.3), it was decided to purify the RFP or RFP-hDaxx 
expressing cells from the mixed populations. Live sorting of both populations of cells was 
carried out using F ACS to isolate the RFP or RFP-hDaxx expressing cells (Fig. 4.4). 
Analysis of the total populations of cells demonstrated that 27.78% of the U373-RFP 
population expressed RFP strongly and that 1.48% of the U373-RFP-hDaxx expressed 
RFP-hDaxx equivalently (Fig. 4.4b ). These cells were then isolated from the population 
(Fig 4.4a, black boxes) and cultured with selection (G418 at lmg/ml). After this time, the 
RFP and RFP-hDaxx expressing cells were subjected to further analysis to determine an 
estimate of RFP or RFP-hDaxx expression by fluorescent microscopy (Fig. 4.5). At least 
10 fields of view were counted and this demonstrated that the level of RFP-positive cells 
within the U373-RFP population had been enhanced slightly to 43%. However, although 
the RFP-hDaxx positive sub-population of the U373-RFP-hDaxx cells was only increased 
to 36%, this was a considerable enhancement from the initial 1.48% and provided a similar 
proportion of RFP-positive cells to the control U373-RFP population. As such, ChIP 
analysis was then carried out on these populations. 
U373-RFP and U373-RFP-hDaxx cells were first incubated for 48 hours with serum-free 
medium to synchronise the cells. Then, after this time, the cells were infected with HCMV 
in serum-containing medium at an MOI of 0.1. At 24 hours post-infection, the cells were 
fixed with formaldehyde (1 %) and ChIP assays carried out using either control serum 
(Con), an anti-acetylated histone-H4 antibody (H4ac), an anti-di-methyl lysine 9 histone-
H3 (H3K9me2) antibody or an anti-HPl~ (HPl~) antibody as described in Chapter 3. The 
irnrnunoprecipitated DNA fragments were then amplified using real-time quantitative-PCR 
(RTQ-PCR) using primers specifically targeting the MIEP. This new method of analysing 
DNA levels was developed during the course this thesis and, due to the non-chronological 
presentation of this data, will be explained in full in Chapter 6. Nevertheless, RTQ-PCR 
provides a fully quantitative analysis of the output of irnrnunoprecipitated DNA from a 
ChIP assay in real-time and provides a much faster. method of analysis. After 
quantification, low background levels of non-specific irnrnunoprecipitation, determined by 
use of serum controls, was subtracted from the appropriate antibody immunoprecipitation 
and the data quantified relative to the input levels, taken as 10% of total. The data was then 
presented in chart form (Fig. 4.6). 
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Figure 4.3 Fluorescent microscopy reveals low levels of RFP and RFP-hDaxx stably transfected 
U373s. U373s, either stably transfected with pDsRed-Nl (U373-RFP) or pDsRed-Nl -hDaxx (U373-RFP-
hDaxx), were stained with Hoechst 33342 (blue) to identify cell nuclei and then viewed under a UV 
fluorescent microscope for expression ofRFP and RFP-hDaxx (red) respectively. 
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Figure 4.4 Fluorescence activated cell sorting profiles of RFP and RFP-hDaxx stably transfected 
U373 populations. (A) U373s, either stably transfected with pDsRed-Nl (U373-RFP) or pDsRed-Nl-
hDaxx (U373-RFP-hDaxx), were trypsinised from monolayers and washed in PBS before sorting of cells 
for RFP expression. RFP-positive cells selected to concentrate the population are shown in the open box for 
each. (B) A histogram of a proportion of the total cells showing the percentage of positive cells within the 
population. 
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Figure 4.5 Fluorescent microscopy reveals increased levels of RFP and RFP-hDaxx stably transfected 
U373s after FACS. U373s, either stably transfected with pDsRed-Nl (U373-RFP) or pDsRed-Nl-hDaxx 
(U373-RFP-hDaxx), were stained with Hoechst 33342 (blue) to identify cell nuclei and then viewed under 
a UV fluorescent microscope for expression of RFP and RFP-hDaxx (red) respectively. 
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The viral MIEP, after 24 hours of infection of the U373-RFP population, was 
predominantly associated with acetylated histone-H4 (Fig 4.6a, lane 1) consistent with the 
expression of IE genes following infection of these permissive cells. In contrast, the levels 
of both H3K9me2 and HPlB were almost 15-fold lower in these cells (Fig. 4.6a, lane 2 & 3 
respectively). However, the MIEPs present in the U373-RFP-hDaxx population 
demonstrated particularly low levels of associated acetylated histone-H4 and H3K9me2 
(Fig. 4.6b, lanes 4 & 5 respectively). Similarly, the MIEP in these cells was substantially 
associated with HP 1 B (Fig. 4.6b, lane 6). Both of these observations are consistent with the 
repression of IE gene expression in hDaxx over-expressing cells. 
Controls to ensure consistent immunoprecipitation with each antibody were also included 
in these assays. Routinely, GAPDH and y-globin promoters for either transcriptionally 
active (acetylated histone-H4) or transcriptionally repressed chromatin (H3K9me2 & 
HPlB) were used, respectively. (The choice of promoters for each control is further 
explained in Chapter 6). The use of RTQ-PCR to analyse the level of acetylated histone-
H4 on the GAPDH promoter showed equivalent levels of acetylated H4 for both the U373-
RFP population (Fig. 4.7a, lane 1) and the 0373-RFP-hDaxx population (Fig. 4.7a, lane 2). 
This was the same for levels ofH3K9me2 and HPl~ associated with the y-globin promoter 
in both populations of cells (Fig. 4.7b & c, lanes 1 & 2). Thus, with controls to show 
equivalent efficiency of immunoprecipitation with all antibodies, the association of the 
MIEP with histone markers of transcriptional activation or repression reflected the level of 
IE transcription in the 0373-RFP and U3 73-RFP-hDaxx cell populations. 
4. 2. 3 hDaxx is transiently degraded during HCMV infection 
Clearly, hDaxx does mediate repression of IE gene expression and this repression can be 
relieved with the use of HDAC inhibitors. However, a recent report has suggested that 
HCMV infection results in the degradation of hDaxx through interaction with pp71 in a 
proteasomal dependent manner (Saffert & Kalejta, 2006). It was decided to confirm these 
observations during HCMV infection of fibroblasts (Fig. 4.8). Cells were infected with 
gradient purified HCMV Toledo at an MOI of 3, to infect all cells, and total cell protein 
was harvested from 3-12 hours post-infection (Fig. 4.8, lanes 2-5) and from control 
uninfected fibroblasts (Fig. 4.8, lane 1). Samples were then analysed by Western blot for 
IE72, hDaxx and GAPDH expression. The presence of IE72 was found by 6 hours post-
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Figure 4.6 Stable expression of hDaxx in normally permissive U373 cells causes repressive chromatin 
at the MIEP. ChIP assays were performed (MOI 0.1) on (A) U373-RFP and (B) U373-RFP-hDaxx cells at 
24 hours post-infection. Analysis was carried out with either an anti-acetylated histone-H4 antibody (H4ac, 
lanes 1 & 4), an anti-dimethyl lysine 9 histone-H3 antibody (H3K9me2, lanes 2 & 5) or an anti-HPl~ 
antibody (HPl~, lanes 3 & 6). Isolated DNA was amplified using an MIEP-specific RTQ-PCR. For 
comparison, the inununoprecipitated DNA was quantified relative to the input DNA. The data is 
representative of three independent experiments. Error bars, 1 S.D. of triplicate PCR reactions. 
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Figure 4. 7 Equivalent chromatin is immunoprecipitated from U373-RFP and U373-RFP-hDaxx cells. 
ChIP assays were performed (MOI 0.1) on U373-RFP (lane 1) and U373-RFP-hDaxx (lane 2) cells at 24 
hours post-infection. Analysis was carried out with either (A) an anti-acetylated histone-H4 antibody, (B) 
an anti-dimethyl lysine 9 histone-H3 antibody or (C) an anti-HPl~ antibody. Isolated DNA was amplified 
using either (A) GAPDH promoter-specific or (B & C) y-globin promoter-specific RTQ-PCR. For 
comparison, the immunoprecipitated DNA was quantified relative to the input DNA. The data is 
representative of three independent experiments. Error bars, 1 S.D. of triplicate PCR reactions. 
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infection (Fig. 4.8, lane 3) and expression continued to rise through to 12 hours post-
infection (Fig. 4.8 , lanes 4-5). However, by 3 hours post-infection it could clearly be seen 
that the level of hDaxx had reduced (Fig. 4.8, lane 2) compared to the uninfected control 
(Fig. 4.8, lane 1). This reduction was maximal between 3 and 6 hours post-infection (Fig. 
4.8, lanes 2 & 3) before expression of hDaxx returned to normal levels by 12 hours post-
infection (Fig. 4.8, lane 5). This reflected the results of Saffert & Kalejta (2006). 
4. 2. 4 hDaxx can be down-regulated using small interfering RNA (siRNA) technology and 
leads to increases in HCMV IE gene expression in fibroblasts 
Since hDaxx clearly contributed in the U373-RFP-hDaxx cell line to the repression of IE 
gene expression by chromatinisation of the MIEP in a repressive form and as hDaxx was 
degraded during infection of fibroblasts, it was next investigated whether down-regulation 
of hDaxx had any effect on IE gene expression within permissive cells using short 
interfering RNA (siRNA) technology. To this end, fibroblasts were either mock transfected 
(Fig. 4.9, lanes 1-4), transfected with a control scramble siRNA (Fig. 4.9, lanes 5-8) or 
with a siRNA specifically designed to target hDaxx (Michaelson & Leder, 2003) 
supplemented with a second commercially available hDaxx-specific siRNA (Fig. 4.9, lanes 
9-12). Protein samples were then taken from transfected cells at timepoints from 24-96 
hours post-transfection and the samples subjected to Western blot analysis for hDaxx and 
GAPDH expression. Transfection of cells with control siRNAs appeared to have little 
effect on the level of hDaxx expression across the timecourse in relation to GAPDH 
loading (Fig. 4.9, lanes 1-4 & 5-8 respectively). However, the transfection of siRNAs 
specifically targeting hDaxx caused a decrease in expression after just 24 hours (Fig. 4.9, 
lane 9) that was maximal at 72 hours post-transfection (Fig. 4.9, lane 11). Therefore, 
analysis of the effect of hDaxx down-regulation was routinely carried out at 72 hours post-
transfection. 
hDaxx down-regulation usmg siRNAs was further assessed by indirect 
immunofluorescence (Fig. 4.10). Fibroblasts were transfected with either scramble siRNA 
(Fig. 4.10, left panels), the two hDaxx-specific siRNAs (sihDaxx) (Fig. 4.10, middle 
panels) or a PML-specific commercially available siRNA as a further control (siPML) 
(Fig. 4.10, right panels). After 72 hours, cells were fixed, permeabilised and stained for 
hDaxx (green) and PML (red), using Hoechst 33342 as counter-stain for nuclei. Cells were 
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Figure 4.8 Infection with HCMV causes a decrease in hDaxx levels. Human fibroblasts were infected 
with gradient purified HCMV Toledo (MOI 3) and protein samples harvested between 3-12 hours (lanes 2-5) post-infection. A protein sample was also taken from uninfected cells at the time of infection (lane 1). 
Samples were then run on 10% polyacrylamide gels and analysed by Western blot for IE72 and hDaxx 
levels. GAPDH was used as a loading control. 
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Figure 4.9 sihDaxx transfection causes transient down-regulation of hDaxx. Human fibroblasts were either mock transfected (lanes 1-4), transfected with scramble (scr; lanes 5-8) or hDaxx-specific siRNA oligonucleotide duplexes (lanes 9-12). Protein samples were harvested from 24-96 hours post-transfection and then run on 10% polyacrylamide gels before Western blot analysis for hDaxx levels. GAPDH was used as a loading control. 
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then viewed using fluorescent microscopy (Fig. 4.10). Scramble siRNA transfected cells 
showed good staining for hDaxx and PML as expected which appeared localised to ND 10 
(Fig. 4.10, left panels). Cells transfected with sihDaxx presented substantial down-
regulation of hDaxx with no noticeable effect to PML expression (Fig. 4.10, middle 
panels). Interestingly, the down-regulation of PML by PML-specific siRNA also resulted 
in a reduced level of hDaxx staining, consistent with PML-mediated recruitment of hDaxx 
to ND10 (Fig. 4.10, right panels). 
Since substantial down-regulation of hDaxx could routinely be established using hDaxx-
specific siRNAs, the effect of hDaxx down-regulation to HCMV IE gene expression was 
next investigated, initially through assessment of the level of IE transcription (Fig. 4.1 1 ). 
Fibroblasts were mock transfected (Fig. 4.11, lane 1) or transfected with scramble (Fig. 
4.11 , lane 2), hDaxx-specific (Fig. 4.11, lane 3) or PML-specific (Fig. 4.11, lane 4) 
siRNAs. After 72 hours, the cells were infected with HCMV Toledo (MOI 0.5) and after a 
further 24 hours, total RNA was harvested and reverse transcription followed by PCR (RT-
PCR) was carried out to determine relative RNA levels of hDaxx, PML, viral IE and 
GAPDH. Mock and scramble siRNA transfected cells showed similar levels of IE, hDaxx 
and PML RNA after 24 hours post-infection (Fig. 4.11, lanes 1 & 2). In comparison, 
sihDaxx transfected cells showed no change in the level of PML RNA but a decreased 
level of hDaxx RNA as expected (Fig. 4.11 , lane 3). Interestingly, down-regulation of 
hDaxx resulted in a concomitant increase in IE RNA level compared to the control levels. 
The · transfection of PML-specific siRNAs and subsequent down-regulation, seen in the 
PML RNA level, also caused an increase in IE RNA level, although not as considerably as 
with hDaxx down-regulation (Fig. 4.11, lane 4). 
As down-regulation of hDaxx had led to an increase in the steady state levels of viral IE 
RNA, parallel analysis was next carried out to determine whether IE protein expression 
was similarly affected (Fig. 4.12). As before, fibroblasts were either mock transfected (Fig. 
4.12, lane 1) or transfected with either scramble siRNA (Fig. 4.12, lane 2), hDaxx-specific 
(Fig. 4.12, lane 3) or PML-specific (Fig. 4.12, lane 4) siRNAs. After 72 hours, the cells 
were infected with HCMV Toledo (MOI 0.5) and after a further 24 hours, protein samples 
were harvested and Western blotting carried out specifically to determine relative levels of 
hDaxx, PML and viral major IE proteins. Coomassie staining was used as a loading 
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Figure 4.10 Transient down-regulation of hDaxx and PML by siRNA oligonucleotide transfection. 
Human fibroblasts were either transfected with scramble (lane 1), hDaxx-specific (lane 2) or PML-specific 
(lane 3) siRNA oligonucleotide duplexes. After 72 hours, cells were fixed and stained for hDaxx (green) or 
PML (red). Hoechst 33342 (blue) was used throughout to identify cell nuclei. 
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Figure 4.11 hDaxx and PML transient down-regulation causes an increase in viral IE RNA 
production. Human fibroblasts were either mock transfected (lane 1) or transfected with scramble (lane 2), 
hDaxx-specific (lane 3) or PML-specific (lane 4) oligonucleotide duplexes. After 72 hours, cells were 
infected with HCMV Toledo (MOI 0.5) for 24 hours before harvest and extraction of total RNA. After 
reverse transcription, specific PCR was carried out for viral IE genes, PML and hDaxx. GAPDH was used 
as a loading control. 
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control. Mock and scramble siRNA transfected cells showed similar levels of IE72 and 
IE86, hDaxx and PML protein after 24 hours post-infection (Fig. 4.12, lanes 1 & 2). In 
comparison, sihDaxx transfected cells showed no change in the level of PML protein 
compared to scramble siRNA transfected cells but a decreased level of hDaxx protein, as 
expected, with a concomitant increase in IE72 and IE86 protein levels compared to the 
control lanes (Fig. 4.12, lane 3). Again, interestingly, the transfection of PML-specific 
siRNAs and subsequent down-regulation, seen in the PML protein level, also caused an 
increase in IE72 and IE86 protein levels although, as before, not to the level observed with 
hDaxx down-regulation (Fig. 4.12, lane 4). 
Although down-regulation of hDaxx and PML had both resulted in increases in IE gene 
expression, it could be argued that any down-regulation of PML would automatically 
affect the recruitment of hDaxx to NDlO. However, it was possible that the increase in IE 
gene expression seen with hDaxx down-regulation could have been due to non-specific 
effects of the siRNAs directed towards hDaxx. Thus, in order to control for possible 'off 
target' effects additional siRNA controls were employed, specifically an siRNA directed 
towards murine Daxx (mDaxx) (Fig. 4.13). Human fibroblasts and murine embryonic 
fibroblasts (MEFs) were either mock transfected (Fig. 4.13a & b, lane 1 ), or transfected 
with scramble siRNA (Fig. 4.13a & b, lane 2), mDaxx-specific (Fig. 4.13a & b, lane 3) or 
hDaxx-specific (Fig. 4.13a & b, lane 4) siRNAs. After 72 hours, the protein samples were 
taken from the MEF populations, whereas human fibroblast populations were infected with 
HCMV Toledo (MOI 0.5) and, after a further 24 hours, protein samples were harvested 
and Western blotting carried out to determine relative levels of hDaxx and viral major IE 
protein in human fibroblasts (Fig. 4.13a) and mDaxx protein in MEFs (Fig. 4.13b). 
Coomassie staining was used in both cases as a loading control. Mock and scramble 
siRNA transfected· controls showed equivalent levels of hDaxx, IE72 and IE86 in human 
fibroblasts (Fig. 4.13a, lanes 1 & 2) and mDaxx in MEFs (Fig. 4.1 3 b lanes 1 & 2). 
simDaxx transfection of human fibroblasts produced no decrease in hDaxx expression or 
subsequent increase in IE gene expression (Fig. 4.13a, lane 3) but down-regulated mDaxx 
expression in MEFs as expected (Fig. 4.1 3b lane 3). Additionally, sihDaxx transfection 
produced decreases in hDaxx expression and increases in IE gene expression as expected 
(Fig. 4.13a, lane 4) but had little effect on the level of mDaxx expression in MEFs (Fig. 
4.13b, lane 4). All results were consistent with a robust specificity of siRNAs and previous 
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Figure 4.12 hDaxx and PML transient down-regulation causes increases in viral IE protein 
production. Human fibroblasts were either mock transfected (lane 1) or transfected with scramble (lane 2), 
hDaxx-specific (lane 3) or Pl\1L-specific (lane 4) oligonucleotide duplexes. After 72 hours, cells were 
infected with HCMV Toledo (MOI 0.5) for 24 hours before harvest and analysis of protein content by 
Western blot for viral IE and hDaxx protein expression. Coomassie stained gels are presented as loading 
controls. 
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Figure 4.13 hDaxx-specific but not mDaxx-specific siRNA oligonucleotides causes increases in viral 
IE protein production in fibroblasts. (A) Human fibroblasts were either mock transfected (lane 1) or 
transfected with scramble (lane 2), mDaxx-specific (lane 3) or hDaxx-specific (lane 4) oligonucleotide 
duplexes. After 72 hours, cells were infected with HCMV Toledo (MOI 0.5) for 24 hours before harvest 
and analysis of protein content by Western blot for viral IE and hDaxx protein expression. (B) MEFs were 
either mock transfected (lane 1) or transfected with scramble (lane 2), mDaxx-specific (lane 3) or hDaxx-
specific (lane 4) oligonucleotide duplexes. After 72 hours, cells were harvested and protein content 
analysed by Western blot for mDaxx. Coomassie stained gels are presented as loading controls. 
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findings (Michaelson & Leder, 2003). Furthermore, since analysis of both RNA and 
protein levels had shown that scramble siRNA transfection had no profound differential 
effect than the mock control, a sole scramble siRNA was used when treating cells from 
here on in. 
4. 2. 5 hDaxx down-regulation increases the level of permissiveness of lytic infection at low 
multiplicities of infection and viral protein production throughout infection 
Similar to treatment of cells with TSA, hDaxx down-regulation clearly led to increases in 
viral IE RNA and protein levels by 24 hours post-infection. As such, it was investigated 
whether a concomitant increase in permissiveness of infection with HCMV also occurred. 
To this end, fibroblasts were transfected with either scramble siRNA (Fig. 4.14a) or 
hDaxx-specific siRNAs (Fig. 4.14b) for 72 hours before infection with HCMV Toledo at a 
low MOI (0.05). After 24 hours, cells were fixed, permeabilised and stained for IE72/86 
expression with counter-staining of nuclei by Hoechst 33342 and viewed under a 
fluorescent microscope (Fig. 4.14). Fibroblasts transfected with scramble siRNA showed a 
low level of infection, as expected using an MOI of 0.05, as determined by expression of 
IE72/86 (green staining; Fig. 4.14a, upper panel). However, cells transfected with hDaxx-
specific siRNAs showed an obvious increase in the number of cells expressing IE72/86 
after infection, approximately 4-fold (Fig. 4.14b, upper panel). 
As hDaxx down-regulation in HCMV infected cells had shown increases in the levels of IE 
gene expression and permissiveness for infection, it was next decided to determine whether 
hDaxx down-regulation was having subsequent effects on viral lytic infection as seen with 
TSA earlier (Chapter 3). Since herpesvirus gene expression is controlled in a temporally 
regulated cascade (Fig. 1.5), dependent upon the initial expression of in IE gene products, 
it was possible that increases in IE gene expression by down-regulation of hDaxx could 
also increase subsequent early and late transcription. Therefore, levels of early and late 
viral gene products, in addition to IE gene products, were, assessed throughout the course 
of lytic infection using Western blotting after hDaxx down-regulation (Fig 4.15). 
Fibroblasts were transfected with either scramble siRNA or hDaxx-specific siRNAs for 72 
hours before infection with HCMV Toledo at a low MOI (0.1) to aid detection of 
differences to the expression profiles. Protein samples were then harvested at 6, 24, 48, 72 
and 96 hours post-infection and levels of expression of the major IE gene product IE72, the 
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Figure 4.14 Transient down-regulation of hDaxx increases the permissiveness of infection with HCMV at low multiplicities of infection. Human :fibroblasts were transfected with either (A) scramble or (B) hDaxx-speci:fic oligonucleotide duplexes. After 72 hours, cells were infected with HCMV Toledo (MOI 0.05) for 24 hours before cells were fixed and stained for IE72/86 (green) and Hoechst 3342 (blue) and 
analysed by fluorescent microscopy. 
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early gene product UL44 and the late gene product pp28 was analysed. Low levels of IE72 
were detectable in scramble siRNA transfected, infected cells by 24 hours post-infection 
(Fig. 4.15, lane 2) as expected, although as previously seen at this timepoint (Fig. 4.12), 
sihDaxx transfection resulted in an increase in the level of IE gene expression (Fig. 4.15, 
lane 7). Indeed, this increase in IE gene expression was observed throughout lytic infection 
as, in comparison to the scramble siRNA transfected cells (Fig. 4.15, lanes 3-5), the 
infection of sihDaxx transfected cells resulted in increased expression of IE gene products 
up to 96 hours post-infection (Fig. 4.15, lanes 8-10). On analysis of the early gene product, 
UL44, a similar temporal increase was seen in sihDaxx transfected, infected cells. Low 
levels of expression of UL44 in scramble siRNA transfected cells was detectable by 48 
hours post-infection (Fig. 4.15, lane 3), however an increased level of expression was seen 
with sihDaxx transfected cells by this timepoint (Fig. 4.15, lane 8). Indeed, increased viral 
late gene expression was also observed in sihDaxx transfected cells: pp28 was visible by 
72 hours post-infection (Fig. 4.15, lane 9) whereas in scramble siRNA transfected cells 
pp28 was not detected until 96 hours post-infection (Fig. 4.15, lane 5). Therefore, hDaxx 
down-regulation prior to infection of fibroblasts with HCMV caused an increase in the 
levels of gene expression of IE, early and late genes throughout the lytic cycle in already 
permissive cells. 
4. 2. 6 hDaxx down-regulation causes increases in viral DNA replication and infectious 
virus output 
hDaxx down-regulation of HCMV infected cells had clearly shown increases in the levels 
of IE gene expression. Consequently, the next aim was to determine whether hDaxx down-
regulation had further consequences on viral lytic infection, as seen with TSA treatment of 
fibroblasts in Chapter 3. Fibroblasts were again transfected with either scramble siRNA or 
hDaxx-specific siRNAs for 72 hours prior to infection with HCMV Toledo (MOI 0.5) 
before DNA was extracted from cells at 6, 24, 48, 72 and 96 hours post-infection. Due to 
the establishment of MIEP-specific and GAPDH promoter'-specific RTQ-PCR, analysis of 
the samples was then carried out in this manner. Levels of viral DNA are shown relative to 
input viral DNA quantified at 6 hours post-infection. The control scramble siRNA 
transfected cells (Fig. 4 .16, grey bars) showed an increase in viral DNA levels by 72 hours 
post-infection. This increase then continued through to 96 hours post-infection, finally 
reaching over a 30-fold increase in the level of viral DNA compared to the input level at 6 
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Figure 4.15 Transient down-regulation of hDaxx promotes viral protein production. Human 
fibroblasts were transfected with either scramble or hDaxx-specific oligonucleotide duplexes. After 72 
hours, cells were infected with HCMV Toledo (MOI 0.1) and protein samples were taken at timepoints 
from 6-96 hours (lanes 1-5). Samples for each timepoint were run on 10% polyacrylamide gels before 
Western blotting for viral IE (IE72), early (UL44) and late (pp28) proteins. GAPDH was used as a loading 
control. 
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hours post-infection. In sihDaxx transfected cells, however, an increase in viral DNA 
levels, compared to the 6 hour input value, was detectable by 48 hours (Fig. 4.16, black 
bars). This increase, which was consistently above the level of viral DNA in scramble 
siRNA transfected cells, then continued to the 96 hour timepoint with final levels 60-fold 
higher than input levels. Interestingly, though, the maximal difference between the control 
and hDaxx down-regulated cells appeared at 72 hours post-infection. 
hDaxx down-regulation clearly increased viral gene expression and DNA replication, as 
had TSA treatment. It was next asked, similarly, whether hDaxx down-regulation led to an 
increase in output of infectious virus (Fig. 4.17). Fibroblasts were transfected as before, 
with either scramble siRNA or hDaxx-specific siRNAs and then infected with HCMV 
Toledo at a low MOI (0.01). Unadsorbed virus was then removed by washing twice with 
fresh EMEM-10 and the medium finally being replaced. Samples of the supernatant were 
then taken every day for six days and the output of virus from both populations of cells 
assessed by plaque assay as well as the virus input used to infect both sets of cells. From 
day O to day 3 post-infection, both scramble siRNA (Fig 4.17, grey diamonds) and 
sihDaxx-transfected cells (Fig. 4.17, black squares) showed no infectious virus output, as 
expected, due to the eclipse period of the virus life cycle (Mocarski et al., 2007). At 4 days 
post-infection, infectious virus was detectable in both control and sihDaxx transfected 
cells. However, by this timepoint hDaxx down-regulated cells had produced a 20% 
increase in the level of infectious virus progeny. The increased output from both 
populations of cells continued through until 6 days post-infection. However, hDaxx down-
regulation resulted in 34% more infectious virus being produced by cells at this time than 
the scramble siRNA transfected cells. 
4. 2. 7 hDaxx down.:regulation causes changes to the chromatinisation of the MIEP at IE 
and early times of infection 
TSA had relieved the repressive effect of hDaxx over-expression in normally permissive 
U373 cells. Additionally, hDaxx down-regulation in permissive fibroblasts had led to 
increased HCMV gene expression and replication in comparison to control cells. 
Furthermore, hDaxx is known to interact with HDACs and recruit these enzymes to ND 10. 
Therefore, it was hypothesised that the repressive effect of hDaxx on the viral MIEP could 
be mediated through regulation of the chromatin structure of the promoter. Consequently, 
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Figure 4.16 Transient down-regulation of hDaxx promotes viral DNA replication. Human fibroblasts 
were transfected with either scramble (grey) or hDaxx-specific (black) oligonucleotide duplexes. After 72 
hours, cells were infected with HCMV Toledo (MOI 0.5) and DNA was extracted at timepoints from 6-96 
hours. Both MIEP and GAPDH RTQ-PCR was then performed on samples and the quantity of viral DNA 
expressed as a proportion of the input DNA (MIEP/GAPDH). Error bars, I S.D. of three independent 
experiments, P value< 0.01. 
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Figure 4.17 Transient down-regulation of hDaxx promotes the production of infectious virus. Human 
fibroblasts were treated with either scramble (grey) or hDaxx-specific (black) oligonucleotide duplexes. 
After 72 hours, cells were infected with HCMV Toledo (MOI 0.01) and supernatant samples were taken at 
tirnepoints for 6 days. Each sample was then used in serial dilutions to infect human fibroblasts and plaque 
assay analysis carried out. The data is representative of three independent experiments. Error bars, 1 S.D. 
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ChIP analyses were carried out on fibroblasts either transfected with scramble siRNA or 
hDaxx-specific siRNA for 72 hours to assess the viral MIEP with respect to the chromatin 
structure. Representative autoradiographs from the 3 hour and 24 hour post-infection 
samples are displayed (Fig. 4.18a & 4.20a). The intensity of amplified products from 
triplicate PCRs of each sample were then quantified using Image J and the data represented 
in chart format for both timepoints (Fig. 4.18b & 4.20b ). As before, to ensure consistent 
immunoprecipitation of specific histone or histone associated proteins across each 
timepoint and throughout the full timecourse, a c-Fos PCR was carried out for both 
timepoints (Fig. 4.19 & 4.21). 
At 3 hours post-infection with HCMV, the viral MIEP in control scramble siRNA 
transfected cells was predominantly associated with H3K9me2 (Fig 4.18b, lane 2), with 
lower but apparent levels of acetylated histone-H4 (Fig. 4.18b, lane 1 ). Although the level 
of associated HP 1 B was much lower (Fig. 4.18b, lane 3) this chromatin profile is still 
consistent with repression immediately upon infection. In contrast, the MIEPs from 
sihDaxx transfected cells exhibited a very low level of association of H3 K9me2 and HP 1 ~ 
(Fig 4.18b, lanes 5 & 6) but a much higher level of association of acetylated histone-H4 
(Fig. 4.18b, lane 4). By 24 hours post-infection, the high association of MIEPs with 
H3K9me2 and HPlB in scramble siRNA transfected cells had diminished to very low 
levels (Fig. 4.20b, lanes 2 & 3) with much higher recruitment of acetylated histone-H4 
having taken place (Fig. 4.20b, lane 1). However, in stark contrast to this, sihDaxx 
transfected cells now demonstrated higher levels of H3K9me2 and HPlB (Fig. 4.20b, lanes 
5 & 6) and a reduced association with acetylated histone-H4 (Fig. 4.20b, lane 4). Although 
no marker of repression or activation is predominant at this timepoint, this chromatin 
profile is consistent with transition of the promoter to a repressive structure. The control 
PCR for c-Fos used throughout the timecourse provided evidence that immunoprecipitation 
had again occurred consistently throughout the analysis of 3 hour and 24 hour post-
infection samples (Fig. 4.19b & 4.21 b, respectively). 
4.3 Discussion 
Work described in Chapter 3 showed an association of the MIEP with repressive chromatin 
immediately upon infection of permissive fibroblasts, likely due to HDACs. As it is known 
that the genomes of herpesviruses upon infection are targeted to ND 10, sites of chromatin 
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Figure 4.18 Transient down-regulation of hDaxx causes changes to the chromatinisation of the MIEP 
at 3 hours post-infection. (A) ChIP assays were performed on serum-starved human :fibroblasts, pre-
treated with either scramble or hDaxx-speci:fic oligonucleotides for 72 hours, at 3 hours post-infection 
(MOI 0.1). Analysis was carried out with either an anti-acetylated histone-H4 antibody (H4ac, lane 1 & 4), 
an anti-dimethyl lysine 9 histone-H3 antibody (H3K9me2, lane 2 & 5) or an anti-HPl~ antibody (HPl~, 
lane 3 & 6). Inputs (10% of total chromatin) are not shown. Isolated DNA was amplified using a l\.1IEP-
speci:fic PCR and products run on a 2% agarose gel before Southern blot analysis. (B) Image J analysis was 
then used to quantify .autoradiograph bands in (A). For comparison, the immunoprecipitated DNA was 
quantified relative to the input DNA. The data is representative of three independent experiments. Error 
bars, 1 S.D. of triplicate PCR reactions. 
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Figure 4.19 Transient down-regulation of hDaxx does not cause changes to the chromatinisation of 
the c-Fos promoter at 3 hours post-infection. (A) ChIP assays were performed on serum-starved hwnan 
fibroblasts, pre-treated with either scramble or hDaxx-specific oligonucleotides for 72 hours, at 3 hours 
post-infection (MOI 0.1). Analysis was carried out with either an anti-acetylated histone-H4 antibody 
(H4ac, lane 1 & 4), an anti-dimethyl lysine 9 histone-H3 antibody (H3K9me2, lane 2 & 5) or an anti-HPl~ 
antibody (HPl~, lane 3 & 6). Inputs (10% of total chromatin) are not shown. Isolated DNA was amplified 
using a c-Fos-specific PCR and products run on a 2% agarose gel before Southern blot analysis. (B) Image 
J analysis was then used to quantify autoradiograph bands in (A). For comparison, the immunoprecipitated 
DNA was quantified relative to the input DNA. The data is representative of three independent 
experiments. Error bars, 1 S.D. of triplicate PCR reactions. 
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remodelling enzymes, it was possible that component proteins ofNDlO may be involved in 
mediating this repression. One such component is hDaxx which is known to interact with 
HDACs and had been shown previously to abrogate HCMV infection of hDaxx-stably 
expressing cells (Woodhall et al., 2006). Therefore, the possible association of hDaxx with 
repression of the MIEP immediately upon infection was investigated here. 
Since U373 cells stably expressmg a RFP-hDaxx fusion protein (U373-RFP-hDaxx) 
inhibited HCMV IE gene expression, TSA was first used to investigate whether de-
repression of viral gene expression was possible, as seen previously with high MOI 
infections (Woodhall et al., 2006). Indeed, pre-treatment of U373-RFP-hDaxx cells with 
TSA showed over a 100-fold increase in the number of cells expressing IE protein at 24 
hours post-infection. Thus, although hDaxx was still present at high levels within these 
cells, the use of a HDAC inhibitor was sufficient to prevent hDaxx expression from 
mediating its repressive effect on IE gene expression. Additionally, to support these 
findings ChIP analysis was carried out on the viral MIEP in control (U373-RFP) and 
U373-RFP-hDaxx cells. Whilst the MIEP in U373-RFP cells had the chromatin profile of 
an active promoter, with predominant association of acetylated histone-H4 by 24 hours 
post-infection, the MIEP in U373-RFP-hDaxx cells had a repressed chromatin structure, 
associated predominantly with HP 1 ~- However, the predominant association of HP 1 ~ with 
the MIEP in U373-RFP-hDaxx cells does not appear as high as acetylated histone-H4 in 
U373-RFP cells. This may be due to the mixed population of cells assessed: only 36% of 
U373-RFP-hDaxx population were RFP-hDaxx positive. Therefore, some promoters may 
have an active chromatin structure due to their location in RFP-hDaxx negative, permissive 
cells. In contrast, all cells of the U373-RFP population, whether RFP-positive or not, 
would be permissive for IE gene expression and thus result in a clear active chromatin 
profile. 
Other studies of the role of hDaxx in HCMV IE gene ,expression repression have now 
shown the pp71-dependent, proteasomal degradation of hDaxx upon infection. Although 
some have shown the complete degradation of hDaxx by pp71 by 6 hours post-infection 
(Saffert & Kalejta, 2006), data presented here is similar to that of other groups where 
hDaxx protein levels decrease from 3 hours post-infection to a maximal level by 6 hours, 
before re-establishing an uninfected cell level by 12 hours post-infection (Tavalai et al., 
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Figure 4.20 Transient down-regulation of hDaxx causes changes to the chromatinisation of the MIEP 
at 24 hours post-infection. (A) ChIP assays were performed on serum-starved human :fibroblasts, pre-
treated with either scramble or hDaxx-speci:fic oligonucleotides for 72 hours, at 24 hours post-infection 
(MOI 0.1). Analysis was carried out with either an anti-acetylated histone-H4 antibody (H4ac, lane 1 & 4), 
an anti-dimethyl lysine 9 histone-H3 antibody (H3K9me2, lane 2 & 5) or an anti-HP!~ antibody (HPl~, 
lane 3 & 6). Inputs (10% of total chromatin) are not shown. Isolated DNA was amplified using a MIEP-
speci:fic PCR and products run on a 2% agarose gel before Southern blot analysis. (B) Image J analysis was 
then used to quantify autoradiograph bands in (A). For comparison, the immunoprecipitated DNA was 
quantified relative to the input DNA. The data is representative of three independent experiments. Error 
bars, I S.D. of triplicate PCR reactions. 
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Figui:e 4.21 Transient down-regulation of hDaxx does not cause changes to the chromatinisation of the c-Fos promoter at 24 hours post-infection. (A) ChIP assays were performed on serum-starved human fibroblasts, pre-treated with either scramble or hDaxx-specific oligonucleotides for 72 hours, at 24 hours post-infection (MOI 0.1). Analysis was carried out with either an anti-acetylated histone-H4 antibody (H4ac, lane 1 & 4), an anti-dimethyl lysine 9 histone-H3 antibody (H3K9me2, lane 2 & 5) or an anti-HPl~ 
antibody (HPW, lane 3 & 6). Inputs (10% of total chromatin) are not shown. Isolated DNA was amplified 
using a c-Fos-specific PCR and products run on a 2% agarose gel before Southern blot analysis. (B) Image J analysis was then used to quantify autoradiograph bands in (A). For comparison, the immunoprecipitated DNA was quantified relative to the input DNA. The data is representative of three independent 
experiments. Error bars, l S.D. of triplicate PCR reactions. 
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2008). This degradation within this time frame appears to fit with hDaxx's role as a 
repressor of IE gene expression which is counteracted by the tegument phosphoprotein 
pp71. Therefore, the use of RNA interference specifically targeting hDaxx, as previously 
published (Michaelson & Leder, 2003), was employed to investigate the effects of hDaxx 
down-regulation on viral IE gene expression. Efficient transient down-regulation of hDaxx 
caused an increase in the expression of IE genes by 24 hours post-infection. Such down-
regulation of gene expression by RNA interference technology can be prone to off-target 
effects (Jackson et al., 2003; Jackson et al., 2006). However, although hDaxx displays 
76% similarity to mDaxx across the coding region, experiments using siRNAs targeting 
both hDaxx and mDaxx in both human and murine fibroblasts provided no evidence for 
off-target effects. Interestingly, the use of a further siRNA directed towards PML, the 
NDlO defining component responsible for hDaxx recruitment, illustrated not only 
reasonable transient down-regulation of PML RNA and protein but also increases in viral 
IE gene expression. This result could be explained by an indirect effect of PML down-
regulation on hDaxx: down-regulation of PML protein would likely affect hDaxx 
recruitment to ND 10 but not total hDaxx protein levels ( as shown in Fig. 4.10 and 4.11 ). 
However, work by others has suggested that hDaxx and PML independently contribute 
towards repression of IE gene expression (Tavalai et al., 2006; Tavalai et al., 2008) as has 
recently been shown for PML and SplOO during HSV-1 infection (Everett et al., 2008). 
PML down-regulation in subsequently infected cells is able to partly complement a pp71-
deleted HCMV, although not as efficiently as hDaxx down-regulation (Tavalai et al., 
2008). Indeed, over-expression of PML in U373 cells has only ever been shown to delay 
the onset of infection but not inhibit infection (Ahn & Hayward, 2000). In contrast, hDaxx 
over-expression in U373 cells has shown a full abrogation of HCMV infection (Woodhall 
et al., 2006). Hence, although PML may have some role in the regulation of HCMV IE 
gene expression, with ·PML known to interact with HDACs itself (Wu et al., 2001c), 
repression still appears more directly linked to the greater activity of hDaxx. 
Since down-regulation of hDaxx in fibroblasts had caused increases in viral IE gene 
expression similar to those with TSA treatment of cells, the effects of the loss of repression 
on full virus replication were next assessed within this system. hDaxx down-regulation 
increased both the permissiveness of fibroblasts for infection and the expression of all 
classes of HCMV genes. Similarly, the levels of viral DNA synthesis and infectious virus 
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output from the cells were also increased. However, increases seen with hDaxx down-
regulation did not reflect the more substantial increases in viral DNA synthesis and 
infectious virus production with TSA treatment shown in Chapter 3. Although these results 
suggest a profound effect of hDaxx on the regulation of the viral MIEP, subsequent viral 
early and late gene expression as well as viral DNA replication, down-regulation of hDaxx 
alone is not sufficient to cause increases to the same level as HDAC inhibition in cells. 
The substantial effect of hDaxx down-regulation on HCMV gene expression and viral 
DNA replication was reflected in the changes to the chromatin structure of the MIEP 
throughout the first 24 hours of infection. At 3 hours post-infection of scramble siRNA 
transfected cells the MIEP showed a predominant association with repressive markers. In 
contrast, in cells in which hDaxx had been down-regulated the MIEP was predominantly 
associated with acetylated histone-H4 consistent with the increase in viral IE gene 
expression within these cells. By 24 hours post-infection, the MIEP in scramble siRNA 
transfected cells was associated predominantly with acetylated histone-H4 as had been 
demonstrated at this timepoint in HCMV infected cells before (Chapter 3). However, by 24 
hours post-infection, hDaxx down-regulation resulted in the MIEP becoming associated 
with similar levels of transcriptional markers. Although this is in contrast to the findings of 
TSA treated cells with HCMV infection at this timepoint, where the promoter was 
predominantly associated with HPl~ consistent with IE86 directed auto-regulation, the 
chromatin profile is consistent with a transition from an active to a repressed promoter 
consistent with the effects of hDaxx down-regulation on IE gene expression. In addition, 
these findings were fully supported by equivalent chromatin profiles at the c-Fos promoter 
across both timepoints. 
Work using pp71 ·mutant viruses has shown that an interaction of pp71 with hDaxx is 
essential for transactivation of the MIEP and IE gene expression (Cantrell & Bresnahan, 
2005). Additionally, work in which hDaxx has been over-expressed in U373 cells showed 
that hDaxx could inhibit IE gene expression and viral replication in a MOI dependent 
manner and that hDaxx knockdown using short hairpin RNA (shRNA) technology led to 
abolition of the impaired growth phenotype of a pp71-null HCMV mutant (Cantrell & 
Bresnahan, 2006). This is consistent with other experiments showing that a pp 71-null 
HCMV could be rescued in hDaxx depleted cells (Preston & Nicholl, 2006). Additionally, 
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expression from the MIEP carried by a HSY -1 mutant was shown to significantly increase 
by 11 hours post-infection, although this could not be recapitulated during wild type 
HCMV infection (Preston & Nicholl, 2006). It is worthy of note though that the positive 
regulation by hDaxx of HCMV major IE gene expression shown previously via 
transfection assays and infection of Daxx-null murine cells has never been recapitulated 
during infection analyses with HCMV of human cells (Hoffman et al., 2002; Ishov et al., 
2002). Indeed, consistent with data presented in this chapter, the use of siRNA technology 
to transiently down-regulate hDaxx expression, in comparison to a siRNA control, has 
been shown to increase IE72 protein expression in human fibroblasts (Saffert & Kalejta, 
2006). Furthermore, the mechanism of repression of viral IE gene expression from the 
MIEP was also hypothesised to be mediated by HDACs as TSA treatment of cells caused 
increases in IE72 protein production during infection, as shown within Chapter 3 (Saffert 
& Kalejta, 2006). 
Interestingly, it has been reported that stabilisation of hDaxx by the proteasome inhibitor 
lactacyctin blocks IE gene expression at low MOI (0.05) (Saffert & Kalejta, 2006). 
Furthermore, this proteasomal degradation of hDaxx driven by pp71 occurs in a ubiquitin-
independent fashion (Hwang & Kalejta, 2007). However, other work has shown that 
inhibition of proteasome activity with MG 132 does not completely inhibit IE gene 
expression and that infection of hDaxx knockdown fibroblasts treated with MG 132 does 
not result in levels of IE gene expression observed in non-MG 132 treated hDaxx 
knockdown fibroblasts (Kaspari et al., 2008). Additionally, work presented in this chapter 
and by others (Tavalai et al., 2008) demonstrated that although depleted by pp71, a low 
level of hDaxx protein remained in HCMV infected cells during IE gene expression, in 
contrast to data from Saffert & Kalejta (2006). Hence, proteasome inhibitors, such as 
MG 132, appear to have other viral targets resulting in a block in late gene expression 
(Kaspari et al., 2008). 
Other viruses also appear to be inhibited by hDaxx during infection. hDaxx has been 
shown to interact with the viral integrase of avian sarcoma virus (ASV), early after 
infection of Hela cells, .and mediate repression of viral gene expression, likely by 
recruitment of HDACs (Greger et al., 2005). Additionally, hDaxx may also mediate the 
maintenance of repression of the virus L TR: siRNA knockdown of hDaxx, HDAC 1 and 
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HPly within ASV infected cells and TSA treatment, pp71 or IE86 expression, all lead to 
L TR-driven reporter gene reactivation (Poleshko et al. , 2008). The fas-binding domain of 
hDaxx has also been shown to interact with the phage <l>C31 integrase, which results in a 
mild loss of integration efficiency (Chen et al., 2006). Hence, the repression of viral 
infection by hDaxx has been demonstrated at other points of a virus life cycle. 
Additionally, the post-translational state of hDaxx has been examined during interaction 
with RNA virus integrases and it has been found that an unmodified form of hDaxx acts as 
the repressor. This is in contrast to the likely SUMO-modified form of hDaxx found at 
ND10. However, it is also known that hDaxx can be post-translationally phosphorylated 
and that the phosphorylation status of the protein and interaction with homeodomain-
interacting protein kinase 1 (HIPKI) can result in changes to hDaxx localisation and ability 
to repress (Ecsedy et al., 2003). Hence, it is likely that these different forms of hDaxx may 
have independent roles within the cell as well as different effects on the virus. 
Overall, it has been demonstrated that hDaxx acts as a mediator of repression of HCMV IE 
gene expression immediately upon infection. This most likely occurs through the 
recruitment of HDACs to ND10 where hDaxx interacts with the viral genome upon 
deposition after infection. Down-regulation of hDaxx causes the relief of repression of IE 
gene expression through a loss of repressive chromatin at the viral MIEP. Indeed, down-
regulation is also responsible for an increase in viral gene expression throughout infection 
and a rise in the level of infectious viral progeny produced. However, the augmentation of 
HCMV infection by hDaxx down-regulation does not occur to the same level as with 
inhibition of HDACs. Hence, it appears that hDaxx mediates recruitment of HDACs to the 
MIEP which cause the repression of virus gene expression. Nevertheless, other factors able 
to recruit HDACs and further chromatin remodelling enzymes to ND10 may also have 
some role during HCMV productive infection. 
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5. Results 
hDaxx down-regulation in in vitro models of latency does not permit HCMV IE gene 
expression 
5.1 Introduction 
Work presented in chapters 3 and 4, as well as work of other laboratories, has established a 
clear role for hDaxx in the repression of HCMV IE gene expression immediately upon 
infection of fully permissive cells. This repression appears to be mediated through the 
formation of a repressed chromatin structure at the HCMV MIEP and could be relieved by 
hDaxx down-regulation or HDAC inhibitors (Cantrell & Bresnahan, 2006; Preston & 
Nicholl, 2006; Saffert & Kalejta, 2006; Woodhall et al., 2006). It is also well established 
that chromatin structure at the MIEP plays a major role in the maintenance of latency and 
reactivation of HCMV. Infection of model cell systems conditionally permissive for 
HCMV IE gene expression (Meier, 2001; Murphy et al., 2002; Reeves et al., 2005a; 
Reeves et al., 2005b) as well as ex viva culture of naturally latent CD34+ cells from a 
healthy seropositive individual (Reeves et al., 2005b) has shown that the MIEP is 
associated with markers of transcriptional repression after infection consistent with a lack 
of IE gene expression. In contrast, infection of differentiated cells now permissive for IE 
gene expression results in association of the MIEP with transcriptionally active chromatin. 
Similarly, in naturally latent CD34+ cells, differentiation to mature DCs also results in the 
viral MIEP becoming associated with markers of transcriptionally active chromatin. 
Analagous results have been obtained using other cell lines conditionally permissive for 
HCMV IE gene expression (Ioudinkova et al., 2006). However, it was unknown whether 
hDaxx had any role in the differentiation-dependent regulation of IE gene expression 
during virus latency or reactivation. 
A number of model cell systems exist that recapitulate the differentiation-dependent 
regulation of viral IE gene expression observed during natural latency and reactivation of 
HCMV. The embryonal carcinoma cell system NT2Dl (T2 cells), which is non-permissive 
for viral infection due to a block in major IE gene expression, can be differentiated with 
retinoic acid (RA) to a fully permissive phenotype, T2RA cells (Andrews et al., 1984; 
Gonczol et al., 1984; Lubon et al., 1989). Furthermore, the human acute monocytic 
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leukaemia cell line, known as THPl cells, is also conditionally permissive to HCMV IE 
gene expression but can be differentiated to a fully permissive cell type by phorbol esters 
(PMA or TPA) (Weinshenker et al., 1988; Sinclair et al., 1992). In these cells, the 
differentiation-dependent regulation of major IE gene expression results from changes in 
the chromatin structure of the MIEP identical to those observed during natural latency and 
reactivation of HCMV in CD34+ stem cells differentiated to DCs (Murphy et al., 2002; 
Reeves et al., 2005b; Ioudinkova et al., 2006). On this basis, both of these cell models have 
been used by a number of laboratories to mimic changes in cellular function associated 
with latency and reactivation of HCMV. As hDaxx had been found to mediate the 
chromatin based repression of HCMV IE gene expression immediately upon infection of 
fully permissive cells, these cell models were employed to determine whether down-
regulation of hDaxx had any effect on the differentiation-dependent regulation of IE gene 
expression and, hence, latency and reactivation. 
5.2 Results 
5. 2.1 Differentiation of conditionally permissive cells for HCMV infection is not associated 
with a decrease in endogenous hDaxx expression 
It has already been established that the absolute levels of factors such as YYl and ERF in 
undifferentiated T2 and THP 1 cells, which are known to recruit chromatin remodelling 
enzymes to the MIEP and impose transcriptional repression in these undifferentiated cells, 
do not decrease upon differentiation (Bain et al., 2003; Wright et al., 2005). Instead, it is 
known that levels of co-factors such as HDACs are reduced (Murphy et al., 2002; Wright 
et al., 2005). As such, if hDaxx was acting as a co-repressor of viral IE gene expression in 
undifferentiated cells, it might be expected that endogenous levels of hDaxx would 
decrease upon differentiation, thus relieving this control. Therefore, the levels of 
endogenous hDaxx ·were first assessed in myeloid cells known to act as carriers of 
naturally latent HCMV as well as the conditionally permissive T2 cell line before and after 
their differentiation to cell types which would support viral · IE gene expression (Fig. 5 .1 ). 
Monocytes harvested from PBMC by adherence (Fig. 5.la, lane 1) were treated with IL-4 
and GM-CSF for 6 days and differentiated to immature dendritic cells (iDC) (Fig. 5.la, 
lane 2), before a further 3 day treatment with LPS to mature DCs (mDC) (Fig. 5 .1 a, lane 
3). Protein samples were harvested from each cell population and analysed by Western blot 
to determine the endogenous level of hDaxx; GAPDH was used as a loading control. No 
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Figure 5.1 Differentiation of cells conditionally permissive to HCMV IE gene expression does not lead 
to a decrease in endogenous hDaxx expression. (A) Monocytes (lane 1) were treated with IL-4 and GM-
CSF for 6 days and differentiated to immature dendritic cells (iDC; lane 2), before a further 3 day treatment 
with LPS to mature DCs (mDC; lane 3). Protein samples were harvested from each cell population and run 
on 10% polyacrylamide gels before Western blot analysis of hDaxx levels. GAPDH was used as a loading 
control. (B) T2 cells were either mock treated (fresh media; lanes 1-5) or treated with retinoic acid (lanes 6-
10). Protein samples w~re taken from 1-5 days and run on 10% polyacrylamide gels before Western blot 
analysis of hDaxx expression levels. GAPDH was used as a loading control. 
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changes in the steady state level of hDaxx protein occurred upon differentiation of 
monocytes to mature DCs (Fig. 5.la). Similarly, differentiation of T2 cells with retinoic 
acid for 5 days showed no change in the levels of hDaxx (Fig. 5 .1 b, lanes 6-10). 
Differentiation to T2RA cells was confirmed by the loss of Oct4 protein levels: Oct4 is a 
POU domain transcription factor used routinely as a marker for undifferentiated embryonic 
stem (ES) cells (Rosner et al., 2000; Deb-Rinker et al. , 2005). This result is consistent with 
the level of RNA from T2 and T2RA cells (Fig. 5.2, lanes 1 & 4) as well as 
undifferentiated and differentiated THPl cells (Fig. 5.10, lanes 1 & 4). 
5.2.2 Transient down-regulation of hDaxx in T2 cells is not associated with an induction of 
IE gene expression or MIEP activity 
As differentiation of cell lines conditionally permissive for HCMV infection due to their 
differentiation state showed no decrease in the endogenous level of hDaxx protein, the 
effect of down-regulating the endogenous levels of hDaxx in undifferentiated T2 cells was 
next assessed (Fig. 5.2 & 5.3a). siRNAs directed specifically to hDaxx were used as 
previously described in Chapter 4. T2 cells were first either mock transfected (Fig. 5.2 & 
5.3a, lane 1) or transfected with scramble siRNA (Fig. 5.2 & 5.3a, lane 2) or hDaxx-
specific (Fig. 5.2 & 5.3a, lane 3) siRNAs. After 72 hours, the transfected T2 cells and 
differentiated T2RA cells (Fig. 5.2 & 5.3a, lane 4) were infected with HCMV Toledo 
(MOI 0.5) for 24 hours before harvest and analysis of total RNA or protein. For RNA, RT-
PCR was then carried out for viral IE genes, hDaxx and Oct4; GAPDH was analysed as a 
loading control. Western blot analysis was employed to determine the levels of protein. 
The hDaxx RNA and protein level was shown to decrease substantially in sihDaxx-
transfected cells (Fig. 5.2 & 5.3a, lane 3) compared to the mock and scramble siRNA 
controls (Fig. 5.2 & 5.3a, lanes 1 & 2). The level of reduction of hDaxx was further 
assessed by serial dilution of protein samples which showed that hDaxx down-regulation 
resulted in a decrease of over 90% of hDaxx protein (Fig. 5.3b, lanes 1-4). Further, this 
reduction of hDaxx had no effect on the differentiation state of T2 cells on the basis of 
Oct4 expression (Fig. 5.2 & 5.3a, lane 3). However, no induction of IE RNA (Fig. 5.2, lane 
3) or protein (Fig. 5.3a, lane 3) occurred in these hDaxx knockdown T2 cells by 24 hours 
post-infection. In contrast, T2RA cells showed both an absence of Oct4 expression due to 
differentiation and the presence of both IE RNA (Fig. 5.2, lane 4) and protein (Fig. 5.3a, 
lane 4) upon infection, as expected for a permissive cell type. 
- 192 -
5. Results 
T2 T2RA 
mock scr sihDaxx (bp) 
hDaxx 
-224 
IE -194 
Oct4 
- 262 
GAPDH - 236 
1 2 3 4 
Figure 5.2 Transient down-regulation of hDaxx in T2 cells does not cause an induction of viral IE 
transcription upon HCMV infection. T2 cells were either mock transfected (lane 1) or transfected with 
scramble (lane 2) or hDaxx-speci:fic (lane 3) oligonucleotide duplexes. After 72 hours, transfected T2 cells 
and differentiated T2RA cells (lane 4) were infected with HCMV Toledo (MOI 0.5) for 24 hours before 
harvest and extraction of total RNA. After reverse transcription, specific PCR was carried out for viral IE 
genes, hDaxx and Oct4. GAPDH was used as a loading control. 
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Figure 5.3 Transient down-regulation of hDaxx in T2 cells does not cause an induction of viral IE 
protein upon HCMV infection. (A) T2 cells were either mock transfected (lane 1) or transfected with 
scramble (lane 2) or hDaxx-speci:fic (lane 3) oligonucleotide duplexes. After 72 hours, transfected T2 cells 
and differentiated T2RA cells (lane 4) were infected with HCMV Toledo (MOI 0.5) for 24 hours before 
harvest and analysis of protein content by W estem blot for viral IE, hDaxx and Oct4 protein expression. 
GAPDH was used as a loading control. (B) Scramble-transfected and sihDaxx-transfected T2 samples from 
A were re-run at 20µ1 , 12µ1, 6µ1 and 2µ1 (lanes 1-4) per lane and Western blot analysis of hDaxx and 
GAPDH expression conducted. 
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However, the down-regulation of hDaxx in the T2 cells was not total: around 10% of 
hDaxx still remained in these cells. Therefore, to ensure that this residual level of hDaxx 
was not sufficient to maintain hDaxx-mediated repression of IE transcription, it was 
assessed whether the level of residual hDaxx was still able to mediate repression of a 
promoter known to be negatively regulated by hDaxx (Fig. 5.4). T2 cells were either 
transfected with scramble siRNA (Fig. 5.4a, lane 1) or hDaxx-specific siRNAs (Fig. 5.4a, 
lane 2). After 72 hours, transfected T2 cells were transfected with an NF-KB-luc construct, 
a promoter known to be repressed by hDaxx and whose repression can be relieved by 
siRNAs to hDaxx (Michaelson & Leder, 2003). After a further 24 hours, cells were then 
harvested and NF-KB promoter activity analysed by luciferase assay. Analysis was 
normalised by co-transfection with a ~-gal expressing plasmid (pJA Tlac ). The activity of 
the NF-KB-luc reporter construct in sihDaxx-transfected T2 cells (Fig. 5.4a, lane 2) was 
increased 4.5-fold compared with scramble siRNA transfected cells (Fig. 5.4a, lane 1). In 
contrast, T2 cells either co-transfected with scramble siRNA (Fig. 5.4b, lane 1) or hDaxx-
specific siRNAs (Fig. 5.4b, lane 2) and an interferon-stimulated response element driven 
luciferase construct (ISRE-luc) showed no increase in activity in sihDaxx-transfected T2 
cells (Fig. 5.4b). Thus, the residual level of hDaxx observed in our transient down-
regulation analysis was insufficient to maintain specific repression of a known hDaxx-
repressible promoter. 
In order to rule out any non-specific effects of MOI or virus strains used on the effect of 
hDaxx down-regulation on IE gene expression, parallel analysis 6f T2 cells was carried out 
using the highly passaged laboratory strain HCMV AD169 (Fig. 5.5). T2 cells were treated 
as shown in Fig. 5.3a and then infected with HCMV AD169 at an MOI of 3. Protein 
samples were then harvested from each cell population and analysed by Western blot for 
hDaxx, Oct4, GAPDH and viral IE gene expression. When GAPDH loading is taken into 
account, the use of a high MOI infection with a laboratory strain virus produced the same 
result, with hDaxx down-regulation having no effect on IE gene expression (Fig. 5.5, lane 
3). Furthermore, additional analysis of the viral MIEP in transient transfection assays using 
a luciferase reporter construct under the control of the full length MIEP (pES-luc) showed 
equivalent results that hDaxx down-regulation had little to no effect on transfected MIEP 
activity (Fig. 5.6, lane 3) when compared to transfection controls (Fig. 5.6, lanes 1 & 2), 
and especially when compared to differentiated T2RA cells (Fig. 5.6, lane 4). 
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Figure 5.4 Transient down-regulation of hDaxx in T2 cells is associated with an increase in NF-KB 
promoter activity. (A) T2 cells were either transfected with scramble (lane 1) or hDaxx-speci:fic (lane 2) 
oligonucleotide duplexes. After 72 hours, transfected T2 cells were transfected with NF-KB-luc. After a 
further 24 hours, cells were harvested and NF-KB promoter activity analysed by luciferase assay. Analysis 
was normalised by co-transfection with 13-gal. (B) T2 cells were either transfected with scramble (lane 1) or 
hDaxx-specific (lane 2) oligonucleotide duplexes. After 72 hours, transfected T2 cells were transfected 
with ISRE-luc. After a further 24 hours, cells were harvested and ISRE promoter activity analysed by 
luciferase assay. Analysis was normalised by co-transfection with ~-gal. (R.L.U. = relative light units). 
Error bars, 1 S.D. of three independent experiments. 
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Figure 5.5 Transient down-regulation of hDaxx in T2 cells does not cause an induction of viral IE 
protein upon HCMV AD169 infection. T2 cells were either mock transfected (lane 1) or transfected with 
scramble (lane 2) or hDaxx-specific (lane 3) oligonucleotide duplexes. After 72 hours, transfected T2 cells 
and differentiated T2RA cells (lane 4) were infected with HCMV AD169 (MOI 3) for 24 hours before 
harvest and analysis of protein content by Western blot for viral IE, hDaxx and Oct4 protein expression. 
GAPDH was used as a loading control. 
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Figure 5.6 Transient down-regulation of hDaxx in T2 cells is not associated with an increase in MIEP 
activity. T2 cells were either mock transfected (lane 1) or transfected with scramble (lane 2) or hDaxx-
specific (lane 3) oligonucleotide duplexes. After 72 hours, transfected T2 cells and differentiated T2RA 
cells (lane 4) were transfected with pES-luc. After 24 hours, cells were harvested and MIEP activity 
analysed by luciferase assay. Analysis was normalised by co-transfection with 13-gal. (R.L.U. = relative 
light units). Error bars, 1 S.D. of three independent experiments. 
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5. 2. 3 Expression of IE gene expression is only associated with differentiated T2 cells 
The results so far had shown that down-regulation of hDaxx in undifferentiated cells did 
not induce IE gene expression. However, these analyses using RT-PCR, Western blot and 
luciferase assays were all investigations of total cell populations. Therefore, additionally, 
indirect immunofluorescence was employed to investigate the effects of hDaxx down-
regulation on individual cells within a population (Fig. 5.7). T2 cells, transfected with 
either scramble siRNA (Fig. 5.7a) or hDaxx-specific siRNAs (Fig. 5.7b) for 72 hours and 
T2RA cells (Fig. 5.7c) were infected with HCMV Toledo (MOI 0.5). After a further 24 
hours, cells were fixed, permeabilised and stained for IE protein (red) and Oct4 expression 
(green). Hoechst 33342 staining was used throughout for detection of nuclei. Consistent 
with all the analysis thus far, neither scramble siRNA transfected or hDaxx down-regulated 
cells showed any evidence of viral IE gene expression and Oct4 expression appeared 
unaffected (Fig 5.7a & b, top panels). In contrast, T2RA cells showed differentiation 
through loss of Oct4 staining, as expected, concomitant with high levels of permissiveness 
for IE gene expression (Fig. 5.7c, top panel). 
5. 2. 4 Transient down-regulation of hDaxx in T2 cells does not affect the structure of the 
MIEP during infection 
Since down-regulation of hDaxx in T2 cells had not resulted in any changes to IE gene 
expression or permissiveness of infection, the prediction would be that the MIEP would 
still be associated with transcriptionally repressive chromatin in these cells. Therefore, 
ChIP analysis was carried out to analyse this (Fig. 5.8). T2 cells transfected with either 
scramble siRNA (Fig. 5.8a) or hDaxx-specific siRNAs (Fig. 5.8b) as above, and T2RA 
cells were infected with HCMV Toledo (MOI 0.1). After 24 hours, cells were fixed and 
ChIP analysis carried out using either control serum, an anti-acetylated histone-H4 
antibody (H4ac) or an anti-HPl~ (HPl~) antibody. RTQ-PCR was then used to quantify 
association of the MIEP with these markers of transcriptional activation (acetylated 
histone-H4) or repression (HPl~). Data are then presented in chart form (Fig. 5.8). 
The viral MIEP, after 24 hours of infection in scramble siRNA transfected cells, was 
predominantly associated with HPl~ (Fig. 5.8a, lane 2), consistent with the lack of IE gene 
expression seen within this cell type. In comparison to this, the level of acetylated histone-
H4 associated with the MIEP was between 4- to 5-fold lower (Fig. 5.8a, lane 1). 
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Figure 5. 7 Expression of HCMV IE protein is only associated with differentiated T2RA cells. T2 cells 
were transfected with either (A) scramble or (B) hDaxx-speci:fic oligonucleotide duplexes. After 72 hours, 
scramble and sihDaxx transfected T2 cells and (C) T2RA cells were infected with HCMV Toledo (MOI 0.5). After 24 hours, cells were fixed, permeabilised and stained for IE72/86 (red) and Oct4 (green) 
expression. Hoechst 33342 staining (blue) was used throughout to identify cell nuclei. 
- 200 -
5. Results 
Comparison of sihDaxx-transfected T2 cells showed equivalent association of markers at 
the viral MIEP (Fig. 5 .Sb), again consistent with a lack of IE gene expression in these cells. 
In contrast, the MIEPs immunoprecipitated from T2RA cells demonstrated little 
association with HPl ~ (Fig. 5.8c, lane 2) but were associated predominantly with 
acetylated histone-H4 (Fig. 5.8c, lane 1), as expected, with these differentiated, permissive 
cells (Murphy et al., 2002). 
As before, control RTQ-PCR using the GAPDH promoter was carried out to ensure 
consistent immunoprecipitation with all antibodies, with the GAPDH promoter being used 
since GAPDH expression did not significantly change during differentiation of T2 cells to 
T2RA cells (see Fig. 5.2 & 5.3a). GAPDH promoter specific RTQ-PCR showed very 
consistent levels of acetylated histone-H4 antibody association for all cell populations 
analysed (Fig. 5.9a). However, analysis of GAPDH promoters with immunoprecipitated 
HPl~ showed an increase in sihDaxx transfected T2 cells (Fig. 5b, lane 2) compared to 
scramble siRN A control transfected T2 cell (Fig. 5. 9b, lane 1) with further HP 1 ~ 
association upon differentiation to T2RA cells (Fig. 5.9b, lane 3). This result, however, 
does not confound the interpretation of analysis of the MIEP, as the level of HP 1 ~ 
associated with the MIEP in hDaxx down-regulated cells is still proportional to that seen in 
scramble siRNA transfected cells such that the level of HPl~ associated with MIEPs in 
T2RA cells would be further reduced. Hence, overall, hDaxx down-regulation in 
undifferentiated T2 cells had little effect on the chromatin status of the promoter, whereas 
equivalent down-regulation in permissive fibroblasts had shown profound effects on the 
chromatin structure of the MIEP both at IE and early times of infection (Fig. 4.18 & 4.20). 
5. 2. 5 Transient down-regulation of hDaxx in THP 1 cells is not associated with an 
induction of IE gene expression 
Parallel studies to those with T2 cells were carried out on conditionally permissive THP 1 
cell line, considered by some to be a more biologically relevant cell type (Fig. 5 .10). THP 1 
cells were first either mock transfected (Fig. 5.10, lane 1) or transfected with scramble 
siRNA (Fig. 5.10, lane 2) or hDaxx-specific siRNAs (Fig. 5.10, lane 3). After 72 hours, 
transfected THPI cells and differentiated THPls (M0) (Fig. 5.10, lane 4) were infected 
with HCMV Toledo (MOI 0.5) for 24 hours before either harvest and extraction of total 
RNA or protein. RT-PCR was then carried out for viral IE genes and hDaxx, using 
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Figure 5.8 Transient down-regulation of hDaxx in T2 cells does not affect the chromatin structure of the viral MIEP and correlates with IE gene expression. ChIP assays were performed 24 hours post-infection (MOI = 0.1) on (A) scramble or (B) sihDaxx-transfected T2 cells and (C) mock-transfected T2RA 
cells with an anti-acetylated histone H4 antibody (lane 1) or an anti-HPl~ antibody (lane 2). Isolated DNA 
was amplified using MIEP-specific RTQ-PCR. For comparison, the immunoprecipitated DNA was quantified relative to the input DNA. The data is representative of three independent experiments. Error bars, 1 S.D. of triplicate PCR reactions. 
- 202 -
5. Results 
A B 
H4ac HPlfl 
0.6 1 2 3 0.4 1 2 3 
0.5 
.... 
= 
0.3 
= 0.4 c. c. 
.s 
.s 
--
--< 0.3 < 0.2 z z Q Q 
~ 0.2 ~ I 
..c 
..c u u 0.1 
0.1 
0 0 
I 
I 
T2 T2 T2RA T2 T2 T2RA 
scr sihDaxx scr sihDaxx 
Figure 5.9 Similar levels of chromatin are immunoprecipitated from siRNA transfected T2 cells and 
T2RA cells. (A) ChIP assays were performed (MOI 0.1) on T2 scr (lane 1), T2 sihDaxx (lane 2) and T2RA 
cells at 24 hours post-infection. Analysis was carried out with an anti-acetylated histone-H4 antibody. 
Isolated DNA was amplified using GAPDH-specific RTQ-PCR. For comparison, the immunoprecipitated 
DNA was quantified relative to the input DNA. (B) ChIP assays were performed (MOI 0.1) on T2 scr (lane 
1), T2 sihDaxx (lane 2) and T2RA cells at 24 hours post-infection. Analysis was carried out with an anti-
HPl~ antibody. Isolated DNA was amplified using GAPDH-specific RTQ-PCR. For comparison, the 
immunoprecipitated DNA was quantified relative to the input DNA. The data is representative of three 
independent experiments. Error bars, 1 S.D. of triplicate PCR reactions. 
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GAPDH as a loading control. Western blot analysis was also used to determine the levels 
of protein. The hDaxx RNA and protein level decreased substantially in sihDaxx-
transfected cells (Fig. 5.10, lane 3) compared to the mock and scramble siRNA controls 
(Fig. 5.10, lanes 1 & 2). However, no induction ofIE RNA (Fig. 5.10a, lane 3) or protein 
(Fig. 5.10b, lane 3) occurred in sihDaxx transfected THPl cells by 24 hours post-infection. 
In contrast, differentiated THPl cells showed good expression of both IE RNA (Fig. 5.10a, 
lane 4) and protein (Fig. 5.10b, lane 4) upon infection. Therefore, down-regulation of 
hDaxx in this cell line also had no effect on induction of IE gene expression. 
5.2.6 Oct4 down-regulation in T2 cells is associated with induction of IE gene expression 
through differentiation 
Accumulating evidence from these experiments suggested that HCMV IE gene expression 
could only be induced by differentiation of conditionally permissive undifferentiated cell 
types and not by down-regulation of hDaxx expression. In T2 cells, differentiation can be 
assayed by the level of down-regulation of endogenous Oct4 (POU5Fl) (Rosner et al., 
1990; Rosfjord & Rizzino, 1994; Deb-Rinker et al., 2005), a transcription factor known to 
be a master regulator of differentiation which is expressed in ES cells and embryonal 
carcinoma cells, such as T2 cells (Chambers & Smith, 2004; Hart et al. , 2004). As other 
octamer proteins were known to be involved in the regulation of herpesvirus IE gene 
expression (see 5.3 Discussion), it was possible that Oct4 may also have a role in 
repression of the MIEP in undifferentiated cells which is relieved upon differentiation of 
these cells to T2RA cells as loss of Oct4 expression occurs. Therefore, siRNA analysis was 
carried out to determine if specific down-regulation of Oct4 had any effect on HCMV IE 
gene expression in T2 cells. 
Initially, it was firsf established that use of a commercially available siRNA targeting Oct4 
resulted in decreased Oct4 expression in T2 cells (Fig. 5 .11 ). Analagous to hDaxx-specific 
down-regulation in Chapter 4, T2 cells were either mock transfected (lane Fig. 5.11 , lanes 
1, 4, 7 & 10) or transfected with scramble siRNA (Fig. 5.11, lanes 2, 5, 8 & 11) or Oct4-
specific siRNA (Fig. 5.1 1, lane 3, 6, 9 & 12). Protein samples were then harvested from 
24-96 hours post-transfection and analysed by Western blot for Oct4 expression levels . 
GAPDH was used as a loading control. As can be clearly seen, si0ct4-transfected cells 
showed down-regulation of Oct4 by 24 hours post-transfection (Fig. 5.11, lane 3) 
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Figure 5.10 Transient down-regulation of hDaxx in THPl cells does not cause an induction of viral IE gene expression upon HCMV infection. THPl cells were either mock transfected (lane 1) or transfected 
with scramble (lane 2) or hDaxx-specific (lane 3) oligonucleotide duplexes. After 72 hours, transfected THPl cells and differentiated THPl cells (M0) (lane 4) were infected with HCMV Toledo (MOI 0.5) for 24 hours. (A) Cells were then harvested and total RNA extracted. After reverse transcription, specific PCR 
was carried out for viral IE genes and hDaxx. GAPDH was used as a loading control. (B) Cells were harvested and protein content analysed by Western blot for viral IE and hDaxx expression. GAPDH was 
used as a loading control. 
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compared with control transfected cells (Fig. 5 .11, lanes 1 & 2). This down-regulation 
increased maximally by 48 hours post-transfection (Fig. 5.11, lane 6). Consequently, this 
protocol was used to investigate whether Oct4 down-regulation in T2 cells could cause 
changes to the activity of the MIEP after transfection. Luciferase assays using the full 
length MIEP driven luciferase construct (pES-luc) were carried out as follows: T2 cells 
were either mock transfected (Fig. 5.12, lane 1) or transfected with scramble siRNA (Fig. 
5.12, lane 2) or Oct4-specific siRNAs (Fig. 5.12, lane 3). After 72 hours, cells including 
T2RA cells as a positive control for MIEP activity (Fig. 5.12, lane 4), were transfected 
with pES-luc. Levels of luciferase activity were again normalised to levels of expression of 
~-gal from a co-transfected pJA Tlac construct. These results showed that Oct4 down-
regulation in T2 cells caused a substantial increase to MIEP activity (Fig. 5.12, lane 3), 
when compared to the control transfected T2 cells (Fig. 5 .12, lanes 1 & 2). Indeed, the 
activity of the MIEP in Oct4 down-regulated T2 cells was almost equivalent to that in the 
differentiated T2RA cell population (Fig. 5.12, lane 4). 
Since activity of the MIEP increased with down-regulation of Oct4, the effect of this 
decrease in Oct4 expression on virus infection was next investigated (Fig. 5 .13 ). T2 cells 
were transfected, as above, for 72 hours before they were infected with HCMV Toledo 
(MOI 0.5) for 24 hours. T2RA cells were used as a positive control for IE gene expression 
after infection. RT-PCR was then carried out to analyse levels of IE gene and Oct4; 
GAPDH was used as a loading control. Western blot analysis was also employed to 
determine the levels of protein. In comparison to mock and scramble siRNA transfected 
controls (Fig. 5.13, lanes 1 & 2), the down-regulation of Oct4 caused induction of both IE 
RNA (Fig. 5.13a, lane 3) and protein expression (Fig. 5.13b, lane 3). Differentiated T2RA 
cells also showed IE gene expression, as expected (Fig. 5.13, lane 4). Additionally, indirect 
immunofluorescence was used to confirm that Oct4 down-regulation induced IE gene 
expression (Fig. 5.14). T2 and T2RA cells transfected and infected as above, 24 hours 
post-infection, were fixed, permeabilised and stained for presence of IE protein (red) and 
Oct4 (green) protein, with Hoechst 33342 staining used to counter-stain nuclei. In 
comparison to scramble siRNA transfected control cells (5.14a, upper panel), T2 cells 
transfected with si0ct4-specific siRNAs showed clear levels of Oct4 down-regulation 
concomitantly with an induction of IE72/86 expression (Fig. 5.14b, upper panel). High 
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Figure 5.11 Oct4-specific siRNA oligonucleotides cause down-regulation of Oct4 in T2 cells. T2 cells 
were either mock transfected (lane 1), transfected with scramble (lane 2) or Oct4-specific (lane 3) siRNA 
oligonucleotide duplexes. Protein samples were harvested from 24-96 hours post-transfection and then run 
on 10% polyacrylamide gels before Western blot analysis for Oct4 expression levels. GAPDH was used as 
a loading control. 
- 207 -
5. Results 
T2 T2RA 
6 
mock si0ct4 scr 
,-... 
5 
~ 
...j 
~ 4 
~ 
.... 
'> 
.: 
3 
(,J 
co: 
(,J 
.a 2 
I 
00. 
r-l 
c. 1 
0 
1 2 3 4 
Figure 5.12 Down-regulation of Oct4 in T2 cells is associated with an increase in MIEP activity. T2 
cells were either mock transfected (lane 1) or transfected with scramble (lane 2) or Oct4-specific (lane 3) 
oligonucleotide duplexes. After 72 hours, transfected T2 cells and differentiated T2RA cells (lane 4) were 
transfected with pES-luc. After 24 hours, cells were harvested and MlEP activity analysed by luciferase 
assay. Analysis was normalised by co-transfection with 13-gal. (R.L.U. = relative light units). Error bars, 1 
S.D. of three independent experiments. 
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Figure 5.13 Down-regulation of Oct4 in T2 cells leads to an induction of viral IE gene expression 
upon HCMV infection. T2 cells were either mock transfected (lane 1) or transfected with scramble (lane 
2) or hDaxx-specific (lane 3) oligonucleotide duplexes. After 72 hours, transfected T2 cells and 
differentiated T2RA cells (lane 4) were infected with HCMV (MOI 0.5) for 24 hours. {A) Cells were then 
harvested and total RNA extracted. After reverse transcription, specific PCR was carried out for viral IE 
genes and Oct4. GAPDH was used as a loading control. (B) Cells were harvested and protein content 
analysed by Western blot for viral IE and Oct4 expression. GAPDH was used as a loading control. 
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levels of IE72/86 expression were observed with differentiated T2RA cells, as expected 
(Fig. 5.14c, upper panel). 
Interestingly, the nuclear morphology of si0ct4-transfected T2 cells (Fig. 5.14b, lower 
panel) was quite similar to differentiated T2RA cells (Fig. 5.14c, lower panel), which was 
not the case for scramble siRNA transfected T2 cells (Fig. 5. l 4a, lower panel). This would 
be consistent with recent reports which suggest that siRNA down-regulation of Oct4 in ES 
cells and T2 cells can result in full cellular differentiation (Hay et al., 2004; Matin et al., 
2004). It is possible that Oct4 down-regulation by siRNA might induce viral IE gene 
expression not because it results in terminal differentiation of the T2 cells but because Oct4 
is an intrinsic repressor of the viral MIEP. However, computational analysis of the MIEP 
using TFsearch for Oct4 binding sites (ATGCAAA T) did not identify any within the 
promoter. To confirm that down-regualtion of Oct4 did result in differentiation of T2 cells, 
cells transfected with scramble siRNA or si0ct4-specific siRNAs for 72 hours and T2RA 
cells (as a positive control for differentiation) were fixed and stained for the surface 
expression of SSEA3 (red), a globoseries glycolipid antigen present on undifferentiated T2 
cells that is down-regulated on the surface of T2RA cells (Andrews et al., 1984). Whereas 
scramble siRNA transfected T2 cells show positive staining for SSEA3 (Fig 5 .15a, upper 
panel), T2RA cells were negative for this undifferentiated marker (Fig. 5. l 5c, upper 
panel), as expected (Murphy et al., 2002). However, si0ct4-transfected T2 cells were also 
negative for SSEA3 staining (Fig. 5.15b, upper panel), consistent with down-regulation of 
Oct4 in these cells resulting in full differentiation, consistent with results of other groups 
(Hay et al., 2004; Matin et al., 2004). 
5.2. 7 Re-expression of Oct4 in permissive T2RA cells is not associated with repression of 
IE gene expression 
As well as the down-regulation of Oct4 in T2 cells upon differentiation of T2RA cells, it 
was also known that the histone deacetylases HDAC3 also decreases in expression after 6 
days with RA treatment (Murphy et al., 2002). These studies also showed that re-
expression of HDAC3 in differentiated T2RA cells decreased the MIEP activity after 
transfection or by analysis of infection efficiency (Murphy et al., 2002). Therefore, it was 
next investigated whether Oct4 re-expression in normally permissive T2RA cells could 
cause a decrease or loss of infectivity as seen with HDAC3 re-expression. T2RA cells were 
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Figure 5.14 Down-regulation of Oct4 in T2 cells is associated with permissiveness to HCMV infection. 
T2 cells were transfected with either (A) scramble or (B) Oct4-speci:fic oligonucleotide duplexes. After 72 
hours, scramble and si0ct4-transfected T2 cells and (C) T2RA cells were infected with HCMV Toledo 
(MOI 0.5). After 24 hours, cells were fixed, penneabilised and stained for IE72/86 (red) and Oct4 (green) 
expression. Hoechst 33342 staining (blue) was used throughout to identify cell nuclei. 
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Figure 5.15 Down-regulation of Oct4 in T2 cells is associated with a loss of the undifferentiated 
marker SSEA3. T2 cells were transfected with either (A) scramble or (B) Oct4-specific oligonucleotide 
duplexes. After 72 hours, scramble and si0ct4-transfected T2 cells and (C) T2RA cells were fixed and 
stained for SSEA3 surface expression (red). Hoechst 33342 staining (blue) was used throughout to identify 
cell nuclei. 
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mock transfected (Fig. 5.16, lane 2), transfected with pcDNA3 control (Fig. 5.16, lane 3) 
or pCMV-Oct4 (p0ct4) (Fig. 5.16, lane 4). After 24 hours, transfected T2RA cells and T2 
cells (Fig. 5.16, lane 1) were infected with HCMV Toledo (MOI 0.5). After a further 24 
hours, total RNA and protein samples were harvested from each population. RT-PCR was 
used to quantify IE and Oct4 RNA. GAPDH was used as a loading control. Concurrently, 
Western blot analysis was employed to determine the levels of protein. Transfection of 
T2RA cells with p0ct4 resulted in levels of re-expression of Oct4 to those observed in T2 
cells (Fig. 5.16, lane 4 & 1 respectively) compared to control pcDNA3 transfected cells 
(Fig. 5.16, lane 3). However, it was noticeable that re-expression of Oct4 in T2RA cells 
resulted in a lower molecular weight form of Oct4 on Western blot analysis (Fig. 5.16b, 
lane 4). Nevertheless, this re-expression of Oct4 did not result in any effect on the 
permissiveness of cells for IE gene expression at the level ofRNA (Fig. 5.16a, lane 4) or 
protein (Fig. 5.16b, lane 4). 
Even though re-expression of Oct4 had no effect on IE gene expression after virus 
infection, it was next assessed whether this lack of an affect could be recapitulated after 
transfection of the MIEP. T2RA cells were treated as above before they were transfected, 
as well as T2 cells, with pES-luc. After 24 hours, cells were then harvested and MIEP 
activity analysed by luciferase assay, with normalisation of data by p-gal co-transfection 
(Fig. 5.17). Although slight variation in MIEP activity was seen above the level of mock 
transfection (Fig. 5.17, lane 2) with pcDNA3 (~11 %) (Fig. 5.17, lane 3) or p0ct4 
transfection ( ~8%) (Fig. 5 .17, lane 4 ), in comparison to control T2 cells (Fig. 5 .17, lane 1) 
no significant effect upon MIEP activity was observed. Finally, indirect 
immunofluorescence was employed to determine any effect of Oct4 re-expression on 
infection at the cell level (Fig. 5.18). T2RA cells were again transfected as above before 
infection with HCMY Toledo (MOI 0.5). After 24 hours, cells were fixed, permeabilised 
and stained for Oct4 (green) and viral IE protein (red). Control transfected T2RA cells 
(Fig. 5. l 8a & b, upper panels) showed no Oct4 expression, as expected, after 
differentiation. In comparison, p0ct4 transfected T2RA cells (Fig. 5 .l 8c, upper panel) 
showed clear Oct4 expression in a number of cells and this co-localised with IE72/86. 
Therefore, Oct4 re-expression in T2RA cells did not result in any detectable decrease in 
permissiveness for HCMV infection. 
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Figure 5.16 Re-expression of Oct4 in T2RA cells is not associated with a repression of viral IE gene 
expression. T2RA cells were either mock transfected (lane 2) or ~sfected with pcDNA3 (lane 3) or 
pCMV-Oct4 (p0ct4; lane 4). After 24 hours, transfected T2RA cells and undifferentiated T2 cells (lane 1) 
were infected with HCMV (MOI 0.5) for 24 hours. (A) Cells were then harvested and total RNA extracted. 
After reverse transcription, specific PCR was carried out for viral IE genes and Oct4. GAPDH was used as 
a loading control. (B) Cells were harvested and protein content analysed by Western blot for viral IE and 
Oct4 expression. GAPDH was used as a loading control. · 
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Figure 5.17 Re-expression of Oct4 in T2RA cells is not associated with a repression of MIEP activity. 
T2RA cells were either mock transfected (lane 2) or transfected with pcDNA3 (lane 3) or pCMV-Oct4 (p0ct4; lane 4). After 24 hours, transfected T2RA cells and undifferentiated T2 cells (lane 1) were 
transfected with pES-luc. After a further 24 hours, cells were harvested and MIEP activity analysed by 
luciferase assay. Analysis was normalised by co-transfection with [3-gal. (R.L.U. = relative light units). 
Error bars, 1 S.D. of three independent experiments. 
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Figure 5.18 Re-expression of Oct4 in T2RA cells is not associated with abrogation of HCMV IE gene 
infection. T2RA cells were either (A) mock transfected or transfected with either (B) pcDNA3 or (C) 
pCMV-Oct4. After 24 hours, T2RA cells were infected with HCMV Toledo (MOI 0.5). After a further 24 
hours, cells were fixed, permeabilised and stained for IE72/86 (red) and Oct4 (green) expression. Hoechst 
33342 staining (blue) was used throughout to identify cell nuclei. 
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5.2.8 Down-regulation of HP 1/3 in T2 cells is not associated with an induction of IE gene 
expression 
Inhibition of hDaxx expression by siRNA did not affect HCMV IE gene expression or the 
chromatin structure of the MIEP after infection: the MIEP was predominantly associated 
with HP 1 B, a marker of transcriptional repression (Bannister et al., 2001; Kouzarides, 
2007a). However, previous work has shown pan-specific inhibition of HDACs by TSA 
results in permissiveness of undifferentiated T2 cells for IE gene expression and virus 
production (Meier, 2001; Murphy et al., 2002). Other reports have also suggested that 
HDAC inhibitors can be used to reactivate other viruses from quiescence: the L TRs of the 
integrated provirus of HIV are known to be chromatinised and repressed via HDAC 
recruitment (Coull et al., 2000; Williams et al., 2006) and TSA treatment activates LTR-
driven transcription (Van Lint et al., 1996). Interestingly, it appears that all isoforms of 
HPl are associated with the repression of the HIV proviral LTRs (Marban et al., 2007) and 
that a siRNA, directed specifically to HPly, results in virus reactivation (du Chene et al., 
2007). As down-regulation of HP 1 B can result in an increase in MIEP-driven transcription 
after transfection (du Chene et al., 2007), the possibility that down-regulation of HPlB in 
T2 cells might induce IE gene expression was investigated. 
T2 cells were mock transfected (Fig. 5.19, lane 1) or transfected with scramble siRNA 
(Fig. 5.19, lane 2) or HPlB-specific (Fig. 5.19, lane 3) siRNA. After 72 hours, transfected 
T2 cells as well as differentiated T2RA cells (Fig. 5.19, lane 4) were infected with HCMV 
Toledo (MOI 0.5) for 24 hours. Total cell RNA and protein was analysed for levels of 
expression of HPl B and Oct4 by RT-PCR or Western blot analysis, respectively. The 
HPlB RNA and protein level was shown to decrease substantially in siHP lB-transfected 
cells (Fig. 5.19, lane 3) compared to the mock and scramble siRNA controls (Fig. 5.19, 
lanes 1 & 2) consistent with previous work ( du Chene et al., 2007). Additionally, this 
down-regulation of HP 1 B had no effect on the differentiation state of T2 cells on the basis 
of expression of Oct4 (Fig. 5.19, lane 3). However, no induction of IE RNA (Fig. 5.19a, 
lane 3) or protein (Fig. 5.19b, lane 3) occurred in HPlB down-regulated T2 cells by 24 
hours post-infection. In contrast, T2RA cells showed both an absence of Oct4 expression 
due to differentiation and the presence of both IE RNA (Fig. 5 .1 9a, lane 4) and protein 
(Fig. 5 .19b, lane 4) upon infection, as expected. 
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Figure 5.19 Transient down-regulation of HP1~ in T2 cells has no effect on viral IE gene expression 
upon HCMV infection. T2 cells were either mock transfected (lane 1) or transfected with scramble (lane 
2) or HP1f3-speci:fic (lane 3) oligonucleotide duplexes. After 72 hours, transfected T2 cells and 
differentiated T2RA cells (lane 4) were infected with HCMV Toledo (MOI 0.5) for 24 hours. (A) Cells 
were then harvested and total RNA extracted. After reverse transcription, specific PCR was carried out for 
viral IE genes, Oct4 and HP1f3. GAPDH was used as a loading control. (B) Cells were harvested and 
protein content analysed by Western blot for viral IE, Oct4 and HP1f3 expression. GAPDH was used as a 
loading control. 
- 218 -
I 
5. Results 
Indirect immunofluorescence was next used to determine if the RT-PCR and Western blot 
results of HPlP down-regulation could be reflected at the cell level (Fig. 5.20 & 5.21). As 
scramble siRNA transfected T2 cells again appeared to behave as mock transfected cells, 
these were solely employed as a control. T2 cells were either transfected with scramble 
siRNA (Fig. 5.20a) or HPIP-specific (Fig. 5.20b) siRNAs. After 72 hours, cell populations 
were fixed, permeabilised and stained for HPlP (red): Hoechst 33342 was used to counter-
stain nuclei. Consistent with the RNA and protein data, the level of down-regulation of 
HP IP in siHP 1 P-transfected T2 cells was substantial (Fig. 5 .20b, upper panel) when 
compared to scramble siRNA transfected cells (Fig. 5.20b, upper panel). In addition, 
differentiated T2RA cells showed a similar level of expression of HP 1 p (Fig. 5 .20c, upper 
panel). Therefore, examination of the effects of HPIP down-regulation on IE gene 
expression was next investigated (Fig. 5.21). T2 cells were treated with scramble siRNA or 
HPIP-specific siRNA as above before infection with HCMV Toledo (MOI 0.5). After 24 
hours, cells were fixed, permeabilised and stained for IE72/86 (red), and Oct4 (green) 
protein: Hoechst 33342 was again used to counter-stain nuclei. HPIP down-regulation 
resulted in no changes in the expression of Oct4 in T2 cells and was not associated with 
any induction of IE gene expression (Fig. 5.21b, upper panel), when compared to scramble 
siRNA transfected control (Fig. 5.21a, upper panel). In contrast, T2RA cells appeared fully 
permissive for IE gene expression (Fig. 5.21c, upper panel), as expected. Thus, HPIP 
down-regulation appears to have little effect on the permissiveness of T2 cells to HCMV 
infection. 
5.3 Discussion 
The down-regulation of hDaxx in fully perm1ss1ve fibroblasts relieved repression of 
HCMV IE gene expression immediately upon infection through a loss of repressive 
chromatin at the MIEP -(see Chapter 4; Woodhall et al., 2006). In addition, expression of 
viral IE genes after infection of conditionally permissive cell types with HCMV is known 
to be regulated by chromatin structure at the MIEP (Murphy -et al., 2002; Reeves et al. , 
2005a; Reeves et al., 2005b; Ioudinkova et al., 2006). Therefore, whether hDaxx had any 
role in establishing a non-permissive environment for HCMV infection in undifferentiated 
cells and thus could play any part in mediation of HCMV latency or reactivation was a key 
. question. 
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Figure 5.20 HPll}-specific siRNA oligonucleotides cause down-regulation of HPll} in T2 cells. T2 cells 
were transfected with either (A) scramble or (B) HPl~-specific oligonucleotide duplexes. After 72 hours, 
transfected T2 cells and T2RA cells (C) were fixed, permeabilised and stained for HPl~ (red) expression. 
Hoechst 33342 staining (blue) was used throughout to identify cell nuclei. 
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Figure 5.21 Transient down-regulation of HPlfl in T2 cells has no effect on viral IE gene expression 
upon HCMV infection. T2 cells were transfected with either (A) scramble or (B) HPl~-speci:fic 
oligonucleotide duplexes. After 72 hours, scramble and siHPl~ transfected T2 cells and (C) T2RA cells 
were infected with HCMV Toledo (MOI 0.5). After 24 hours, cells were fixed, permeabilised and stained 
for viral IE (red) and Oct4 (green) expression. Hoechst 33342 staining (blue) was used throughout to 
identify .cell nuclei. 
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Clearly, differentiation of both monocytes ex viva and conditionally permissive cell models 
leads to permissiveness for HCMV IE gene expression (Murphy et al., 2002; Reeves et al., 
2005a; Reeves et al., 2005b ). Therefore, if hDaxx is involved in mediating repression in 
undifferentiated cells, it is possible that the steady state levels of hDaxx protein would 
decrease during and after differentiation. However, hDaxx protein levels did not change 
significantly throughout differentiation of monocytes to mature DCs or during 
differentiation of T2 cells to T2RA cells. Similarly, levels of hDaxx did not change during 
the differentiation of THP 1 cells to macrophages consistent with levels of hDaxx 
expression having little correlation to differentiation status and hence regulation of IE gene 
expression. hDaxx down-regulation caused no change to the differentiation state of the T2 
cells, as assessed by Oct4 expression, nor did it lead to any induction of IE gene 
expression. Although residual amounts of hDaxx protein were still present in hDaxx 
knockdown T2 cells, this was unlikely to be responsible for maintaining the repression of 
IE gene expression as this level of residual hDaxx was not sufficient to repress a known 
hDaxx-repressed promoter. 
Despite the convincing result that hDaxx down-regulation had no effect upon HCMV IE 
gene expression within undifferentiated T2 cells, it remained that this could be due to a 
peculiarity of the strain of HCMV or MOI used to infect cells. However, further analagous 
experiments carried out using the highly passaged laboratory strain HCMV AD 169 at a 
high MOI failed to result in any induction of IE gene expression. Indeed, the activity of the 
MIEP in isolation, as determined by luciferase assay, showed no change with hDaxx 
down-regulation in undifferentiated T2 cells. Although the use of a likely activator, such as 
the HDAC inhibitor TSA, was not used here to confirm the viability of the system (as had 
been before: Murphy et al., 2002), use of down-regulation of Oct4 discussed later did 
confirm that our siRNA technology could result in T2 cells becoming permissive for IE 
gene express10n. 
T2 cells are known to spontaneously differentiate to T2RA like cells if their culture 
environment is not optimal. Therefore, to assess cells individually, indirect 
immunofluorescence was employed. The presence or down-regulation of hDaxx cannot be 
verified by indirect immunofluorescence in T2 cells, as in fibroblasts (see Chapter 4), due 
to the low level of nucleated protein at abnormal NDlO (Hsu & Everett, 2001). However, it 
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is clear that hDaxx down-regulation firstly does not lead to any differentiation and 
secondly does not cause an induction of IE gene expression. Consistent with this, 
subsequent analysis of the chromatin structure of the viral MIEP found little to no 
difference in the chromatin state with hDaxx knockdown T2 cells. Hence, down-regulation 
of hDaxx in T2 cells had been shown unequivocally to cause no change to the MIEP in 
those infected cells concomitant with a lack of induction of IE gene expression. 
The observation that hDaxx down-regulation in T2 cells does not lead to an induction of IE 
gene expression (Groves & Sinclair, 2007) is inconsistent with a recently published 
parallel study by Saffert & Kalejta (2007). In this analysis, hDaxx down-regulation in 
NTera-2 cells, the parental line from which the NT2Dl (T2) cell line was cloned, resulted 
in permissive infection of these cells with HCMV. The reasons for this discrepancy are 
unclear. However, Saffert & Kalejta's work employed the highly passaged laboratory 
isolate of HCMV, AD169, which has known genome deletions and has lost tropism for 
other cells such as monocytes and endothelial cells. In addition, the NTera-2 cell line is 
known to regularly spontaneously differentiate (Kalejta, personal communication) and it is 
interesting to note that in their hDaxx knockdown cells there did appear to be a reduction 
in Oct4 expression, suggesting their cells may have become partially differentiated, and a 
low background level of IE gene expression occurring in apparently undifferentiated cell 
populations (Saffert & Kalejta, 2006). 
Interestingly, although the work of Saffert & Kalejta demonstrates an induction of HCMV 
IE gene expression in hDaxx down-regulated NTera-2 cells and THPI cells, again in 
contrast to the data presented in this chapter, viral early gene expression (UL44) was 
reduced in these cells and there was also a block in late gene expression and the production 
of infectious virus. This is consistent with another study where ectopic expression of IE72 
and IE86 can cause induction of early gene expression but not full virus replication in 
THPI cells (Yee et al., 2007). It is questionable though whether hDaxx plays any role in 
the establishment of latency or maintenance of repression in NTera-2 or T2 cells since they 
do not appear to have normal NDIO (Hsu & Everett, 2001). Therefore, it is likely that the 
differentiation-dependent transcriptional milieu is the over-riding factor which determines 
whether a cell is permissive or not for HCMV IE gene expression and productive infection. 
- 223 -
5. Results 
The differentiation-dependent regulation of IE gene expression in T2 cells paralleled Oct4 
expression levels. Oct4, which is also known as POU5Fl, Oct3 or Oct3/4, is a master 
regulator of differentiation and used routinely as a marker for undifferentiated ES cells 
(Rosner et al., 2000; Deb-Rinker et al., 2005). All members of the Oct family contain two 
highly conserved domains, a POU homeodomain and a POU-specific domain, that are 
separated by 14 to 26 variable amino acids. These domains are required for DNA binding 
and are involved in protein-protein interactions. Intriguingly, a number of other octamer 
proteins have been implicated in the regulation of herpesvirus IE gene expression. Octl 
(POU2Fl) has been highlighted as playing an important and definite role in HSV-1 
transcriptional activation (Efstathiou & Preston, 2005) (see Introduction). During HCMV 
infection of GM-Ps, Oct2 (POU2F2) is up-regulated and the authors suggest that this may 
aid repression of IE gene expression, thus favouring establishment of latency (Slobedman 
et al., 2004). Similarly, Oct2 has also been suggested to be involved in repression of HSV-
1 and VZV IE gene expression in other models (Lillycrop et al., 1991; Patel et al., 1998). 
In T2 cells, Octl expression can cause an increase in MIEP activity when analysed using 
transfection assays and Oct6 expression can cause MIEP repression (Mendelson thesis, 
1997). 
Although a computational analysis of the MIEP using TFSearch did not identify Oct4 
binding sites (A TGCAAAT), differentiation of . T2 cells and their concomitant 
permissiveness for HCMV IE gene expression coincided with a decrease in Oct4 
expression. Therefore, it was hypothesised that Oct4 could be acting as a repressive 
transcription factor in undifferentiated T2 cells. Down-regulation of Oct4 by siRNA 
treatment in T2 cells led to an induction of MIEP activity and of expression of IE RNA and 
protein. Therefore, it appeared that Oct4 may have some role in directly controlling the 
activity of the MIEP during HCMV infection in T2 cells. However, it was found that the 
morphology of the nuclei of Oct4 knockdown T2 cells changed to that more reminiscent of 
differentiated T2RA cells. Hence, it was possible that Oct4 down-regulation in T2 cells 
was actually leading to differentiation of this cell type and subsequently causing 
permissiveness to HCMV infection. Also, recently published work had shown that Oct4 
down-regulation in T2 and ES cells lines led to differentiation (Hay et al., 2004; Matin et 
al., 2004). Indeed, the absence of surface expression of SSEA3 concluded that down-
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regulation of Oct4 in T2 cells had caused differentiation, consistent with permissiveness of 
these cells for HCMV infection. 
Recently, the validity of using Oct4 as a marker for undifferentiated ES cells has been 
questioned as some adult mammalian differentiated cells continue to express Oct4 
(Zangrossi et al., 2007). Additionally, Oct4 expression appears not to be necessary for 
mouse somatic stem cell self-renewal (Lengner et al., 2007). However, the use of Oct4 as a 
marker of differentiation of the T2 cell line is routinely accepted. Indeed, it is interesting to 
note that Oct4 expression has also been found in the PBMC of humans (Tai et al., 2005). 
Although, it remains to be determined whether similar Oct4 down-regulation of an as yet 
unspecified PBMC sub-population may lead to permissive infection with HCMV. 
Work from our laboratory has previously demonstrated that the re-expression of HDAC3, 
which decreases upon differentiation of T2 cells, in T2RA cells is sufficient to cause 
repression of IE gene expression (Murphy et al., 2002). However, analagous experiments 
re-expressing Oct4 in T2RA cells found no inhibition of MIEP activity or IE gene 
expression during HCMV infection. This data is consistent with the above finding that it is 
the differentiation status and the associated levels of factors in the infected cell which are 
important for the permissiveness of HCMV infection. It is possible that the re-introduction 
of other additional factors to T2RA cells would be necessary to cause repression of MIEP 
activity. Recently published data from several laboratories has shown that the re-
expression of certain factors including Oct4 can lead to the production of pluripotent stem 
cells from once differentiated cells. The expression of Oct4, Sox2, c-Myc and Klf4 in 
fibroblast cultures was first shown to direct the generation of pluripotent murine stem cells 
(Takahashi & Yamanaka, 2006; Wernig et al. , 2007) whilst the further inclusion of Nanog 
resulted in the selection of germ-line competent induced pluripotent stem (iPS) cells (Okita 
et al., 2007). This work was followed by production of iPS cells from adult human somatic 
dermal fibroblasts through re-expression of either Oct4, Sox2, Klf4 and c-Myc (Takahashi 
et al., 2007) or Oct4, Sox2, Nanog and LIN28 (Yu et al., 2007a). Most recently, re-
expression of Oct4, Sox2, Klf4 and c-Myc in fetal, neo-natal and adult human primary 
cells (including dermal fibroblasts) has provided iPS cells, with Lin28 and Nanog 
complementing this reprogramming event (Park et al., 2008). Overall, this has led to an 
exciting new method of developing pluripotent stem cells specific for an individual which, 
- 225 -
5. Results 
hypothetically, could be used at a therapeutic level against many human diseases. Although 
Oct4 re-expression alone did not lead to a repression of HCMV infection due to de-
differentiation of the cell type, it is possible that a similar subset of factors could be used to 
reprogram these cells to cause this effect. However, this so far remains untested and it is 
unknown whether this may be possible within a neuroblastoma cell line. 
As down-regulation of hDaxx had proved insufficient for induction of IE gene expression, 
other factors were investigated for a possible role in the establishment of latency or 
regulation of permissiveness of HCMV infection within the T2 cell line. Recently, it has 
been established that the induction of gene expression from the L TR of certain retroviruses 
can be repressed by HDAC recruitment and is associated with all HPI isoforms; relief of 
this repression has been shown through the use of RNAi technology or TSA treatment 
(Coull et al., 2000; Williams et al., 2006; du Chene et al., 2007; Marban et al., 2007; 
Poleshko et al., 2008). In addition, HP 1 ~ down-regulation has also specifically caused an 
increase in the activity of the MIEP in isolation ( du Chene et al., 2007). However, the 
down-regulation of HP 1 ~ in T2 cells caused no induction of IE gene expression during 
HCMV infection. Therefore, it remains that further repressive features of the chromatin 
structure (di- and tri-methylated lysine 9 on histone-H3) and the presence of factors, such 
as HDACs, able to repress the MIEP may still be sufficient to inhibit the induction of IE 
gene expression even with HPI~ down-regulation in T2 cells. 
Overall, the work in this chapter demonstrates that down-regulation of factors such as 
hDaxx and HPI ~ is not sufficient for induction of IE gene expression to take place in 
HCMV infected, undifferentiated cell types. Indeed, the down-regulation of the master 
regulator of differentiation Oct4 further substantiates the understanding that HCMV IE 
gene expression is ultimately dependent upon the differentiation status of the infected cell 
and that it is changes to the transcriptional milieu that is ultimately responsible for the 
permissiveness of infection within these cells. 
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All classes of HCMV gene promoters are subject to chromatinisation and remodelling 
throughout productive infection 
6.1 Introduction 
Work presented in chapters 3, 4 and 5, as well as other published data, has established a 
clear role for the modulation of chromatin structure at the viral MIEP during reactivation 
from latency and full productive infection. This form of control of transcription has also 
been shown to be important in the regulation of a number of other DNA viruses ( described 
in section 1.11) including the prototypic alphaherpesvirus HSV-1 (reviewed in: Knipe & 
Cliffe, 2008). Studies have shown that, as with HCMV, the HSV-1 genome is associated 
with histones and repressive chromatin during latent infection of various tissues and model 
systems which is relieved upon reactivation of the virus (Dressler et al., 1987; Deshmane 
& Fraser, 1989; Arthur et al., 2001; Bloom, 2004; Kubat et al., 2004; Wang et al., 2005; 
Amelio et al., 2006). More recently, it has been shown that the promoters of certain HSV-1 
genes are also associated with histones throughout productive, lytic infection and are 
modulated throughout infection in a temporally controlled manner (Herrera & Triezenberg, 
2004; Kent et al., 2004 ). 
Investigations into chromatin remodelling at HSV-1 promoters throughout lytic infection 
have established that the promoters are remodelled in a temporally regulated fashion 
consistent with expression of those genes examined. This has been demonstrated by two 
studies where investigation of the genes and promoters of archetypal examples of each 
class of herpesvirus gene have been employed: during lytic infection, the genes and 
promoters of ICPO (I~), thymidine kinase (early) and VP16 (early/late) were found to be 
associated with acetylation of lysine 9 on histone-H3 in a temporally associated fashion 
and, in addition, H3K9me2 was associated with the ICPO promoter at late times of 
infection (Kent et al., 2004 ). Furthermore, analysis of HSV-1 promoters during 
reactivation from quiescence via exogenous ICPO expression through HSV-2 super-
infection demonstrated the additional association of HP la after increases at H3K9me3 at 
temporally controlled times of infection on the promoters of ICPO (IE), ICP27 (IE) and gC 
(late) whilst the chromatin status of the Lat region was reversed (Coleman et al. , 2008). 
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During investigation of chromatin association with the MIEP during HCMV productive 
infection in this study, it was demonstrated that negative regulation of viral IE gene 
expression was prevented by the use of HDAC inhibitors (Chapter 3) and also by hDaxx 
down-regulation (Chapter 4). As a consequence of this loss ofrepression, an increase in the 
level of IE gene expression occurred. However, it was also apparent that the subsequent 
expression of HCMV early and late genes was also increased in a similar fashion. During 
the beginning of this investigation into the involvement of chromatin remodelling and the 
control of HCMV gene expression, work from another group was published also consistent 
with the aforementioned observations. During a study of the involvement of major IE 
proteins and HDAC in the regulation of HCMV gene expression, ChIP analysis of both the 
MIEP and the UL44 promoter demonstrated an increase in the level of acetylated histone-
H4 association from 1 to 12 hours post-infection (Nevels et al., 2004b ). This suggested that 
promoters other than the MIEP were also associated with histone proteins and that the 
regulation of their transcription appeared to involve histone modification during the first 12 
hours of infection. Consequently, other viral promoters might also be similarly regulated. 
However, before this could be investigated, it was decided that a MIEP-specific RTQ-PCR 
should be devised to ensure more quantitative analyses of ChIP samples. 
6.2 Results 
6.2.1 Development of MIEP-specific RTQ-PCR analysis 
A set of four PCR primers was designed such that they could be used for analysis of viral 
DNA from any strain of HCMV. Additionally, primers were designed to anneal between 
the sites of primers already used for all the semi-quantitative analysis carried out so far: 
+ 13 to -272 relative to the transcription start site (Fig. 6.1 ). Both sense and anti-sense 
primers were first tested in all combinations, using previously isolated HCMV DNA, at 
MgCb concentrations ·of2.5 and 3.5mM and SYBR Green reagent (for a full description of 
the method, see section 2.8.2.2). RTQ-PCR reactions were then analysed using a Rotor-
Gene 3000 real-time PCR machine with a graphical representation of the data presented in 
Fig. 6.2. All combinations of primers produced positive reactions with both MgCb 
concentrations used. However, the combination of sense primer S and anti-sense primer A 
(Fig. 6.2, blue lines) produced data with the lowest cycle threshold (Ct), which is inversely 
proportional to the efficiency of PCR. Indeed, this result was not surprising as the primer 
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Figure 6.1 MIEP RTQ-PCR primer sites. The figure shows the sites of four primers, sense (S), antisense (A), forward (F) and reverse 
(R) and the TaqMan probe (TM) for the MIEP specific RTQ-PCR analysis positioned along the aligned MIEP sequences of four strains 
(AD169, Toledo, Towne and Merlin) ofHCMV from +13 to -272 relative to the MIEP transcription start site. 
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Figure 6.2 Optimisation of primer combination for MIEP-specific RTQ-PCR. PCR reactions were set 
up in duplicate using SYER Green such that MIEP-specific sense primers (S & F) and antisense primers (A 
& R) were each used in combination at a MgCI2 concentration of 2.5 & 3.5mM. Above is a graphical 
representation of the data. Primer combinations: SIA, blue; SIR, green; FIA, red; FIR, yellow. 
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pair highlighted produced the smallest PCR product (Fig. 6.1 ), which is generally accepted 
to promote efficient RTQ-PCR reactions. 
It was next necessary to determine the optimum concentration of primers and TaqMan 
probe used for TaqMan MIEP-specific RTQ-PCR (for a full description of TaqMan RTQ-
PCR, see section 2.8.2.1). The volume of primers S and A were varied from 0.1 to 1.8µ1 
per reaction whilst the TaqMan probe concentration was varied from 0.05 to 0.2µ1 (see 
Table 6.1). RTQ-PCR was then performed on isolated HCMV DNA and the data is 
represented graphically in Fig. 6.3. TaqMan RTQ-PCR produced positive reactions at all 
concentration combinations, which are grouped together closely. In order to differentiate 
between the closely grouped data, the reactions were assessed through the Ct value (Table 
6.1). Although combinations of primers and probe produced a Ct value as low as 15.54 
(Table 6.1, U), the combination that produced the lowest Ct value with the least TaqMan 
probe used was J (primer S - 0.6µ1; primer A - 0.1µ1; TaqMan probe - 0.05µ1). The reaction 
curve produced by combination J is also highlighted in Fig. 6.3. Therefore, this 
combination of primers and TaqMan probe was used routinely in all further experiments. 
6.2.2 MIEP-specific RTQ-PCR can be employed for analysis ofChIP samples 
The optimised combination of primers and TaqMan probe, established for the MIEP-
specific RTQ-PCR was carried out using isolated HCMV DNA. However, it had not yet 
been tested on ChIP assay samples. Therefore, fibroblasts were infected (MOI 0.1) and 
ChIP analysis was carried out as before (Chapter 3). Resultant ChIP samples were then 
analysed by MIEP-specific RTQ-PCR for the level of association of modified histones and 
histone-associated proteins with viral MIEPs. The raw data produced and PCR curves are 
represented in Fig. 6.4a. In addition to RTQ-PCR of ChIP samples, for full quantification 
of data standard sample RTQ-PCRs were simultaneously carried out with known copy 
number dilutions of plasmid containing the MIEP (pEScat). An example of this standard 
curve is presented in Fig. 6.4b. Triplicate PCRs of standard plasmids can be seen as closely 
associated blue dots on the curve, whilst samples are represented along the curve (red 
dots). Sample data, normalised to the standard curve, was then calculated by the Rotor-
Gene software and a threshold level set at which quantitative results could be determined 
within the linear range of PCR (Fig. 6.5). Numerical data is presented as a chart with low 
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Primer S Primer A MIEP 
(µI) (µI) Taqman Ctave probe (µI) 
A 0.1 0.1 0.05 16.09 
B 0.1 0.1 0.1 15.85 
C 0.1 0.1 0.2 15.84 
D 0.1 0.6 0.05 18.16 
E 0.1 0.6 0.1 17.59 
F 0.1 0.6 0.2 17.30 
G 0.1 1.8 0.05 18.75 
H 0.1 1.8 0.1 18.48 
I 0.1 1.8 0.2 18.26 
J 0.6 0.1 0.05 15.94 
K 0.6 0.1 0.1 15.77 
L 0.6 0.1 0.2 15.80 
M 0.6 0.6 0.05 17.81 
N 0.6 0.6 0.1 17.40 
0 0.6 0.6 0.2 16.95 
p 0.6 1.8 0.05 18.42 
Q 0.6 1.8 0.1 18.00 
R 0.6 1.8 0.2 17.77 
s 1.8 0.1 0.05 16.04 
T 1.8 0.1 0.1 15.64 
u 1.8 0.1 0.2 15.54 
V 1.8 0.6 0.05 17.45 
w 1.8 0.6 0.1 17.24 
X 1.8 0.6 0.2 16.99 
y 1.8 1.8 0.05 18.07 
z 1.8 1.8 0.1 17.95 
a 1.8 1.8 0.2 17.60 
Table 6.1 Optimisation of primers and TaqMan probe for MIEP-specific RTQ-PCR. PCR reactions 
were set up in triplicate such that MJEP-specific primers (S & A) and TaqMan probe were each titrated 
across a range of volumes: 0.1 to 1.8µ1 for primers and 0.05 to 0.2µ1 for TaqMan probe. The resultant 
average Ct (cycle threshold) value for each reaction is presented above. Bold = lowest Ct value with the 
lowest volume ofTaqMan probe used. 
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Figure 6.3 Optimisation of primers and TaqMan probe for MIEP-specific RTQ-PCR. PCR reactions 
were set up in triplicate such that MIEP-specific primers (S & A) and TaqMan probe were each titrated 
across a range of volumes: 0.1 to 1.8µ1 for primers and 0.05 to 0.2µ1 for TaqMan probe. Above is a 
graphical representation of the data presented in Table 6.1 . (J) the highest Ct value with the lowest volume 
of TaqMan probe used per reaction. 
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Figure 6.4 MIEP-specific RTQ-PCR of 3-96 hours post-infection ChlP analysis samples: raw data 
and standard curve. PCR reactions were set up in triplicate for ChIP samples produced 3-96 hours post-
infection. (A) Graphical representation of raw data produced by TaqMan RTQ-PCR. (B) Graphical 
representation of the standard curve for the RTQ-PCR run using triplicate reactions (blue dots). Samples 
are shown along the standard curve (red dots). 
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Figure 6.5 MIEP-specific RTQ-PCR of 3-96 hours post-infection ChIP analysis samples: 
compensated data. Graphical representation of PCR curves after standard curve has been applied to data 
for 3-96 hours post-infection ChIP assay samples. Threshold line (red) at which Ct value is taken and copy 
nwnber calculated is shown. 
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level serum-control background subtracted from the sample data and results normalised to 
inputs - given a arbitrary value of 1.0 (Fig. 6.6). 
At 3 hours post-infection, although the viral MIEP was associated with some acetylated 
histone-H4 (Fig 6.6a, lane 1) and H3K9me2 (Fig. 6.6a, lane 2), it was predominantly 
associated with HPl~ (Fig. 6.6a, lane 3), consistent with previous semi-quantitative 
analysis (Chapter 3, Fig. 3.2). These quantitative data again corresponded with levels of IE 
gene transcription driven by the MIEP at this time. At 24 hours post-infection, the 
proportion of viral MIEPs associated with acetylated histones increased (Fig. 6.6b, lane 1) 
approximately 20-fold compared to 3 hours post-infection. In addition, there was also an 
increase in the association of H3K9me2 onto the MIEP (Fig. 6.6b, lane 2). Interestingly, 
although at this early timepoint major IE gene expression is still elevated, a recruitment of 
HPI~ could be seen (Fig. 6.6b, lane 3). Nevertheless, the MIEP remains predominantly 
associated with acetylated histone-H4 at this time. By 96 hours post-infection, the 
recruitment of acetylated histone-H4 (Fig. 6.6c, lane 1) seen at 24 hours post-infection was 
lost with more than a 4-fold reduction. There was a small decrease in H3K9me2 
association (1.8-fold) (Fig. 6.6c, lane 2). However, HPl~ appeared most associated with 
the MIEP at this late timepoint (Fig. 6.6c, lane 3) with levels around 3 times higher than 
any other marker, consistent with transcriptional repression of the MIEP at this timepoint. 
In previous chapters, the c-Fos promoter had been used as a positive control for semi-
quantitative ChIP analysis. For RTQ-PCR analysis, other target promoters were used for 
positive controls of immunoprecipitation. It was necessary to verify that 
immunoprecipitation of both transcriptionally active and repressive chromatin had 
occurred consistently at each timepoint. Consequently, two targets were employed: the 
GAPDH promoter ·and the y-globin promoter. GAPDH is a housekeeping enzyme 
employed in glycolysis within the cell and, as such, the promoter of the gene is routinely 
associated with transcriptionally active chromatin. Indeed,· even super-infection of cells 
with HSV has shown no change to the levels of acetylated histone-H3 and H4 at the 
GAPDH promoter (Coleman et al., 2008). Consequently, it is a robust target to analyse 
promoters associated with acetylated histone-H4. In contrast, the human y-globin gene 
encodes the foetal haemoglobin protein that is not produced after gestation; hence the 
promoter is associated with transcriptionally repressed chromatin in differentiated cells 
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Figure 6.6 MIEP-specific RTQ-PCR can be employed for analysis of ChIP samples. ChIP assays were 
performed (MOI 0.1) on serum-starved human :fibroblasts at 3, 24 and 96 (A-C) hours post-infection. 
Analysis was carried out with either an anti-acetylated histone-H4 antibqdy (lane 1), an anti-dimethyl lysine 
9 histone-H3 antibody (lane 2) or an anti-HPl~ antibody (lane 3). Isolated DNA was amplified using an 
MIEP-speci:fic RTQ-PCR and for comparison, the immunoprecipitated DNA was quantified relative to the 
input DNA The data is representative of three independent experiments. Error bars, 1 S.D. of triplicate 
PCR reactions. 
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(Stamatoyannopoulos & Grosveld, 2001; Bottardi et al., 2003). Additionally, the 
association of H3K9me2 and HPIB with the y-globin promoter is unaffected by 
herpesvirus infection (Reeves et al., 2006; Coleman et al., 2008). Therefore, it was 
routinely employed as a control for transcriptionally repressed chromatin association in all 
further experiments. 
RTQ-PCR for the GAPDH promoter at the 3, 24 and 96 hour post-infection showed 
variable levels of association of the GAPDH promoter with acetylated histone-H4 (Fig. 
6.7a). However, during the course of infection, the association with acetylated histone-H4 
only varied up to two-fold (Fig. 6.7a, lanes 1 & 2). Consequently, this would have little 
effect on the overall profile of acetylated histone-H4 associated with the viral MIEP at 
each timepoint (Fig. 6.6). The data produced from y-globin promoter RTQ-PCR for DNA 
immunoprecipitated with H3K9me2 (Fig. 6.7b) and HPIB (Fig. 6.7c) again had an upper 
most range of two-fold change in efficiency: this level of variation would have little effect 
on the MIEP RTQ-PCR data for each antibody and timepoint illustrated in Fig 6.6. In 
addition, many studies normalise immunoprecipitation data directly to PCR from a single 
promoter, such as GAPDH, with only one antibody and one control target promoter. 
However, two RTQ-PCR targets were used here (GAPDH promoter and y-globin 
promoter) due to the antibody targets. These controls generally show that the ChIP 
efficiency across the timescale of the experiment was consistent and robust. 
6. 2. 3 The MIEP is temporally regulated throughout productive infection by chromatin 
remodelling 
Thus far, the ChIP analyses had been carried out on permissive cells that had allowed full 
productive infection which includes viral DNA replication. Since it was possible that the 
ChIP results at later times of infection might have included newly synthesised and 
chromatinised MIEPs, phosphonoformic acid (PF A) was used to specifically inhibit viral 
DNA synthesis during infection (MOI 0.1) (see section 1.5.4). ChIP analysis was then 
carried out as in Fig. 6.6. Samples were analysed by MIEP-specific RTQ-PCR, including 
GAPDH promoter and y-globin promoter RTQ-PCR to establish immunoprecipitation 
efficiency for each timepoint with each antibody. 
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Figure 6. 7 RTQ-PCR controls for chromatin immunoprecipitation. (A) ChIP assays were performed (MOI 0.1) on serum-starved human fibroblasts at 3, 24 and 96 (lanes 1-3) hours post-infection. Analysis 
was carried out with an anti-acetylated histone-H4 antibody. Isolated DNA was amplified using a GAPDH-
specific RTQ-PCR and for comparison, the immunoprecipitated DNA was quantified relative to the input DNA. (B) Analysis was carried out with an anti-dimethyl lysine 9 histone-H3 antibody. Isolated DNA was 
amplified using a y-globin-specific RTQ-PCR and for comparison, the immunoprecipitated DNA was quantified relative to the input DNA. (C) Analysis was carried out with an anti-HPl~ antibody. Isolated DNA was amplified using a y-globin-specific RTQ-PCR and for comparison, the immunoprecipitated DNA 
was quantified relative to the input DNA. The data is representative of three independent experiments. Error bars, 1 S.D. of triplicate PCR reactions. 
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At 3 hours post-infection, the viral MIEP was associated with low levels of all forms of 
chromatin assessed by the study (Fig. 6.8a). The MIEP was associated with very low levels 
ofacetylated histone-H4 (Fig. 6.8a, lane 1) but higher levels ofHPlP (Fig. 6.8a, lane 3), 
consistent with repression of IE gene transcription at this time. By early times of infection, 
acetylated histone-H4 recruitment had increased 24-fold (Fig. 6.8b, lane 1) in comparison 
to smaller increases of H3K9me2 and HPlP (Fig. 6.8b, lanes 2 & 3). At 96 hours post-
infection, in the absence of viral DNA replication due to PF A, the association of chromatin 
structure at the MIEP (Fig. 6.8c) actually appeared similar to that of PFA untreated cells 
(Fig. 6.6c) and showed a substantial decrease in acetylated histone-H4 (Fig. 6.8c, lane 1) 
with a considerable recruitment of HPlP (Fig. 6.8c, lane 3). Again, control GAPDH 
promoter RTQ-PCR of acetylated histone-H4 immunoprecipitated samples (Fig. 6.9a) and 
y-globin promoter RTQ-PCR of H3K9me2 and HPlP immunoprecipitated samples (Fig. 
6.9b & c respectively) showed less than 2-fold variation across the timecourse of the 
infection (Fig. 6.9b, lane 2) which could account for a slightly higher level of H3K9me2 
than in other experiments on the MIEP at 24 hours post-infection. In order to confirm that 
PF A treatment had effectively inhibited viral DNA synthesis during infection, the MIEP-
specific RTQ-PCR of input samples from untreated and PFA treated ChIP timecourses was 
analysed (Fig. 6.10). After correction for total DNA precipitation by GAPDH-specific 
RTQ-PCR, it can clearly be seen that when untreated fibroblasts are infected with HCMV 
Toledo the level of viral DNA increases 35-fold after 96 hours post-infection. In 
comparison, PF A treated fibroblasts show only a 2-fold increase in viral DNA level after 
96 hours post-infection. Consequently, PF A treatment did efficiently prevent viral DNA 
replication and the small decrease in the amount of chromatin immunoprecipitated with the 
MIEP at late times of infection suggests that replicated viral genomes, or at least a 
proportion of them, do not become chromatinised. 
6. 2. 4 An early promoter (UL44) is temporally regulated throughout productive infection by 
chromatin remodelling 
Work presented in chapters 3 and 4 clearly demonstrated that the chromatin associated 
repression of viral IE gene expression immediately upon infection is mediated by 
chromatin remodelling via repressors and co-repressors, namely HDACs and hDaxx. The 
prevention of this repression by HDAC inhibitors and hDaxx down-regulation resulted in 
an increase of IE gene expression. However, it was also noted that relief of this repression 
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Figure 6.8 The MIEP of HCMV is chromatinised throughout a productive lytic infection - real-time quantitative-PCR. ChIP assays were performed (MOI O .1) on serum-starved, PF A treated human fibroblasts at 3, 24 and 96 (A-C) hours post-infection. Analysis was. carried out with either an anti-
acetylated histone-H4 antibody (lane 1), an anti-dimethyl lysine 9 histone-H3 antibody (lane 2) or an anti-HPl~ antibody (lane 3). Isolated DNA was amplified using an MIEP-specific RTQ-PCR and for 
comparison, the irnrnunoprecipitated DNA was quantified relative to the input DNA. The data is 
representative of two independent experiments. Error bars, 1 S.D. of triplicate PCR reactions. 
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Figure 6.9 RTQ-PCR controls for chromatin immunoprecipitation. (A) ChIP assays were performed 
(MOI 0.1) on serum-starved, PFA treated human fibroblasts at 3, 24 and 96 (lanes 1-3) hours post-
infection. Analysis was carried out with an anti-acetylated histone-H4 antibody. Isolated DNA was 
amplified using a GAPDH-specific RTQ-PCR and for comparison: the immunoprecipitated DNA was 
quantified relative to the input DNA (B) Analysis was carried out with an anti-dimethyl lysine 9 histone-
H3 antibody. Isolated DNA was amplified using a y-globin-specific RTQ-PCR and for comparison, the 
immunoprecipitated DNA was quantified relative to the input DNA (C) Analysis was carried out with an 
anti-HPl~ antibody. Isolated DNA was amplified using a y-globin-specific RTQ-PCR and for comparison, 
the immunoprecipitated DNA was quantified relative to the input DNA The data is representative of two 
independent experiments. Error bars, 1 S.D. of triplicate PCR reactions. 
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Figure 6.10 ChIP assay input data demonstrates inhibition of viral DNA synthesis with PFA treatment. ChIP assays were performed on either serum-starved, untreated (grey) or PF A treated (black) HCMV Toledo infected (MOI 0.1) human fibroblasts at 3, 24 and 96. Both MIEP and GAPDH RTQ-PCR was then performed on input samples and the quantity of viral DNA expressed as a proportion of the isolated total DNA (MIEP/GAPDH) relative to the 3 hour post-infection level (taken as 1.0). Error bars, I S.D. of three independent experiments. 
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additionally resulted in an increase of early and late viral gene expression. Since a recently 
published study at the time had shown an increasing association of acetylated histone-H4 
at the promoter of the UL44 early gene over the first 12 hours of infection (Nevels et al., 
2004b ), ChIP analysis of this promoter during the course of a full productive infection was 
next carried out. 
The UL44 protein (p52) is a double-stranded DNA processivity factor required for viral 
DNA synthesis and is able to interact specifically with the viral DNA polymerase (UL54) 
(Parietal., 1993; Weiland et al., 1994; Ripalti et al., 1995). The UL44 promoter has three 
initiation sites: the distal and proximal initiate at early times, regulated through a canonical 
TATA sequence (TATAA; -163 & -58 from ATG). Initiation of transcription from the 
middle basal promoter occurs at late times of infection, dependent upon viral DNA 
synthesis and a non-canonical TATA sequence (-112 from ATG). The resulting gene 
product predominantly affects late viral gene expression rather than viral DNA synthesis 
(Leach & Mocarski, 1989; Isomura et al., 2007; Isomura et al., 2008b). As previous work 
had successfully utilised RTQ-PCR of the proximal UL44 promoter, with the PCR target 
positioned from -27 to +248 in relation to the ATG (Nevels et al., 2004b), the same primer 
set was employed in this investigation. Furthermore, to provide a standard template that 
could be used for the production of a standard curve upon each RTQ-PCR run, the PCR 
product was first cloned into the pcDNA3 backbone plasmid before dilution to the 
appropriate concentrations and subsequent amplification. ChIP samples previously 
analysed by MIEP-specific RTQ-PCR (Fig. 6.6) were now analysed using UL44 promoter-
specific RTQ-PCR (Fig. 6.11). 
At 3 hours post-infection, the UL44 promoter was associated with low levels of modified 
histones (Fig. 6. lla). Although this comprised equal levels of both acetylated histone-H4 
(Fig. 6.1 la, lane 1) and HPl~ (Fig. 6.1 la, lane 3), a 2.5-fold higher recruitment of the 
marker of transcriptional repression H3K9me2 was evident (Fig. 6.1 la, lane 2) by this 
timepoint. This is consistent with the known lack of expression of UL44 at this time of 
infection from this proximal promoter. By 24 hours post-infection, though, the chromatin 
profile of the UL44 promoter had changed considerably (Fig. 6.11 b ). The proportion of 
UL44 promoters associated with H3K9me2 decreased by approximately 20% (Fig. 6.11 b, 
lane 2) and the association of acetylated histone-H4 increased over 6.5-fold (Fig. 6.11 b, 
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Figure 6.11 An early promoter (UL44) of HCMV is chromatinised throughout a productive lytic 
infection. ChIP assays were performed (MOI 0.1) on serum-starved human :fibroblasts at 3, 24 and 96 (A-
C) hours post-infection. Analysis was carried out with either an anti-ac~tylated histone-H4 antibody (lane 
1), an anti-dimethyl lysine 9 histone-H3 antibody (lane 2) or an anti-HPl~ antibody (lane 3). Isolated DNA 
was amplified using an UL44-speci:fic RTQ-PCR and for comparison, the immunoprecipitated DNA was 
quantified relative to the input DNA. The data is representative of two independent experiments. Error 
bars, 1 S.D. of triplicate PCR reactions. 
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lane 1) consistent with the initiation of early viral gene expression at this time. 
Intriguingly, there was also an increase in association of the promoter with HPl p (Fig. 
6.llb, lane 3). However, by late times of infection, this increase in HPlP association seen 
at 24 hours post-infection was lost almost entirely (19-fold reduction) (Fig. 6.11 c, lane 3). 
Indeed, all forms of associated histones appeared to decrease by this timepoint (Fig. 6.11 c ), 
although the promoter was still predominantly associated with acetylated histone-H4 (Fig. 
6.11 c, lane 1 ). 
6.2.5 A late promoter (pp28) is temporally regulated throughout productive infection by 
chromatin remodelling 
As chromatin remodelling of an early promoter throughout productive infection clearly 
occurred during infection and increased late gene expression also occurred with TSA 
treatment or hDaxx down-regulation in these cells, a late promoter was next analysed by 
ChlP analysis. To this end, the true late promoter of the tegument phosphoprotein pp28 
was chosen. The pp28 region has at least two promoter elements: a true late promoter and 
an upstream promoter that has been shown to be up-regulated at early times by virus 
infection (Depto & Stenberg, 1992). True late gene expression is absolutely dependent 
upon viral DNA synthesis and is driven from -609 to + 106 in relation to the transcriptional 
start site with leader sequences present from -6 to +46 regulating the translation of late 
transcripts (Kohler et al., 1994; Kerry et al. , 1997). Therefore, primers were designed to 
anneal between the upstream promoter leader and the putative translational regulatory 
element, resulting in amplification of nucleotides from -290 to -180 of the true late region 
in relation to the transcriptional start site. Again, to act as standard controls for the RTQ-
PCR, the PCR product was cloned into the pcDNA3 backbone plasmid before dilution to 
the appropriate concentrations and subsequent amplification. Analysis was then carried out 
on the 3-96 hour post-infection ChIP samples. 
At 3 hours post-infection, the MIEP was predominantly associated with H3K9me2 (Fig. 
6.12a, lane 2) with little association of acetylated histone-H4 (Fig. 6.12a, lane 1) or HPIP 
(Fig. 6.12a, lane 3). By 24 hours post-infection, the profile of chromatin association at the 
pp28 promoter changed little: a 15% increase in H3K9me2 (Fig. 6.12b, lane 2) was 
concurrent with decreases in acetylated histone-H4 (2-fold) (Fig. 6.12b, lane 1) and HPlP 
(2.5-fold) (Fig. 6.12b, lane 3). This is consistent with the known lack of transcription from 
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Figure 6.12 A late promoter (pp28) of HCMV is chromatinised throughout a productive lytic 
infection. ChIP assays were performed (MOI 0.1) on serum-starved human fibroblasts at 3, 24 and 96 (A-
C) hours post-infection. Analysis was carried out with either an anti-acetylated histone-H4 antibody (lane 
1), an anti-dimethyl lysine 9 histone-H3 antibody (lane 2) or an anti-HPl~ antibody (lane 3). Isolated DNA 
was amplified using an pp28-specific RTQ-PCR and for comparison, the immunoprecipitated DNA was 
quantified relative to the input DNA. The data is representative of two independent experiments. Error 
bars, I S.D. of triplicate PCR reactions. 
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this promoter at this time of infection. However, by 96 hours post-infection a significant 
change in the chromatin profile occurred: whilst HPl~ decreased 12-fold (Fig. 6.12c, lane 
3) and H3K9me2 8-fold (Fig. 6.12c, lane 2), the promoter was predominantly associated at 
this timepoint with acetylated histone-H4 (a 5-fold increase) (Fig. 6.12c, lane 1). This is 
consistent with the known levels of transcription of this late gene at this timepoint post-
infection. 
6.2.6 Di-methylation of lysine 4 of histone-H3 (H3K4me2) can be used as a marker for 
active transcription at viral promoters 
Immunoprecipitation of chromatin markers for active and repressed promoters had 
determined that all classes of HCMV genes were temporally associated with chromatin 
structure throughout productive infection, and that, in general, this reflected the known 
gene expression profiles from these promoters. However, other chromatin modifications 
have been characterised during the course of this work. Notably, whilst di-methylation of 
lysine 9 on histone-H3 (H3K9me2) is a known marker for repressive chromatin 
(Kouzarides, 2007a), di-methylation of lysine 4 on histone-H3 (H3K4me2) has been 
characterised as a marker of an active promoter and transcriptional elongation in mammals 
(Schneider et al., 2004). Furthermore, this chromatin modification has been assessed 
during HSV-1 productive infection and found to be temporally associated with promoters 
of viral genes (ICPO, TK and VP16) during transcription and preferentially associated with 
the 5' end of transcribed viral genes (Kent et al., 2004). Therefore, the association of this 
modified histone was assessed at the HCMV major IE, UL44 and pp28 promoters during a 
timecourse of infection. 
Fibroblasts were infected as above (MOI 0.1). At the appropriate timepoint (3, 8, 24, 48 or 
96 hours post-infection), the cells were fixed and ChIP assays carried out using either 
control serum or an anti-di-methyl lysine 4 histone-H3 (H3K4me2) antibody with 10% of 
the total chromatin fraction used as input for each timepoint: Resultant ChIP samples were 
then analysed by promoter-specific RTQ-PCR and, subsequently, GAPDH promoter RTQ-
PCR to establish immunoprecipitation efficiency for each timepoint with each antibody. 
The results, normalised relative to input and GAPDH promoter immunoprecipitation 
levels, are presented in Fig. 6.13 to Fig. 6.15 . 
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At 3 hours post-infection, the MIEP was clearly associated with H3K4me2 (Fig. 6.13). 
This association increased 2.3-fold by 8 hours and a further 2-fold by 24 hours. Thereafter, 
association of H3K4me2 with the MIEP decreased 5.6-fold by 48 hours before a further 
decrease of 3-fold by 96 hours. Overall, this is consistent with the known levels of major 
IE gene transcription at these timepoints. Association of H3K4me2 with the UL44 
promoter was not clearly detected until 24 hours post-infection (Fig. 6.14). However, this 
association then increased dramatically by 48 hours (5-fold) before a further 1.5-fold 
increase by 96 hours post-infection. Although the increases seen from 8 to 48 hours are 
consistent with early gene transcription, the high level of H3K4me2 association at 96 hours 
is unexpected although possibly due to the presence of further distal promoters within the 
UL44 gene and consistent with previous ChlP analysis (Fig 6.1 lc ). Low levels of 
H3K4me2 were observed associated with the pp28 promoter from 8 to 24 hours post-
infection, whereupon a small increase occurred by 48 hours (Fig. 6.15). A further 11-fold 
increase also occurred at 48 hours until, at 96 hours post-infection, this was maximal (Fig. 
6.12). These observations are also consistent with pp28 transcription throughout the course 
of infection and previous ChlP analysis (Fig. 6.12). Intriguingly, a high level of H3K4me2 
association with the pp28 promoter was observed at 3 hours post-infection ( 40% of the 
maximal 96 hour post-infection level). However, overall, levels of association of 
H3K4me2 with the HCMV promoters analysed correlate directly with the temporal 
regulation of gene expression from those promoters. 
6. 2. 7. A substantial proportion of viral genomes are chromatinised during productive 
infection 
Although ChlP analyses presented in all chapters of this study show an association of 
modified histones and histone-associated proteins with promoters of various temporal 
classes of HCMV genes, the proportion of the total population of viral genomes associated 
with histones is unknown. This is important, since if only a small proportion of viral 
genomes were associated with histones/histone-associated proteins, then the relevance of 
changes in the chromatin structure of this low proportion of incoming viral genomes could 
be questioned. Therefore, ChIP analysis using an antibody specific for histone-H3 was 
carried out. After isolation of immunoprecipitated DNA, MIEP-specific RTQ-PCR was 
employed to quantify the number of viral genomes associated with histone-H3 , whilst 
GAPDH-specific RTQ-PCR was used to quantify the efficiency of histone-H3 
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Figure 6.13 Di-methylation of lysine 4 histone-H3 (H3K4me2) acts as a marker for transcriptional 
expression at the MIEP. ChIP assays were performed (MOI 0.1) on serum-starved human fibroblasts at 3, 8, 24, 48 and 96 hours post-infection. Analysis was carried out with either serum control or an anti-H3K4me2 antibody. Isolated DNA was amplified using an MIEP-specific and a GAPDH-specific RTQ-PCR. For comparison, the immunoprecipitated DNA was quantified relative to the input DNA and the 
amount of MIEP DNA at each timepoint then normalised to the GAPDH loading control. The data is 
representative of two independent experiments. Error bars, 1 S.D. of triplicate MIEP PCR reactions. 
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Figure 6.14 H3K4me2 acts as a marker for transcriptional expression at the UIA4 promoter. ChIP 
assays were performed (MOI 0.1) on serum-starved human fibroblasts at 3, 8, 24, 48 and 96 hours post-
infection. Analysis was carried out with either serum control or an anti-H3K4me2 antibody. Isolated DNA 
was amplified using an MIEP-specific and a GAPDH-specific RTQ-PCR. For comparison, the 
immunoprecipitated DNA was quantified relative to the input DNA and the amount of MIEP DNA at each 
timepoint then normalised to the GAPDH loading control. The data is representative of two independent 
experiments. Error bars, 1 S.D. of triplicate UL44 PCR reactions. 
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Figure 6.15 H3K4me2 acts as a marker for transcriptional expression at the pp28 promoter. ChIP 
assays were performed (MOI 0.1) on serum-starved human fibroblasts at 3, 8, 24, 48 and 96 hours post-infection. Analysis was carried out with either serum control or an anti-H3K4me2 antibody. Isolated DNA 
was amplified using an :MIEP-specific and a GAPDH-specific RTQ-PCR. For comparison, the immunoprecipitated DNA was quantified relative to the input DNA and the amount of :MIEP DNA at each timepoint then normalised to the GAPDH loading control. The data is representative of two independent 
experiments. Error bars, 1 S.D. of triplicate pp28 PCR reactions. 
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immunoprecipitation. The number of viral genomes was then normalised usmg the 
efficiency of equivalent GAPDH promoter immunoprecipitation and the data is provided in 
table 6.2. At 8 hours post-infection, by which time histone-association has occurred with 
the viral genome, an average of 19.8% of virus genomes are associated with histone-H3. 
Thus, a substantial proportion of viral genomes are associated with histones at an IE 
timepoint of infection. However, it was not known whether, after viral DNA replication, 
newly synthesised genomes become associated with histones. Therefore, ChlP analysis for 
global histone-H3 was also carried out at 72 hours post-infection, by which time viral 
DNA synthesis would have occurred and samples were again assessed using RTQ-PCR 
analysis. At 72 hours post-infection, an average of 10.8% of viral genomes were associated 
with histone-H3, a decrease in the proportion of total genomes histone-associated. 
Although the range ofresults at this timepoint produced a higher standard error (6.6%), the 
2-fold decrease in proportion of total genomes associated with histones is consistent with 
the decrease seen in total modified histone association of the MIE, UL44 and pp28 
promoters at late times of infection. 
6.3 Discussion 
Control of viral major IE gene expression has been shown to be controlled by temporal 
association of chromatin structure at the MIEP throughout HCMV productive infection 
(see Chapter 3). In addition, relief from mediators of repression (HDACs - Chapter 3; 
hDaxx - Chapter 4) results in an increase in levels of expression of IE genes and an 
advance of the infection cycle such that higher levels of viral early and late gene 
expression also occur but earlier during infection. Recently, it has been shown that the 
promoters of all classes of HSV-1 genes are associated with histones throughout 
productive, lytic infection and modification of these histones occurs throughout infection 
in a temporally controlled manner (Herrera & Triezenberg, 2004; Kent et al., 2004; 
Coleman et al., 2008). Consequently, this chapter analysed the possibility that the 
promoters of all classes of HCMV genes (IE, early and late) were similarly modified 
during the timecourse of infection. 
The establishment of real-time quantitative PCR (RTQ-PCR) for analysis of ChlP samples 
proved advantageous. It shortened the analysis time and removed the use of radioactivity to 
analyse samples, providing normalised, quantitative data. Analysis of the viral MIEP 
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% of total viral genomes 
immunoprecipitated 
Experiment 8 hr p.i. 72 hr p.i. 
I 19.1 I 7. I 
2 19.7 11.4 
3 20.6 4.0 
Average 19.8 (± 0.8) 10.8 (± 6.6) (± 1 SD) 
Table 6.2 A substantial proportion of viral genomes are chromatinised throughout productive 
infection. ChlP assays were performed (MOT 0.1) on serum-starved human fibroblasts at 8 and 72 hours 
post-infection. Immunoprecipitation was carried out with a pan-histone-H3 antibody. Isolated DNA was 
amplified using MTEP-specific RTQ-PCR and the immunoprecipitation efficiency in each sample normalised 
using GAPDH promoter-specific RTQ-PCR. The data represents three independent experiments. 
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throughout full productive infection confirmed the temporal association of chromatin 
structure seen in Chapter 3 consistent with the known levels of major IE gene transcription 
during infection. Analysis of a further marker of active transcription, H3K4me2, was also 
consistent as before. Indeed, such changes in the association of chromatin markers with the 
MIEP are also consistent with other analysis from our laboratory examining MIEP auto-
regulation by IE86 (Reeves et al., 2006). In part, this analysis (Reeves et al., 2006) goes 
some way to explain the increased association of the MIEP with markers of transcriptional 
repression as the virus infection progresses. In addition, the temporal association of 
acetylated histone-H4 shown in Chapter 3 and in this chapter is consistent with recently 
published data (Park et al., 2007b ). However, RTQ-PCR analysis of ChlP samples showed 
a lower total association of modified histones with the MIEP at 3 hours post-infection than 
the semi-quantitative PCR analysis in Chapter 3. This is likely due to the specificity of 
RTQ-PCR, which provides data from the linear phase of amplification, and provides 
evidence that the MIEP is still undergoing recruitment of histones and histone associated 
proteins at this time of infection. 
Other studies have also recently shown the association of early HCMV promoters with 
modified histones. The promoter of the UL44 gene has been shown to become associated 
with acetylated histones by 12 hours post-infection (Nevels et al., 2004b) whilst the 
promoter of the viral DNA polymerase, UL54, becomes associated with acetylated histone-
H4 by 48 hours post-infection (Park et al., 2007b). The data presented in this chapter is 
consistent with these findings: at IE times the UL44 promoter was shown to be associated 
with H3K9me2 predominantly at an IE timepoint whereas by 24 hours post-infection the 
promoter had become predominantly associated with acetylated histone-H4, consistent 
with the known time course of UL44 transcription. However, and slightly surprisingly, at 
late timepoints, when -UL44 expression is not expected, the promoter still appears 
associated with acetylated histone-H4 and H3K4me2. This may be consistent with the 
activation of a known upstream cryptic element in the UL44 promoter which is active at 
late times (Leach & Mocarski, 1989) and could cause the true promoter to appear to remain 
transcriptionally active. In addition, although it is known that factors, such as IE86, are 
responsible for negative auto-regulation of the MIEP (Reeves et al. , 2006), it is not known 
if such directed regulation of early or late viral promoters takes place or is necessary. 
Elucidation of this will require further work. 
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Chromatinisation of the pp28 true late promoter also occurred throughout infection. Again, 
the association of acetylated histone-H4 and H3K4me2 was consistent with the known 
profile of pp28 transcription during infection. However, at IE and early times of infection, 
when pp28 transcription is known to be low (Mocarski et al., 2007), very little HPl~ was 
associated with the promoter. Instead, H3K9me2 was the predominantly associated factor. 
Therefore, it is possible that this 'H3K9me2-repressed' promoter state may be akin to a 
poised state that can become remodelled to an active state when the appropriate levels of 
viral factors (IE72 and IE86) become available. Interestingly, this association of H3K9me2 
at IE times of infection was also observed with the early UL44 promoter. 
Analysis of the pp28 promoter did show an association with H3K4me2, a marker of 
transcriptional activation, at 3 hours post-infection. Similar to the UL44 promoter, the 
pp28 promoter also contains certain elements that have been shown to be active at times of 
infection other than late (Depto & Stenberg, 1992). However, whether the activity of a 
cryptic element may be the cause of H3K4me2 association at this timepoint is unclear. 
One consistent finding was that, at 96 hours post-infection, all viral promoters appeared 
less associated with known chromatin markers. This would be consistent with a dilution 
effect after viral DNA synthesis if newly replicated genomes were not chromatinised, as 
hypothesised with HSV-1 (Oh & Fraser, 2008). Indeed, although blocking of viral DNA 
synthesis by phosphonoformic acid did not change the association of markers of 
transcriptionally active or repressed chromatin at the MIEP, it did lead to a slight increase 
in total precipitated chromatin compared to untreated cells at late times on infection. This 
is consistent with the hypothesis that newly replicated viral genomes are less 
chromatinised. Furthermore, ChIP analysis of the association of histone-H3 with the MIEP 
demonstrated that although around 20% of viral genomes are associated with histones at 8 
hours post-infection, by late times after viral DNA synthesis this proportion decreases 2-
fold. This finding is consistent with the decrease of total modified histones associated with 
all viral promoters analysed and a dilution effect at late times of infection. However, 
although the proportion of viral genomes associated with histones decreases, the total 
number of viral genomes present increases after viral DNA synthesis and, as such, the 
number of genomes that are histone-associated increases. Whether this increase in histone 
association after replication aids repression of MIEP activity at late times of infection, 
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when IE gene transcription is not wanted, is unknown. However, ChIP analysis in the 
presence of PF A did not cause any particular change in the association of acetylated 
histone-H4 at late times of infection. Indeed, the increase in the total number of viral 
genomes present at late times and the decrease in histone association with this population 
would likely provide an environment conducive to packaging of viral DNA into capsids. 
Overall, the data presented within this chapter show that the regulation of expression of all 
classes of HCMV genes during the full timecourse of virus infection involves chromatin 
remodelling of their respective promoters. The MIEP and promoters of prototypical early 
and late genes, UL44 and pp28 respectively, become associated with histones and histone 
associated proteins upon infection and the temporal regulation of transcription is associated 
with class-specific changes to the chromatin structure such that expression occurs at the 
necessary point throughout productive infection. In addition, upon viral DNA synthesis, 
although some newly replicated genomes do become associated with histones and histone-
associated proteins, it is likely that the presence of a high number of viral genomes that do 
not become associated with histones provides an environment from which packaging of 
viral DNA can occur. 
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7. Final Discussion 
7.1 Introduction 
It is becoming increasingly clear that the regulation of gene transcription of a number of 
viruses is mediated by the association of histones and histone-associated proteins with viral 
DNA. Studies have shown that the differentiation-dependent control of HCMV gene 
expression that occurs during HCMV latency and reactivation is regulated by the 
chromatin status of the MIEP which drives expression of the viral major IE proteins that 
are crucial for productive infection. In undifferentiated, non-permissive HCMV infected 
cells, the MIEP is associated with H3K9me2 or HPl~, markers of transcriptional 
repression, whereas in differentiated, permissive infected cells the MIEP becomes 
associated instead with high levels of acetylated histones (Murphy et al., 2002; Reeves et 
al., 2005a; Reeves et al., 2005b; Ioudinkova et al., 2006). This regulation of viral gene 
expression by the state of viral chromatin is not restricted to HCMV. There is good 
evidence that regulation of latency and reactivation of a number of other herpesviruses, 
including EBV, KSHV and HSV-1, is mediated by the chromatin structure of the viral 
major lytic gene promoters. 
However, the control of gene expression of different classes of viral genes throughout a 
productive, lytic infection of fully permissive cells with HSV-1 has also been shown to be 
mediated by chromatinisation and remodelling of promoters (Herrera & Triezenberg, 2004; 
Kent et al., 2004). Similarly, in the case of MCMV, productive infection appears to be 
regulated by the chromatinisation of the viral MIEP as the HDAC inhibitor TSA is able to 
relieve histone-associated repression of the promoter during infection (Tang & Maul, 
2003). Furthermore, in the case of HCMV, the impairment in growth of an IE72-deficient 
mutant HCMV can be rescued with the use of HDAC inhibitors (Nevels et al., 2004b). 
This repression has been hypothesised to be mediated by chromatin remodelling enzymes 
present at ND10 where the viral genome is deposited upon infection. Consequently, the 
remit for this thesis was initially to determine whether chromatinisation of the HCMV 
MIEP also occurs during productive infection and, if so, which viral and cellular factors 
may play a role in this process. 
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7.2 The MIEP of HCMV is chromatinised throughout productive infection 
It is now well established that the transcriptional regulation of gene expression m 
eukaryotic organisms is mediated by the modulation or remodelling of chromatin structure 
associated with promoters and coding sequences of genes. Studies have led to a consensus 
that particular modifications at certain positions along gene promoters and coding regions 
are in fact hallmarks for repression (H3K9me2 and HPl~) or activation (acetylated 
histone-H4) of gene expression and that they can be used to determine the transcriptional 
activity of the gene. ChIP analyses of HCMV infected cells showed clearly that the viral 
MIEP is associated with many of the histone markers described above throughout 
productive infection. As early as 3 hours post-infection, semi-quantitative PCR analysis 
showed that histones were recruited to the MIEP. RTQ-PCR also established that, although 
the promoter was associated with histones at this time, the total association of chromatin 
was lower than that observed at 24 and 96 hours post-infection. This is likely due to 
continued recruitment of histones until a later IE timepoint of infection. 
The association of markers of transcriptionally active or repressed chromatin observed 
throughout lytic infection was consistent with the known temporal regulation of IE gene 
transcription. For instance, association of acetylated histone-H4 with the MIEP was 
maximal by 24 hours post-infection, consistent with a recently published study (Park et al., 
2007b), and this was also concomitant with the association of H3K4me2 - a marker of 
transcriptional activation and elongation (Schneider et al., 2004). At a late timepoint of 
infection (96 hours), the MIEP became predominantly associated with the histone-
associated marker of repression, HP 1 ~- This, in turn, is consistent with the known IE86-
mediated negative auto-regulation of the MIEP at later times of infection through 
interaction via the crs element of the promoter and the recruitment of HDACs (Reeves et 
al., 2006). Interestingly, late in infection, a low level of acetylated histone-H4 was still 
associated with the MIEP, consistent with Reeves et al. (2006). By this timepoint, viral 
DNA synthesis would have begun and, thus, newly synthesised viral genomes would have 
been subject to chromatinisation. However, PF A treatment of cells demonstrated little 
change to the quantity of histone association with the MIEP at 96 hours post-infection. 
Hence, although chromatinisation of newly synthesised viral genomes may occur (see 
section 7.9 for further discussion), it does not appear to alter the relative association of 
modified histones. Indeed, it is possible that the residual association of acetylated histone-
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H4 with the MIEP by this timepoint is consistent with the known transcription and 
expression of the minor IE86 gene products, also known as IE2-p55 and IE2-p38 (see Fig. 
1.9), which have been shown essential for full productive infection at late times (Jenkins et 
al., 1994; Stenberg et al., 1989). Hence, although the MIEP must be negatively auto-
regulated by late times of infection to inhibit expression of IE86, which at high level is 
toxic to the infected cell, nevertheless transcription may still be occurring at a low level. 
7.3 The MIEP is associated with repressive chromatin immediately upon infection 
Although viral IE genes are accepted to be expressed immediately upon infection (Meier & 
Stinski, 1996), ChIP analysis showed that at 3 hours post-infection the MIEP was 
predominantly associated with markers of transcriptional repression such as H3K9me2 and 
HPl p. This association occurred post-infection and most likely after entry of the viral 
genome to the nucleus since purified infectious virions were not found associated with any 
histone protein. This is consistent with a recent examination of the HSV -1 infectious 
particle (Oh & Fraser, 2008). Thus, although the MIEP begins transcription within the first 
few hours of infection within a permissive cell, it must first overcome control dictated by a 
repressive chromatin structure that is presumably mediated by intrinsic cellular repressors. 
7.4 Repression of the MIEP immediately upon infection is mediated by HDACs 
The observation that an initial environment of transcriptional repression exists during 
HCMV infection is consistent with a number of studies using HDAC inhibitors. For 
instance, viral IE gene expression and virus replication is increased by TSA during MCMV 
infection (Tang & Maul, 2003). TSA can also complement an IE72 mutant HCMV (Nevels 
et al., 2004b ). Indeed, other HDAC inhibitors, such as valproic acid (VP A), were shown 
some time ago to stimulate HCMV gene expression (Kuntz-Simon & Obert, 1995; 
Michaelis et al., 2004; Michaelis et al., 2005). The work presented in this thesis also found 
a correlation of HDAC activity with repression of the viral MIEP immediately upon 
infection. TSA treatment of fibroblasts, permissive for HCMV infection, caused increases 
in gene expression of viral IE genes, consistent with a recent study (Saffert & Kalejta, 
2006). TSA also caused an increase in subsequent expression of early and late genes and 
also augmented viral DNA synthesis and production of infectious progeny. However, TSA, 
a hydroxamic acid based inhibitor, is a global inhibitor of class I and II HDACs. 
Consequently, it is not known which specific class or individual HDACs act to repress the 
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MIEP at this infection timepoint. Use of valproic acid has already implicated HDACl as a 
possible repressor. However, other HDAC inhibitors are also available, such as sodium 
butyrate and HC toxin, which have different specificities to those of TSA and VP A. A 
more direct method to analyse the role of individual HDACs might be to employ siRNA 
technology specific for each enzyme. This type of anaJysis would also decrease the 
unspecific effects of using a global HDAC inhibitor which may confound the investigation. 
7.5 Repression of the MIEP immediately upon infection is controlled by hDaxx 
Although it is clear that HDACs have a role in the production of a repressive chromatin 
structure at the MIEP immediately upon HCMV infection, these types of chromatin 
remodelling enzymes are usually recruited to promoters or genes by other transcription 
factors. The HCMV genome, after entry to the nucleus, is thought to locate near to, or at, 
ND 10 and these are known sites of such chromatin remodelling enzymes. Certain 
components ofNDlO are also known to interact with HDACs and one component, hDaxx, 
was of interest as its over-expression in normally permissive U3 73 cells is known to result 
in a complete abrogation of HCMV IE gene expression and virus replication after infection 
and that this appeared due to increased association of the MIEP with HP 1 p which could be 
overcome with TSA (Woodhall et al., 2006). hDaxx has been demonstrated to interact with 
a number of different chromatin remodelling enzymes including HDACs (Hollenbach et 
al., 2002). Therefore, it was likely that hDaxx mediated repression of the viral MIEP in 
hDaxx over-expressing cells via recruitment of HDACs. 
Indeed, degradation of hDaxx within the first 12 hours of HCMV infection is driven by 
pp71 interaction upon infection (Saffert & Kalejta, 2006). This necessary directed 
proteasomal degradation of hDaxx would be consistent with it acting as a repressor of IE 
gene expression. Experimental hDaxx down-regulation has also been shown to aid the 
replication of pp71 mutant HCMVs (Cantrell & Bresnahan, 2005; Cantrell & Bresnahan, 
2006; Preston & Nicholl, 2006). However, the complete degradation of hDaxx, as 
postulated by Saffert & Kalejta (2006), does not appear necessary for IE gene expression: 
only partial degradation, as shown in this thesis and other studies (Tavalai et al., 2008), or 
indeed the inhibition of any hDaxx degradation during HCMV infection by MG 132 
(Kaspari et al., 2008) still leads to good levels of IE gene expression. Therefore, although 
the presence of hDaxx at the MIEP causes repression of IE gene expression, it may simply 
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be the removal of this repressor from this location, and not degradation, which is sufficient 
for pp71 -driven transactivation. Additionally, the transient transactivation of the MIEP by 
pp71 may also be sufficient for immediate expression of IE72, which would lead to full 
disruption of the intrinsic intracellular anti-viral ND 10 environment and, thus, a full 
productive infection. 
An interesting finding of Park et al. (2007b) is that the level of HDAC2 protein in HCMV 
infected cells decreases concomitantly with the known degradation profile of hDaxx 
protein. It is known that HDAC2 turnover is controlled by the ubiquitin-proteasome 
pathway (Kramer et al., 2003) and is possible that HDAC2, when associated with hDaxx, 
may be directed for proteasomal degradation by pp71 immediately upon infection. 
However, this specific hypothesis requires investigation. More intriguingly, Park et al. 
(2007b) observed increased levels of HDAC2 protein at delayed-early timepoints. As IE86 
was also shown to interact with HDAC2 by their study, it is likely that HDAC2 may be 
involved in the negative auto-regulation of the MIEP at these times of infection, in addition 
to HDACI and the HMTs G9a and Suvar (Reeves et al., 2006). 
Although both TSA treatment and down-regulation of hDaxx prior to HCMV infection 
resulted in increases in viral gene expression, viral DNA synthesis and production of 
infectious progeny, these two increases were not equivalent. It is possible that other 
components of ND 10 might recruit chromatin remodelling enzymes that are able to repress 
the MIEP in addition to HDACs recruited by hDaxx. Indeed, PML has been shown to 
interact with HDACs (Wu et al., 2001c) and an independent contribution of PML to 
HCMV gene expression has been suggested (Tavalai et al., 2006; Tavalai et al., 2008) 
which may in part be due to this recruitment. Furthermore, the PML-associated repressor 
of transcription (P AROT), which is able to associate with all HP 1 isoforms and, 
interestingly, is inhibited from association with DNA by TSA, can be recruited to NDIO by 
the PML-IV isoform (Fleisher et al., 2006). Moreover, the possibility that independent but 
convergent mediators of repression of herpesvirus gene expression has been suggested for 
PML and Sp 100 during HSV-1 infection (Everett et al., 2008). More direct evidence of the 
involvement of PML in chromatin-mediated MIEP repression could be gained through 
ChIP analysis for the protein at the MIEP. 
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As well as HDACs, hDaxx is also able to recruit further chromatin remodelling enzymes to 
ND 10, most notably the SWI/SNF chromatin remodelling family member A TRX (Ishov et 
al., 2004; Tang et al., 2004). ATRX contains a putative ATPase/helicase domain 
homologous to that found in SNF2 family members and a plant homeodomain (PHD) zinc 
finger domain similar to that of the DNMT3 protein family (Picketts et al., 1996; Gibbons 
et al., 1997). Although its function remains enigmatic, it is likely that the ATRX protein 
can function as a chromatin modifying enzyme. As recruitment of A TRX to ND 10 is 
dependent upon hDaxx, it is likely that the two could contribute towards a repressive 
chromatin state at associated DNA:histone complexes. Therefore, the growing number of 
viruses that hDaxx appears to be able to repress, at least at some point during their life 
cycle (see section 4.3), makes it clear that hDaxx has an important role as a mediator of 
chromatin remodelling during herpesvirus infections. 
As yet, there is no evidence for a direct physical interaction of hDaxx with any promoters 
which it has been shown to repress. It has been suggested that hDaxx does not interact with 
DNA directly but is targeted indirectly to promoters by the association of other factors: for 
example, hDaxx has been found to interact with core histones via the cellular Dek protein 
(Hollenbach et al., 2002). Similarly, a recent report has shown the association of Daxx 
with an endogenous promoter. In this study, mDaxx was immunoprecipitated and showed 
an interaction with the murine c-Met promoter, which it is known to repress (Michaelson 
& Leder, 2003; Morozov et al., 2008). Hence, it might yet be possible to show interaction 
of hDaxx with the MIEP of HCMV, most likely within a complex of proteins, through 
ChIP analysis, although the availability of ChIP assured antibodies for hDaxx must first be 
improved. 
7 .6 hDaxx down-regulation is not associated with an induction of HCMV IE gene 
expression in in vitro models of latency 
The ability of hDaxx to mediate repression of viral IE gene expression at the earliest times 
of infection by chromatin-mediated changes raised the question as to whether repression by 
hDaxx could also mediate the differentiation-dependent control of MIEP activity observed 
during latency and reactivation. However, down-regulation of endogenous hDaxx protein 
in normally non-permissive T2 and THPl cells was not associated with any induction in 
viral IE gene expression. Furthem10re, the level of endogenous hDaxx in these cells and 
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The ability of hDaxx to mediate repression of viral IE gene expression at the earliest times 
of infection by chromatin-mediated changes raised the question as to whether repression by 
hDaxx could also mediate the differentiation-dependent control of MIEP activity observed 
during latency and reactivation. However, down-regulation of endogenous hDaxx protein 
in normally non-permissive T2 and THPl cells was not associated with any induction in 
viral IE gene expression. Furthermore, the level of endogenous hDaxx in these cells and 
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isolated monocytes did not decrease upon differentiation. The protein levels of 
transcriptional repressors such as YYl and ERF also do not change upon differentiation of 
cells to a permissive form (Bain et al., 2003 ; Wright et al. , 2005) and it is interesting to 
note that knockdown of these repressors also does not result in permissiveness for IE gene 
expression. However, the level of the chromatin remodelling enzyme, HDAC3, known to 
repress the MIEP in T2 cells does indeed decrease (Murphy et al. , 2002). Therefore, the 
presence or level of hDaxx protein does not appear to be involved in the switch from a 
latent infection to reactivation either. 
In complete contrast to the findings presented in this thesis, Saffert & Kalejta (2007) did 
find a correlation between down-regulation of hDaxx, specifically in the T2 and THPl cell 
lines, and an induction of HCMV IE gene expression. However, as described in detail in 
section 6.3, these observations could be explained by augmentation of IE gene expression 
in a spontaneously differentiating sub-population of T2 or THPl cells after hDaxx down-
regulation, similar to that shown in permissive human fibroblasts in Chapter 4. A crucial 
question that needs to be addressed is whether the increase in T2 and THP 1 cells 
expressing IE72 after hDaxx down-regulation actually occurred in differentiated cells. 
It is also interesting that the increase in IE gene expression observed by Saffert & Kalejta 
(2007) after hDaxx down-regulation did not lead to full productive infection. Instead, 
replication appeared to stall after expression of certain early viral genes. This is also true 
when the major IE proteins IE72 and IE86 are ectopically expressed in the THPl cell line 
(Yee et al., 2007) and would appear to show that even if leaky IE gene transcription did 
occur within undifferentiated cells, the cells would not allow full virus replication, most 
likely due to the transcriptional milieu of these undifferentiated cells (Sinclair & Sissons, 
2006). It is also important to note that the use of the HDAC inhibitor VPA used by Saffert 
& Kalejta (2007) can result in differentiation of a number of cells types (Gottlicher et al. , 
2001 ). This has been shown not to be the case with use of TSA treatment of the T2 cell line 
(Murphy et al., 2002). 
A criticism of both Saffert & Kalejta' s (2007) work and that presented in this thesis is that 
the undifferentiated T2 cells commonly used for investigation of HCMV latency and 
reactivation do not possess normal ND10 (Hsu & Everett, 2001): the level of PML protein 
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within these cells is lower than that observed in most other cell types and leads to the 
preferential association of hDaxx with centromeres. In fact, normal ND 10 structure is 
actually restored by differentiation of these cells (Hsu & Everett, 2001), posing the 
question of whether this cell type is a fair in vitro model of HCMV latency. Additionally, 
the theory put forward by Saffert & Kalejta (2007) that the lack of proteasomal degradation 
of ND 10-associated hDaxx, due to the inability of pp71 to enter the nucleus, leads to a 
latent HCMV infection is difficult to reconcile with the fact that ND10 are not present in 
these cells. Furthermore, during experimental latent infection of CD34+ cells it appears that 
NDIO may be actively dispersed by latent HCMV gene products (McGregor-Dallas & 
Sinclair, unpublished data), yet IE gene expression does not occur within these cells until 
they are differentiated to DCs. Hence, from this analysis, hDaxx appears to have little role 
in the maintenance of latency or the control of reactivation of HCMV. 
7.7 Experimental differentiation of cells is associated with an induction of HCMV IE 
gene expression in an in vitro model of latency 
Whilst the down-regulation of hDaxx was associated with no induction of MIEP activity, 
the effort to control this study led to the discovery that down-regulation of the master 
regulator of differentiation, Oct4, did indeed lead to an induction of IE gene expression 
equivalent to that seen in RA differentiated cells. Although at first it was thought that 
permissiveness in Oct4 knockdown cells may be due to relief from Oct4 driven repression 
of the MIEP, a hypothesis made more interesting by the recent finding that Oct4 can form 
repressive complexes with HDACs and PML in some ES cells · (Liang et al., 2008), it 
quickly became clear that down-regulation of this master regulator of differentiation 
actually led to differentiation of T2 cells. The reciprocal experiment in which Oct4 was re-
expressed in differentiated cells did not lead to repression of HCMV infection. This fits 
with recent data showing that additional cellular factors must also be re-expressed to de-
differentiate cells (see section 5.3). These observations and other published studies suggest 
levels of chromatin remodelling or modifying enzymes and not necessarily the proteins 
which recruit them to promoters are intrinsically linked with the ability of conditionally 
permissive cells to support HCMV gene expression. This is also consistent with the fact 
that down-regulation of HPl p is not in itself sufficient to induce IE gene transcription from 
the viral MIEP, most likely since chromatin remodelling enzymes such as HDAC3 are still 
present in high levels to maintain the latent infection of HCMV. 
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7.8 Regulation of all classes of HCMV genes is controlled by chromatin remodelling 
of promoters 
The expression of HSV-1 genes had been shown to involve regulation through chromatin 
remodelling of promoters throughout infection and work in this thesis analysing 
prototypical early and late genes, UL44 and pp28 respectively, also showed modulation of 
their chromatin structure in a temporal fashion which coincided with known levels of gene 
transcription: when UL44 and pp28 transcription was not expected, markers of 
transcriptional repression (H3K9me2 and HPlP) were associated with promoters. In 
contrast, at times when the genes were expected to be actively transcribed, a marker of 
transcriptional activation (acetylated histone-H4) was associated with their promoters. 
Pleasingly, a further marker of transcriptional activity and elongation, H3K4me2, used to 
demonstrate chromatin modification at viral promoters during HSV-1 infection (Kent et 
al., 2004) was also associated with these promoters at times of active transcription. Other 
novel markers for active transcription at promoters have recently been identified, including 
ubiquitinated histone-H2A, and these may provide a better ability to demonstrate truly 
active promoters due to the very high turnover of these markers (Minsky et al., 2008). 
Despite the general correlation between the association of markers of active or repressed 
transcription at the UL44 and pp28 promoters, it appeared that an association with HP 1 p 
did not occur to any appreciable level even during their repression. Instead, H3K9me2 
association was found predominantly at timepoints prior to the induction of UL44 and 
pp28 transcription. This observation is indicative of chromatin structure found within 
domains of cellular chromosomes in which chromatin appears to be structured as 
facultative heterochromatin (Trojer & Reinberg, 2007) and is consistent with a 'poised 
state' with respect to transcription such that transcription can be activated upon the 
attainment of a threshold level of activators, in this case IE72 and IE86. This is in contrast 
to the seemingly terminal negative auto-regulation of the MIEP by IE86 at late timepoints 
of infection which results in the high association of HPlP· (Reeves et al., 2006). 
Interestingly, neither the UL44 or pp28 promoter appeared to be negatively regulated at 
late times of infection. Although this may not be surprising for the pp28 promoter, it is 
unexpected for the early UL44 promoter. However, it is worth noting that association of 
acetylated histone-H4 has also been observed at late times of infection in a recent study of 
the HCMV UL54 promoter (Park et al., 2007b ). One reason which may explain this 
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observation at the UL44 promoter is the possible activation of an upstream cryptic 
promoter at late times (Leach & Mocarski, 1989). However, such an element is unknown 
within the UL54 promoter. Furthermore, parallel studies on HSV-1 gene promoters have 
shown that, although histone acetylation decreases at late timepoints, recruitment of 
markers of transcriptional repression such as H3K9me3 does not occur to any appreciable 
level except at the ICPO promoter (Kent et al., 2004). Additional analysis of other early 
and late promoters may shed some light on this aspect of the regulation of HCMV gene 
expression. However, whether specific repression of early and late promoters is necessary 
at late times of infection remains unclear. In addition, it would be interesting to examine 
whether IE gene promoters other than the MIEP may be differentially regulated since the 
MIEP is known to provide atypically high transcriptional activity and has such a 
fundamental role in HCMV infection. 
Although the regulation of HCMV gene transcription is clearly related to association of 
modified histones and histone-associated proteins throughout infection and the mechanism 
by which this regulates the MIEP is relatively well understood, the mechanism by which 
early and late promoters become activated is relatively unclear. IE86, an activator of early 
and late promoters, is known to interact with the histone acetyltransferase (HAT) P/CAF 
(Bryant et al., 2000) which may represent one mechanism by which early and late 
promoters are activated. IE72 and IE86 are also known to interact with HDACs and it has 
been shown that the sequestration of HDACs by IE72 may be important for the activation 
of the UL44 promoter (Nevels et al., 2004b). Therefore, the most likely explanation for the 
premature activation of the UL44 and pp28 promoters in the presence of TSA or hDaxx 
down-regulation is the elevated levels of IE proteins due to loss of repression at the MIEP. 
TSA or hDaxx down-regulation may also promote an environment conducive to UL44 and 
pp28 promoter activation alone as well. It is also interesting to note that the association of 
RNA pol II, which binds to promoters before mRNA transcription initiates with the ICPO 
promoter of HSV-1 occurs in the absence of de nova viral protein synthesis. In contrast, 
recruitment of RNA pol II to early and late promoters is dependent upon the expression of 
the IE ICP4 protein (Sampath & DeLuca, 2008). Thus, it appears that the active 
recruitment of RNA pol II appears necessary at early and late herpesvirus promoters in 
contrast to IE promoters, although this is unconfirmed during HCMV infection. 
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A further question which has yet to be addressed during HCMV infection is whether the 
histone:DNA structure termed chromatin throughout this thesis has the classical structure 
of nucleosomes. Early work on the control of HCMV gene expression appeared to show 
the association of chromatin or nucleosomal-like structures with viral DNA during 
infection (Kierszenbaum & Huang, 1978; St Jeor et al., 1982). However, a definitive 
demonstration of classical nucleosomes at viral promoters or at coding regions of the viral 
genome has yet to be shown. The work of Kent et al. (2004) on HSV-1 productive 
infection has shown classical nucleosomal laddering upon micrococcal nuclease digestion 
of viral chromatin. Therefore, this type of analysis could be carried out during HCMV 
infection to determine whether regions of the viral genome apparently associated with 
modified histones are in a classical nucleosome structure. 
7.9 The proportion of viral genomes associated with histones decreases during the 
course of productive infection 
The observation that total levels of chromatin associated with all promoters (MIE, UL44 
and pp28) analysed by ChIP decreased at 96 hours post-infection was consistent with a 2-
fold reduction in the proportion of viral genomes associated with histone-H3 by late times 
of infection. At the earliest times of infection investigated, around 20% of incoming viral 
genomes were associated with histones. Although this is a sizable proportion of the 
incoming viral genomes, 80% of incoming genomes appear not to be associated with 
histones. The reason for this is unclear. However, it is also not known how many of these 
genomes are actually capable of initiating transcription. It is well established that particle 
to PFU ratios of many herpesviruses are high, reflecting a large proportion of virus 
particles which are defective for replication. This may be consistent with the proportion of 
genomes that appear not to be associated with histones. To test this hypothesis, an analysis 
of active RNA pol II association (Morris et al., 2005) with HCMV promoters could be 
carried out to ascertain the proportion of genomes transcriptionally active. Although this 
might not directly implicate a certain genome population with transcriptional activity, if 
the proportion of genomes associated with RNA pol II correlated with a similar proportion 
of histone-H3 associated genomes, it may be concluded that the histone-associated 
population included the definitively active genomes. However, this awaits confirmation. 
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7.10 Could repression of HCMV gene expression be mediated by other factors or 
mechanisms? 
The control of HCMV gene expression is clearly regulated by histone association during 
latency, reactivation and productive infection. One area of epigenetic control not yet 
discussed is DNA methylation. The methylation of DNA at CpG sites has long been 
associated with silencing of gene expression (Gilbert et al., 2007) and the genomes of 
some viruses, including HPV, are known to become differentially DNA methylated during 
infection (Badal et al., 2004). Since histone modification is known to be affected by 
changes in DNA methylation (Gilbert et al., 2007) and histone modification plays such an 
important role in the control of HCMV gene expression, it is possible that modification of 
viral DNA methylation could be involved in control of viral gene expression. Indeed, 
hDaxx has been shown to interact with such DNMTs (Michaelson et al., 1999; Muramoto 
et al., 2004). However, in a model of HCMV latency and reactivation using rat cells with 
integrated MIEPs, it has been shown that the MIEP is resistant to DNA methylation and 
this is consistent with a lower than average level of CpG sites along the promoter (Boom et 
al., 1987; Honess et al., 1989). In support of these findings, analysis of the MCMV MIEP 
during reactivation studies found little DNA methylation in latently infected cells 
(Hummel et al., 2007). However, DNA methylation has not yet been completely 
discounted as a mechanism of control of HCMV gene expression. Such analyses can be 
difficult to carry out but if DNA methylation does have a role in control of HCMV gene 
expression it is likely that this may be observed during latency. Consequently, the CD34+ 
cells of seropositive donors could be assessed using methylation specific PCR (MSP) or 
bisulphite sequencing during ex viva reactivation. This analysis could also be carried out 
on viral DNA during a full productive infection. 
An emerging mechanism by which both cellular and viral gene expression is known to be 
controlled is through the production of micro RNAs (miRNAs). miRNAs can function to 
down-regulate gene expression in a similar fashion to small interfering RNAs (siRNAs) 
through the RNA interference (RNAi) pathway. To date, over 100 novel miRNAs have 
been found to be expressed by DNA viruses, with targets present in both viral and cellular 
genes (Grey et al., 2008). Approximately 13 miRNAs have been identified in the HCMV 
genome (Grey et al., 2005). However, intriguingly, one of the miRNAs identified, miR-
UL122-1, in addition to targeting the cellular MHC class I related chain B (MICB) (Stem-
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Ginossar et al., 2007), has been shown to target the expression of IE72 during productive 
infection (Grey et al., 2007). Therefore, expression of miR-UL112-1 or other miRNAs 
may be involved in the control of viral gene expression during lytic infection as well as 
during latency and reactivation. 
Although a number of markers of transcriptionally active or repressed chromatin can now 
be widely used to assess the activity of cellular and viral promoters, many more factors are 
known to be important in transcriptional control. For instance, although the nucleosomal 
structure comprises core histones H2A, H2B, H3 and H4, certain variants of histone 
proteins are known to exist. More specifically, histone-H3 has at least four variants (H3 .1, 
H3.2, H3.3 and CENP-A), with histone-H3.3 known to accumulate in actively transcribing 
regions (Hake & Allis, 2006; Loyola & Almouzni, 2007). Since the histone-H3.3 
chaperone HIRA is a known component of ND10 (Zhang et al., 2005), it is possible that 
viral genomes are preferentially associated with histone-H3.3 upon infection of permissive 
cells due to enzymatic recruitment onto nascent DNA. The association of histones such as 
H3.3 could, therefore, be examined by ChlP analysis across a timecourse of HCMV 
infection as to gauge the importance of these additional factors in control of HCMV gene 
express10n. 
Certain chromatin modifying enzymes, such as G9a and Suvar, are known to be important 
during HCMV infection for IE86-mediated repression of IE gene expression at late times 
of infection (Reeves et al. , 2006). However, the mechanism by which the association of 
histone-associated proteins, such as HPl ~' could be removed from viral promoters to, for 
instance, activate the MIEP, remains unknown. Increasing numbers of chromatin 
remodelling enzymes are being identified and this information has lead to two possible 
mechanisms by which HPl~ could be displaced from H3K9me3 residues: phosphorylation 
of HPl~ directly by DNA damage response associated enzymes such as casein kinase 2 
(CK2), which causes chromodomain interactions to decrease (Ayoub et al., 2008); and 
phosphorylation of H3S 10, adjacent to H3K9me3, by enzymes such as Aurora B kinase 
(AuBK) which causes HPl ~ displacement (Fischle et al., 2005; Hirota et al., 2005). It is 
likely that many more chromatin modifying and remodelling enzymes exist and remain to 
be identified. As such, the number of different mechanisms by which chromatin 
modification could influence viral gene expression is also likely to increase. 
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7.11 Concluding remarks 
Work from several groups, as well as work described in this thesis, has now gone some 
way to identifying both cellular and viral factors that control transcription from HCMV 
promoters, including the MIEP (see Fig. 7.1), and the mechanisms by which this occurs. 
These include chromatin-mediated regulation during reactivation from latency and also full 
productive infection. It is likely that HCMV has co-evolved with humans to usurp cellular 
mechanisms of repression imposed upon it during infection. HCMV is able to lie latent 
within the myeloid cells of an individual after primary infection due to their non-
permissive, undifferentiated state and subsequent transcriptional milieu. This latent 
infection then enables asymptomatic persistence of the virus for the lifetime of the host. 
Transmission of HCMV to new recipients is then dependent upon reactivation of the virus 
from latency, most likely upon differentiation of the latently infected cell. Full lytic 
infection can occur after the virus overcomes any intrinsic intracellular repressors, which it 
is likely to face upon primary infection also. Efficient replication is then dictated by 
temporal regulation of viral gene expression throughout productive infection before 
transmission can occur. The success of this virus lifecycle is clearly indicated by the 
proportion of the human population asymptomatically and latently infected with HCMV 
today. 
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Figure 7.1 Current understanding of MIEP regulation throughout lytic infection. (very IE) 
Immediately upon HCMV infection of permissive cells the MIEP becomes associated with repressive 
chromatin structure through interaction with ND 10 components. Incoming pp7 l targets the MIEP via 
interaction with hDaxx and trans-activates MIEP activity, most likely by proteasomal degradation of 
hDaxx, which leads to transient major IE gene expression. (IE) The major IE gene product IE72 then 
disrupts the intrinsic anti-viral NDIO structure via interaction with PML, relieving repressive chromatin at 
the MIEP and further supporting IE gene expression. (Late) At a late timepoint, IE86 negatively auto-
regulates the MIEP through binding to the crs element, resulting in chromatin-mediated repression of the 
MIEP. 
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The cellular protein human Daxx (hDaxx), a component of nuclear domain 1 0 structures, is known 
to mediate transcr iptional repression of human cytomegalovirus immed iate-early (I E) gene 
express ion upon infection of permissive cell types, at least in part, by regulation of chromatin 
structure around the major IE promoter (MIEP). As it is now clear that d ifferentiation-dependent 
regulation of the MIEP also plays a pivotal role in the control of latency and reactivat ion, we asked 
whether hDaxx-mediated repression is involved in differentiation-dependent MIEP regulation. 
We show that downregulation of hDaxx by us ing small interfering RNA technology in 
und ifferent iated NT201 cells does not permit expression of viral IE genes, nor does it result in 
changes in chromatin structure around the MIEP. Viral IE gene expression is only observed upon 
cellular differentiation, suggesting little involvement of hDaxx in the regu lation of the viral MIEP in 
undifferentiated cells. 
Human cytomegalovirus (HCMV) is the prototypic 
member of the subfamily Betaherpesvirinae. Primary 
.infection of healthy, immunocompetent individuals, 
although usually asymptomatic, results in lifelong persist-
ence of the virus (Ho, 1990). However, primary infection 
or reactivation in immunosuppressed individuals, such as 
transplant or human immunodeficiency virus/A lDS 
patients, can lead to serious disease (Drew, 1988; Rubin, 
1990). 
Like other herpesviruses, early in infection, the genome of 
HCMV becomes associated with nuclear structures known 
as nuclear domain 10 (ND10), which later become 
replication compartments (Ishov & Maul, 1996; Maul, 
1998). ND10 are discrete, interchromosomal accumula -
tions of specific cellular proteins, several of which are 
known transcriptional repressors (Negorev & Maul, 2001). 
[nterestingly, the immediate-early (IE) proteins of several 
human herpesvirnses are known to disrupt these structures 
(Everett, 2001) . Indeed, the HCMV major [E protein IE72 
has been found to be both necessary and sufficient for this 
disruption (Kelly et al., 1995; Korioth et al., 1996; Ahn & 
Hayward, 1997, 2000; Wilkinson et al., 1998). 
Other viral proteins also appear to target these nuclear 
structures. The HCMV tegument protein pp71 has also 
been found to associate with NDlO via interaction with 
hDax:x (Hofmann et al., 2002; [shov et al., 2002). hDaxx is 
known to act as a promiscuous transcriptional repressor 
and probably controls gene expression via recruitment of 
histone deacetylases (HDACs) (Hollenbach et al., 2002; 
Michaelson & Leder, 2003). Therefore, it has been 
0008-3019 © 2007 SGM Printed in Great Britain 
suggested that hDaxx may play some role in control of 
HCMV gene expression upon infection. Consistent with 
this, overexpression of hDaxx in permissive cells causes the 
abrogation of virus infection, whereas, conversely, down-
regulation of hDaxx in permissive cells increases gene 
expression and virus replication ( Cantrell & Bresnahan, 
2006; Preston & Nicholl, 2006; Saffert & Kalejta, 2006a; 
Woodhall et al., 2006). 
Other evidence also suggests that hDaxx plays an 
important role in the repression of infection. The 
recruitment of pp71 to ND lO has been found to cause 
the proteosornal degradation of hDaxx 3- 12 h post -
infection (Saffert & Kalejta, 2006a). In addition, pp71 
knocko ut viruses or a pp71 mutant virus unable to bind to 
hDaxx have been found to result in low levels of IE gene 
expression upon infection. This is relieved if hDax:x 
expression is repressed prior to infection (Cantrell & 
Bresnahan, 2005, 2006; Preston & Nicholl, 2006). 
Fu rthermore, this repression of viral IE gene expression 
appears Lo be regulated through hDaxx-med.iated changes 
to chromatin structure around the viral MIEP, as .infection 
of fibroblasts in which bDax:x expression has been inhibited 
by small interfering RNA (siRNA) technology results in the 
association of the viral MIEP with transcriptionally active 
chromatin (Woodball et al., . 2006). As expected, this 
regulation appears to involve HDACs, as HDAC inhibitors 
such as trichostatin-A (TSA) relieve this repression (Saffert 
& Kalejta, 2006a; Woodhall et al., 2006). 
hDaxx, therefore, plays an important regulatory role in the 
control of HCMV lE gene expression from the MIEP 
2935 
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during productive infection in pennissive cells. However, 
chromatin structure also appears to play an important role 
in the control of viral IE gene expression in non-permissive 
cell types and in the differentiation-dependent control of 
latency and reactivation of HCMV (Sinclair & Sissons, 
2006). Firstly, experimental infection of CD34 + cells and 
monocytes results in the MIEP becoming associated with 
markers of transcriptional repression (Reeves et al., 2005a ), 
namely heterochromatin protein-I (HPl) (Baruuster et al., 
2001 ), and is consistent with a lack of IE gene expression in 
these cells. In contrast, infection of monocyte-derived 
macrophage or mature dendritic cells (DCs) leads to an 
accumulation of acetylated histones around the MIEP, a 
marker of transcriptional activation (Strahl & Allis, 2000), 
and an increase in IE gene expression (Murphy et al., 2002; 
Reeves et al., 2005a). This regulation of gene expression 
from the MIEP also appears to take place in cells from 
naturally infected seropositive donors (Reeves et al., 
2005b) . However, it is unknown whether hDaxx has any 
role in the differentiation-dependent regulation of IE gene 
expression during virus latency or reactivation. 
A number of model cell systems exist that recapitulate the 
differentiation-dependent regulation of viral IE gene 
expression observed during latency and reactivation of 
HCMV. The embryonal carcinoma cell system NT2Dl (T2 
cells), which are non-permissive for viral infection due to a 
block in major IE gene expression, can be differentiated 
with retinoic acid (RA) to a fully permissive phenotype, 
T2RA cells (Andrews et al., 1984; Gonczol et al., 1984; 
Lubon et al., 1989). Differentiation leads to changes in the 
chromatin structure around the viral MIEP in HCMV-
infected cells identical to those observed upon reactivation 
of endogenous latent virus from CD34 + stem cells 
differentiated to DCs (Murphy et al., 2002; Reeves et al., 
2005b). Indeed, treatment of normally non-permissive T2 
cells with TSA has also been forn1d to cause permissiveness 
of tllese cells for productive infection, entirely consistent 
witl1 the involvement of HDACs in tl1e control of MIEP 
activity (Meier, 2001; Murphy et al., 2002). Although T2 
cells have been found to have abnormal ND10, with lower 
levels of PML protein (Hsu & Everett, 2001), these cells 
have been used by a number of laboratories to mimic 
changes in cellular function associated with latency and 
reactivation of HCMV. Therefore, we have sought to 
address whether knockdown of hDaxx in T2 cells bas any 
effect on expression of viral IE genes during HCMV 
infection. 
Firstly, we transiently downregulated cellular hDaxx 
expression in T2 cells through the use of siRNA technology 
described previously (Michaelson & Leder, 2003), supple-
mented with simultaneous transfection via Lipofectamine 
2000 (lnvitrogen) of a second hDaxx-specific siRNA 
(Dharmacon) . Knockdown of hDaxx was confirmed 72 h 
post-transfection both by analysis of RNA levels by RT-
PCR (Fig. la), using sense primer 5'-GACGGACATTT-
CCTCTTCCA-3 ' and antisense primer 5' -TCTCATGCAC-
TGACCTTTGC-3 ' , and by analysis of protein levels by 
2936 
Western blot (Fig. lb), using an hDaxx-specific antibody 
(D7810; Sigma) as described previously (Woodhall et al., 
2006). hDaxx expression was reduced substantially in 
sihDaxx-transfected cells (Fig. la, b, lane 3), confirmed by 
serial dilution of both scramble siRNA-transfected and 
sihDaxx-transfected T2 protein samples (Fig. le, lanes 1-
4), whereas hDaxx levels remained unaffected in mock- or 
scramble siRNA-transfected cells (Fig. la and b, lanes land 
2) . The knockdown of endogenous hDaxx had no effect on 
the differentiation state of T2 cells on the basis of 
expression of Oct4, a POU domain transcription factor 
used routinely as a marker for rn1differentiated cells 
(Rosner et al., 1990), as assessed by RT-PCR using sense 
primer 5' -GCATACTGTGGACCTCAGG-3' and antisense 
primer 5'-CCAAGGTGATCCTCTTCTG-3', and by 
Western blot using an Oct4-specific antibody (abl9857; 
Abeam) (Fig. la, b, lanes 1- 3). As can be seen in Fig. l, 
little or no induction of IE RNA (Fig. la, lane 3) or IE 
protein (Fig. lb, hme 3) occurred in hDaxx knockdown 
cells 24 h post-infection with HCMV strain Toledo. In 
contrast, T2RA cells showed both an absence of Oct4 
expression due to differentiation and the presence of both 
IE RNA (Fig. la, lane 4) and protein (Fig. lb, lane 4) upon 
infection. Ifowever, as tlle Western blot analysis suggested 
that around 10 % of hDaxx protein still remains in 
sihDaxx-transfected T2 cells (Fig. lb, c), we wanted to 
ensure that this residual hDaxx was not sufficient to 
maintain hDaxx-mediated repression of transcription. 
To this end, we used a nuclear factor KB (NF-KB) luciferase 
construct (NF-KB-luc; Stratagene) (0.2 ~Lg per sample) that 
is known to be repressed by hDaxx and whose repression 
can be relieved by siRNAs to hDaxx (Michaelson & Leder, 
2003). All transfections included a fi-actin promoter-driven 
lacZ plasmid ( 0.5 µg per sample) to normalize transfection 
efficiency. Fig. l(d) shows that, 24 h post-transfection, the 
activity of the NF-,cB-luc reporter in sihDaxx-transfected T2 
cells was increased by 4.5-fold compared with scramble 
siRNA-transfected T2 cells. In contrast, an interferon-
responsive luciferase construct that is not NP-KB-dependent 
(ISRE-luc; Poole et al., 2006) (0.5 ~Lg per sample) showed no 
increase in activity in sihDaxx-transfected cells (Fig. ld). 
Thus, the residual level of hDaxx observed in our transient 
knockdown analysis is insufficient to maintain specific 
repression of a known hDaxx-repressible promoter. 
As knockdown of hDaxx in T2 cells had no effect on LE gene 
expression, we hypothesized that the viral MIEP would still 
be associated witl1 transcriptionally repressive chromatin in 
tl1ese cells. Therefore, 'we carried out chromatin immlmo-
precipitation (ChIP) analysis of scramble siRNA- or 
sihDaxx-transfected T2 cells and T2RA cells infected for 
24 h with HCMV exactly as described previously (Reeves 
et al., 2005a). DNA-protein complexes were incubated with 
either control (1: 200 dilution; Sigma-Aldrich), anti-acety-
lated histone H4 ( 1: 200 dilution; Upstate Biotech) or anti-
HPl (1: 200 dilution; Serotec) antiserrnn. The acetylation 
sta tus of histones associated with tlle viral MIEP was then 
analysed by real -time quantitative PCR: the MIEP was 
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amplified with sense primer 5' -CCAAGTCTCCACCCC-
ATTGAC-3' and antisense primer 5' -GACATTTTGGAAA-
GTCCCGTTG-3', complementary to positions -157 aJ1d 
-86 relative to the MIEP start site, aJ1d using a Taqman 
Fig. 1. Transient downregulation of hDaxx in 
T2 cell s is not associated with the presence of 
viral IE gene expression upon HCMV infection. 
(a) RT-PCR analysis of total RNA isolated from 
mock-transfected, scramble siRNA-trans-
fected (Ser) and sihDaxx-transfected infected 
T2 ce lls or infected, d ifferentiated T2 (T2RA) 
cells for hDaxx, IE72, Oct4 and glyceraldehye-
3-phosphate dehydrogenase (GAPDH) RNA 
level s. (b) Western blot analysis of hDaxx, 
IE72/86, Oct4 and GAPDH expression in 
mock-transfected, scramble siRNA-trans-
fected (Ser) and sihDaxx-transfected infected 
T2 cells or infected T2RA cell s. (c) Western 
blot analysis of hDaxx and GAPDH expression 
in 20, 12, 6 and 2 ftl (lanes 1-4, respectively) 
scramble siRNA-transfected (Ser) and 
sihDaxx-tran sfected T2 cells. (d) Luciferase 
activity analys is of an NF-KB luciferase (NF-
KB-luc) construct and an ISRE luciferase 
(ISRE-luc) construct in scramble siRNA-trans-
fected (Ser) and sihDaxx-transfected T2 cells. 
Luciferase analysis was normalized by co-
transfection w ith fi-galactosidase. R.L.U., 
Relative light units. Error bars represent 1 so 
of triplicate experiments. 
probe (FAM-5' -TGGGAGTTTGTTTTGGCACCAAA-3' -
TMR). The IVIIEP in scramble siRNA-transfected T2 cells 
showed little association with acetylated histones (Fig. 2a, 
lane 3 ), but was associated predominantly with HP I (Fig. 2a, 
1.2 (a) T2 Ser 1.2 (b) T2 sihDaxx 1.2 (c) T2RA Mock 
1.0 1.0 1.0 
'5 
a. 
.E 0.8 0.8 0.8 
<! 
z 0.6 0.6 0.6 0 
Q. 
:c 0.4 0.4 0 .4 () 
0.2 0.2 0.2 
1 2 3 4 1 2 3 4 2 3 4 
Fig. 2. Transient downregulation of hDaxx in T2 cell s does not affect the chromatin structure of the viral MIEP and correlates 
w ith IE gene expression. ChlP assays were performed 24 h post-infection (m.o.i., 0.1) on (a) scramble siRNA-transfected T2 
cel ls (Ser), (b) sihDaxx-transfected T2 cel ls and (c) mock-transfected T2RA cells with either control serum (lane 2), an anti-
acetylated histone-H4 antibody (lane 3) or an anti-HP1 antibody (lane 4). Inputs are shown in lane 1. Isolated DNA was 
amplified by using an MIEP-specific real-time quantitative PCR. For comparison, the immunoprecipitated DNA was quantified 
relative to the input DNA. The data are representative of three independent experiments. Error bars represent 1 so of triplicate 
PCRs. 
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lane 4), consistent with a lack of IE gene expression within 
these undifferentiated cells. T2 cells transfected with sihDaxx 
also showed the MIEP to be associated with low levels of 
acetylated histones (Fig. 2b, lane 3), but with high levels of 
HP l (Fig. 2b, lane 4 ), again consistent with a lack of lE gene 
expression in these cells. In contrast, the viral MIEP in T2RA 
cells, permissive for IE gene expression, was associated 
predominantly with acetylated histones (Fig. 2c, lane 3) and 
little HPl (Fig. 2c, lane 4 ), as we have shown previously 
(Murphy et al., 2002). hDaxx knockdown in undifferenti-
ated T2 cells, therefore, appears to have little effect on the 
chromatin status of the promoter, whereas equivalent levels 
of hDaxx knockdown in permissive fibroblasts have 
profound effects on the chromatin structure of the MIEP 
(Woodhall et al., 2006). 
We also confirmed tl1at knockdown of hDaxx did not 
result in permissiveness of T2 cells for viral IE gene 
(a) Ser sihDaxx Mock 
(b) Ser si0ct4 Mock 
2938 
expression by indirect immunofluorescence (Fig. 3a). T2 
cells, transfected with either scramble or hDaxx-specific 
siRNAs for 72 h, and T2RA cells were infected with HCMV 
(at an m.o.i. of 0.5). After a further 24 h, cells were fixed 
( 4 % paraformaldehyde at room temperature for 10 min), 
permeabilized (70% etl1,mol at -20 ·c for 30 min) and 
stained for IE protein and Oct4 expression by using a 
mouse anti -IE72/IE86 antibody (clone El3; Argene) and an 
antibody specific for Oct4 (Abeam). Antibodies were 
detected by using an Alexa Fluor 594-labelled anti -mouse 
antibody (Invitrogen) and a fluoresce.in isothiocyanate-
conjugated anti-rabbit antibody (Sigma) . Consistent with 
our Western blot analysis, neither sihDaxx- nor scramble 
siRNA-transfected cells showed evidence of viral lE gene 
expression. In contrast, T2RA cells showed high levels of 
permissiveness for IE gene expression (Fig. 3a), as expected. 
Differentiation of cells by RA was confirmed by co-staining 
for Oct4 (Fig. 3). 
Fig. 3. Expression of HCMV IE protein is only 
associated with differentiated T2 ce lls. (a) 
Scramble siRNA-transfected (Ser) or 
sihDaxx-transfected T2 cells and T2RA ce lls 
were infected with HCMV (m.o.i., 0.5) and then 
stained for IE72/IE86 (red) and Oct4 (green) 
expression 24 h post-infection. (b) Scramble 
siRNA-transfected (Ser) or si0ct4-transfected 
T2 cells and T2RA cells were infected with 
HCMV (m.o.i., 0.5) and then stained for IE72/ 
IE86 (red) and Oct4 (green) expression 24 h 
post-infection. Hoechst 33342 staining (blue) 
was used throughout to identify cell nuclei. 
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HCMV can bind to and enter w1differentiated T2 cells, but 
cannot initiate IE gene expression (Meier, 2001 ), and this is 
probably due to the presence of high levels of transcrip-
tional repressors and low levels of transcriptional activators 
of the MIEP (Sinclair & Sissons, 2006). Activators of the 
MIEP, such as NF-KB, CREB and Spl (Hunninghake et al., 
1989; Sambucetti et al., 1989; Lang et al., 1992), are known 
to be at lower levels in lmdifferentiated cells than repressors 
such as YYl and ERF, which also bind to sites in the MIEP 
(Liu et al., 1994; Bain et al., 2003; Wright et al., 2005). In 
addition, some of these repressors are able to interact with 
specific co-repressors, such as HDACs and histone 
methyltransferases (Yang et al., 1996; Wright et al., 
2005). Consequently, the transcriptional mi lieu of cells is 
likely to dictate whetl1er infection with HCMV results in 
viral IE gene expression and productive infection. Indeed, 
specific knockdown of Oct4, a master regulator of 
differentiation, in T2 cells resulted in differentiation of 
these cells, as expected (Hay et al., 2004; Matin et al., 2004), 
and increased their pennissiveness for HCMV IE gene 
expression (Fig. 3b). This also confinns that our knock-
down technology can indeed resu lt in T2 cells becoming 
permissive for IE gene expression. 
In conclusion, although hDaxx has been implicated in 
repression of IE gene expression from the MIEP in 
permissive cell types, our results show tl1at hDaxx does 
not control differentiation-dependent regulation of the 
viral MIEP in tl1e conditionally permissive cell line NT2Dl. 
IE gene expression and productive infection could only be 
seen in cells that were differentiated. We are aware that 
these results are in contrast to results of Saffert & Kalejta 
(2006b), who observed increased IE gene expression in 
undifferentiated cells after hDaxx knockdown; in collab-
oration, experiments are being carried out to address these 
discrepancies. However, it is also worth noting that levels 
of hDa..xx protein do not differ significantly between non-
permissive, undifferentiated cells and differentiated, per-
missive cells (data not shoW11), making it difficult to 
propose that levels of hDaxx protein alone control 
permissiveness in this model system. Consequently, our 
data support the argument that the permissiveness of cells 
for viral IE gene expression ultimately depends on the 
differentiation status of the infected cell. 
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Upon herpesvirus infection, viral DNA becomes associated 
with nuclear structures known as nuclear domain 10 (NDIO). 
The role of NDIO during herpesvirus infection has long been 
contentious; data arguing for a role for NDIO in repression of 
infection have been countered by other data showing little effect 
of NDH> on virus infection. Here we show that knockdown of 
human Daxx (hDaxx) expression, an important component of 
ND 10, prior to infection with human cytomegalovirus resulted 
in increased levels of viral immediate early RNA and protein 
expression and that this correlated with an increased associa-
tion of the major immediate early promoter with markers of 
transcriptionally active chromatin. Conversely, we also show that 
stable overexpression ofhDaxx renders cells refractory to cytomeg-
alovirus immediate early gene expression. Intriguingly, this hDaxx-
mediated repression appears to be restricted to cells stably overex-
pressing hDaxx and is not recapitulated in transient transfection 
assays. Finally, hDaxx-mediated repression of cytomegalovirus 
major immediate early gene expression was overcome by infecting 
at higher virus titers, suggesting that an incoming viral structural 
protein or viral DNA is responsible for overcoming the repression 
of viral gene expression in hDaxx superexpressing cells. These data 
suggest that hDaxx in NDH> functions at the site of cytomegalovi-
rus genome deposition to repress transcription of incoming viral 
genomes and that this repression is mediated by a direct and imme-
diate effect of hDaxx on chromatin modification around the viral 
major immediate early promoter. 
Human cytomegalovirus (HCMV) 3 js an extremely wide-
spread, opportunistic pathogen of considerable clinical signifi-
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IE72 and IE86, immediate early protein 72 and 86, respectively; TSA, tricho-
statin A; MOI, mul t iplicity of infect ion; ChlP, chromatin immunoprecipita-
tion assay; RFP, red fluorescent protein; pp71 , phosphoprotein TI ; PML, 
promyelocytic leukemia; siRNA, small interfering RNA; hDaxx, human 
Daxx; siDaxx, small interfering Daxx; mDaxx, mouse Daxx; sihDaxx, small 
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cance. Primary infection of healthy, immunocompetent indi-
viduals with HCMV is normally asymptomatic. However, as is 
the case with all herpesviruses, after the initial control of pri-
mary infection by the immune system, HCMV establishes life-
long latency in the host. During latency and througho ut the 
lifetime of the infected individual, the herpesviruses can reacti-
vate. Although generally asymptomatic, such reactivation can 
res ul t in severe disease. As such, the disease burden of herpes-
viruses can be life-long and particularly severe when associated 
with immunos uppress ion, such as in transplant patients and in 
human immunodeficiency virus-infected patients who have 
developed immunodeficiency (1, 2). 
After infection with herpes simplex virus-1, the viral 
genomes appear to co-localize with cellular nuclear structures 
known as nuclear domain 10 (NDlO) and give rise to replication 
centers in close proximity to these sites (3, 4). NDlO are discrete 
interchromosomal accumulations of a number of proteins, 
many of which are transcriptional repressors. Intriguingly, 
many of the human herpesviruses encode an immediate early 
protein, which functions to destroy or redistrib ute components 
of NDlO (5-17), and a number of studies have attempted to 
address the role of ND l O during infection. One of the fi rst 
observations was that ICPO (intracellular protein O) of herpes 
simplex virus-1 was sufficient for the disruption ofNDlO (14) 
and that disruption occurred via proteosomal degradation of 
the promyelocytic leukemia (PML) protein, an essential struc-
tural component ofNDlO (15, 18, 19). 
Parallel studies with HCMV have identified that an immedi-
ate early protein, IE72, is similarly necessary and sufficient for 
the disruption of NDlO (5, 6, 11, 12, 16), although this disrup-
tion is mediated through an unknown mechanism and does not 
occur thro ugh ubiquitination and degradation via the proteo-
some (5, 20). In HCMV-infected cells, despite its relocation, 
PML has not been shown to be altered biochemically. Experi-
ments that analyzed HCMV infection of a fully permissive 
astrocytoma cell line engineered to stab ly express PML (21), 
showed that disruption of NDlO by virus was delayed by up to 
6 h compared with controls. Concomitant with this, viral DNA 
replication compartment formation was delayed, and the 
expression of early and late viral proteins were suppressed. 
interfering human Daxx; simDaxx, small interfering mouse Daxx; EMEM, 
Eagle's minimal essential medium; H3-K9, histone H3 dimethylated at 
lysine residue 9; TRITC, tetramethylrhodamine isothiocyanate. 
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Overall, these data supported the suggestion that NDlO repre-
sents a nuclear environment which is unsupportive of viral gene 
transcription and that may function in an antiviral capacity. 
Consistent with this, a recent report has shown that the tar-
geted knockdown of PML expression (and thus NDlO integrity) 
prior to viral infection results in the release of increased titers of 
progeny virus following productive infection (22). 
The interaction of HCMV proteins with NDlO does not 
appear to be exclusive to IE72. The viral tegument protein and 
transactivator, pp71, accumulates at NDlO in a process medi-
ated by another major NDlO component, the hDaxx protein 
(23-25). This results in a transient pp71 -mediated degradation 
of hDaxx between 3 and 12 h of infection, argu ing for a role of 
hDaxx in repression of infection (26). Cons is tent with t his, 
hDaxx can function as a promiscuous transcriptional repressor, 
possibly via the recruitment of histone deacetylases to tran-
scriptionally active chromatin (27), resul ting in a closed chro-
matin structure and the repression of transcription (28 -30). 
It is becoming increasingly clear that herpesvirus gene 
expression may also be regulated by chromatin structure (31, 
32). For example, the regulation of the major immediate early 
promoter (MIEP) is likely to involve higher order chromatin 
structure (32, 33). In experimentally infected monocytes and 
CD34+ cells, the MIEP is associated with HP-1 (heterochroma-
tin protein 1), a classical marker of transcriptionally repressed 
chromatin (34), which is consistent with a lack of IE gene 
expression in these cells. In contrast, following infection of 
macrophages or mature dendritic cells, the MIEP is associated 
with acetylated histones, a marker of transcriptional activation 
(29, 30), and this correlates with detectable IE gene expression 
in these cells (32). Furthermore, this regulation of the MIEP by 
chromatin structure is also likely to be important during 
HCMV latency and reactivation in cells isolated from naturally 
infected seropositive individuals (35). 
Although chromatin structure of the viral MIEP is clearly 
associated with latency and reactivation of viral IE gene expres-
sion, there is increasing evidence that chromatinization of the 
MIEP may also play a role during productive infection of fully 
permissive cell types. Although the virus and its major IE pro-
moter exhibit only limited sequence homology with HCMV, in 
mouse cytomegalovirus there is evidence that chromatiniza-
tion of the viral genome accompanies productive infection (36). 
The addition of the general histone deacetylase inhibitor tri-
chostatin A (TSA) to permissive mouse embryonic fibroblast 
cells increased both the levels of murine IEl gene expression 
and the titer of the virus recovered from these cells. Since one of 
the earliest events postinfection is the deposition of viral 
genomes at NDlO bodies (3, 37) and both the hDaxx and PML 
proteins interact with chromatin-remodeling enzyme activity (27, 
38, 39), increased mouse cytomegalovirus IE gene expression 
induced by TSA upon deposition of the viral genomes to NDlO 
bodies may, at least in part, be due to the inhibition of histone 
deacetylases localized to NDlO bodies (36). Furthermore, we have 
observed that the MIEP ofHCMV is also dynamically regulated by 
changes in post-translational modification of histones during pro-
ductive infection of human fibroblast cells (40). 
In this study, we have investigated the roles of hDaxx expres-
sion in the context of infection with HCMV. By the use of small 
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interfer ing RNA (siRNA), we show that knockdown of hDaxx 
express ion in fully permissive cell lines prior to infection 
resulted in increased levels of LE RNA and protein expression in 
the siDaxx-treated cells and that this correlated with an 
increased association of the MIEP with markers of transcrip-
tionally active chromatin. Conversely, we also show that stable 
overexpression of hDaxx or a red fluorescent protein-tagged 
hDaxx (RFP-hDaxx) renders cells refrac tory to HCMV imme-
diate early gene expression. Intriguingly, this Daxx-mediated 
repression appears to be restricted to cells stably overexpress-
ing hDaxx and is not recapitulated in transient transfection 
assays. Finally, hDaxx-mediated repression of HCMV major IE 
gene expression in cells stably overexpressing hDaxx was over-
come by infecting at higher MO Is or by preincubating the cells 
with the histone deacetylase inhibitor TSA, suggesting that an 
incoming viral structural protein or viral DNA can overcome 
this hDaxx-mediated repression and that the observed Daxx-
mediated repression of IE gene expression requires the recruit-
ment of chromatin-modifying enzymes to the MIEP. 
EXPERIMENTAL PROCEDURES 
Cells and Viruses-Human foreskin fibroblasts and human 
malignant glioma cells (U373 MG), were grown in Eagle's min-
imal essential medium (EMEM) (Invitrogen), supplemented 
with 10% (v/v) feta! calf serum with added penicillin/strepto-
mycin (EMEM-10) at 37 °C in a humidified 5% C02 atmo-
sphere. The low passage strain Toledo or AD169 was used for 
all HCMV infections. For infection with HCMV, cells were 
infected at room temperature for 1 h, with rocking, before the 
virus-containing medium was aspirated and replaced with fresh 
EMEM-10. 
Plasmids and Transjections-pCDNA3hDaxx contains a 
full-l ength cDNA of hDaxx in the pCDNA3 expression vector. 
pDsRed (Clontech) encodes a novel RFP under the control of 
the minimal HCMV MIEP. pDsRed-hDaxx (a kind gift of Rich-
ard Caswell, Cardiff University) consists of the full-length 
hDaxx cDNA, minus the stop codon, cloned into EcoRI/ 
BamHI-digested sites in pDsRedl-Nl. To create cell popula-
tions transiently or stably expressing plasmid constructs, 
25-cm2 flasks were seeded with - 1 X 106 cells 24 h prior to 
transfection. 2 h prior to transfection, cells were washed once 
with phosphate-buffered saline and overlaid with 4 ml of fresh 
EMEM-10. Each flask was transfected with 20 µ,g of plasmid 
DNA using the CaCl2 method. To se lect for stable transfec-
tants, 24 h later, the EMEM-10 was replaced with fresh 
EMEM-10 containing 1 mg/ml G418 (Invitrogen), to select for 
cells expressing the Geneticin res istance cassette. 
lmmunojluorescent Microscopy-For immunofluorescence, 
5 X 10'' U373 cells/well were seeded on 8-well slides (Nunc) and 
infected at an MOI of 0.5-1, as described above. To detect pp65 
protein at 8 h post-infection, cells were fixed in 4% paraformalde-
hyde for 15 min at room temperature and then permeabilized in 
70% EtOH (-20 °C) for 15 min. Following washing, a mouse 
monoclonal anti-pp65 antibody (described in Ref. 41 and a kind 
gift ofBodo Plachter, Universitat Mainz, Germany) diluted 1: 10 in 
phosphate-buffered saline containing 1 % bovine serum albumin 
was added to cells for 1 h at room temperature. Cells were then 
washed twice in phosphate-buffered saline and stained with rabbit 
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Daxx-mediated Repression of HCMV Gene Expression 
anti-mouse fluorescein isothiocyanate (1: 100 dilution; Santa Cruz 
Biotechnology Inc., Santa Cruz, CA). 
For PML, hDaxx, and IE72/IE86 staining, cells were stained 
as described above with either a rabbit anti-hDaxx antiserum 
(1:100 dilution; Upstate Biotechnology, Charlottesville, VA) for 
1 h, a mouse anti-IE72/IE86 antibody (1:100 dilution; clone El3, 
Argene, Varilhes, France) or a mouse anti-PML antibody (1 :200 
dilution; Santa Cruz Biotechnology). hDaxx expression was 
then detected by staining with a fluorescein isothiocyanate-
co njugated goat anti-rabbit IgG antibody (1:30 dilution; Sigma) 
or donkey anti-rabbit Alexatluor 594 (1 : 100 dilution; Sigma) for 
1 h. PML or IE72/IE86 expression was detected using a fluores-
cein isothiocyanate-conj ugated goat anti-mouse IgG antiserum 
for 1 h (1:30 dilution; Sigma). All nuclei were co unterstained 
with Hoechst 33242 (Sigma). 
Cells were examined by UV microscopy, using the appropri-
ate narrow band filters, in a Nikon Eclipse TE300 inverted 
microscope (Nikon UK Ltd.). Images were captured using a 
Hamamatsu color chilled 3CCD camera (Hamamatsu City, 
Japan), linked to the microscope, and Image Pro 4.1 software 
(Media Cybernetics UK). 
W here specified, a minimum of 10 representative fields of 
view were counted for total cell number and the corresponding 
number of cells that were positive for hDaxx, RFP-hDaxx, or IE 
antigen expression as well as co-expression of IE antigen and 
hDaxx or RFP-hDaxx. 
Chromatin lmmunoprecipitation (ChlP} Assay-Chromatin 
immunoprecipitations were carried out essentially as previ-
ously described (32, 35). Briefly, fibroblasts were fixed with 1 % 
fo rmaldehyde to cross- link the DNA-protein interactions and 
then lysed. DNA associated with histones was immunoprecipi-
tated with rabbit control serum (Sigma), anti-acetyl histone H4 
antiserum (ChIP grade; Upstate Biotechnology), or anti-di-
methylated (K9) histone H3 antiserum (Upstate Biotechnol-
ogy) at a 1:200 dilution overnight at +4 °C. 
DNA from disrupted nucleosomes was precipitated and 
amplified by PCR using the following conditions. The MIEP 
was amplified with sense primer (5 ' -TGG GAC TTT CCT ACT 
TGG-3') and antisense primer (5' -CCA GGC GAT CTG ACG 
GTT-3') complementary to positions -272 and + 13 relative to 
the MIEP start site. The cycle parameters for amplification by 
MIEP-PCR were 20 cycles at 94 °C (40 s), 50 "C (40 s), and 72 "C 
(90 s). PCR products were transferred to nitrocellulose and 
hybridized to an MIEP-specific 3 2P (Amersham Biosciences)-
radiolabeled probe. The probe fragment was generated by PCR 
of HCMV DNA using sense primer (5' -ATT ACC ATG GTG 
ATG CGG TT-3') and antisense primer (5'-GGC GGA GTT 
GTT ACG ACA T-3'). Band intensity was analyzed using 
Image J analysis software. 
Transient Down-regulation of Human and Murine Daxx 
Expression-siRNAs, previously shown to down-regulate 
hDaxx and mDaxx expression (42), were used in primary fibro-
blasts. The hDaxx siRNA was supplemented with a second 
hDaxx-specific siRNA (Dharmacon, Lafayette, CO) to maxi-
mize knockdown in subsequent experiments. All siRNAs were 
res uspended as 20 mM stocks. siRNAs were transfected into 
primary fibroblasts (passages 16-19) using Lipofectamine-
2000 according to the manufacturer's instructions (Invitrogen). 
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Scramble siRNA (Dharmacon, Lafayette, CO) was used as a 
negative contro l siRNA duplex in these studies. The knock-
down of hDaxx expression-transfected fibroblasts was assessed 
by Western blot analysis of to tal ce ll extracts. 
Western Blotting-Western blot analyses of hDaxx, mDaxx, 
or IE72/IE86 expression were performed on total protein 
extracts of 105 fibroblasts, which, following SDS-P AGE electro-
phores is and transfer to nitrocellulose, were incubated with 
either a rabbit anti-hDaxx antiserum (1:4000 dil ution; Sigma), a 
rabbit anti-mDaxx antiserum (1:200 dilution; Santa Cruz Bio-
technology), or mouse anti-IE72/IE86 antibody (1:1200 dilu-
tion; clone El 3; Argene, Varihles, France) for 1 h and then a 
secondary horseradish peroxidase-conj ugated goat anti-rabb it 
or rabbit anti-mouse antiserum (1:2000 dilution; Sigma) for 20 
min. Horseradish peroxidase activity was detected using ECL 
(Amersham Biosciences) as described by the manufacturer. 
The hDaxx and mDaxx proteins are detected as a 120-kDa band 
by SDS-PAGE. 
Reverse Transcription-PCR-RNA was iso lated from fibro -
blasts using RNazol B (Biogenes is, Poole, UK) as described by 
the manufacturer. Reverse transcription of 10 /Lg of total RNA 
was achieved using an avian myeloblastosis reverse tran-
scriptase kit (Pro mega, Madison, WI) as described by the man-
ufacturer. Primers designed to the IE region of the HCMV 
genome (between 172,468 and 172,776 n ucleotides) were used 
to amplify a 194-bp fragment from cDNA using sense primer 
(5 ' -CGT CCT TGA CAC GAT GGA GT-3 ' ) and antisense 
primer (5'-ATT CTT CGG CCA ACT CTG GA-3 '). The cycle 
parameters for amplification of immediate early cDNA were 20 
cycles at 94 °C ( 40 s), 55 °C (40 s) , and 72 °C (90 s) . Cellular 
housekeeping gene glyceraldehyde-3-phosphate dehydrogen-
ase was amplified using sense primer (5'-GAG TCAACG GAT 
TTG GTC GT-3') and antisense primer (5'-TTG ATT TTG 
GAG GGA TCT CG-3'). The cycle parameters for amplifica-
tion by glyceraldehyde-3-phosphate dehydrogenase-PCR were 
20 cycles at 94 °C (40 s), 60 °C (40 s), and 72 °C (90 s). 
RESULTS 
It has been shown that a number of enzymes involved in 
chromatin remodeling are localized to NDlO bodies, including 
histone deacetylases and histone methyltransferases (27, 38, 
39). The activity of the MIEP is regulated by higher order chro-
matin structure in both cell lines (32, 43) and primary myeloid 
cells during productive infection (32, 33) and during natural 
latency (35). More recently, we have observed that the MIEP is 
also associated with specific forms of chromatin during produc-
tive infection of fibroblasts,4 and thus we wished to determine 
whether repression qfIE gene expression co uld be due to hDaxx 
mediating a repressive chromatin structure aro und the virai 
MIEP. 
To do this, we used siRNAs to specifically target the down-
regulation of endogenous hDaxx protein expression in primary 
human fibroblasts. Western blot analysis of hDaxx protein in 
siRNA-treated cells (Fig. lA) clearly shows good down-regula-
tion of hDaxx protein expression in cells transfected with sih-
Daxx (Fig. 1, A (lane 3) and D (lane 4)) and not in untreated 
4 I. J. Groves, M. B. Reeves, and J. Sincla ir, unpublished data. 
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FIGURE 1. Transient down-regulation of Daxx correlates with changes in 
the activity of the viral MIEP in permissive cells. A, Western blot analysis of 
hDaxx expression in mock-transfected (lane 1), scramble-transfected (lane 2), 
and sihDaxx-transfected (lane 3) primary human foreskin fibroblast ce lls. A 
Coomassie Blue-stained gel is shown as a protein loading control. 8, Western 
blot analysis of mock-transfected (lane 1), scramble-transfected (lane 2), and 
sihDaxx-transfected (lane 3) fibroblasts for IE72/IE86 protein expression 24 h 
postinfection at an MOI of 0.5. A Coomassie Blue-stained gel is shown as a 
protein loading control. C. reverse transcription-PCR analysis of total RNA 
isolated from mock-transfected (lane 1), scramble-transfected (lane 2), and 
sihDaxx-transfected (lane 3) fibroblasts for IE72 and glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) expression. 0 , Western blot analysis ofhDaxx 
and IE72/ IE86 expression in mock-transfected (lane 1), scramble-transfected 
(lane 2), sim Daxx-transfected (lane 3), and sihDaxx-transfected (lane 4) pri-
mary human foreskin fibroblast cell s. A Coomassie Blue-sta ined gel is shown 
as a protein loading control. E, Western blot analysis of mDaxx expression in 
mock-transfected (lane 7), scramble-transfected (lane 2). and sim Daxx-trans-
fected (lane 3) primary mouse embryo fibroblast ce ll s. A Coomassie Blue-
stained gel is shown as a protein loading control. 
(lane 1) or scramble siRNA-transfected fibroblasts (lane 2). 
This knock-down ofhDaxx by specific siRNAs was maintained 
at similar levels up to 70 h post-transfection (data not shown). 
As additional contro ls for off-target effects of siRNA treatment, 
an siDaxx directed against the murine form of Daxx that 
resulted in the knock down of murine Daxx in mouse embryonic 
fib roblasts (Fig. 1£ , lane 3) had no effect on hDaxx expression in 
human fibroblasts (Fig. ID, lane 3). 
Having established that the transfection of sihDaxx resulted 
in the substantial knock-down of hDaxx expression, cells trans-
fected with siDaxx or scramble siRNA duplexes were subse-
quently infected with HCMV to deterrnine the effect of hDaxx 
on H CMV infection. Western blot analysis for IE gene expres-
sion was performed on mock-, scramble siRNA-, sihDaxx-, and 
simDaxx-transfected cells at 24 h postinfection at an MOI of 0.5. 
Infected fibroblasts transfected with hDaxx-specific siRNAs show 
increased levels ofl.E72 and IE86 gene expression (Fig. 1, B (lane 
3) and D (lane 4)), compared with mock-transfec ted (lane 1), 
scramble siRNA-transfected (la ne 2), or simDaxx- transfected 
(Fig. ID, lane 3) controls. This increase in IE protein expression 
correlated with increased ab undance of the I.E72 RNA as 
detected by a concomitant reverse transcription-PCR analysis 
for IE expression (Fig. 1 C). The data also shows that there are 
increased quantit ies of IE RNA present in cells at 24 h postin-
fection in sihDaxx-transfected fibroblas ts (Fig. 1 C, lane 3) when 
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FIG URE 2. Transient down-regulation of hDaxx prior to infection results 
in a loss of repressive chromatin structure around the viral MIEP. ChlP 
assays were performed 3 h postinfection on mock, scramble, and siDaxx-
transfected ce ll s with an anti-acetylated histone H4 antibody (lanes 3, 7, and 
7 7), an anti-di methylated hi stone H3-K9 an tibody (lanes 4, 8, and 7 2), or a 
rabbit isotype contro l (lanes 2, 6, and 70). Inputs are shown (lanes 7, 5, and 9). 
Isolated DNA was amplified using an MIEP-specific PCR and analyzed by 
Southern blot. For comparison, the immunoprecipitated DNA was quantified 
relative to the input DNA. Error bars, 1 S.D. of three independent experiments. 
compared with either mock (Fig. lC, lane 1) or scramble 
siRNA-transfected (Fig. lC, lane 2) cells. 
The levels of the l.E72 and IE86 mRNAs detected in sihDaxx-
treated cells during HCMV infection is consistent with a model 
in which hDaxx acts to suppress transcription from the MIEP. 
Consequently, we asked whether knock-down of hDaxx in 
these cells correlated with an increase in the proportion of 
MIEPs associated with transcriptionally active chromatin. 
Chromatin was isolated from infected cells (MO! = 1) and ana-
lyzed by a ChIP assay specific for the viral MIEP (Fig. 2). At 3 h 
postinfection, the MIEP in untransfected control cells was asso-
ciated with acetylated histones (Fig. 2, bar 3), as might be pre-
dicted for an immediate early promoter. We observed a similar 
pattern following the infection of scrambled siRNA-transfected 
fibroblasts (Fig. 2, bar 7). Interestingly, a substantial proportion 
of the viral MIEPs were also immunoprecipitated with histone 
H3 dimethylated at lysine residue 9 (H3-K9) (Fig. 2, bars 4 and 
8) . The methylation of H:3-K9 is a highly characterized marker 
of transcriptionally silenced chromatin, and thus this observa-
tion suggests that a proportion of incoming viral genomes at 
this MOI are associated with repressive chromatin at 3 h 
postinfection. However, when we perfo rmed the same analysis 
in infected fib roblasts, which had been transfected with hDaxx-
specific siRNAs, a different pattern of chromatinization was 
observed. Fig. 2 shows that a greater proportion of the MIEPs in 
siDaxx-treated cells were associated with an increased level of 
acetylated histones (Fig. 2, bar 11) and with much lower levels 
of dimethylated histones (Fig. 2, bar 12). Down-regulation of 
hDaxx prior to infection, therefore, appears to res ult in a dis-
cernible increase in the level of acetylation and concomitant 
decrease in the level, of methylation of his tones bound to the 
MIEP at 3 h postinfection. 
hDaxx knock-down experiments strongly suggested that 
hDaxx was involved in repression of HCMV major IE gene 
expression as early as 3 h postinfection. We decided to deter-
mine, conversely, if overexpression of hDaxx could inhibit 
HCMV infect ion. To do this, we overexpressed hDaxx in U373 
cells by transient transfect ion. Surprisingly, cells transiently 
overexpressing hDaxx were as permissive for HCMV (F ig. 3A) , 
as contro l DsRed-transfected cells (data not shown) or the 
untransfected cells in the pcDNA3hDaxx-transfected popula-
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FIGURE 3. Transient overexpression of hDaxx has little effect on levels of 
superinfection with HCMV. A, U373 ce ll transiently transfected w ith 
pCDNA3Daxx were infected with HCMV at an MOI of 1 and then stained for 
hDaxx expression (Daxx) and vira l IE gene expression (IE) 24 h postinfection. 8 
and C, uninfected U373 ce lls transiently transfected with pcDNA3hDaxx were 
also sta ined for hDaxx (Daxx) and PML (PML) expression. In A-C, Hoechst 
33342 sta ining was used to identify cell nuclei. 
tion (nonred cells in Fig. 3A), as determined by IE gene expres-
sion. Consistent with observations from other workers, com-
mercial anti-hDaxx antibodies are unable to detect endogenous 
hDaxx by indirect immunofluorescence but can detect hDaxx 
overexpressed by transfection. However, overexpressed hDaxx 
in transiently transfected cells was seldom detected associated 
with NDlO (see Fig. 3B), as might be expected. Co-localization 
of transiently expressed hDaxx with PML appeared only to 
occur in cells expressing relatively low levels of hDaxx (Fig. 3C). 
Such cells made up - 10% of the transiently transfected popu-
lation (data not shown). 
Since it is becoming increasingly clear that hDaxx: function 
can be profoundly affected by its location, and in particular 
whether it is free or NDlO-associated, we decided to also over-
express hDaxx by stable co-transfection (Fig. 4) . Cautious of the 
differences we observed in hDaxx locali?-ation during transient 
transfection, we generated G418r cells stably expressing hDaxx. 
To avoid nonrepresentative clones, a polyclonal population of 
G418r hDaxx-expressing cells was used. In contrast to tran-
siently expressed hDaxx, U373 cells stably transfected with 
hQaxx all exhibited punctuate fluorescence, which co-localized 
with PML-stained NDlO (Fig. 4B). Interestingly, these stably 
transfected hDaxx cells were refractory to infection with 
HCMV (MOI = 1) as determined by viral IE gene expression 
(Fig. 4A). Direct quantification of the immunofluorescence 
shown in Fig. 4A revealed that stably superexpressing hDaxx 
cells exhibited an approximate 10-fold decrease in HCMV IE 
gene expression after superinfection (Fig. 4, A and C) .We also 
quantified the level of overexpression of hDaxx in these cells by 
Western blot analysis (see Fig. 7 A). On the basis that - 20% of 
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FIGURE 4. U373 cells constitutivelyoverexpressing Daxxare refractory to 
infection with HCMV. A, U373 cells stably transfected with pcDNA3hDaxx 
were superinfected with HCMVat an MOI of 1. Cells were fixed and stained for 
hDaxx expression (Oaxx) and vira l IE gene expression (IE). 8, these ce ll s fixed 
and sta ined for hDaxx expression (Daxx) were also sta ined for PML expression 
(PML). A and 8, Hoechst 33342 sta ining was used to identify ce ll nuclei. C, cell s 
stably transfected with DsRed or pcDNA3hDaxx, superinfected with HCMV, 
were also co-stained for hDaxx and viral IE gene expression and analyzed by 
counting of representative fields; a minimum of 100 ce ll s were counted from 
each of two independent experiments. The percentage of red ce ll s (RFP- or 
TRITC-stained hDaxx-expressing ce lls) co-fluore scing green (IE-expressin g 
cells) was quantified. Error bars, S.D. 
cells discernibly overexpressed hDaxx by indirect immunotlu-
orescence (Fig. 4A), Image J analysis of hDaxx band intensities 
of stably transfected cDNA3hDaxx versus stably transfected 
DsRed cells (Fig. 7A, tracks 1 and 4, respectively) suggest that 
hDaxx was overexpressed 3-4-fo ld in stably transfected 
cDNA3hDaxx cells. 
In order to expedite analysis of co-expression of superex-
pressed hDaxx and viral IE gene expression, we also con-
structed a plasmid vector in which hDaxx was expressed as in 
frame with reel fluorescent protein, generating RFP-tagged 
hDaxx (RFP-hDaxx). To do this, we stably transfected U:373 
ce lls with DsRed and DsRed-hDaxx (Fig. 5) and investigated the 
effects of RFP-hDaxx stable expression on infection with a 
HCMV. Once again, we generated G418r nonclonal pop ula-
tions of cells stably expressing RFP and RFP-hDaxxto minimize 
the risk of selection of nonrepresentative cell clones. Stably, 
overexpressed RFP-hDaxx exhibited punctate nuclear expres-
sion (Fig. 5, A and B) characteristic of NDlO, consistent with 
our observations in U373 cells stably transfected with untagged 
hDaxx. Interestingly, transiently transfected DsRed-hDaxx 
again showed that, ll1 most cells, the RFP-hDaxx did not co-
localize with PML except in cells expressing very low amo un ts 
of transfected RFP-hDaxx (data not shown), again suggesting 
that ana lyses in which hDaxx is transiently transfected in to cells 
may be difficult to interpret. In contrast to our transient trans-
fection data, we clearly observed that stably, overexpressed 
RFP-hDaxx localized to NDlO by immunofluorescent staining 
for endogenous PML protein (Fig. SB). The punctate staining of 
both RFP-hDaxx and PML fully co-localized, confirming that in 
DsRed-hDaxx stably transfected cells RFP-hDaxx localized pre-
dominantly to NDlO bodies (Fig. SB). In contrast, RFP 
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FIG URE 5. Cells stably expressing RFP-Daxx show co-localization of RFP-
Daxx to bona fide ND10 bodies. A, U373 cells stably transfected with DsRed 
and expressing RFP (RFP) or stably transfected with DsRed-hDaxx and 
express ing RFP-hDaxx (RFP-Oaxx) were analyzed by fluorescent microscopy. 
8, ce ll s stably expressing RFP-hDaxx were also co-stained for PML (PML). 
Hoechst 33342 staining was used to identify ce ll nuclei . 
expressed in DsRed-transfected cells showed diffuse cytoplas-
mic and nuclear expression (Fig. SA), entirely different from 
RFP-hDaxx localization. 
To test whether expression of other NDlO components was 
affected by RFP or RFP-hDaxx in stably transfected cells, Western 
blot analyses were performed on untransfected U373 cells or U373 
cells transfected with DsRed or DsRed-hDaxx. Analysis of nuclear 
extracts showed that endogenous levels of hDaxx were equal in all 
of the three cell lines, as were levels of SplOO and PML (data not 
shown). Based on a comparison of the number of cells in the stably 
transfected DsRed-hDaxx population overtly expressing RFP-
hDaxx (-16%; see Fig. SA) and Western blot analysis of endoge-
nous hDaxx versus RFP-hDaxx (as was carried out for stablytrans-
fected cDNA3hDaxx cells, above), RFP-hDaxx was overexpressed 
- 2-fold with respect to endogenous DMX in stably transfected 
DsRed-hDaxx cells (Fig. 7B) . 
We then investigated the effec ts of this RFP-hDaxx overex-
pression on HCMV infection. U373 DsRed- and U373 DsRed-
hDaxx-transfected cells were infected with HCMV at an MOI 
of 1. At 18 h postinfection, cells were fixed and stained for IE 
gene expression and visualized by fluorescence microscopy for 
the co-expression of IE72, RFP, and RFP-hDaxx proteins. The 
U373 DsRed cells were fully permissive for HCMV IE gene 
expression {Fig. 6A, b).However, in U373 cells overexpressing 
RFP-hDaxx, no IE72 expression co uld be detected (Fig. 6A, e) . 
This effect was specific to DsRed-hDaxx-transfected cells, since 
in the same field of view, cells that were not overexpressing 
RFP-hDaxx expressed detectable levels ofIE72. Consistent with 
our observations with untagged hDaxx, these data suggested 
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that HCMV IE gene expression is precluded by high levels of 
RFP-hDaxx expression (Fig. 6A, e) but not RFP (Fig. 6A, b). 
In order to rule out the possibility that U373 DsRed-hDaxx-
transfected cells were refractory to virus binding and internal-
ization, we also infected and analyzed them for expression of 
HCMV tegument protein, pp65. By indirect immunofluores-
cence, pp65 tegument protein could clearly be visualized within 
U:373 RFP-Daxx-expressing cells (Fig. 6A, h), precluding the 
possibility that the repressive effects of RFP-Daxx overexpres-
sion on virus IE gene expression res ults from effects on virus 
binding or entry. 
We also quantified the number of RFP- or RFP-hDaxx-ex-
pressing cells co-expressing viral IE72 in the polyclonal popu-
lations of U:373 cells transfected with either DsRed or DsRed-
hDaxx, respectively. Fig. 6B shows that cells that stably 
overexpressed RFP-hDaxx also showed a 7-fold decrease in 
their ability to support HCMV IE gene expression after super-
infection. This repression was less pronounced in cells infected 
at higher MO Is, such that the 7-fold decrease in HCMV IE gene 
expression observed in hDaxx-RFP-expressing cells infected at 
an MOI of 1 was substantially reduced by infection at an MOI of 
10 (Fig. 6C), suggesting that hDaxx-mediated repression of the 
MIEP in cells stably expressii1g RFP-hDaxx can be titrated away 
by increasing MO Is. Indeed, consistent with this, a Western 
blot analys is of hDaxx protein levels at 3 h postinfection of 
cDNA3hDaxx and DsRed stably transfected cells showed that 
HCMV-induced degradation of hDaxx protein required higher 
viral titers in cells stably transfected with cDNA3hDaxx (Fig. 
7A). Consistent with published data (26), hDaxx degradation 
was induced by HCMV infection of control U373 cells stably 
transfected with DsRed at both 0.5 and 5 MOI (Fig. 7 A, lanes 2 
and 3) when compared with mock-infected cells (Fig. 7 A, lane 
I). In contrast, HCMV-induced hDaxx degradation in cells sta-
bly overexpressing hDaxx was only observed at higher MOis 
(Fig. 7A, lane 3) and not lower MOis (Fig. 7A, lane 2) when 
compared with mock-infected controls (Fig. 7A, lane 1). Simi-
larly, in RFP-hDaxx-expressing cells, only high titers of virus 
were able to result in degradation ofRFP-hDaxx or endogenous 
hDaxx in these cells (Fig. 7 B). 
Our ChIP analyses of the MIEP (Fig. 2) suggested that 
hDaxx-mediated repression of the IE gene expression could be 
associated with the known interaction of hDaxx with chroma-
tin-modifying enzymes, since the knockdown of hDaxx 
res ulted in a concomitant increase in the proportion of acety-
lated promoters following infection. Therefore, we reasoned 
that if hDaxx requires chromatin remodeling enzymes to 
repress the MIEP then inhibition of histone deacetylase activity 
co uld abrogate the abili ty of hDaxx to repress the MIEP. 
First, a polyclonal population of RFP-hDaxx cells was 
infected at an MOI of 0.2, and the level of infection was calcu-
lated in the red and nonred populations. As expected, - 15% of 
nonred cells (i.e. not overexpressing hDaxx) expressed IE72 
(F ig. 6D, bar 1) . In contrast, we observed that 0.3% of RFP-
hDaxx cells were expressing IE72 (Fig. 6D, bar 2) , entirely con-
sistent with data in Figs. 4, and 6. The same analysis was then 
performed on cells incubated with TSA prior to infec tion. Our 
analysis of the nonred cells showed that 60% of cells were 
infected and th us TSA itself induced a -4-fold increase in the 
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Dek (27, 38) based upon the phos-
phorylation status of hDaxx (27), 
and hDaxx is thought to recruit his -
tone deacetylases to sites of active 
transcription by direct interaction 
with the transcription machinery. 
Histone tails are subsequently 
deacetylated. Histone deacetylation 
then results in a closed chromatin 
structure and the repression of tran-
scription. Consistent with this, we 
observed that the HCMV MIEP was 
associated with dimethylated his-
tones following the infection of syn-
chronous cells. In hDaxx knock-
down cells, histones were still 
associated with the MIEP upon 
infection; however, there was an 
overt difference in the pattern of 
chromatinization of the MIEP such 
that the MIEP was predominantly 
associated with acetylated histones . 
Consistent with this, analysis of the 
levels of viral IE gene expression 
also showed that hDaxx knock-
FIG URE 6. U373 cells constitutively overexpressing RFP-hDaxx are refractory to infection with HCMV. 
A, U373 stablytransfected with DsRed (RFP) (a-c) or DsRed-hDaxx (RFP-hDaxx) (d-fand g-h) were infected with 
HCMV at an approximate MOI of 1. Cells were then stained with an anti-lE antibody (IE) (b-e). The arrows 
identify ce ll s overexpressing RFP-hDaxx in the appropriate panels. Alternative ly 6-8 h postinfection RFP-
hDaxx expressing (g) cell s were fixed and stained for pp65 expression (pp65) (h) . Hoechst 33342 staining was 
used to identify cell nuclei. 8, RFP- and RFP-hDaxx-expressing cells, infected with HCMV at an MOI of 1, were 
also stained for viral IE gene expression and analyzed by counting of representative fields; a min imum of 100 
ce ll s were counted from each of two independent experiments. The percentage of red cells (RFP- or RFP-
hDaxx-expressing cells) co-fluorescing green (IE-expressing cells) was quantified. The error bars represent S.D. 
C, U373 stably transfected w ith DsRed-hDaxx cells were also superinfected w ith HCMV at an MOI of 10 and 
analyzed as described in 8, above. 0 , a polyclonal population of RFP-hDaxx cells (20% expressing RFP-hDaxx) 
were incubated with control (lanes 7 and 2) orTSA (lanes 3 and 4) 18 h prior to infection. 24 h postinfection, the 
number ofRFP-hDaxx (lanes 2 and 4) and non-RFP-hDaxx cells (lanes 7 and 3) expressing IE72 was quantified by 
fluorescent microscopy. Error bars, 1 S.D. OMSO, Me250. 
down cells expressed considerably 
higher levels of viral major IE RNA 
and protein. 
Conversely, overexpressed hDaxx 
could inhibit viral IE gene expression 
after virus infection. Either wild-
type Daxx or RFP-Daxx when stably 
overexpressed in U373 cells was 
shown to localize predominantly to 
NDlO bodies. Both indirect immu-
nofluorescence and Western blot 
analysis showed that these cells 
overexpressing hDaxx were sub-
level of infection (Fig. 6D, bar 3), consistent with previous 
observations made during murine (36) and human4 CMV 
infection. Interestingly, however, 33% of RFP-hDaxx were also 
expressing 1£72, representative of a 100-fold increase in the 
level of permissiveness of the RFP-hDaxx cells (Fig. 6D, bar 4). 
Although the addition of TSA did result in a 4-fold increase in 
infection in nonred cells, this was modest compared with the 
effect on RFP-hDaxx cells (100-fold increase). Thus, these data 
support the hypothesis that the observed hDaxx mediated 
repression of the MIEP is regulated, at least in part, by chroma-
tin remodeling enzymes, since their inhibition with TSA 
co unters the effects of hDaxx overexpression. Furthermore, 
these data confirm that the RFP-hDaxx cells retain the capacity 
to be productively infected and are not irreversibly compro-
mised by RFP-hDaxx overexpression. 
DISCUSSION 
The hDaxx protein physically interacts with various proteins 
of the chromatin matrix, including histone deacetylase II, H2A, 
H2B, H3, and H4, and with the chromatin-associated protein 
37658 JOURNAL OF BIOLOGICAL CHEMISTRY 
stantially less able to support viral IE gene expression when 
infected at low multiplicities. This would be consistent with the 
proposed role of hDaxx as a promiscuous transcriptional 
repressor (38, 44-47), and when overexpressed, hDaxx would 
be present at high levels at NDlO, a location in close proximity 
to herpesvirus genome deposition (3, 4) . This hDaxx-mediated 
repression of viral IE gene expression was not due to an inability 
of cells to bind and internalize virus, since hDaxx superexpres-
sion did not affect upta)<e of HCMV tegument protein pp65. 
Furthermore, we could render these cells permissive for HCMV 
gene expression by infecting al higher MOls or by incubating 
the cells with TSA, confirming that these cells are not just a 
subpopulation of cells that are irreversibly refractory to HCMV 
infection. · 
Intriguingly, we saw no such inhibition of viral lE gene 
expression after superinfection when hDaxx was transiently 
overexpressed in cells. We are not sure how the functionality of 
hDaxx differs between cells thal are transiently expressing or 
stably overexpressing this prolein. However, il has been sug-
gested that hDaxx function can be profoundly affected by its 
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FIG URE 7. Western blot analysis of hDaxx protein expression in trans-
fected cells.A, cDNA3hDaxx stably transfected U373 cell s (tracks 7-3) or con-
trol DsRed stably transfected U373 ce ll s (tracks 4-6) were left uninfected 
(mock) or infected at MO ls of 0.5 or 5 for 6 hand analyzed by Western blot for 
hDaxx expression. 8, DsRed-hDaxx stably transfected U373 ce ll s expre ss ing 
RFP-hDaxx were left uninfected (mock ) or infected at MOls of 0.5 or 5 for 6 h 
and analyzed by Western blot for h Daxx expression. The arrows designate 
endogenous Daxx- and RFP-tagged Daxx. 
location (48) and in particular whether it is free or NDlO-asso-
ciated. We note that transiently overexpressed hDaxx only 
res ulted in association of the protein with NDlO structures 
infrequently, and it is possible that this may explain the activa-
tion of the MIEP by hDaxx observed using transient co-trans-
fection assays (23). We are presently investigating the differ-
ences between t ransiently and stably overexpressed hDaxx in 
transfected cells but note that even cells expressing transiently 
transfected hDaxx at low levels, in which hDaxx does co- local-
ize with NDlO, do not show repression of viral IE gene expres-
sion (data not shown). Indeed, a recent study that looked at the 
effect of PML knock-down on HCMV infection showed t hat IE 
gene expression was elevated in these cells (22). In these ce lls, 
ND10 bodies are absent due to the degradation of PML, and 
thus, hDaxx remained diffuse throughout the cells. Although 
these data show a role for PML in the regulation of IE gene 
expression, they also suggest that the availability of co-factors 
and localization of hDaxx may be important for determining its 
repressive function on the MIEP. 
Our experiments also indicated that repression of HCMV IE 
gene expression by stable overexpres_sion of hDaxx could be 
overcome by increasing HCMV titers. Whether this titration of 
Daxx-mediated inhibition by increas ing virus titers is mediated 
by viral structural proteins or simply increasing copy number of 
vira l genomes will require further investigation. However, the 
pp71 tegument protein of HCMV, encoded by UL82, interacts 
with hDaxx (23), and this interaction is important for efficient 
IE gene expression and viral replication (25, 49, 50). Recently, it 
has also been reported that pp71 mediates the transient protea-
somal degradation of hDaxx, leading to increased IE expression 
(26). The authors suggest that degradation cif hDaxx by pp71 
plays a profound role in regulation of viral IE gene expression. 
In this study, we show that cells stably overexpressing hDaxx 
are refractory to infection at an MOI of 1, a titer of virus that 
would normally result in 60% of cells infected. Since one con-
DECEMBER 8, 2006• VOLUME 281 ·NUMBER 49 
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sequence of infection is the transient degradation of endoge-
nous hDaxx between 3 and 12 h of infection (26), this suggests 
that, in cells overexpressing hDaxx or RFP-hDaxx, the incom-
ing pp71 tegument pro tein is unable to overcome this stable 
overexpression of hDaxx. However, our observa tions that over-
expressed hDaxx or RFP-hDaxx degradation does occur at 
higher MOis suggest that this effect of overexpression hDaxx is 
not d'ue to an intrinsic inability of overexpressed hDaxx to be 
degraded by pp71. 
Our siRNA knock-down data also argue that t he presence of 
hDaxx prior to the onset of its degradation by pp71, which 
starts at 2-3 h postinfection (26), as well as when it returns to 
wild-type levels at 12-24 h postinfection (49) still has profo und 
effects on the level of IE gene expression despite the pp71-
mediated transient degradation of endogenous hDaxx; specifi-
cally, we observe that even in the presence of pp71, inhibition of 
hDaxx expression prior to infectio n h as profound effects on IE 
gene expression. Clearly, the presence of hDaxx in the cells 
within the first 2-3 h of infection, prior to its degradation by 
pp 71, has an immediate effect at the chromatin level on the viral 
MIEP consistent with established interactions between hDaxx and 
repressive components of higher order chromatin structure for-
mation (27). Indeed, we observed that the observed repression of 
the MIEP by hDaxx in these cells was alleviated by the addition of 
TSA, suggesting that chromatin remodeling enzymes are in an 
important factor in hDaxx repression of 1E gene expression. Con-
sequently, the knock-down ofhDaxx prior to infection could result 
in the establishment of a chromatin structure around the MIEP 
that is more conducive to transcriptional activation prior to any 
delivery of pp71. Similarly, maintaining a knock-down of hDaxx 
expression by siRNA until later than 24 h postinfection (the time 
by which pp71-mediated degradation of hDaxx no longer occurs 
and hDaxx returns to wild-type levels) also profoundly increased 
IE gene expression in our study. Thus, it is likely that HCMV needs 
to employ multiple mechanisms over the immediate early time 
course of infection to overcome the intrinsic repression mediated 
by hDaxx; this probably a_lso includes ND10 disruption by IE72 (6, 
21, 22). 
hDaxx then appears to act as an intrinsic inhibitor of effi cient 
viral IE gene expression, which is mediated by packaging of the 
viral genome into a transcriptionally repressive chromatin state 
almost immediately upon infection, but this repressive function 
of hDaxx can be partially "overcome" by incoming viral factors, 
such as pp 71, and is probably augmented by de novo expression 
of IE72 as the infection proceeds. During the course of this 
work, Preston and Nicholl (51) reported that siRNA knock-
down of hDaxx res ults in increased IE expression after HCMV 
infection but only in the absence of incoming pp71 (using a 
pp71 deletion mutant). We are not sure why this discrepancy 
exists between our observations and theirs, but we note that, in 
co ntrast to our use of transiently siRNA transfected primary 
fibroblast cells, which vir tually eliminated endogenous hDaxx 
(see Fig. IA), they used G41W-selected clones of immortalized 
U373 cells stably transfected with siRNA constructs in which 
endogeno us hDaxx needed to be further reduced by a subse-
quent transfection protocol. 
It would appear that the imposition of a transcriptionally 
inactive chromatin structure on the HCMV MIEP immediately 
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upon infection would be intrins ically unfavorable for the virus. 
However, herpesvirus gene expression is classically regulated in 
a tempora l cascade, and this may be achieved, in part, using 
dynamic chromatin structure, a chrornatin structure that is 
imparted on the incoming viral genome immediately upon 
infection. Similarly, if chromatinization of the viral MIEP into a 
more repressive structure occurs preferentially under cellular 
co nditions that are suboptimal for replication, this may provide 
the virus an opportunity to synchronize its phase of IE gene 
expression to when the cellular conditions are more favorable. 
For example, cells t hat have progressed into late S phase do not 
appear to be conducive to vira l IE express ion, and viral replica-
tion does not occur until the cell cycle returns back into G1/S 
phase, when the cell is believed to be an optimal environment 
for viral DNA replication (52). One possibility is that the virus 
utilizes chromatin structure to temporarily repress viral gene 
expression until the environment is more favorable for 
replication. 
Given the dynamic nature of NDIO and NDlO components, 
it is likely that they may have a number of roles in infection, 
some supportive and others repressive. Most human herpesvi-
ruses have evolved mechanisms to disperse or destroy NDIO 
during the IE phase of the lytic cycle. A model in which NDlO 
functions in a repressive role prior to IE gene expression but in 
which their components then become beneficial to viral repli-
cation once released from the ND l O structure might explain 
such apparent contradictions in the literature. Indeed, it has 
been noted that infection of NDlO-deficient cells with HCMV 
promotes the formation of rudimentary NDlO-like structures 
of hDaxx and Spl 00 (22). Further experimental approaches that 
critically examine specific NDIO-virus interactions are 
required to clarify their ro le in virus infection. 
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